Winl' .. ' ‘ " ‘H‘tr:3li1=ng=-» -' " ' " I " "H usnmv . Puauc HEALI N0. 934 DEC 01 ‘ 1993 URRE NT UNIVERSITY OF CALIF. BERKEiEY EILEC® GRAPHEE S Morbidity and Mortality of Dialysis January 1991 through August 1993 National Library of Medicine 2115 Citations NATIONAL INSTITUTES OF HEALTH 0 National Library of Medicine guaug HEALYH LIBRARY -\ 34 x K t t“! Y ‘ LIBRARY . umveasmov‘ \_ cmvomm CBM 93-4 Morbidity and Mortality of Dialysis January 1991 through August 1993 21 15 Citations Prepared by Martha H. Glock, M.L.S., National Library of Medicine Willis R. Foster, M.D., Benjamin T. Burton, Ph.D., and M. James Scherbenske, Ph.D., National Institute of Diabetes and Digestive and Kidney Diseases US. DEPARTMENT OF HEALTH AND HUMAN SERVICES Public Health Service National Institutes of Health National Library of Medicine Reference Section 8600 Rockville Pike Bethesda, Maryland 20894 1993 Marmidity afid martalitv j} 341% a 3 National Library of Medicine Cataloging in Publiwtion iggi thrflflfifi ~i. . . .L. ' " .——- —.—. m. Hugmau $17" psupmimd 5 Md" {5% U i ' . V1x2”. and Human Servicegn L! "‘3" Via '5— t 5 «:1! , F7. 3 C! I" "1' EMS? Rackvil m 1 i HIE Libr Ty mf Suctla 7.: ‘~ ... . .' 1"" ~... m V". —. I 1'“ _‘ ' 3 :0 'J by the EULA... CIT .{JCIC’Ltz-n :2 Ls.-::-. L1..~ a E w- {Current bibiiographiea in medicin. Quailable from NLM at no cost thrxugh Intwrmat 1. Bialysis ~ adverae affec ~ biblimgraphy 3. Mortaiifi Factara M bibliagraghy I Library of flmdicine iU.5n f'“ ---I BE“; .LE‘E- ~.,.r EH 1 KEVE no @3-4 a Cit. NO. 9314?31 SERIES NOTE Current Bibliographies in Medicine (CBM) is a continuation in part of the National Library of Medicine’s Literature Search Series, which ceased in 1987 with No. 87 -15 . In 1989 it also subsumed the Specialized Bibliography Series. Each bibliography in the new series covers a distinct subject area of biomedicine and is intended to fulfill a current awareness function. Citations are usually derived from searching a variety of online databases. NLM databases utilized include MEDLINE', AVLINE', BlOETHICSLINE', CAN CERLIT', CATLINE', HEALTH, POPLINE" and TOXLINE'. The only criterion for the inclusion of a particular published work is its relevance to the topic being presented; the format, ownership, or location of the material is not considered. Comments and suggestions on this series may be addressed to: Karen Patrias, Editor Current Bibliographies in Medicine Reference Section National Library of Medicine Bethesda, MD 20894 Phone: 301-496-6097 Fax: 301-402—1384 Internet: patrias@nlm.nih. gov Ordering Information: Current Bibliographies in Medicine is sold by the Superintendent of Documents, U. S. Government Printing Office, P.O. 371954, Pittsburgh, PA 15250-7954. To order the entire CBM series for calendar year 1993 (approximately 7 bibliographies), send $24.00 ($30.00 foreign) to the Superintendent of Documents citing GPO List ID: CBM93. For your convenience an order blank is given inside the back cover. Orders for individual bibliographies in the series ($3.50, $4.38 foreign) should be sent to the Superintendent of Documents citing the title CBM number and the GPO List ID given above. Internet Access: The Current Bibliographies in Medicine series is also available at no cost to anyone with Internet access through FTP (File Transfer Protocol). FTP to nlmpubs.nlm.nih.gov and login: as nlmpubs. The index file in the "bibs" directory provides information on the bibliographies available. Use of funds for printing this periodical has been approved by the Director of the Qfi‘ice of Management and Budget through September 30, 1993. iii MORBIDITY AND MORTALITY OF DIALYSIS Each year, increasing numbers of people with irreversible end stage renal failure are treated under the United States Medicare ESRD (End-Stage Renal Disease) programs. Contributing to an increase in the overall size of the national ESRD program is the increased acceptance of patients, a greater incidence among older Americans, and an improvement in the survival of patients with ESRD. For example, during 1990 more than 195,000 Americans were treated for end-stage renal disease under the Medicare program. There has been a small but significant improvement in survival in the dialytic population, first seen over the period of 1988-89 and which has continued over 1989-90. Because of the continuing interest in the adequacy of dialysis therapy and its impact on mortality, this trend is of particular importance to the renal community. The question of what constitutes an adequate dialysis dose, however, remains a very controversial issue among renal care professionals. This bibliography was prepared in support of the National Institutes of Health Consensus Development Conference titled Morbidity and Mortality of Dialysis convened in Bethesda, Maryland on November 1-3, 1993. The purpose of the Conference was to examine all of the relevant data concerning the delivery of maintenance dialysis and the management of associated life—threatening complications. The citations were selected to cover various aspects of dialysis, including dialysis complications, co-morbidity, adequacy, and causes and prevention. The bibliography consists primarily of English language journal articles from January 1991 through August 1993. The 2115 citations included were individually selected from a total of 5419 generated by a search of the literature. In general, books, case reports, letters and editorials have been excluded. Arrangement of the bibliography is by subject. The four main categories are: Causes and Prevention of Morbidity and Mortality, including data on risk factors, role of nutrition, data on outcomes; Adequacy of Dialysis: Access and Dose, including catheter and membrane studies, hemodynamics and factors affecting blood flow and volume; Co-Morbidity; and Complications of Dialysis, including pre—existing, and other non-dialytic morbidity, especially cardiovascular, diabetic and parathyroid conditions. Within each category, references to controlled clinical trials have been separated out and are listed first. A citation may appear in more than one category. SEARCH STRATEGY A variety of online databases are usually searched in preparing bibliographies in the CBM series. To assist you in updating or otherwise manipulating the material in this search, the strategy used for the NLM’s MEDLINE database is given below. Please note that the search strategies presented here differ from individual demand searches in that they are generally broadly formulated and irrelevant citations edited out prior to printing. SS 1 = SUBS APPLY AE, CO, IS, ME, TD, PX, UT SS 1 = EXPLODE HEMODIALYSIS SS 2 = SUBS CANCEL SS 2 = EXPLODE HEMODIALYSIS SS 3 = 2 AND MORTALITY (SH) OR 2 AND MORBIDITY OR 2 AND COMPLICATIONS (SH) OR 2 AND CONTRAINDICATIONS (SH) OR 2 AND IATROGENIC (TW) OR 2 AND QUALITY OF LIFE SS 4 = VENOUS (TW) AND ACCESS (TW) OR VASCULAR (TW) AND ACCESS (TW) SS 5 = 2 AND 4 ' SS 6 = HEMODIALYSIS (TF) OR PERITONEAL (TF) AND DIALYSIS (TF) SS 7 = 2 AND 6 SS 8 = 7 AND KIDNEY FAILURE OR 7 AND KIDNEY FAILURE, CHRONIC OR 7 AND PREDIALYSIS (TW) OR 7 AND CATHETERS, INDWELLING OR 7 AND EXPLODE CATHETERIZATTON OR 7 AND EXPLODE OUTCOME ASSESSMENT SS 9 = CATHETERS, INDWELLING AND BALLOON ANGIOPLASTY SS 10 = SUBS APPLY AE, TO SS 10 = DIALYSIS SOLUTIONS SS 11 SUBS CANCEL SSII 10R3OR50R80R90R10 GRATEFUL MED“ To make online searching easier and more efficient, the Library offers GRATEFUL MED, microcomputer- based software that provides a user—friendly interface to most NLM databases. This software was specifically developed for health professionals and features multiple choice menus and "fill in the blank" screens for easy search preparation. GRATEFUL MED runs on an IBM PC (or IBM-compatible) with DOS 2.0 or a Macintosh, and requires a Hayes (or Hayes-compatible) modem. It may be purchased from the National Technical Information Service in Springfield, Virginia, for $29.95 (plus $3.00 per order for shipping). For your convenience, an order blank has been enclosed at the back of this bibliography. vi SANIPLE CITATION Citations in this bibliographic series are formatted according to the rules established for Index Medicus'*. A sample journal citation appears below. Journal Article: Authors Article Title ,/ \ Rubin J, Hsu H. Continuous ambulatory peritoneal dialysis: ten years at one facility. Am J Kidney myl Feb;l7(2):165-9. Abbreviated Journal Date Volume Issue Pages Title *For details of the formats used for references, see the following publication: Patrias, Karen. National Library of Medicine recommended formats for bibliographic citation. Bethesda (MD): The library; 1991 Apr. Available from: N'I'IS, Springfield, VA; PB9l-182030. vii TABLE OF CONTENTS CAUSES AND PREVENTION OF MORBIDITY AND MORTALITY Data on Risk Factors Clinical Trials Other The Role of Nutrition Clinical Trial Other Data on Outcomes Clinical Trial Other ADEQUACY OF DIALYSIS: ACCESS AND DOSE Clinical Trials Other CO-MORBIDITY Clinical Trials Other COMPLICATIONS OF DIALYSIS Anemia and Erythropoietin Clinical Trials Other Peritonitis Clinical Trials Other Other Dialysis-Related Problems Clinical Trials Other ix page 29 54 54 65 66 76 76 CAUSES AND PREVENTION OF MORBIDITY AND MORTALITY Data on Risk Factors -Clinical Trials Himmelfarb J, Zaoui P, Hakim R. Modulation of granulocyte LAM-1 and MAC-1 during dialysis--a prospective, randomized controlled trial. Kidney Int 1992 Feb;41(2):388-95. Kramer BK, Pickert A, Hohmann C, Liebich HM, Muller GA, Hablitzel M, Risler T. In vivo clearance and elimination of nine marker substances during hemofiltration with different membranes. Int J Artif Organs 1992 Jul;15(7):408-12. Nurmohamed MT, ten Cate J , Stevens P, Hock J A, Lins RL, ten Cate J W. Long-term efficacy and safety of a low molecular weight heparin in chronic hemodialysis patients. A comparison with standard heparin. ASAIO Trans 1991 Jul-Sep;37(3): M459-61. Ring T, Nielsen C, Andersen SP, Behrens JK, Sodemann B, Kornerup HJ. Calcium acetate versus calcium carbonate as phosphorus binders in patients on chronic haemodialysis: a controlled study. Nephrol Dial Transplant 1993;8(4):341-6. Salusky IB, Foley J, Nelson P, Goodman WG. Aluminum accumulation during treatment with aluminum hydroxide and dialysis in children and young adults with chronic renal disease. N Engl J Med 1991 Feb 21;324(8):527-31. Comment in: N Engl J Med 1991 Feb 21;324(8):558-9; N Engl J Med 1991 Jul 18;325(3):208-9. Schiffl H, Strasser T. Hemodialysis-related leukotriene B4 generation and neutropenia during calcium channel blockade. Biomater Artif Cells Immobilization Biotechnol 1991;19(1):85-96. Stegmayr BG, Esbensen K, Gutierrez A, Lundberg L, Nielsen B, Stroemsaeter CE, Wehle B. Granulocyte elastase, beta-thromboglobulin, and C3d during acetate or bicarbonate hemodialysis with Hemophan compared to a cellulose acetate membrane. Int J Artif Organs 1992 Jan;15(1):10—8. Zaoui P, Green W, Hakim RM. Hemodialysis with cuprophane membrane modulates interleukin-2 receptor expression. Kidney Int 1991 May;39(5): 1020-6. -0ther Acchiardo SR, Runyan K, Hatten KW, Dyson B, Fuller J, Moore L. Impact of Kt-V and protein catabolic rate (PCR) on hemodialysis (HD) mortality [abstract]. J Am Soc Nephrol 1992;3(3):351. 1 Akiba T, Tachibana K, Ozawa K, Chida Y, Ogasawara H, Yoshiyama N, Hoshino M, Inada T, Marumo F. Long-term use of low molecular weight heparin ameliorates hyperlipidemia in patients on hemodialysis. ASAIO J 1992 Jul-Sep;38(3): M326-30. Anwar N, Bhatnagar D, Short CD, Mackness MI, Durrington PN, Prais H, Gokal R. Serum lipoprotein (a) concentrations in patients undergoing continuous ambulatory peritoneal dialysis. Nephrol Dial Transplant 1993;8(1):71-4. Attman PO, Alaupovic P. Lipid and apolipoprotein profiles of uremic dyslipoproteinemia—-relation to renal function and dialysis. Nephron 1991;57(4): 401-10. Attman PO, Knight-Gibson C, Tavella M, Samuelsson O, Alaupovic P. Increased concentrations of Apo B- containing triglyceride-rich lipoprotein particles in patients with chronic renal failure. Miner Electrolyte Metab 1992;18(2-5):199-202. Avram MM, Goldwasser P, Burrell DE, Antignani A, Fein PA, Mittman N. The uremic dyslipidemia: a cross-sectional and longitudinal study. Am J Kidney Dis 1992 Oct;20(4):324—35. Baris E, McGregor M. The reuse of hemodialyzers: an assessment of safety and potential savings. Can Med Assoc J 1993 Jan 15;148(2):175-83. Published erratum appears in Can Med Assoc J 1993 Apr 15; 148(8):1278. Bednar B. Hemodialysis monitoring and evaluation of therapy: review of clinical indicators and use of data collection tools. ANNA J 1991 Jun;18(3): 280-3. Betjes MG, Tuk CW, Struijk DG, Krediet RT, Arisz L, Hoefsmit EC, Beelen RH. Immuno—effector characteristics of peritoneal cells during CAPD treatment: a longitudinal study. Kidney Int 1993 Mar;43(3):641-8. Boje Rasmussen H, Teisner B, Bangsgaard-Petersen F, Yde—Andersen E, Kassem M. Quantification of fetal antigen 2 (FA2) in supematants of cultured osteoblasts, normal human serum, and serum from patients with chronic renal failure. Nephrol Dial Transplant 1992;7(9):902-7. Brunner FP, Selwood NH. Profile of patients on RRT in Europe and death rates due to major causes of death groups. The EDTA Registration Committee. Kidney Int Suppl 1992 Oct;38:S4-15. Burrell DE, Antignani A, Goldwasser P, Mittman N, Fein PA, Slater PA, Gan A, Avram MM. Lipid abnormalities in black renal patients. N Y State J Med 1991 May;91(5):192—6. 2 Carney SL. Ionized calcium concentration in maintenance hemodialysis patients. Clin Nephrol 1992 Sep;38(3):167-70. Caruana RJ, Leffell MS, Lobel SA, Campbell HT, Cheek PL. Chronic T—lymphocyte activation in chronic renal failure: a study of hemodialysiI, CAPD and pre-dialysis patientI. Int J Artif Organs 1992 Feb;15(2):93-8. Castellano M, Turconi A, Chaler E, Rivarola MA, Belgorosky A. Hypothalamic-pituitary-gonadal function in prepubertal boys and girls with chronic renal failure. J Pediatr 1993 Jan;122(1):46-51. Cavaillon JM, Poignet JL, Fitting C, Delons S. Serum interleukin-6 in long-term hemodialyzed patients. Nephron 1992;60(3):307-13. Chazan JA, Lew NL, Lowrie EG. Increased serum aluminum. An independent risk factor for mortality in patients undergoing long-term hemodialysis. Arch Intern Med 1991 Feb;151(2):319—22. Chazan JA, London MR, Pono L. Markedly elevated BUN is not correlated with increased morbidity and mortality in a large chronic hemodialysis population. Dial Transplant l991;20(9):547-50. Chen WT, Yamaoka K, Nakajima S, Tanaka Y, Yamamoto T, Satomura K, Okada S, Seino Y. Evaluation of vitamin D-binding protein and vitamin D metabolite loss in children on continuous ambulatory peritoneal dialysis. Bone Miner 1992 Jun;17(3):389-98. Chew SL, Lina RL, Daelemans R, Zachee P, De Clerck LS, Vermylen I. Are antiphospholipid antibodies clinically relevant in dialysis patients? Nephrol Dial Transplant 1992;7(12):1194-8. Christ F, Weidel S, Mcintyre K, Jameson T, Kox WJ, Gamble J. Changes in colloid osmotic pressure (COP) during continuous veno-venous or arteriovenous hemodialysis (CVVI-lD—CAVHD) in man. J Physiol (Camb) 1991;438:1-58. Christensen AJ, Smith TW, Turner CW, Holman J M Jr, Gregory MC, Rich MA. Family support, physical impairment, and adherence in hemodialysis: an investigation of main and buffering effects. J Behav Med 1992 Aug;15(4):313-25. Christensen AJ, Turner CW, Smith TW, Holman JM Jr, Gregory MC. Health locus of control and depression in end-stage renal disease. J Consult Clin Psychol 1991 Jun;59(3):419-24. ChriItenson M, Fivush B, Racusen L. Safety of intraperitoneal calcium therapy in a rodent model. Adv Perit Dial l992;8:15-7. Coburn JW, Mischel MG, Goodman WG, Salusky IB. Calcium citrate markedly enhances aluminum absorption from aluminum hydroxide. Am J Kidney Dis 1991 Jun;17(6):708-11. Coburn JW, Salusky IB, Norris KC, Goodman WG. Oral and parenteral calcitriol for the management of end-stage renal disease. Contrib Nephrol 1991;90: 166-82. Coen G, Mazzaferro S, Ballanti P, Bonucci E, Bondatti F, Pasquali M, Perruzza I, Manni M, Sardella D. Plasma insulin-like growth factor-1 and bone formation parameters in predialysis chronic renal failure. Miner Electrolyte Metab 1991;17(3):153-9. Cohen B, Kagan L, Richter B, Topor M, Saveedra M. Children’s compliance to dialyIis. Pediatr Nurs 1991 Jul-Aug;17(4):359-65, 420. Cohen-Solal ME, Sebert JL, Boudailliez B, Westeel PF, Moriniere PH, Marie A, Garabedian M, Fournier A. Non-aluminic adynamic bone disease in non- dialyzed uremic patients: a new type of osteopathy due to overtreatment? Bone 1992;13(l):1-5. Craven J, Littlefield C, Rodin G, Murray M. The Endstage Renal Disease Severity Index (ESRD—SI). Psychol Med 1991 Feb;21(l):237—43. Cressman MD, Heyka RJ, Paganini EP, O’Neil J, SkibinIki CI, Hoff HF. Lipoprotein (a) is an independent risk factor for cardiovascular disease in hemodialysis patients. Circulation 1992 Aug;86(2): 475-82. Cressman MD, Hoff HF, Nally JV Jr, Schreiber M Jr, Van Lente F. Lipoprotein a and the cardiovascular risk of end stage renal disease [abstract]. J Am Soc Nephrol 199l;2(3):234. Cristal JP, Canaud B, Damon M, Chavis C, Amoux B, Mion C. Platelet-activating factor production during hemodialysis: effect of BN 52021. Prostaglandins Leukot Essent Fatty Acids 1992 Jan;45(1):37-42. Crum R, Fairchild R, Bronsther 0, Dominic W, Ward D, Fernandez R, Brown MR. Neuroendocrinology of chronic renal failure and renal transplantation. Transplantation 1991 Nov;52(5):818-23. Cunningham J, Beer J, Coldwell RD, Noonan K, Sawyer N, Makin H]... DialyIate calcium reduction in CAPD patients treated with calcium carbonate and alfacalcidol. Nephrol Dial Transplant 1992; 7(1):63-8. Dagogo-Jack S, Rodger RS, Kendall-Taylor P. Increased salivary concentration of human epidermal growth factor in patients undergoing CAPD. Perit Dial Int 1991;11(3):270-3. de Chatel R, Mako J, Toth M, Barna I, Lang RE. Atrial natriuretic peptide (ANP) in patients with chronic renal failure on maintenance haemodialysis. Int Urol Nephrol l991;23(2):177—83. D’Elia JA, Weinrauch LA, Gleason RE, DeSilva RA, Nesto RW. Preliminary screening of the relationship of serum lipids to survival of chronic dialysis patients. Ren Fail 1993;15(2):203-9. Deray G, Carayon A, Maistre G, Benhmida M, Masson F, Barthelemy C, Petitclerc T, Jacobs C. Endothelin in chronic renal failure. Nephrol Dial Transplant 1992;7(4):300-5. Diaz RJ, Washbum S, Cauble L, Siskind MS, Van Wyck D. The effect of dialyzer reprocessing on performance and beta 2-microglobulin removal using polysulfone membranes. Am J Kidney Dis 1993 Apr;21(4):405-10. Dieplinger H, Lobentanz EM, Konig P, Graf H, Sandholzer C, Matthys E, Rosseneu M, Utermann G. Plasma apolipoprotein A-IV metabolism in patients with chronic renal disease. Eur J Clin Invest 1992 Mar;22(3):166-74. Dilena BA, White GH. Assessing acute parathyroid responsiveness in hemodialysis patients by measuring intact parathyrin in pre and post-dialysis serum. Clin Chem 1991 Jul;37(7):1216-20. Dinarello CA. Interleukin—1 and tumor necrosis factor and their naturally occurring antagonists during hemodialysis. Kidney Int Suppl 1992;38:868-77. Direskeneli H, Ozgun S, Ozener C, Lawrence R, Errnan M, Sarsmaz N, Akoglu E. Anti-lymphocyte, anti-monocyte, and anti-endothelial cell antibodies in chronic haemodialysis patients. Nephrol Dial Transplant 1992;7(5):422—6. Djordjevic VB, Strahinjic S, Koracevic D, Miljkovic P, Djordjevic V, Pavlovic D, Stefanovic V. Erythrocyte delta-aminolevulinate dehydratase measurements in Balkan endemic nephropathy. Kidney Int Suppl 1991;34:893-6. Domingo JL, Gomez M, Llobet JM, Corbella J. Influence of some dietary constituents on aluminum absorption and retention in rats. Kidney Int 1991; 39(4):598-601. Donati D, Degiannis D, Combates N, Raskova J, Raska K Jr. Effects of hemodialysis on activation of lymphocytes: analysis by an in vitro dialysis model. J Am Soc Nephrol 1992 Apr;2(10):1490-7. Donati D, Degiannis D, Combates N, Raskova J, Raska K Jr. Evidence of mononuclear cell activation by hemodialysis. ASAIO Trans 1991 Jul-Sep;37(3): M386—7. Donati D, Degiannis D, Homer L, Gastaldi L, Raskova J, Raska K Jr. Immune deficiency in uremia: interleukin-2 production and responsiveness and interleukin-2 receptor expression and release. Nephron 1991;58(3):268-75. 3 Donati D, Degiannis D, Homer L, Raska K, Raskova J. Interleukin-1 kinetics in hemodialysis. ASAIO Trans 1991 Jul-Sep;37(3):M39l-2. Donati D, Degiannis D, Homer L, Raska K Jr, Raskova J. Production and kinetics of interleukin-1 in hemodialysis. In vivo and in vitro study. Am J Nephrol 1991;11(6):451-8. Donnelly PK, Burwell N, McBumey A, Ward J W, Walls J, Watkin EM. Clearance of iopamidol, a non-ionic contrast medium, by CAPD in patients with end-stage renal failure. Br J Radiol 1992 Dec; 65(780):1108-l3. Donnelly SM, Ali MA, Churchill DN. Effect of n-3 fatty acids from fish oil on hemostasis, blood pressure, and lipid profile of dialysis patients. J Am Soc Nephrol 1992 May;2(l 1):1634-9. Donovan'KL, Pacholok S, Phillips A, Humes JL, Coles GA, Williams JD. Effect of dialyser composition and reuse on neutrophil count and elastase alpha-1 proteinase inhibitor complex formation. Int J Artif Organs 1992 Mar;15(3):139-43. Douvdevani A, Rapoport J, Konforti A, Zlotnik M, Chaimovitz C. The effect of peritoneal dialysis fluid on the release of IL-1 beta and TNF alpha by macrophages/monocytes. Perit Dial Int 1993;13(2): 112-7. Duer D, Pimmel P, Baretto S, Caillette A, Labeeuw M, Baverel G, Zech P. 31P NMR spectroscopy investigation of muscle metabolism in hemodialysis patients. Kidney Int 1993 Apr;43(4): 885-92. Dzurik R, Lajdova I, Spustova V, Opatrny K Jr. Pseudouridine excretion in healthy subjects and its accumulation in renal failure. Nephron 1992;61(1): 64-7. Eisenhauer T, Muller U, Schuff-Wemer P, Armstrong VW, Bosch T, Thiery J, Gurland H, Seidel D. Simultaneous heparin extracorporeal LDL precipitation and hemodialysis. First clinical experience. ASAIO Trans 1991 Jul-Sep;37(3): M494F6. El-Saaran A, Kader O, Gamil F, Sadek SA. Immunological alterations associated with end-stage renal disease. J Med Res Inst l991;12(4):39—57. Elisaf MS, Dardamanis MA, Papagalanis ND, Siamopoulos KC. Lipid abnormalities in chronic uremic patients. Response to treatment with gemfibrozil. Scand J Urol Nephrol 1993;27(1): 101-8. Emmett M, Sirmon MD, Kirkpatrick WG, Nolan CR, Schmitt GW, Cleveland MB. Calcium acetate control of serum phosphorus in hemodialysis patients. Am J Kidney Dis 1991 May;l7(5):544-50. 4 Emoto M, Tabata T, lnoue T, Nishizawa Y, Morii H. Plasma 1,5-anhydroglucitol concentration in patients with end-stage renal disease with and without diabetes mellitus. Nephron 1992;61(2):181-6. Espana F, Gilabert J, Vicente V, Estelles A, Vazquez L, Hendl S, Aznar J. Activated protein C: alpha 1- antitrypsin (APC: alpha 1 AT) complex as a marker for in vitro diagnosis of prethrombotic states. Thromb Res 1992 Jun 1;66(5):499-508. Evans RC, Holmes CJ. In vitro study of the transfer of cytokine—inducing substances across selected high- flux hemodialysis membranes. Blood Purif 1991; 9(2):92—101. Fellner SK, Lang RM, Neumann A, Bushinsky DA, Borow KM. Parathyroid hormone and myocardial performance in dialysis patients. Am J Kidney Dis 1991 Sep;18(3):320—5. Felsenfeld AJ, Ross D, Rodriguez M. Hysteresis of the parathyroid hormone response to hypocalcemia in hemodialysis patients with low turnover aluminum bone disease. J Am Soc Nephrol 1991 Dec;2(6): 1136-43. Feriani M, Kimmel PL, Kurantsin—Mills J, Bosch JP. Effect of renal replacement therapy on viscosity in end-stage renal disease patients. Am J Kidney Dis 1992 Feb;19(2):131-9. Fernandez JM, Carbonell ME, Mazzuchi N, Petruccelli D. Simultaneous analysis of morbidity and mortality factors in chronic hemodialysis patients. Kidney Int 1992 Apr;41(4):1029—34. Fervenza FC, Meredith D, Ellory J C, Hendry BM. Abnormal erythrocyte choline transport in patients with chronic renal failure. Clin Sci 1991 Feb;80(2): 137-41. Feussner G, Wey S, Bommer J, Deppermann D, Grutzmacher P, Ziegler R. Apolipoprotein E phenotypes and hyperlipidemia in patients under maintenance hemodialysis. Hum Genet 1992 Jan; 88(3):307-12. Fine A, Cox D. Modest reduction of serum albumin in continuous ambulatory peritoneal dialysis patients is common and of no apparent clinical consequence. Am J Kidney Dis 1992 Ju1;20(1):50-4. Comment in: Am J Kidney Dis 1992 Ju1;20(1):76-7. Fischbach M, Hamel G, Simeoni U, Geisert J. Phosphate dialytic removal: enhancement of phosphate cellular clearance by biofiltration (with acetate-free buffer dialysate). Nephron 1992;62(2): 155-60. Fleming LW, Stewart WK, Parratt D. Dextran antibodies, complement conversion and circulating immune complexes after intravenous iron dextran therapy in dialysed patients. Nephrol Dial Transplant 1992;7(1):35—9. Fleming SJ, Foreman K, Shanley K, Mihrshahi R, Siskind V. Dialyser reprocessing with Renalin. Am J Nephrol 1991;11(1):27-31. Fluck RJ, McMahon AC, Alameddine FM, Dawnay AB, Baker LR, Raine AB. Platelet cytosolic free calcium concentration and parathyroid hormone: changing relationships with haemodialysis in end- stage renal disease. Clin Sci 1992 Jun;82(6):651-8. Fournier A, MoriniBere P, Ben Hamida F, e1 Esjer N, Shenovda M, Ghazali A, Bouzernidj M, Achard JM, Westeel PF. Use of alkaline calcium salts as phosphate binder in uremic patients. Kidney Int Suppl 1992 0ct;38:SSO—61. Freedman BI, Spray BJ, Tuttle AB, Buckalew VM Jr. The familial risk of end-stage renal disease in African Americans. Am J Kidney Dis 1993;21(4): 387-93. Fruits RG, Kinney R, Hegeman T. Maintaining iron balance by decreasing blood loss. ANNA J 1992 Apr;19(2):156. Furlong T, Chan YL, Cornish C, McDowall D, Mahony J, Clifton-Bligh P. Immunoreactive serum calcitonin and skeletal histology in chronic renal failure. Nephron 1991;58(2):138-43. Gafter U, Malachi T, Barak H, Levi J. Red blood cell calcium level is elevated in women: enhanced calcium influx by estrogens. J Lab Clin Med 1993 Mar;121(3):486-92. Gal G, Kiss E, Foldes I, Dombi A. Disinfection of regenerated dialyzers with ozone. Int J Artif Organs 1992 Aug;15(8):461-4. Gamaas KR, Windebank AJ, Blexrud MD, Kurtz SB. Ultrastructural changes produced in dorsal root ganglia in vitro by exposure to ethylene oxide from hemodialyzers. J Neuropathol Exp Neurol 1991 May;50(3):256-62. Garnero P, Grimaux M, Dcmiaux B, Preaudat C, Seguin P, Delmas PD. Measurement of serum osteocalcin with a human-specific two-site immunoradiometric assay. J Bone Miner Res 1992 Dec;7(12):1389-98. Gault MH, Vasdev SC, Longerich I, Purchase L, Sampon C, Johnson E. Heparin, fatty acids and sodium, potassium-ATPase inhibition by plasma factors during hemodialysis. Nephron 1992;60(3): 292-301. Gelder FB, McDonald JC, Landreneau MD, McMillan RM, Aultman DF. Identification, characterization, and quantitation of soluble HLA antigens in the circulation and peritoneal dialysate of renal patients. Ann Surg l991;213(6):591-9. Gellert R, Billip-Tomecka Z, Hijaz H, Bogdanska- Straszynska B, Malecka B Sicinski A. Intradialytic erythrocyte volume changes. Nephrol Dial Transplant 1991;6 Suppl 3:10-3. Gendeh BS, Said H, Gibb AG, Aziz NS, Zahir ZM. Gentamicin administration via peritoneal dialysis fluid: the risk of ototoxicity. J Laryngol Otol 1991; 105(12):999-1001. Gerez L, Madar L, Shkolnik T, Kristal B, Arad G, Reshef A, Steinberger A, Ketzinel M, Sayar D, Shasha S, et 31. Regulation of interleukin-2 and interferon-gamma gene expression in renal failure. Kidney Int 1991 Aug;40(2):266—72. Gill DS, Fonseca VA, Barradas MA, Balliod R, Moorhead J F, Dandona P. Plasma histamine in patients with chronic renal failure and nephrotic syndrome. J Clin Pathol 1991 Mar;44(3):243-5. Girelli D, Lupo A, Trevisan MT, Olivieri O, Bernich P, Zorzan P, Bassi A, Stanzial AM, Ferrari S, Corrocher R. Red blood cell susceptibility to lipid peroxidation, membrane lipid composition, and antioxidant enzymes in continuous ambulatory peritoneal dialysis patients. Perit Dial Int 1992; 12(2):205—10. Girelli D, Olivieri O, Stanzial AM, Azzini M, Lupo A, Bernich P, Menini C, Gammaro L, Corrocher R. Low platelet glutathione peroxidase activity and serum selenium concentration in patients with chronic renal failure: Relations to dialysis treatments, diet and cardiovascular complications. Clin Sci 1993;84(6):611-7. Girolami JP, Bascands IL, Vega Vidalle C, Pecher C, Moatti JP, Adam A, Suc JM. Increase in urinary kallikrein excretion following hemodialysis. Nephron 1991;59(1):51-6. Gitelman HJ, Alderman FR, Perry SJ. Silicon accumulation in dialysis patients. Am J Kidney Dis 1992 Feb;19(2):140-3. Gladziwa U, Bares R, Klotz U, Dakshinamurty KV, Ittel TH, Seiler KU, Sieberth HG. Pharmacokinetics and pharmacodynamics of cisapride in patients undergoing hemodialysis. Clin Pharmacol Ther 1991 Dec;50(6):673-81. Gladziwa U, Wagner S, Dakshinamurty KV, Bechtel B, Mann H, Sieberth HG. Intragastric long-term pH- metry in hemodialysis patients. A study with famotidine. Clin Nephrol 1991 Aug;36(2):97—102. Gladziwa U, Wagner S, Kock R, Mann H, Sieberth HG. Sonographic evaluation of gallbladder motility in patients with end-stage renal disease on haemodialysis. Nephrol Dial Transplant 1992;7(8): 840-3. Glez-Gutierrez M, de Francisco AL, Sanz de Castro S, Ruiz JC, Prieto M, Garcia Fuentes M, Arias M. Interleukin-2 deficit in hemodialysis patients. Role of prostaglandins. Ren Fail 1992;14(4):563-9. Goldberg U. Lipoprotein metabolism in normal and uremic patients. Am J Kidney Dis 1993;21(1): 87-90. Goldwasser P, Mittman N, Antignani A, Burrell D, Michel MA, Collier I, Avram MM. Predictors of mortality in hemodialysis patients. J Am Soc Nephrol 1993;3(9):1613-22. Goren A, Stankiewicz H, Goldstein R, Drukker A. Fish oil treatment of hyperlipidemia in children and adolescents receiving renal replacement therapy. Pediatrics 1991 Aug;88(2):265—8. Grimm PC, Ettenger RB. High cellular anti-HLA immune responsiveness accompanies the highly sensitized (high PRA) state in dialysis patients. Transplant Proc 1991 Feb;23(1 Pt 1):405-6. Gutierrez R, Oster JR, Schlessinger FB, Perez GO, Federman DG, Vaamonde CA. Serum sulfate concentration and the anion gap in hemodialysis patients. ASAIO Trans 1991 Apr-Jun;37(2):92-6. Haag—Weber M, Hable M, Fiedler G, Blum I, Schollmeyer P, Kreusser W, Horl WH. Alterations of polymorphonuclear leukocyte glycogen metabolism and glucose uptake in dialysis patients. Am J Kidney Dis 1991 May;17(5):562-8. Hug-Weber M, Horl WH. Calcium-dependent neutrophil activation. Contrib Nephrol 1992;100: 269—85. Haag-Weber M, Mai B, Horl WH. Effect of hemodialysis on intracellular calcium in human polymorphonuclear neutrophils. Miner Electrolyte Metabol 1992;18(2-5):151-5. Haeffner-Cavaillon N, Jahns G, Poignet JL, Kazatchkine MD. Induction of interleukin-1 during hemodialysis. Kidney Int Suppl 1993 Jan;39: 8139—43. Haffner SM, Gruber KK, Aldrete G Jr, Morales PA, Stern MP, Tuttle KR. Increased lipoprotein (a) concentrations in chronic renal failure. I Am Soc Nephrol 1992 Nov;3(5):1156-62. Hakim RM, Nissenson AR. Report of workshop on technique and technology. Am J Kidney Dis 1993 Jan;21(1):109-10. Halma C, Dalia MR, Feitsma RI, van Holthe MS, Evers-Schouten JI-I, Pauwels EK, van Es LA. Does haemodialysis impair macrophage Fc receptor function? Nephrol Dial Transplant 1992;7(7): 618-22. Hanaki Y, Kamiya H, Ohno M, Hayakawa M, Sugiyama S, Ozawa T. Leukotoxin, 9, 10- epoxy- 12—octadecenoate: a possible responsible factor in circulatory shock and disseminated intravascular coagulation. Jpn J Med 1991 May—Jun;30(3):224—8. 6 Haran N, Bar-Khayim Y, Frensdorff A, Barnard G. Tumor necrosis factor (TNF alpha) binding protein: interference in immunoassays of TNF alpha. Kidney Int 1991 Dec;40(6):1166-70. Hart PH, Jones CA, Finlay-Jones JJ. Inflammatory fluids regulate TNF-alpha, but not IL-1 beta, production by human peritoneal macrophages. A study of patients on continuous ambulatory peritoneal dialysis with peritonitis. J Leukoc Biol 1993 Mar;53(3):309-19. Hart PH, Jones CA, Jones KL, Finlay-Jones JJ. Reduced secretion of IL-1 beta by peritoneal cells from patients on continuous ambulatory peritoneal dialysis. Immunol Cell Biol 1993 Apr;71(Pt 2): 99-107. Hasnain Q, Macdonald G, Haupert GT. Metabolism of uridine in expanded extracellular volume states. Clin Exp Pharmacol Physiol 1993;20(5):313-6. Haubitz M, Kloppel B, Lonnemann G, Nonnast-Daniel B. In vitro production of interleukin-1 from blood mononuclear cells of patients on chronic hemodialysis therapy. Clin Nephrol 1992 Jul;38(1): 30-5. Haynes AP, Daniels I, Porter C, Fletcher J, Morgan AG. Abnormal cytoplasmic pH regulation during activation in uremic neutrophils. Kidney Int 1992 Sep;42(3):690-9. Hegbrant J, Martensson L, Thysell H, Ekman R, Boberg U. Effects of sham hemodialysis on plasma levels of vasoactive peptides in patients with uremia. ASAIO J 1992 Jul-Sep;38(3):M197-200. Hegbrant J, Thysell H, Ekman R. Plasma levels of gastrointestinal regulatory peptides in patients receiving maintenance hemodialysis. Scand J Gastroenterol 1991 Jun;26(6):599-604. Hegbrant J, Thysell H, Ekman R. Plasma levels of vasoactive regulatory peptides in patients receiving regular hemodialysis treatment. Scand J Urol Nephrol 1992;26(2):169—76. Hegbrant J, Thysell H, Martensson L, Ekman R, Boberg U. Changes in plasma levels of vasoactive peptides during sequential bicarbonate hemodialysis. Nephron 1993;63(3):309-13. Hegedus ZL, Frank HA, Steinman TI, Nayak U. Dialysis of plasma soluble lipofuscins in patients with end-stage renal failure. Arch Int Physiol Biochim Biophys 1991 Aug;99(4):355—63. Heimann P, Josephson MA, Fellner SK, Thistlethwaite JR Jr, Stuart FP, Dasgupta A. Elevated lipoprotein (a) levels in renal transplantation and hemodialysis patients. Am J Nephrol 1991;11(6):470-4. Heintz B, Mann H, Kierdorf H, Konigs F, Nelson K, Kirsten R, Heicke N, Wieland D, Gladziwa U, Sieberth HG. Immunoreactive parathyroid hormone after volume change in normo- and hypotensive hemodialysis patients. Clin Nephrol 1992 Mar; 37(3):140-4. Heintz B, Reiners K, Gladziwa U, Kirsten R, Nelson K, Wieland D, Riehl J, Mann H, Sieberth HG. Response of vasoactive substances to reduction of blood volume during hemodialysis in hypotensive patients. Clin Nephrol 1993 Apr;39(4):198-204. Hellman P, Backman U, Danielson BG, Akerstrom G, Rastad J, Wide L, Ljunghall S. Values of intact serum parathyroid hormone in different stages of renal insufficiency. Scand J Urol Nephrol 1991; 25(3):227-32. Herbelin A, Urena P, Nguyen AT, Zingraff J, Descamps—Latscha B. Elevated circulating levels of interleukin-6 in patients with chronic renal failure. Kidney Int 1991 May;39(5):954—60. Herbelin A, Urena P, Nguyen AT, Zingraff J, Descamps—Latscha B. Influence of first and long- ‘term dialysis on uraemia-associated increased basal production of interleukin-1 and tumour necrosis factor alpha by circulating monocytes. Nephrol Dial Transplant 1991;6(5):349-57. Her-tel J, Kimmel PL, Phillips TM, Bosch JP. Eosinophilia and cellular cytokine responsiveness in hemodialysis patients. J Am Soc Nephrol 1992 Dec; 3(6):1244—52. Himmelfarb J, Gerard NP, Hakim RM. Intradialytic modulation of granulocyte C5a receptors. J Am Soc Nephrol 1991 Oct;2(4):920-6. Himmelfarb J, Lazarus JM, Hakim R. Reactive oxygen species production by monocytes and polymorphonuclear leukocytes during dialysis. Am J Kidney Dis 1991 Mar;17(3):271-6. Hirano T, Toyoshima Y, Oka K, Tamaki T, Kozaki M. Promotion of lymphocyte blastogenesis by hemodialysate of chronic renal failure. Nephron 1992;61(1):45-53. Hisano S, Miyazaki C, Hatae K, Kaku Y, Yamane I, Ueda K, Okamua S. Immune status of children on continuous ambulatory peritoneal dialysis. Pediatr Nephrol 1992 Mar;6(2): 179-81. Holley J L, Bernardini J, Piraino B. Risk factors for tunnel infections in continuous peritoneal dialysis. Am J Kidney Dis 1991 Sep;18(3):344-8. Holzberger G, Seidl S, Peschke B, Fursch A, Scheuermann EH, Schoeppe W. The prevalence of anti-HCV in hemodialysis patients and blood donors in Germany. Transplant Proc 1991;23(5):2658-9. Holzberger G, Seidl S, Peschke B, Scheuermann EH, Schoeppe W. Second generation anti-HCV test: seroprevalence in hemodialysis patients and blood donors. Transplant Proc 1992:24(6):2648-9. Hombrouckx R0, Bogaert AM, Leroy FM, De Vos I Y, Vermaercke NM, Picavet LM, Lamo LA. Polyunsaturated fatty acids of the n—3 class in chronic dialysis. ASAIO J 1992 Jul-Sep;38(3): M331-3. Honkanen E, Froseth B, Gronhagen-Riska C. Serum hyaluronic acid and procollagen III amino terminal propeptide in chronic renal failure. Am J Nephrol 1991;11(3):201-6. Honkanen E, Gronhagen-Riska C, Teppo AM, Maury CP, Meri S. Acute-phase proteins during hemodialysis: correlations with serum interleukin-1 beta levels and different dialysis membranes. Nephron 1991;57(3):283-7. Honkanen E, Kala AR, Gronhagen-Riska C, Ikaheimo R. CAPD with low calcium dialysate and calcium carbonate: results of a 24-week study. Adv Perit Dial 1992;8z356-61. Hory B, Racadot E, Saint-Hillier Y, Peters A, Perol C. Soluble interleukin-2 receptors in chronic renal failure. Am J Nephrol 1991;11(4):276-80. Hosokawa S, Yoshida 0. Removal of silicon, aluminum and beta 2-microglobu1in in chronic haemodialysis patients. Int Urol Nephrol 1991;23(3):281-4. Huang JY, Huang CC, Lim PS, Wu MS, Leu ML. Effect of body iron stores on serum aluminum level in hemodialysis patients. Nephron 1992;61(2): 158-62. Hubel E, Kiefer T, Weber J, Mettang T, Kuhlmann U. In vivo effect of 1,25-dihydroxyvitamin D3 on phagocyte function in hemodialysis patients. Kidney Int 1991 Nov;40(5):927-33. Hutchison AJ, Boulton HF, Herman K, Day JP, Prescott M, Gokal R. Use of oral stable strontium to provide an index of intestinal calcium absorption in chronic ambulatory peritoneal dialysis patients. Miner Electrolyte Metabol 1992;18(2-5):160-5. Hutchison AJ, Gokal R. Improved solutions for peritoneal dialysis: physiological calcium solutions, osmotic agents and buffers. Kidney Int Suppl 1992; 38:S153-9. Huting J, Schutterle G. Cardiovascular factors influencing survival in end-stage renal disease treated by continuous ambulatory peritoneal dialysis. Am J Cardiol 1992 Jan l;69(1):123-7. Hylander BI, Dalton CB, Castell DO, Burkart J, Rossner S. Effect of intraperitoneal fluid volume changes on esophageal pressures: studies in patients on continuous ambulatory peritoneal dialysis. Am J Kidney Dis 1991 Mar;17(3):3(T7-10. Ierino FL, Miach PJ , Hogarth PM, McKenzie IFC. Serum soluble Fc gamma RII levels in dialysis and renal transplant recipients. Transplant Proc 1992;24(5):2328. Inamoto H, Ozaki R, Matsuzaki T, Wakui M, Saruta T, Osawa A. Incidence and mortality patterns of malignancy and factors affecting the risk of malignancy in dialysis patients. Nephron 1991; 59(4):611-7. Innes A, Rowe PA, Burden RP, Morgan AG. Early deaths on renal replacement therapy: the need for early nephrological referral. Nephrol Dial Transplant 1992;7(6):467-71. Comment in: Nephrol Dial Transplant 1993;8(1):93-4. Ireland HA, Boisclair MD, Lane DA, Thompson E, Curtis JR. Hemodialysis and heparin. Alternative methods of measuring heparin and of detecting activation of coagulation. Clin Nephrol 1991 Jan; 35(1):'26-33. Irish AB, Simons LA, Savdie E, Hayes JM, Simons J. Lipoprotein (a) levels in chronic renal disease states, dialysis and transplantation. Aust N Z J Med 1992 Jun;22(3):243-8. Iseki K, Kawazoe N, Fukiyama K. Predictive values of clinical indices on survival in chronic hemodialysis patients a short-term prospective study [abstract]. J Am Soc Nephrol 1992;3(3):371. Ittel TH, Schafer C, Schmitt H, Gladziwa U, Sieberth HG. Calcium carbonate as a phosphate binder in dialysis patients: evaluation of an enteric-coated preparation and effect of additional aluminium hydroxide on hyperaluminaemia. Klin Wochenschr 1991 Jan 22;69(2):59-67. Janatova J, Cheung AK, Parker CJ. Biomedical polymers differ in their capacity to activate complement. Complement Inflamm 1991;8(2):61-9. Jankova T, Tchankova P, Nenov D. Low prekallikrein and high angiotensin—converting enzyme activity in patients with chronic renal failure on haemodialysis. Nephrol Dial Transplant 1991;6 Suppl 3:6—9. J ethon FU, Weber-Fursicht I, Steudle V, Guleke R, Kirschner U. Peritonitis prevention by eliminating the risk factor disconnection. Contrib Nephrol 1991;89:53-8. Johnson DW, Fleming SJ. The use of vaccines in renal failure. Clin Pharmacokin 1992;22(6):434—46. Jones KR. Factors associated with hospitalization in a sample of chronic hemodialysis patients. Health Serv Res 1991 Dec;26(5):671-99. Jones KR. Risk of hospitalization for chronic hemodialysis patients. Image J Nurs Sch 1992 Summer;24(2):88-94. 8 Jorres A, Jorres D, Gahl GM, Schulz E, Mahiout A. Leukotriene release from neutrophils of patients on hemodialysis with cellulose membranes. Int J Artif Organs 1992 Feb;15(2):84-8. Jorres A, Jorres D, Topley N, Gahl GM, Mahiout A. Leukotriene release from peripheral and peritoneal leukocytes following exposure to peritoneal dialysis solutions. Nephrol Dial Transplant 1991;6(7): 495-501. Joven J, Vilella E, Ahmad S, Cheung MC, Brunzell JD. Lipoprotein heterogeneity in end-stage renal disease. Kidney Int 1993 Feb;43(2):410-8. Jung BC, Laidlaw SA, Kopple JD. Taurine levels in plasma and blood cells in patients undergoing routine maintenance hemodialysis. Am J Kidney Dis 1991 Ju1;18(1):74-9. Kagan A, Gertler A, Ulman M, Bar-Khayim Y. Serum levels and peritoneal loss of prolactin in CAPD patients. Adv Perit Dial 1991;7z247-52. Kandoussi A, Cachera C, Pagniez D, Dracon M, Fruchart J C, Tacquet A. Plasma level of lipoprotein Lp(a) is high in predialysis or hemodialysis, but not in CAPD. Kidney Int 1992 Aug;42(2):424-5. Kandoussi A, Cachera C, Pagniez D, Saile R, Tacquet A. Quantification of beta 2-microglobulin and albumin in plasma and peritoneal dialysis fluid by a noncompetitive immunoenzymometric assay. Clin Chem 1993;39(1):93-6. Kandus A, Benedik M, Bren AF, Drinovec J, Fliser D, Knap B, Kladnik S, Ivanovich P. Inhibition of complement activation with EDTA in vivo during sham hemodialysis. Int J Artif Organs 1991 Aug; 14(8):515—7. Katoh S, Ida K, Mizunoya A. Irregular isoantibodies in the sera of patients undergoing chronic hemodialysis. Int J Artif Organs 1991 Mar;l4(3): 136-40. Kawanilhi H, Tsuchiya T, Namba S, Takahashi N, Toyota T, Fukuma K, Kawai T. Clinical application of low calcium peritoneal dialysate. ASAIO Trans 1991 Jul-Sep;37(3):M404—6. Kayirna JK, Otieno LS, Gitau W, Mwai S. Thyroid hormone profiles in patients with chronic renal failure on conservative management and regular haemodialysis. East Afr Med J 1992 Jun;69(6): 333-6. Kerr PG, Argiles A, Canaud B, Flavier JL, Mion C. The effects of reprocessing high-flux polysulfone dialyzers with peroxyacetic acid on beta 2- microglobulin removal in hemodiafiltration. Am J Kidney Dis 1992 May;19(5):433-8. Kerr PG, Argiles A, Mion C. Whole blood serotonin levels are markedly elevated in patients on dialytic therapy. Am J Nephrol 1992;12(l-2):14-8. Ketchersid TL, Van Stone J C. Dialysate potassium. Semin Dial 1991;4(1):46—51. Kiersztejn M, Smogorzewski M, Thanakitcharu P, Fadda GZ, Massry SG. Decreased 02 consumption by PMNL from humans and rats with CRF: role of secondary hyperparathyroidism. Kidney Int 1992 Sep;42(3):602-9. Kimura Y, Nakayama M, Kuriyama S, Watanabe S, Kawaguchi Y, Sakai 0. Pharmacokinetics of active vitamins D3, 1 alpha-hydroxyvitamin D3 and 1 alpha, 25-dihydroxyvitamin D3 in patients on chronic hemodialysis. Clin Nephrol 1991 Feb;35(2): 72—7. Klein GL, Alfrey AC, Shike M, Sherrard DJ. Parenteral drug products containing aluminum as an ingredient or a contaminant: response to FDA notice of intent. ASCN/ASPEN Working Group on Standards for Aluminum Content of Parenteral Nutrition Solutions. Am J Clin Nutr 1991 Feb; 53(2):399—402. Comment in: Am J Clin Nutr 1991 Nov;54(5):951-3. Klein JR, Grunewald RW, Steffgen J, Franz HE. Clearance of osteocalcin in adults with end-stage renal disease undergoing CAPD. Adv Perit Dial l991;7:225-9. Koenig KG, Lindberg J S, Zerwekh J E, Padalino PK, Cushner HM, Copley JB. Free and total 1,25- dihydroxyvitamin D levels in subjects with renal disease. Kidney Int 1992 Jan;41(1):161-5. Kolb G, Fischer W, Seitz R, Muller T, Egbring R, Lange H, Havemann K. Hemodialysis and blood coagulation: the effect of hemodialysis on coagulation factor XIII and thrombin-antithrombin III complex. Nephron 1991;58(1):106-8. Kolb G, Nolting C, Eckle I, Muller T, Lange H, Havemann K. The role of membrane contact in hemodialysis-induced granulocyte activation. Nephron 1991;57(1):64—8. Korbet SM, Vonesh EF, Firanek CA. A retrospective assessment of risk factors for peritonitis among an urban CAPD population. Perit Dial Int 1993;13(2): 126-31. Kouw PM, Olthof CG, ter Wee PM, 0e LP, Donker AJ, Schneider H, de Vries PM. Assessment of post- dialysis dry weight: an application of the conductivity measurement method. Kidney Int 1992 Feb;41(2):440-4. Kraus LM, Kraus AP Jr. Tyrosine and N-carbamoyl- tyrosine in end-stage renal disease during continuous ambul peritoneal dialysis. J Lab Clin Med 1991 Dec;118(6):555-62. Krediet RT, Asghar SS, Koomen GC, Venneker GT, Struijk DG, Arisz L. Effects of renal failure on complement C3d levels. Nephron 1991;59(1):41-5. Ksiazek A, Kozio M. Phagocytic function of neutrophils during dialysis in relation to some immunological findings. Nephrol Dial Transplant 1991;6 Suppl 3: 31-4. Kumano K, Yokota S, Go M, Suyama K, Sakai T, Era S, Sogami M. Quantitative and qualitative changes of serum albumin in CAPD patients. Adv Perit Dial 1992;8z127-30. Kustel M, Buki B, Gyimesi J, Mako J, Komora V, Ribari O. Auditory brainstem potentials in uraemia. ORL 1993;55(2):89-92. Kuzniewski M, Suowicz W. Influence of prostacyclin infusion on haemodialysis efficiency and blood cells. Int Urol Nephrol 1992;24(5):555—63. Kuzniewski M, Suowicz W, Lisiewicz J. Effect of heparin and prostacyclin-heparin infusion on blood coagulation in haemodialysed patients. Int Urol Nephrol 1991;23(l):89-96. Lai KN, Li PK, Woo KS, Lui SF, Leung JC, Law E, Nicholls MG. Vasoactive hormones in uremic patients on continuous ambulatory peritoneal dialysis. Clin Nephrol 1991 May;35(5):218-23. Lai KN, Yin JA, Yuen PM, Li PK. Effect of hemodialysis on protein C, protein S, and antithrombin III levels. Am J Kidney Dis 1991 Jan; 17(1):38-42. Lamb E, Venton TR, Cattell WR, Dawnay A. Serum glycated albumin and fructosamine in renal dialysis patients. Nephron 1993;64(1):82-8. Lang CC, Choy AM, Henderson IS, Coutie WJ, Struthers AD. Effect of haemodialysis on plasma levels of brain natriuretic peptide in patients with chronic renal failure. Clin Sci 1992 Feb;82(2): 127-31. Lee BW, Yap HK, Tan M, Guan R, Quak SH, Choong L, Murugasu B, Woo KT, Jordan SC. Cell- mediated immunity in patients on hemodialysis: relationship with hepatitis B carrier status. Am I Nephrol 1991;11(2):98-101. Liberek T, Topley N, Jorres A, Coles GA, Gahl GM, Williams JD. Peritoneal dialysis fluid inhibition of phagocyte function: effects of osmolality and glucose concentration. I Am Soc Nephrol 1993 Feb;3(8):1508-15. Lightfoot BO, Caruana RJ. Endothelin-l in continuous ambulatory peritoneal dialysis and hemodialysis patients: a preliminary study. Perit Dial Int 1993; 13(1):55-8. Lin CY, Huang TP. Enhancement of ionized calcium and 1,25-dihydroxycholecalciferol loss from peritoneal fluid during peritonitis in patients treated with continuous ambulatory peritoneal dialysis. Nephron 1991;59(1):90—5. Lin CY, Lin CC, Huang TP. Serial changes of interleukin-6 and interleukin-8 levels in drain dialysate of uremic patients with continuous ambulatory peritoneal dialysis during peritonitis. Nephron 1993 ;63 (4) :404-8 . Lin SY, Chen LQ, Wang YH, Zhou JH. Influence of hemoultrafiltration and hemodialysis on endothelin. Chin Med J (Engl) 1991 Apr;104(4):288-91. Lind L, Wengle B, Lithell H, Ljunghall S. Reduction in serum alkaline phosphatase levels by treatment with active vitamin D (alphacalcidol) in primary and secondary hyperparathyroidism and in euparathyroid individuals. Scand J Urol Nephrol 1991;25(3): 233-6. Lindblad AS, Nolph KD. Recovery of renal function in continuous ambulatory peritoneal dialysis: a study of National CAPD Registry data. Perit Dial Int 1992; 12(1):43-7 . Lindner A, Gagne ER, Zingraff J , Jungers P, Drueke TB, Hannaert P, Garay R. A circulating inhibitor of the RBC membrane calcium pump in chronic renal failure. Kidney Int 1992 Dec;42(6):1328-35. Lipkin GW, Forbes MA, Cooper EH, Tumey JH. Hyaluronic acid metabolism and its clinical significance in patients treated by continuous ambulatory peritoneal dialysis. Nephrol Dial Transplant 1993;8(4):357-60. Lofberg E, Wernerman J, Noree LO, von der Decken A, Vinnars E. Ribosome and free amino acid content in muscle during hemodialysis. Kidney Int 1991 May;39(5):984-9. London GM, Marchais SJ, Guerin AP, Fabiani F, Metivier F. Cardiovascular function in hemodialysis patients. Adv Nephrol Necker Hosp 1991;20: 249-73. Longfield RN, Wortham WG, Fletcher LL, Nauscheutz WF. Clustered bacteremias in a hemodialysis unit: cross-contamination of blood tubing from ultrafiltrate waste. Infect Control Hosp Epidemiol 1992 Mar;l3(3):160—4. Lonnemann G. Dialysate bacteriological quality and the permeability of dialyzer membranes to pyrogens. Kidney Int Suppl 1993;41:S195—200. Lonnemann G, Behme TC, Lenzner B, Floege J, Schulze M, Colton CK, Koch KM, Shaldon S. Permeability of dialyzer membranes to TNF alpha- inducing substances derived from water bacteria. Kidney Int 1992 Ju1;42(1):61-8. 10 Lonnemann G, Floege J, Shaldon S, Koch KM. Blood- dialyzer interactions: their role in long-term complications of hemodialysis. Contrib Nephrol 1992;100:155-71. Lonnemann G, Mahiout A, Schindler R, Colton CK. Pyrogen retention by the polyamide membranes. Contrib Nephrol 1992;96:47-63. Lowrie EG, Lew NL. Commonly measured laboratory variables in hemodialysis patients: relationships among them and to death risk. Semin Nephrol 1992 May;12(3):276-83. Lubrano R, Taccone-Gallucci M, Piazza A, Morosetti M, Meloni C, Citti G, Mannarino O, Castello MA, Casciani CU. Vitamin E supplementation and oxidative status of peripheral blood mononuclear cells and lymphocyte subsets in hemodialysis patients. Nutrition 1992 Mar-Apr;8(2):94—7. Luciak M. Oxidative metabolism of peripheral blood neutrophils in chronic renal failure on conservative and dialysis treatment. Arch Immunol Ther Exp (Warsz) 1992;40(2):93-5. Luciak M, Trznadel K. Free oxygen species metabolism during haemodialysis with different membranes. Nephrol Dial Transplant 1991;6 Suppl 3:66-70. Lundahl J, Hed J, Jacobson SH. Dialysis granulocytopenia is preceded by an increased surface expression of the adhesion-promoting glucoprotein Mac-1. Nephron 1992;6l(2):163-9. Lye WC, Leong SO, Lee EJC. Methicillin—resistant Staphylococcus aureus nasal carriage and infections in CAPD. Kidney Int 1993;43(6):l357-62. Ma KW, Greene EL, Raij L. Cardiovascular risk factors in chronic renal failure and hemodialysis populations. Am J Kidney Dis 1992 Jun;19(6): 505-13. Mackenzie RK, Coles GA, Williams JD. The response of human peritoneal macrophages to stimulation with bacteria isolated from episodes of continuous ambulatory peritoneal dialysis-related peritonitis. J Infect Dis l991;163(4):837-42. Maillet F, Kazatchkine MD. Specific antibodies enhance alternative complement pathway activation by cuprophane. Nephrol Dial Transplant 1991;6(3): 193-7. Main J, Ward MK. Potentiation of aluminium absorption by effervescent analgesic tablets in a haemodialysis patient. BMJ 1992 Jun 27;304(6843): 1686. Malaponte G, Mazzarino C, Fatuzzo P, Interlandi P, Monte V, Nicosia A, Rosa Calamaro A, Rapisarda F. IL-2 and its receptors in elderly subjects on hemodialysis. Arch Gerontol Geriatr 1991; 12 Suppl 2:527-30. Malluche III-I, Monier-Faugere MC. Risk of adynamic bone disease in dialyzed patients. Kidney Int Suppl 1992 Oct;38:862-7. Man NK, Chauveau P, Kuno T, Poignet JL, Yanai M. Phosphate removal during hemodialysis, hemodiafiltration, and hemofiltration. A reappraisal ASAIO Trans 1991 Jul-Sep;37(3):M463-5. Manescalchi F, De Mayo E, Bertoni E, Martinelli F, Patti F, Ciccarelli C, Baccaro C, Lo Nostro A, Comodo N. Anti-hepatitis C virus epidemiological study in two dialysis centers in Florence. Nephron 1992;61(3):342-3. Marangella M, Bagnis C, Bruno M, Petrarulo M, Gabella P, Linari F. Determinants of oxalate balance in patients on chronic peritoneal dialysis. Am J Kidney Dis 1993 Apr;21(4):419—26. Marangella M, Petrarulo M, Mandolfo S, Vitale C, Cosseddu D, Linari F. Plasma profiles and dialysis kinetics of oxalate in patients receiving hemodialysis. Nephron 1992;60(1):74-80. Mariano F, Tetta C, Montrucchio G, Cavalli PL, Camussi G. Role of alpha l-proteinase inhibitor in restraining peritoneal inflammation in CAPD patients. Kidney Int 1992 Sep;42(3):735-42. Markert M, Wauters JP. New aspects on oxidative metabolism of neutrophils during hemodialysis on different dialyzer membranes. Adv Exp Med Biol 1991;297:207-13. Marsen TA, Pollok M, Baldamus CA. Influence of various hemofilter membranes in elimination of beta-2-microglobulin during dialysis treatment. Dial Transplant 1992;21(12):788-9, 792, 805. Martin-Mala A, Velasco F, Rojas R, Castillo D, Rodriguez M, Torres A, Aljama P. Fibrinolytic activity during hemodialysis: a biocompatibility- related phenomenon. Kidney Int Suppl 1993;41: 8213-6. Martinson E, Wieslander A, Kjellstrand P, Boberg U. Toxicity of heat sterilized peritoneal dialysis fluids is derived from degradation of glucose. ASAIO J 1992 Jul-Sep;38(3):M370—2. Marumo F, Shichiri M, Emori T, Ando K. Circulating and excreted forms of atrial natriuretic peptide in healthy subjects and patients with renal diseases. Clin Nephrol 1992 Oct;38(4):203-8. Matthys E, Schurgers M, Lamberigts G, Lameire N, Vandecasteele N, Labeur C, Beisiegel U, Rosseneu M. Effect of simvastatin treatment on the dyslipoproteinemia in CAPD patients. Atherosclerosis 1991 Feb;86(2-3):183-92. Maurin N. Antithrombotic management with a stable prostacyclin analogue during extracorporeal circulation. Contrib Nephrol 1991;93:205-9. McCance DR, Maxwell AP, Hill CM, Doherty CC. Glomerulonephritis associated with antibodies to neutrophil cytoplasm and glomerular basement membrane. Postgrad Med J 1992 Mar;68(797): 186—8. McClellan WM, Anson C, Birkeli K, Tuttle E. Functional status and quality of life: predictors of early mortality among patients entering treatment for end stage renal disease. J Clin Epidemiol 1991; 44(1):83-9. McConnell KN, Rolton HA, Modi KS, MacDougall AI. Plasma oxalate in patients with chronic renal failure receiving continuous ambulatory peritoneal dialysis or hemodialysis. Am J Kidney Dis 1991 0ct;18(4): 441-5. McKenna RM, MacDonald C, Berstein K, Rush D. Tumor necrosis factor and hemodialysis [abstract]. Clin Invest Med 1991;14(4 Suppl):A135. Mege IL, Olmer M, Purgus R, Bertocchio P, Farnarier C, Kaplanski S, Capo C, Bongrand P. Haemodialysis membranes modulate chronically the production of TNF alpha, ILl beta and ID6. Nephrol Dial Transplant 1991;6(11):868-75. Mege JL, Sanguedolce MV, Purgus R, Moulin B, Bongrand P, Capo C, Olmer M. Chronic and intradialytic effects of high-flux hemodialysis on tumor necrosis factor-alpha production: relationship to endotoxins. Am J Kidney Dis 1992 Nov;20(5): 482-8. Memoli B, Libetta C, Rampino T, Dal Canton A, Conte G, Scala G, Ruocco MR, Andreucci VE. Hemodialysis related induction of interleukin-6 production by peripheral blood mononuclear cells. Kidney Int 1992 Aug;42(2):320-6. Memoli B, Libetta C, Rampino T, De Simone W, Meccariello S, Stangerlin P, Dal Canton A, Andreucci VE. Interleukin-6 production of uraemic haemodialysed patients: effects of different membranes. Nephrol Dial Transplant 1991; 6 Suppl 2:96-8. Merchant MR, Hutchinson AJ, Butler SJ, Boulton H, Hintchliffe R, Gokal R. Calcium, magnesium mass transfer and lactate balance study in CAPD patients with reduced calcium/magnesium and high lactate dialysis fluid. Adv Perit Dial 1992;82365—8. Michel A, Goldwasser P, Tan D, Antignani A, Fein PA, Mittman N, Avram MM. Correlates of four- year survival on hemodialysis [abstract]. J Am Soc Nephrol 1991;2(3):339. Milly K, Wit L, Diskin C, Tulley R. Selenium in renal failure patients. Nephron 1992;61(2):139-44. Miyata T, Inagi R, Hong K, Iida Y, Oda O, Kinoshita T, Inoue K, Miyama A, Maeda K. Fluid-phase activation of the alternative pathway of complement 11 by excess factor D in regularly dialyzed patients. Nephron 1992;60(2):144-9. Miyata T, Inagi R, Oda O, Inoue I, Okada H, Miyama A, Nakashima I, Maeda K. Deterioration of immune complex solubilization activity of serum by increased concentration of factor D. Nephron 1991; 59(3):409-15. Mocan MZ, Mocan H, Fell GS, Junor BI, Boyce BF. Autonomous hyperparathyroidism not associated with increased aluminum absorption. Isr J Med Sci 1992 Jan;28(1):24—6. Moinard J, Guenard H. Membrane diffusion of the lungs in paients with chronic renal failure. Eur Respir J 1993 Feb;6(2):225-30. Mondelli MU, Smedile V, Piazza V, Villa G, Barbieri C, Gattarello G, Mancini F, Rairnondo G. Abnormal alanine aminotransferase activity reflects exposure to hepatitis C virus in haemodialysis patients. Nephrol Dial Transplant 1991;6(7):480—3. Montalto G, Carroccio A, Sparacino V, Lorello D, Di Martino D, Soresi M, Galione A, Notarbartolo A. Pancreatic enzymes in chronic renal failure and transplant patients. Int J Pancreatol 1992 Dec;12(3): 211-7. Moore GE, Brinker KR, Stray-Gundersen J, Mitchell J H. Determinants of V02 peak in patients with end- stage renal disease: on and off dialysis. Med Sci Sports Exerc 1993 Jan;25(1):18-23. Morgan JD, Tilsed JV, Bell PR, Veitch PS, Donnelly PK. Continuous ambulatory peritoneal dialysis in patients with aortic grafls. Br J Surg 1992 Aug; 79(8):755-6. Morton LP, Reynolds L, Zent R, Rayner BL. Hearing thresholds in CAPD patients. Adv Perit Dial 1992; 8:150-2. Motojima M, Nishijima F, Ikoma M, Kawamura T, Yoshioka T, Fogo AB, Sakai T, Ichikawa I. Role for "uremic toxin" in the progressive loss of intact nephrons in chronic renal failure. Kidney Int 1991 Sep;40(3):461-9. Moughal NA, McGregor SJ, Brock JH, Briggs JD, Junor BJ. Expression of transferrin receptors by monocytes and peritoneal macrophages from renal failure patients treated by continuous ambulatory peritoneal dialysis (CAPD). Eur J Clin Invest 1991 Dec;21(6):592—6. Mrowka Ch, Schiffl H. Comparative evaluation of beta 2-microglobulin removal by different hemodialysis membranes: a six-year follow-up. Nephron 1993; 63(3):368-9. Muijsken MA, Heezius HJ, Verhoef I, Verbrugh HA. Role of mesothelial cells in peritoneal antibacterial defence. J Clin Pathol 1991 Jul;44(7):600-4. 12 Muirhead N, Mitton R. Use of bone char as an adsorbent in preparation of water for dialysis. ASAIO J 1992 Jul-Sep;38(3):M334-7. Muller GY, Zabaleta ME, Arminio A, Colmenares CI, Capriles FI, Bianco NE, Machado IV. Risk factors for dialysis-associated hepatitis C in Venezuela. Kidney Int 1992 Apr;41(4):1055—8. Murphy BG, McNamee P, Duly E, Henry W, Archbold P, Trinick T. Increased serum apolipoprotein (a) in patients with chronic renal failure treated with continuous ambulatory peritoneal dialysis. Atherosclerosis 1992 Mar;93(1-2):53-7. Nakahama H, Nakanishi T, Uyama O, Sugita M, Miyazaki M, Yokokawa T, Okamura K, Tanaka Y, Shirai D. Niceritrol reduces plasma lipoprotein (a) levels in patients undergoing maintenance hemodialysis. Renal Fail 1993;15(2):189-93. Nakahama H, Tanaka Y, Shirai D, Miyazaki M, Imai N, Yokokawa T, Okada M, Kubori S. Plasma interleukin-6 levels in continuous ambulatory peritoneal dialysis and hemodialysis patients. Nephron 1992;61(2):132-4. Nakamura M, Suzuki H, Yamakawa H, Saruta T. Role of platelet cytosolic calcium in regulation of blood pressure in patients on chronic hemodialysis. Nephron 1992;61(4):435—41. Nakamura Y, Chida Y, Tomura S. Enhanced coagulation-fibrinolysis in patients on regular hemodialysis treatment. Nephron 1991;58(2):201-4. Nakamura Y, Tomura S, Tachibana K, Chida Y, Marumo F. Enhanced fibrinolytic activity during the course of hemodialysis. Clin Nephrol 1992 Aug;38(2):90—6. Nakano H, Gomi H, Shibasaki T, Ishimoto F, Sakai 0. An experimental study on selective elimination of beta 2-microglobulin using immunoadsorption method in patients with chronic renal failure. Biomater Artif Cells Immobilization Biotechnol 1991;19(1):61-9. Nelson SR, Tennent GA, Sethi D, Gower PE, Ballardie FW, Amatayakul-Chantler S, Pepys MB. Serum amyloid P component in chronic renal failure and dialysis. Clin Chim Acta 1991 Aug 30;200(2-3): 191-9. Nguyen P, Toupance 0, Chanard I, Potron G. Variations of protein C in uremic hemodialysed patients. Thromb Res 1993 Mar 15;69(6):509-18. Nielsen G, Bredahl C, Nielsen C. Continuous blood gas monitoring in haemodialysis using an electrode inserted in the extrac eal dialysis circulation. Scand J Clin Lab Invest 1993 Apr;53(2):197-200. Nielsen H, Espersen F, Kharazmi A, Antonsen S, Ejlersen E, Joffe P, Pedersen FB. Specific opsonic activity for staphylococci in peritoneal dialysis effluent during continuous ambulatory peritoneal dialysis. Am J Kidney Dis 1992 Oct;20(4):372-5. Nishimura M, Nakanishi T, Yasui A, Tsuji Y, Kunishige H, I-Iirabayashi M, Takahashi H, Yoshimura M. Serum calcium increases the incidence of arrhythmias during acetate hemodialysis. Am J Kidney Dis 1992 Feb;l9(2): 149-55. Nishitani H, Yamakawa M, Nishizawa Y, Morii H. Bone mineral loss in patients on maintenance hemodialysis with hyperphosphatemia treated with l alpha-hydroxycholecalciferol and calcium carbonate. J Nutr Sci Vitaminol (Tokyo) 1991 Dec;37 Suppl: 8113-8. Nissenson AR. Dialysis therapy in the elderly patient. Kidney Int Suppl 1993 Feb;40:SSl-7. Nuwayri-Salti N, Jabre F, Daouk M, Sa’ab G, Salem Z. Hematologic parameters and iron stores in patients on hemodialysis for chronic renal failure. Clin Nephrol 1992 Aug;38(2):101-4. Nuwayri-Salti N, Jabre F, Saab G, Daouk M, Salem Z. Blood leukocyte contribution to serum ferritin levels in patients on chronic hemodialysis. Nephron 1991; 57(2):144-8. O’Doherty MJ, Breen D, Page C, Barton I, Nunan TO. Lung 99mTc DTPA transfer in renal disease and pulmonary infection. Nephrol Dial Transplant 1991; 6(8):582-7. Oettinger CW, Oliver J C, Macon EJ. The effects of calcium carbonate as the sole phosphate binder in combination with low calcium dialysate and calcitriol therapy in chronic hemodialysis patients. J Am Soc Nephrol 1992 Oct;3(4):995-1001. Olivares J, Cruz C, Gas JM, Prados MC, Perdiguero M, Caparros G, Santiago C, Franco A. Evolution of lipid profiles in long-term peritoneal dialysis. Adv Perit Dial 1992;8:373-5. Onishi S, Andress DL, Maloney NA, Coburn JW, Sherrard DJ. Beta 2-microglobulin deposition in bone in chronic renal failure. Kidney Int 1991 May;39(5):990-5. Opatrny K Jr, Opatrny K, Vit L, Racek J, Valek A. What are the factors contributing to the changes in tissue-type plasminogen activator during haemodialysis? Nephrol Dial Transplant 1991; 6 Suppl 3:26-30. Os 1, Nordby G, Lyngdal PT, Eide I. Plasma _ . vasopressin, catecholamines and atrial natnuretic factor during hemodialysis and sequential ultrafiltration. Scand J Urol Nephrol l993;27(1): 93-9. Ozben T. Elevated serum and urine sialic acid levels in renal diseases. Ann Clin Biochem 1991 Ian; 28(Pt 1):44-8. Ozdemir O, Arik N, Ozcebe O, Arinsoy T, Sungur C, Dundar S, Turgan C, Yasan U, Caglar S, Kirazli S. Evidence for the role of dialysis hypoxemia in the pathogenesis of hemodialysis-induced rise in tissue-type plasminogen activator. Thromb Res 1992 Sep 15;67(6):697—704. Pacitti A, Tetta C, Mangiarotti G, Canavese C, Segoloni GP. Beta-2-microglobulin serum profiles in different settings of mass transport and fluid pyrogen content. Kidney Int Suppl 1993;41:896-9. Paczek L, Czarkowska B, Schaefer L, Schaefer RM, Heidland A. Effect of beta 2-microglobulin on immunoglobulin production. Immunol Lett 1992 Iun;33(1):87-91. Paczck L, Schaefer RM, Heidland A. Dialysis membranes decrease immunoglobulin and interleukin-6 production by peripheral blood mononuclear cells in vitro. Nephrol Dial Transplant 1991;6 Suppl 3:41-4. Padovese P, Gallieni M, Brancaccio D, Pietra R, Fortaner S, Sabbioni E, Minoia C, Markakis K, Berlin A. Trace elements in dialysis fluids and assessment of the exposure of patients on regular hemodialysis, hemofiltration and continuous ambulatory peritoneal dialysis. Nephron l992;61(4): 442-8. Pagliari B, Baretta A, De Cristofaro V, Sama F, Cantaluppi A, Martis L, Imbasciati E. Short-term effects of low-calcium dialysis solutions on calcium mass transfer, ionized calcium, and parathyroid hormone in CAPD patients. Perit Dial Int 1991; 11(4):326-9. Parfrey PS. Cardiac and cerebrovascular disease in chronic uremia. Am I Kidney Dis 1993 Ian;21(l): 77-80. Paul IL, Roch-Arveiller M, Man NK, Luong N, Moatti N, Raichvarg D. Influence of uremia on polymorphonuclear leukocytes oxidative metabolism in end-stage renal disease and dialyzed patients. Nephron 1991;57(4):428-32. Paul IL, Sall ND, Soni T, Poignet IL, Lindenbaum A, Man NK, Moatti N, Raichvarg D. Lipid peroxidation abnormalities in hemodialyzed patients. Nephron 1993;64(1):106—9. Pauri P, Salvoni G, Vitolo W, Carletti P, Fanciulli E, Ricciatti AM, Della Bella S, Mioli VA. Risk factors and clinical expression of HCV infection in hemodialysis patients. Nephron 1992;6l(3):3l3-4. Pelegri A, Romero R, Senti M, Nogues X, Pedro-Botet I, Rubies-Prat J. Effect of bezafibrate on lipoprotein (a) and triglyceride-rich lipoproteins, including 13 intermediate-density lipoproteins, in patients with chronic renal failure receiving haemodialysis. Nephrol Dial Transplant 1992;7(7):623-6. Pereira BI, Poutsiaka DD, King AI, Strom IA, Narayan G, Levey AS, Dinarello CA. In vitro production of interleukin-1 receptor antagonist in chronic renal failure, CAPD and HD. Kidney Int 1992 Dec;42(6):1419-24. Pereira BI, Poutsiaka DD, Strom IA, Narayan G, Levey AS, King AI, Dinarello CA. Effect of first use and reuse of cuprophane membrane on interleukin-l-beta il-l-beta production by peripheral blood mononuclear cells PBMC. I Am Soc Nephrol 1991;2(3):344. Perez-Fontan M, Rosales M, Rodriguez-Carmona A, Moncalian I, Femandez—Rivera C, Cao M, Valdes F. Treatment of Staphylococcus aureus nasal carriers in CAPD with mupirocin. Adv Perit Dial 1992;8:242-5. Pertosa G, Gesualdo L, Tarantino EA, Ranieri E, Bottalico D, Schena FP. Influence of hemodialysis on interleukin-6 production and gene expression by peripheral blood mononuclear cells. Kidney Int Suppl 1993 Ian;39:S149—53. Pertosa G, Marfella C, Tarantino EA, Di Cillo M, Manno C, Russo R, Schena FP. Involvement of peripheral blood monocytes in haemodialysis: in vivo induction of tumour necrosis factor alpha, interleukin 6 and beta 2-microglobulin. Nephrol Dial Transplant 1991;6 Suppl 2:18-23. Pertosa G, Tarantino EA, Gesualdo L, Montinaro V, Schena FP. C5b-9 generation and cytokine production in hemodialyzed patients. Kidney Int Suppl 1993;41:8221-5. Petersen I , Moore RM Ir, Kaczmarek RG, Singh B, Yeh I, Hamburger S, Kankam M. The effects of reprocessing cuprophane and polysulfone dialyzers on beta 2-microglobulin removal from hemodialysis patients. Am J Kidney Dis 1991 Feb;17(2):174-8. Published erratum appears in Am I Kidney Dis 1991 Iul;18(1):144. Phillips G, Hudson S, Stewart WK. Microbial growth and blockage of sub-floor drains in a renal dialysis centre: a problem highlighted. I Hosp Infect 1992 Iul;21(3):l93-8. Piraino B, Perlmutter IA, Holley IL, Johnston IR, Bernardini I. The use of dialysate containing 2.5 mEq/l calcium in peritoneal dialysis patients. Perit Dial Int 1992;12(1):75—6. Port FK, Held PI, Nolph KD, Turenne MN, Wolfe RA. Risk of peritonitis and technique failure by CAPD connection technique: a national study. Kidney Int 1992 Oct;42(4):967-74. 14 Portman RJ, Scott RC III, Rogers DD, Loose-Mitchell DS, Lemire JM, Weinberg RB. Decreased low- density lipoprotein receptor function and mRNA levels in lymphocytes from uremic patients. Kidney Int 1992;42(5):1238-46. Potempa LA, Motie M, Anderson B, Klein E, Baurmeister U. Conjugation of a modified form of human C-reactive protein to affinity membranes for extracorporeal adsorption. Clin Mater 1992;11(1-4): 105- 17. Powell AC, Bland LA, Oettinger CW, McAllister SK, Oliver JC, Arduino MJ, Favero MS. Enhanced release of TNF-alpha, but not IL—1 beta, from uremic blood after endotoxin stimulation. Lymphokine Cytokine Res 1991 Oct;10(5):343-6. Powell AC, Bland LA, Oettinger CW, McAllister SK, Oliver J C, Arduino MJ, Favero MS. Lack of plasma interleukin-1 beta or tumor necrosis factor- alpha elevation during unfavorable hemodialysis conditions. J Am Soc Nephrol 1991 Nov;2(5): 1007-13. Puppo F, Gurreri G, Pattarini R, Ranise A, Indiveri F. Proliferation in autologous mixed lymphocyte reactions, expression of I-ILA-class II antigen and serum immunomodulatory activity in patients with renal insufficiency on chronic dialysis. Allergol Immunopathol (Madr) 1991 Jul-Aug;19(4):167-73. Querfeld U, LeBoeuf RC, Salusky IB, Nelson P, Laidlaw S, Fine RN. Lipoproteins in children treated with continuous peritoneal dialysis. Pediatr Res 1991 Feb;29(2):155-9. Querfeld U, Wendtland J, von Hodenberg E, Mehls O. Lipid levels in monocytes of patients with moderate hyperlipoproteinemia. Atherosclerosis 1992 Jun; 94(2-3): 129-34. Qureshi GA, Baig SM. Application of high performance liquid chromatography in study of sulphur amino acid metabolism in uremic patients. Biochem Mol Biol Int 1993 Feb;29(2):359—68. Ramirez JA, Goodman WG, Menezes C, Segre GV, Salusky IB. Disodium ethylenediaminetetraacetate: adverse effects in dialyzed children. Pediatr Nephrol 1993 Apr;7(2):182-4. Reichel H, Recker A, Deppisch R, Stier E, Ritz E. 25- Hydroxyvitamin D3 metabolism in vitro by mononuclear cells from hemodialysis patients. Nephron 1992;62(4):404-12. Remuzzi A, Boccardo P, Benigni A. In vitro platelet adhesion to dialysis membranes. Nephrol Dial Transplant 1991;6 Suppl 2236-9. Richard M], Arnaud J, Jurkovitz C, Hachache T, Mefiahi H, Laporte F, Foret M, Favier A, Cordonnier D. Trace elements and lipid peroxidation abnormalities in patients with chronic renal failure. Nephron 1991;57(1):10-5. Ringoir S, Vanholder R. Phagocytic function in the uremic patient. Contrib Nephrol 1992;100:15-24. Roccatello D, D’Alfonso S, Peruccio D, Quattrocchio G, Cavalli G, Isidoro C, Piccoli G, Richiardi PM. Induction of mRNA for tumor necrosis factor alpha in hemodialysis. Kidney Int Suppl 1993 Jan;39: Sl44-8. Rodby RA, Trenholme GM. Vaccination of the dialysis patient. Semin Dial 1991 Apr-Jun;4(2):102-5. Rodger RS, Muralikrishna GS, Halls DJ, Henderson JB, Forrest JA, Macdougall AI, Fell GS. Ranitidine suppresses aluminium absorption in man. Clin Sci 1991 May;80(5):505—8. Rodriguez M, Felsenfeld A], Williams C, Pederson JA, Llach F. The effect of long-term intravenous calcitriol administration on parathyroid function in hemodialysis patients. J Am Soc Nephrol 1991 Nov;2(5):1014-20. Roger SD, Crewe E, Cunningham A, Harris DC. Hepatitis C virus infection in haemodialysis patients. Aust N Z J Med 1991 Feb;21(1):22-4. Ross RD, Kalidindi V, Vincent JA, Kassab J, Dabbagh S, Hsu JM, Pinsky WW. Acute changes in endothelin-l after hemodialysis for chronic renal failure. J Pediatr 1993 Jun;122(6):S74—6. Rudnicki M, McNair P, Transbl I, Nielsen B. Lack of relationship between parathyroid hormone and 1,25- dihydroxyvitamin D in chronic renal failure. Nephron 1991;58(2):144—9. Ryan J], Beynon HL, Rees AJ, Cassidy M]. In vitro production of tumor necrosis factor by monocytes cultured from dialysis patients. Kidney Int Suppl 1993;41:5226-9. Sabater J, Quereda C, Herrera I, Pascual J, Villafruela JJ, Ortuno I. Nonenzymatic glycosylation of hemoglobin and total plasmatic proteins in end-stage renal disease. Am J Nephrol 1991;11(1):37-43. Sacchetti A, Harris R, Patel K, Attewell R. Emergency department presentation of renal dialysis patients: indications for EMS transport directly to dialysis centers. J Emerg Med 1991 May-Jun;9(3):141-4. Sadler DB, Brown J, Nurse H, Roberts J. Impact of hemodialysis on left and right ventricular Doppler diastolic filling indices. Am J Med Sci 1992 Aug; 304(2):83-90. Sagripanti A, Cupisti A, Baicchi U, Ferdeghini M, Morelli E, Barsotti G. Plasma parameters of the prothrombotic state in chronic uremia. Nephron 1993;63(3):273-8. Saha H, Pietila K, Mustonen J, Pastemack A, Morsky P. Acute effect of dialysate calcium concentration and intravenous vitamin D3 on the secretion of parathyroid hormone in hemodialysis patients. Clin Nephrol 1992 Sep;38(3):145-8. Saito Y, Kazuwa N, Shirakami G, Mukoyama M, Arai H, Hosoda K, Suga S, Ogawa Y, Imura H. Endothelin in patients with chronic renal failure. J Cardiovasc Pharmacol 1991;17 Suppl 7:S437-9. Sakaguchi K, Morimoto S, Chen YH, Nakamoto Y, Ogihara T. Increases in circulating level of platelet- activating factor lag behind transient neutropenia during hemodialysis with cuprophane membranes. Nephron 1991;59(3):455—60. Sanders PW. Role of nitric oxide in regulation of blood pressure. I Nephrol 1992;5(1):23-30. Saniabadi AR, Fisher TC, Lau CS, Bridges A, Taylor J, Belch J, Forbes CD. Dipyridamole increases human red blood cell deformability. Eur J Clin Pharmacol 1992;42(6):651-4. Santoro A, Spongano M, Ferrari G, Bolzani R, Augella F, Borghi M, Briganti M, Cagnoli L, Docci D, Feletti C, Fusaroli M, Gattiani A, Sanna G, Stallone C, Zucchelli P. Analysis of the factors influencing bicarbonate balance during acetate-free biofiltration. Kidney Int Suppl 1993;41:S184-7. Saragoca MA, Canziani ME, Cassiolato JL, Gil MA, Andrade JL, Draibe SA, Martinez EE. Left ventricular hypertrophy as a risk factor for arrhythmias in hemodialysis patients. J Cardiovasc Pharmacol 1991;17 Suppl 2:S136—8. Sasagawa I, Nakada T, Hashimoto T, Ishigooka M, Kubota Y, Hirano K, Hirano I, Suzuki Y. Serum prostatic acid phosphatase, gamma-seminoprotein and prostatic specific antigen in hemodialysis patients. Urol Int 1992;48(2):181-3. Sato Y, Takagi T, Seto H, Shibayama S, Narumiya K, Osaku A, Koyama S, Uchiyama T, Kajiwara N. Diastolic properties of the left ventricle in uremic patients undergoing long-term hemodialysis. Nihon Univ J Med 1991;33(4):279-90. Savica V, Bellinghieri G, Barbera CM, Egitto M, Consolo F. The coagulative system in haemodialyzed patients: the relationship between the elderly and hypertrygliceridaemia. Arch Ital Urol Nefrol Androl 1992 Jun;64(2):155-63. Schaefer F, Hamill G, Stanhope R, Preece MA, Scharer K. Pulsatile growth hormone secretion in peripubertal patients with chronic renal failure. Cooperative Study Group on Pubertal Development in Chronic Renal Failure. J Pediatr 1991 Oct; 119(4):568-77. Schaefer F, Seidel C, Mitchell R, Scharer K, Robertson WR. Pulsatile immunoreactive and bioactive 15 luteinizing hormone secretion in adolescents with chronic renal failure. The Cooperative Study Group on Pubertal Development in Chronic Renal Failure (CSPCRF). Pediatr Nephrol 1991 Jul;5(4):566—71. Schaefer RM, Paczek L, Heidland A. Cytokine production by monocytes during haemodialysis. Nephrol Dial Transplant 1991;6 Suppl 2:14-7. Schaefer RM, Paczek L, Heidland A. Suppression of beta 2-microglobulin release from lymphocytes by dialysis membranes. Nephrol Dial Transplant 1991; 6 Suppl 3:53-6. Schambye HT, Pedersen FB, Wang P. Bicarbonate is not the ultimate answer to the biocompatibility problems of CAPD solutions: a cytotoxicity test of CAPD solutions and effluents. Adv Perit Dial 1992; 8:42-6. Schauer S, Stein G, Suss I, Falkenhagen D, Linss W. Phagocytosis activity of polymorphonuclear cells of normal persons and dialysis patients is influenced by different dialysis membranes. Nephrol Dial Transplant 1991;6 Suppl 3:35-40. Schiffl H. Correlation of blood pressure in end-stage renal disease with platelet cytosolic free calcium concentration during treatment of renal anemia with recombinant human erythropoietin. Int J Artif Organs 1992;15(6):343-8. Schiffl H, D’Agostini B, Held E. Removal of beta 2- microglobulin by hemodialysis and hemofiltration: a four year follow up. Biomater Artif Cells Immobilization Biotechnol 1992;20(5):1223-32. Schiller B, Ziegler-Heitbrock HW, Meyer N, Schmidt B, Blumenstein M. Monocyte phenotype and interleukin-1 production in patients undergoing haemodialysis. Nephron 1991;59(4):573-9. Schindler R, Linnenweber S, Schulze M, Oppermann M, Dinarello CA, Shaldon S, Koch KM. Gene expression of interleukin-1 beta during hemodialysis. Kidney Int 1993 Mar;43(3):712—21. Schlatter C. Biomedical aspects of aluminium. Med Lav 1992 Sep-Oct;83(5):470—4. Schmidtmann S, Muller M, von Baehr R, Precht K. Changes of antioxidative homeostasis in patients on chronic haemodialysis. Nephrol Dial Transplant 1991;6 Suppl 3:71-4. Schohn DC, Jahn HA, Pelletier BC. Dose-related cardiovascular effects of spironolactone. Am J Cardiol 1993;71(3):40a—5a. Selgas R, Castro MI, Bajo MA, Femandez—Reyes MI, Lopez-Revuelta K, Romero J R, de Alvaro F, Borrego F, Rinon C. Staphylococcus aureus nasal carrier status (SANCS) in CAPD patients; is it induced or favored by subcutaneous rHu- erythropoietin? Adv Perit Dial 1992;8:253-7. 16 Selgas R, Lopez-Rivas A, Miranda B, Munoz J, Rinon C, Borrego F, Molina S, Sanchez-Sicilia L. Characterisation of the mitogenic-induced capacity of peritoneal effluent on human and mice fibroblasts in culture. Nephrol Dial Transplant 1991;6(1): 44—50. Selgas R, Martinez ME, Miranda B, Bajo MA, Romero JR, Ausejo M, Sanchez-Cabezudo MJ, Lopez- Revuelta K, Sanchez-Sicilia L. The pharmacokinetics of a single dose of calcitriol administered subcutaneously in continuous ambulatory peritoneal dialysis patients. Perit Dial Int 1993;13(2):122—5. Senti M, Romero R, Pedro-Botet J, Pelegri A, Nogues X, Rubies-Prat J. Lipoprotein abnormalities in hyperlipidemic and normolipidemic men on hemodialysis with chronic renal failure. Kidney Int 1992 May;41(5):1394—9. Seres DS, Strain GW, Hashim SA, Goldberg IJ, Levin NW. Improvement of plasma lipoprotein profiles during high-flux dialysis. J Am Soc Nephrol 1993 Jan;3(7):1409-15. Shaldon S. Dialyzer reuse: the time has come to stop this practice. Dial Transplant 1993;22(3):122, 125-6. Shapira OM, Bar-Khayim Y. ECG changes and cardiac arrhythmias in chronic renal failure patients on hemodialysis. J Electrocardiol 1992 Oct;25(4): 273-9. Sheu JC, Lee SH, Wang JT, Shih LN, Wang TH, Chen DS. Prevalence of anti-HCV and HCV viremia in hemodialysis patients in Taiwan. J Med Virol 1992 Jun;37(2): 108- 12. Shoji T, Nishizawa Y, Nishitani H, Yamakawa M, Morii H. High serum lipoprotein(a) concentrations in uremic patients treated with continuous ambulatory peritoneal dialysis. Clin Nephrol 1992 Nov;38(5):271—6. Shoji T, Nishizawa Y, Nishitani H, Yamakawa M, Morii H. Impaired metabolism of high density lipoprotein in uremic patients. Kidney Int 1992 Jun; 41(6):1653-61. Shulman LM, Rudich C, Sayar Y, Goldfeld G, Mendelson B, Blau A, Vonsover A. Detection of CMV-DNA in cells from peritoneal fluid of IPD/CAPD patients by polymerase chain reaction. Adv Perit Dial 1992;8z258-64. Sieniawska M, Roszkowska-Blaim M, Weglarska J, Jabczynska A, Welc-Dobies J. Calcium carbonate as a phosphate binder in children on continuous ambulatory peritoneal dialysis and hemodialysis. Mater Med Pol 1991 Jul-Sep;23(3):203—8. Sitter T, Spannagl M, Schiffl H. Anticardiolipin antibodies and lupus anticoagulant in patients treated with different methods of renal replacement therapy in comparison to patients with systemic lupus erythematosus. Ann Hematol 1992 Aug;65(2): 79-82. Skroeder NR, Jacobson SH, Holmquist B, Kjellstrand P, Kjellstrand CM. Beta 2-microglobulin generation and removal in long slow and short fast gemodialysis. Am J Kidney Dis 1993 May;2l(5): 19-26. Sloand EM, Sloand JA, Prodouz K, Klein HG, Yu MW, Harvath L, Fricke W. Reduction of platelet glycoprotein Ib in uraemia. Br J Haematol 1991 Mar;77(3):375-81. Comment in: Br J Haematol 1992 May;81(l):13l. Smit JC, Jones JG. Oxygen saturation during hemodialysis. Ren Fail 1993;15(2):239—45. Smolenski O, Tabarowski Z, Miszta H, Dabrowski Z. Effect of haemodialysate and its peptide fractions on lactate dehydrogenase activity in erythrocytes from healthy subjects and patients with end-stage renal disease. Int Urol Nephrol 1992;24(6):673—8. Smollich BP, Falkenhagen D, Schneidewind J, Mitzner S, Klinkmann H. Importance of endotoxins in high- flux dialysis. Nephrol Dial Transplant 1991; 6 Suppl 3:83-5. Comment in: Nephrol Dial Transplant 1992;7(8):884-5. Sohn HJ, Stokes GS, Johnston H. An Na, K ATPase inhibitor from ultrafiltrate obtained by hemodialysis of patients with uremia. J Lab Clin Med 1992 Aug; 120(2):264—71. Solomon R, Dubey A. Diltiazem enhances potassium disposal in subjects with end-stage renal disease. Am J Kidney Dis 1992 May;19(5):420-6. Solski J, Ksiazek A, Szymonik—Lesiuk S, Marzec Z. Membrane ATPase, erythrocyte sodium and potassium in haemodialysis patients. Int Urol Nephrol 1991;23(3):275-80. Spiegel DM, Anderson M, Campbell U, Hall K, Kelly G, McClure E, Breyer JA. Serum albumin: a marker for morbidity in peritoneal dialysis patients. Am J Kidney Dis 1993 Jan;21(1):26-30. Spiegel DM, Sprague SM. Serum amyloid P component: a predictor of clinical beta 2- microglobulin amyloidosis. Am J Kidney Dis 1992 May;19(5):427—32. Stein G, Schneider A, Thoss K, Ritz E, Linke RP, Schaefer K, Sperschneider H, Abendroth K, Funfstuck R. Beta-2—microglobulin—derived amyloidosis: onset, distribution and clinical features in 13 hemodialysed patients. Nephron 1992;60(3): 274-80. Stein G, Schneider A, Thoss K, Ritz E, Schaefer K, Huller M, Sperschneider H, Marzoll I. Beta 2- microglobulin serum concentration and associated amyloidosis in dialysis patients. Nephrol Dial Transplant 1991;6 Suppl 3:57-61. Steyn ME, Viljoen M, Ubbink JB, van Rensburg BW, Reinach SG. Whole blood serotonin levels in chronic renal failure. Life Sci 1992;51(5):359—66. Stockenhuber F, Gottsauner—Wolf M, Marosi L, Liebisch B, Kurz RW, Balcke P. Plasma levels of endothelin in chronic renal failure and after renal transplantation: impact on hypertension and cyclosporin A-associated nephrotoxicity. Clin Sci 1992 Mar;82(3):255-8. Subra JF, Krari N, Tirot P, Mauras Y, Balit G, Van- Weydevelt FC, Allain P. Aluminium determination in the skin of patients with and without end-stage renal failure. Nephron 1991;58(2):170—3. Sugisaki H, Yamada K, Kataoka H, Kunitomo T. Long- term observation on renal-osteodystrophy-related parameters in dialysis patients. Nephrol Dial Transplant 1991;6 Suppl 2:99-103. Sulkova S, Laurincova Z, Valek A. Haemofiltration or haemodialysis in aluminium elimination? Nephrol Dial Transplant 1991;6 Suppl 3:3-5. Sulkova S, Valek A. Aluminum elimination in patients receiving regular dialysis treatment for chronic renal failure. Trace Elem Med 1991;8 Suppl 1: 826-30. Sulowicz W, Hanicki Z, Chichocki T, Zembala M, Ruggiero I, Uracz W. Functional characteristics of peritoneal macrophages of renal failure patients on peritoneal dialysis. Perit Dial Int 1991;11(3):265—9. Sulowicz W, Hanicki Z, Uracz W, Hajto B, Ruggiero I, Zembala M. Effect of peritoneal macrophages from intermittent peritoneal dialysis patients on lymphocytes in culture. Perit Dial Int 1992;12(2): 234-40. Sundaram S, Irvine L, Courtney JM, Lowe GD. Modification of the influence of biomaterials on contact activation. Int J Artif Organs 1991 Nov; 14(11):729-31. Sunder-Plassmann G, Heinz G, Wagner L, Prychzy B, Derfler K. T-cell selection and T-cell receptor variable beta-chain usage in chronic hemodialysis patients. Clin Nephrol 1992 May;37(5):252—9. Sunder—Plassmann G, Sedlacek PL, Sunder-Plassmann R, Derfler K, Swoboda K, Fabrizii V, Hirschl MM, Balcke P. Anti-interleukin-l alpha autoantibodies in hemodialysis patients. Kidney Int 1991 Oct;40(4):787—91. Suowicz W, Lisiewicz J, Kosiniak-Kamysz A. Activity of some lysosomal enzymes in peritoneal lymphocytes from patients with terminal renal 17 failure treated by intermittent peritoneal dialysis. Rom J Intern Med 1991 Jul-Dec;29(3—4):167-72. Suppiej A, Caara G, Boniver C, Pozzan GB, Montini G, Zacchello G, Zacchello F. Somatosensory pathway dysfunction in uremic children. Brain Develop 1991;13(4):238-41. Svehag SE. Adverse effects of clinical intervention on the complement system. Complement Inflamm 1991;8(5-6):359-69. Swars H, Hafner G, Weilemann LS, Ehrenthal W, Schinzel H, Prellwitz W, Meyer J. Acute dialysis: PMN—elastase as a new parameter for controlling individual anticoagulation with low molecular weight heparin (Fragmin). Intensive Care Med 1991;17(1):52—6. Taccone-Gallucci M, Lubrano R, Clerico A, Meloni C, Morosetti M, Meschini L, Elli M, Trapasso E, Castello MA, Casciani CU. Administration of GSH has no influence on the RBC membrane: oxidative damage to patients on hemodialysis. ASAIO J 1992 Oct-Dec;38(4):855—7. Takagi T, Nishikawa M, Mori Y, Matsubara H, Inada M. Effects of atrial natriuretic peptide infusion and its metabolism in patients with chronic renal failure. Endocrinol Jpn 1991 Oct;38(5):497-503. Taylor A, Walker AW. Measurement of aluminium in clinical samples. Ann Clin Biochem 1992 Jul; 29(Pt 4):377—89. Tetta C, David S, Biancone L, Canino F, Cambi V, Camussi G. Role of platelet activating factor in hemodialysis. Kidney Int Suppl 1993 Jan;39: 8154-7. I Tetta C, Fidelio T, Licata C, Iacono L, Sancipriano G, Biancone L, Ragni R, Segoloni G, Camussi G. Production of tumor necrosis factor-alpha in patients on hemodiafiltration. Nephron 1992;61(2): 135-8. Tetta C, Segoloni G, Mariano F, Montrucchio G, Turello E, Camussi G. Leukocyte-derived mediators and biocompatibility. Nephrol Dial Transplant 1991;6 Suppl 2:24-30. Thylen P, Lundahl J, Fernvik E, Hed J, Svenson SB, Jacobson SH. Mobilization of an intracellular glycoprotein (Mac-1) on monocytes and granulocytes during hemodialysis. Am J Nephrol 1992;12(6):393-400. Tibi L, Chhabra SC, Sweeting VM, Winney RJ, Smith AF. Multiple forms of alkaline phosphatase in plasma of hemodialysis patients. Clin Chem 1991 Jun;37(6):815-20. Comment in: Clin Chem 1991 Jun;37(6):783-4. Tobe S, Chu MG, Bargman JM. Characterization of peritoneal transport in patients with failed renal 18 allografis receiving CAPD. Adv Perit Dial 1991;7: 39-43. Toborek M, Wasik T, Drozdz M, Klin M, Magnet- Wrobel K, Kopieczna—Grzebieniak B. Effect of hemodialysis on lipid peroxidation and antioxidant system in patients with chronic renal failure. Metabolism 1992 Nov;4l(11):1229-32. Tokars JI, Alter MJ, Favero MS, Moyer LA, Bland LA. National surveillance of hemodialysis associated diseases in the United States, 1990. ASAIO J 1993 Jan-Mar;39(1):71-80. Trevino-Becerra A. Successful factors in peritoneal dialysis. Transplant Proc 1991;23(2):1843-4. Tsai TI, Tsai HF, Chen YM, Hsieh BS, Chen WY, Yen TS. CAPD in patients unable to do their own bag change. Perit Dial Int 199l;l 1(4):356-8. Turan B, Delilbasi E, Dalay N, Sert S, Afrasyap L, Sayal A. Serum selenium and glutathione peroxidase activities and their interaction with toxic metals in dialysis and renal transplantation patients. Biol Trace Elem Res 1992 Apr-Jun;33:95-102. Turi S, Nemeth I, Vargha I, Matkovics B, Dobos E. Erythrocyte defense mechanisms against free oxygen radicals in haemodialysed uraemic children. Pediatr Nephrol 1991 Mar;5(2):179-83. Tumey JH, Davison AM, Forbes MA, Cooper EH. Hyaluronic acid in end-stage renal failure treated by haemodialysis: clinical correlates and implications. Nephrol Dial Transplant 1991;6(8):566-70. Urena P, Bonnardeaux A, Eckardt KU, Kurtz A, Drueke TB. Insulin-like growth factor I: a modulator of erythropoiesis in uraemic patients? Nephrol Dial Transplant 1992;7(1):40—4. Urena P, Herbelin A, Zingraff J, Lair M, Man NK, Descamps-Latscha B, Drueke T. Permeability of cellulosic and non-cellulosic membranes to endotoxin subunits and cytokine production during in-vitro haemodialysis. Nephrol Dial Transplant 1992;7(1):16-28. Van Gool S, Van Damme—Lombaerts R, Cobbaert C, Proesmans W, Eggermont E. Lipid and lipoprotein abnormalities in children on hemodialysis and after renal transplantation. Transplant Proc 1991 Feb; 23(1 Pt 2):1375-7. Van Renterghem D, Comelis R, Vanholder R. Behaviour of 12 trace elements in serum of uremic patients on hemodiafiltration. J Trace Elem Electrolytes Health Dis 1992 Sep;6(3):169—74. Vanholder R, Dell’Aquila R, Jacobs V, Dhondt A, Veys N, Waterloss MA, Van Landschoot N, Van Biesen W, Ringoir S. Depressed phagocytosis in hemodialyzed patients: in vivo and in vitro mechanisms. Nephron 1993;63(4):409-15. Vanholder R, Ringoir S. Cefodizime: enhancement of depressed phagocytosis-associated respiratory burst activity in chronic uremic patients. Infection 1992; 20 Suppl 1:S71-4. Vanholder R, Ringoir S. Polymorphonuclear cell function and infection in dialysis. Kidney Int Suppl 1992 0ct;38:S91-5. Vanholder R, Van Haecke E, Veys N, Ringoir S. Endotoxin transfer through dialysis membranes: small- versus large-pore membranes. Nephrol Dial Transplant 1992;7(4):333-9. Vanholder R, Waterloos M, Van Landschoot N, Ringoir S. Suppression of phagocytosis in patients on complement activating dialyzers. Clin Mater 1991;8(1-2):89—93. Vannucchi MT, Vannucchi H, Humphreys M. Serum levels of vitamin A and retinol binding protein in chronic renal patients treated by continuous ambulatorial peritoneal dialysis. Int J Vitam Nutr Res 1992;62(2):1(T7-12. Vasilakakis DM, D’Haese PC, Lamberts LV, Lemoniatou E, Digenis PN, De Broe ME. Removal of aluminoxamine and ferrioxamine by charcoal hemoperfusion and hemodialysis. Kidney Int 1992 May;41(5):1400-7. Vasile A, Allegra V, Canciani D, Forchi G, Mengozzi G. Prospective and retrospective assessment of clinical and laboratory parameters in maintenance hemodialysis patients with and without HCV antibodies. Nephron 1992;61(3):318—9. Vasson MP, Paul JL, Couderc R, Albuisson E, Bargnoux PJ, Baguet I C, Raichvarg D. Serum alpha-1 acid glycoprotein in chronic renal failure and hemodialysis. Int J Artif Organs 1991 Feb; 14(2):92-6. Vaziri ND, Kaupke Cl, Yousefi S, Gonzales E, Cesario TC. Cytokine levels during hemodialysis. ASAIO Trans 1991 Jul-Sep;37(3):M389-91. Viljoen M, de Oliveira AA, Milne Fl. Physical properties of the red blood cells in chronic renal failure. Nephron 1991;59(2):271-8. Vincent C, Chanard J, Caudwell V, Lavaud S, Wong T, Revillard JP. Kinetics of 1251-beta 2- microglobulin turnover in dialyzed patients. Kidney Int 1992 Dec;42(6):1434-43. Wadhwa NK, Howell N, Suh H, Cabralda T. Low calcium (2.5 mEq/l) and high calcium (3.5 mEq/l) dialysate in peritoneal dialysis patients. Adv Perit Dial 1992;8:385-8. Wakasugi K, Sasaki M, Suzuki M, Azuma N, Nobuto T. Increased concentrations of free light chain lambda in sera from chronic hemodialysis patients. Biomater Artif Cells Immobilization Biotechnol 1991;19(1):97-109. Walshaw MJ, Lim R, Ahmad R, Hind CR. Bronchial reactivity in patients undergoing long-term haemodialysis for chronic renal failure. Blood Purif 1991;9(2):70-3. Wanner C, Frommherz K, Horl WH. Hyperlipoproteinemia in chronic renal failure: pathophysiological and therapeutic aspects. Cardiology 1991;78(3):202-17. Weinberg U, Dolev S, Werber MM, Shapiro MS, Shilo L, Shenkman L. Identification and preliminary characterization of two human digitalis-like substances that are structurally related to digoxin and ouabain. Biochem Biophyl Res Commun 1992 Nov 16;188(3):1024-9. Weinrauch LA, D’Elia JA, Gleason RE, Hampton LA, Smith-Ossman S, DeSilva RA, Nesto RW. Usefulness of left ventricular size and function in predicting survival in chronic dialysis patients with diabetes mellitus. Am J Cardiol 1992 Aug 1;70(3): 300-3. Weinstein T, Fishman P, Djaldetti M, Levi J. Cytokine production by mononuclear cells from patients with chronic renal failure. Isr J Med Sci 1993 Apr;29(4): 183-6. Wieslander AP, Nordin MK, Kjellstrand PT, Boberg UC. Toxicity of peritoneal dialysis fluids on cultured fibroblasts, L-929. Kidney Int 1991 Jul; 40(1):77—9. Wilkie ME, Khandan-Nia N, Ghatei MA, Bloom SR, Raflery MJ, Cunningham J. Does the arteriovenous fistula in chronic haemodialysis patients stimulate endothelin-l release? Nephrol Dial Transplant 1992; 7(10):1019-21. Willems M, de Jong G, Moshage H, Verresen L, Goubau P, Desmyter J, Yap SH. Surrogate markers are not useful for identification of HCV carriers in chronic hemodialysis patients. J Med Virol 1991 Dec,35(4):303-6. Yamada K, Nakayama M, Miura Y, Nakano H, Mimura N, Yoshida S. Role of AVP in the regulation of vascular tonus and blood pressure in patients with chronic renal failure. Regul Pept 1993;45(1-2):91-5. Yamalik N~, Delilbasi L, Gulay H, Caglayan F, Haberal M, Caglayan G. The histological investigation of gingiva from patients with chronic renal failure, renal transplants, and periodontitis: a light and electron microscopic study. J Periodontol 1991 Dec; 62( 12) 2737-44. Yamazaki M, Asakura H, Sato T, Tsugawa Y, Matsumura M, Kawamura Y, Ohka T, Matsuda T. Changes in plasma levels of thrombomodulin during 19 haemodialysis. Blood Coagul Fibrinolysis 1992 Feb;3(l):113-7. Yukawa S, Tone Y, Sonobe M, Maeda T, Mimura K, Mune M, Fujiwara S, Tsujimoto K, Maeshima E, Saika Y, et al. Study on the inhibitory effect of uremic plasma on lipoprotein lipase. Nippon Jinzo Gakkai Shi 1992 Sep;34(9):979-85. Zeferos N, Digenis GE, Christophoraki M, Alexopoulos I, Kostakis A, Gyftaki H, Moulopoulos S. Tumor markers in patients undergoing hemodialysis or kidney transplantation. Nephron 1991;59(4):618-20. Zemel D, ten Berge RJ, Struijk DG, Bloemena E, Koomen GC, Krediet RT. Interleukin-6 in CAPD patients without peritonitis: relationship to the intrinsic permeability of the peritoneal membrane. Clin Nephrol 1992 Feb;37(2):97-103. Zevin D, Malachi T, Gafier U, Friedman J, Levi J. Impaired DNA repair in patients with end-stage renal disease and its improvement with hemodialysis. Miner Electrolyte Metab 1991;17(5): 303-6. Zhou XI, Vaziri ND, Kaupke CI. Glomerulopressin in end-stage renal disease. Effect of hemodialysis. ASAIO Trans 1991 Jul-Sep;37(3):M235-6. Zimmerman SW, Oxton L, Roecker E, Wakeen M, Johnson CA. Risk factors for peritoneal dialysis (PD) related infections [abstract]. J Am Soc Nephrol 1991;2(3):371. 20 The Role of Nutrition -Clinical Trial Fouque D, Laville M, Boissel JP, Chifflet R, Labeeuw M, Zech PY. Controlled low protein diets in chronic renal insufficiency: meta-analysis. BMJ 1992 Jan 25;304(6821):216-20. Comment in: BMJ 1992 Mar 7;304(6827):640; BMJ 1992 Apr 11; 304(6832):983. -0ther Allman MA, Pang E, Yau DF, Stewart PM, Tiller DJ, Truswell AS. Elevated plasma vitamers of vitamin B6 in patients with chronic renal failure on regular haemodialysis. Eur J Clin Nutr 1992 Sep;46(9): 679-83. Bergstrom J. Anorexia and malnutrition in hemodialysis patients. Blood Purif 1992;10(1):35-9. Bergstrom J. Factors causing catabolism in maintenance hemodialysis patients. Miner Electrolyte Metab 1992;18(2—5):280—3. Blagg CR. Importance of nutrition in dialysis patients [editorial]. Am J Kidney Dis 1991 Apr;17(4): 458-61. Butler BA. Nutritional management of catabolic acute renal failure requiring renal replacement therapy. ANNA J 1991 Jun;18(3):247-59. Cancarini G, Costantino E, Brunori G, Manili L, Camerini C, Spitti C, Maiorca R. Nutritional status in long-term CAPD patients. Adv Perit Dial 1992; 8:84-7. Canepa A, Perfume F, Carrea A, Giallongo F, Verrina E, Cantaluppi A, Gusmano R. Long-term effect of amino-acid dialysis solution in children on continuous ambulatory peritoneal dialysis. Pediatr Nephrol 1991 Mar;5(2):215-9. Cano N, Stroumza P, Lacombe P, Labastie- Coeyrehourcq J, Durbec JP. Serum transthyretin and protein intake in haemodialysis patients. Nephrol Dial Transplant 1992;7(10):1069-70. Capelli JP, Kushner H, Camiscioli TC, Chen SM, Stuccio-White N. Effect of intra-dialytic parenteral nutrition IDPN on mortality in ESRD care [abstract]. J Am Soc Nephrol 1992;3(3):357. Chiappini MG, Selvaggi G, Traietti P, Bartoli R. Nutritional status in haemodialysis patients a cross- sectional and longitudinal study [abstract]. Nephrol Dial Transplant 1992;7(7):723. Compher C, Mullen JL, Barker CF. Nutritional support in renal failure. Surg Clin North Am 1991;71(3): 597-608. Dabbagh S, Fassinger N, Clement K, Fleischmann LE. The effect of aggressive nutrition on infection rates in patients maintained on peritoneal dialysis. Adv Perit Dial 1991;7z161-4. Dombros NV, Digenis GE, Oreopoulos DG. Malnutrition in continuous ambulatory peritoneal dialysis and use of intraperitoneal amino acids. Contrib Nephrol 1992; 100: 188-206. Domingo JL, Gomez M, Llobet JM, Corbella J. Influence of some dietary constituents on aluminum absorption and retention in rats. Kidney Int 1991; 39(4):598-601. Druml W, Lochs H, Roth E, Hubl W, Balcke P, Lenz K. Utilization of tyrosine dipeptides and acetyltyrosine in normal and uremic humans. Am J Physiol 1991 Feb;260(2 Pt 1):E280-5. Dumler F, Schmidt R, Kilates C, Faber M, Lubkowski T, Frinak S. Use of bioelectrical impedance for the nutritional assessment of chronic hemodialysis patients. Miner Electrolyte Metab 1992;18(2—5): 284-7. Foulks CJ. Indications for the use of intradialytic parenteral nutrition in the malnourished hemodialysis patient. I Renal Nutr 1991 Jan;1(1): 23-33. Girelli D, Olivieri O, Stanzial AM, Azzini M, Lupo A, Bernich P, Menini C, Gammaro L, Corrocher R. Low platelet glutathione peroxidase activity and serum selenium concentration in patients with chronic renal failure: Relations to dialysis treatments, diet and cardiovascular complications. Clin Sci 1993;84(6):611-7. Goldstein DJ, Bertel SF. Unresolved malnutrition of the dialysis patient: is supplementation enough? Nephrol News Issues 1992 Oct;6(10):40-2, 44-5, 53. Hug-Weber M, Dumann H, Horl WH. Effect of malnutrition and uremia on impaired cellular host defence. Miner Electrolyte Metab 1992;18(2-5): 174-85. Hakim RM, Levin N. Malnutrition in hemodialysis patients. Am J Kidney Dis 1993 Feb;21(2):125-37. Himmelfarb J, Robinson R, Nye R, McMonagle E, Spratt D. Anabolic and catabolic hormone levels are better predictors of nutritional status than KT-V or PCR in hemodialysis [abstract]. J Am Soc Nephrol 1992;3(3):369. Hitchcock PB, Brantley P], Jones GN, McKnight GT. Stress and social support as predictors of dietary compliance in hemodialysis patients. Behav Med 1992 Spring;18(1):l3-20. Hombrouckx R0, Bogaert AM, Leroy FM, De Vos JY, Vermaercke NM, Picavet LM, Lame LA. Polyunsaturated fatty acids of the n—3 class in chronic dialysis. ASAIO J 1992 Jul-Sep;38(3): M331-3. Honda M, Kamiyama Y, Hasegawa O, Hoshinaga K, Ogawa O, Kawamura T, Ito H. Effect of short-term essential amino acid-containing dialysate in young children on CAPD. Peritoneal Dial Int 1991;ll(1): 76-80. Jones MR, Martis L, Algrim CE, Bernard D, Swartz R, Messana J, Bergstrom J, Lindholm B, Lim V, Serkes KD, et a1. Amino acid solutions for CAPD: rationale and clinical experience. Miner Electrolyte Metab 1992;18(2-5):309-15. Jones MR, Mattis L, Cantaluppi A. Approaches to correcting protein malnutrition with modified peritoneal dialysis solutions. Contrib Nephrol 1992; 98:174-82. Laorpatanaskul S, Pochanugool C, Sitprija V. The use of oral essential amino acids in hemodialysis patients. J Med Assoc Thai 1991 Feb;74(2):66-70. Lazarus J M. Nutrition in hemodialysis patients. Am J Kidney Dis 1993 Jan;21(1):99—105. Lindholm B, Bergstrom J. Nutritional aspects on peritoneal dialysis. Kidney Int Suppl 1992 Oct; 38:8165-71. Lombardi M, Pizzarelli F, Righi M, Cerrai T, Dattolo P, Nigrelli S, Michelassi S, Sisca S, Alecci A, Di Geronimo P, Maggiore Q. Hepatitis B vaccination in dialysis patients and nutritional status. Nephron 1992;61(3):266-8. Lowrie EG, Lew NL, Huang WH. Race and diabetes as death risk predictors in hemodialysis patients. Kidney Int Suppl 1992 Oct;38:822-31. Lubrano R, Taccone-Gallucci M, Piazza A, Morosetti M, Meloni C, Citti G, Mannarino O, Castello MA, Casciani CU. Vitamin E supplementation and oxidative status of peripheral blood mononuclear cells and lymphocyte subsets in hemodialysis patients. Nutrition 1992 Mar-Apr;8(2):94—7. Makoff R. Water-soluble vitamin status in patients with renal disease treated with hemodialysis or peritoneal dialysis. J Renal Nutr 1991 Apr;1(2):56-73. Matthys DA, Vanholder RC, Ringoir SM. Benefit of intravenous essential amino-acids in catabolic patients on chronic maintenance hemodialysis. Acta Clin Belg 1991;46(3):150—8. Mayer DR, Kosmus W, Pogglitsch H, Mayer D, Beyer W. Essential trace elements in humans. Serum arsenic concentrations in hemodialysis patients in comparison to healthy controls. Biol Trace Elem Res 1993 Apr;37(1):27-38. 21 Mitch WE. Dietary protein restriction in patients with chronic renal failure [clinical conference]. Kidney Int 1991 Aug;40(2):326-41. Musk M, Anderson H, Oreopoulos D, Leiter L, Bargman J, Pettit J, Jones M. Effects of amino acid dialysate on appetite in CAPD patients. Adv Perit Dial 1992;8:153-6. Mydlik M, Derzsiova K, Guman M, Hrehorovsky M. Vitamin B6 requirements in chronic renal failure. Int Urol Nephrol 1992;24(4):453-7. Oksa H, Ahonen K, Pastemack A, Marnela KM. Malnutrition in hemodialysis patients. Scand J Urol Nephrol 1991 ;25(2): 157-61 . Ono K, Hisasue Y. Is folate supplementation necessary in hemodialysis patients on erythropoietin therapy. Clin Nephrol 1992 Nov;38(5):290-2. Rammohan M, Aplasca EC. Caliper method vs bioelectrical impedance analysis for determining body fat in patients undergoing chronic dialysis and in healthy individuals. I Am Diet Assoc 1992 Nov; 92(11):l395-7. Rayner HC, Stroud DB, Salamon KM, Strauss BJ, Thomson NM, Atkins RC, Wahlqvist ML. Anthropometry underestimates body protein depletion in haemodialysis patients. Nephron 1991; 59(1):33-40. Reid DJ, Barr SI, Leichter J. Effects of folate and zinc supplementation on patients undergoing chronic hemodialysis. J Am Diet Assoc 1992 May;92(5): 574-9. Riedel E, Hampl H, Nundel M, Farshidfar G. Essential branched-chain amino acids and alpha-ketoanalogues in haemodialysis patients. Nephrol Dial Transplant 1992;7(2):117-20. Sanders HN, Narvarte J, Bittle PA, Ramirez G. Hospitalized dialysis patients have lower nutrient intakes on renal diet than on regular diet. I Am Diet Assoc 1991 Oct;91(10)21278-80. Comment in: J Am Diet Assoc 1992 Jun;92(6):674. Saxenhofer H, Scheidegger J, Descoeudres C, Jaeger P, Horber FF. Impact of dialysis modality on body composition in patients with end-stage renal disease. Clin Nephrol 1992 Oct;38(4):219-23. Schmidt R, Dumler F, Cruz C, Lubkowski T, Kilates C. Improved nutritional follow-up of peritoneal dialysis patients with bioelectrical impedance. Adv Perit Dial l992;8:157-9. Schulman G, Wingard RL, Hutchison RL, Lawrence P, Hakim RM. The effects of recombinant human growth hormone and intradialytic parenteral nutrition in malnourished hemodialysis patients. Am J Kidney Dis 1993 May;21(5):527-34. 22 Scopelite IA. Dietary modifications: impact on diabetic nephropathy. ANNA I 1992 Oct;19(5):447-52. Shah GM, Ross EA, Sabo A, Pichon M, Bhagavan H, Reynolds RD. Ascorbic acid supplements in patients receiving chronic peritoneal dialysis. Am J Kidney Dis 1991 Jul;18(1):84-90. Shah GM, Ross EA, Sabo A, Pichon M, Reynolds RD, Bhagavan H. Effects of ascorbic acid and pyridoxine supplementation on oxalate metabolism in peritoneal dialysis patients. Am J Kidney Dis 1992 Ju1;20(1):42-9. Shimomura A, Tahara D, Azekura H, Matsuo H, Kamo M. Key factors to improve survival of elderly patients on CAPD. Adv Perit Dial 1992;8z166—72. Singh RG, Gupta AK, Dubey SS, Usha, Sharma MR. Ascorbic acid status in uremics. Indian J Med Res 1992 Aug;96:266-9. Snyder S, Bergen C, Sigler MH, Teehan BP. Intradialytic parenteral nutrition in chronic hemodialysis patients. ASAIO Trans 1991 Jul-Sep; 37(3):M373-5. Sreide R, Dracup B, Svarstad E, Iversen BM. Increased total body fat during PD treatment. Adv Perit Dial 1992;8z173-6. Steinhauer I-IB, Lubrich—Birkner I, Kluthe R, Baumann G, Schollmeyer P. Effect of amino acid based dialysis solution on peritoneal permeability and prostanoid generation in patients undergoing continuous ambulatory peritoneal dialysis. Am J Nephrol 1992;12(1-2):61-7. Tabata T, Shoji S, Morita A, Emoto M, Inoue T, Miki T, Nishizawa Y, Morii H. Effects of dietary phosphorus restriction on secondary hyperpara— thyroidism in hemodialysis patients during intermittent oral high-dose 1,25(0H)2D3 treatment. J Nutr Sci Vitaminol (Tokyo) 1991 Dec;37 Suppl: 5105- 12. Tietze IN, Pedersen EB. Effect of fish protein supplementation on aminoacid profile and nutritional status in haemodialysis patients. Nephrol Dial Transplant 1991;6(12):948-54. Vannucchi MT, Vannucchi H, Humphreys M. Serum levels of vitamin A and retinol binding protein in chronic renal patients treated by continuous ambulatorial peritoneal dialysis. Int J Vitam Nutr Res 1992;62(2):107-12. Varella L, Utermohlen V. Nutritional support for the patient with renal failure. Crit Care Nurs Clin North Am 1993 Mar;5(1):79-96. Vehe KL, Brown R0, Moore LW, Acchiardo SR, Luther RW. The efficacy of nutrition support in infected patients with chronic renal failure. Pharmacotherapy 1991 ; 1 1 (4) :303—7. Watson AR, Coleman J E, Taylor EA. Gastrostomy buttons for feeding children on continuous cycling peritoneal dialysis. Adv Perit Dial 1992;8z391-5. Young GA, Kopple JD, Lindholm B, Vonesh EF, De Vecchi A, Scalamogna A, Castelnova C, Oreopoulos DG, Anderson GH, Bergstrom J, et a1. Nutritional assessment of continuous ambulatory peritoneal dialysis patients: an international study. Am J Kidney Dis 1991 Apr;17(4):462-71. Data on Outcomes -Clinical Trial Albertazzi A, Palmieri PF, Mastrangelo E. Efficacy and tolerance of acetate free biofiltration: a central Italian multicenter trial. Kidney Int Suppl 1993; 41:5188-94. -0ther Alarabi AA, Danielson BG, Wikstrom B. Continuous arteriovenous hemodialysis: outcome in intensive care acute renal failure patients. Nephron 1993; 64(1):58-62. Alexander SR, Honda M. Continuous peritoneal dialysis for children: a decade of worldwide growth and development. Kidney Int Suppl 1993 Feb;40: S65-74. Allen TW. Link between length of hemodialysis treatment and mortality. J Am Osteopath Assoc 1991;91(4):329. Andrassy K, Erb A, Koderisch J, Waldherr R, Ritz E. Wegener’s granulomatosis with renal involvement: patient survival and correlations between initial renal function, renal histology, therapy and renal outcome. Clin Nephrol 1991 Apr;35(4):139-47. Antonoff A, Mallinger M. Vocational rehabilitation: limitations and resistance of renal patients. Dial Transplant 1991;20(lO):604—6, 608-9. Barakat M, Savage JM, Burns A, Stewart M. Efficacy of CAPD as the primary treatment for end-stage renal failure in children. Child Nephrol Urol 1992; 12(4):216—20. Beckingham IJ, O’Rourke J S, Bishop MC, Blamey RW. Are backup arteriovenous fistulae necessary for patients on continuous ambulatory peritoneal dialysis? Lancet 1993 May 29;341(8857):1384-6. Besselink RA, Schroder CH, van Oort AM. Influence of dialysate exchange on cardiac left ventricular function in children treated with CAPD. Perit Dial Int 1991;11(2):141-3. Blagg CR. The US Renal Data System and the Case- Mix Severity Study. Am J Kidney Dis 1993 Jan; 21(1):106-8. Blake PG, Flowerdew G, Blake RM, Oreopoulos DG. Serum albumin in patients on continuous ambulatory peritoneal dialysis--predictors and correlations with outcomes. J Am Soc Nephrol 1993 Feb;3(8):1501-7. Blowey DL, McFarland K, Alon U, McGraw-Houchens M, Hellerstein S, Warady BA. Peritoneal dialysis in the neonatal period: outcome data. J Perinatol 1993 Jan-Feb;13(1):59—64. 23 Brogan D, Kutner NG, Flagg E. Survival differences among older dialysis patients in the southeast. Am J Kidney Dis 1992 Oct;20(4):376-86. Brownbridge G, Fielding DM. Psychosocial adjustment to end-stage renal failure: comparing haemodialysis, continuous ambulatory peritoneal dialysis and transplantation. Pediatr Nephrol 1991 Sep;5(5): 612-6. Comment in: Pediatr Nephrol 1992 Jul;6(4): 405-6. Brunner FP, Selwood NH. Profile of patients on RRT in Europe and death rates due to major causes of death groups. The EDTA Registration Committee. Kidney Int Suppl 1992 Oct;38:S4—15. Brunori G, Camerini C, Cancarini G, Manili L, Sandrini S, Movilli E, Galvani G, Maiorca R. Hospitalization: CAPD versus hemodialysis and transplant. Adv Perit Dial 1992;8271-4. Chan PC, Tam SC, Robinson JD, Yu L, Ip MS, Chan CY, Cheng IK. Effect of phosphatidylcholine on ultrafiltration in patients on continuous ambulatory peritoneal dialysis. Nephron 1991;59(l):100—3. Chandran PK, Liggett R, Kirkpatrick B. Patient survival on PAN/AN69 membrane hemodialysis: a ten year analysis. Kidney Int Suppl 1993;41: 8287-90. Choong HL, Pwee HS, Woo KT, Lim CH. Maintenance haemodialysis in Singapore. Singapore Med J 1991 Jun;32(3):133-8. Churchill DN. Comparative morbidity among hemodialysis and continuous ambulatory peritoneal dialysis patients. Kidney Int Suppl 1993 Feb;40: SIG-22. Churchill DN, Taylor DW, Cook RJ, LaPlante P, Barre P, Cartier P, Fay WP, Goldstein MB, Jindal K, Mandin H, et al. Canadian Hemodialysis Morbidity Study. Am J Kidney Dis 1992 Mar;l9(3):214—34. Civati G, Guastoni C, Ballerini L, Perego A, Teatini U, Perrino ML, Benazzi E, Minetti L. Survival and morbidity in 200 chronic patients treated by high flux hemodialysis [abstract]. J Am Soc Nephrol l992;3(3):359. Clark T], Richards NT, Adu D, Michael J. Increased prevalence of dialysis-dependent renal failure in ethnic minorities in the west Midlands. Nephrol Dial Transplant 1993;8(2):146-8. Coburn J W. Mineral metabolism and renal bone disease: effects of CAPD versus hemodialysis. Kidney Int Suppl 1993 Feb;40:S92—100. Davison JM. Dialysis, transplantation, and pregnancy. Am J Kidney Dis 1991 Feb;l7(2):127-32. Comment in: Am J Kidney Dis 1991 Nov;18(5):621. 24 Dell’Aquila R, Feriani M, Mascalzoni E, Bragantini L, Ronco C, La Greca G. Oxalate removal by differing dialysis techniques. ASAIO J 1992 Oct-Dec;38(4):797—800. Dombros NV, Digenis GE, Balaskas EV, Sombolos K, Abraham G, Oreopoulos DG. Long-term continuous ambulatory peritoneal dialysis. Clin Nephrol 1993 Feb;39(2):70-4. Doyle CL, Flanigan MJ, Mabe C. Tidal peritoneal dialysis vs. continuous cyclic peritoneal dialysis: children’s preference. ANNA J 1992 Jun;19(3): 249-54. Dumler F, Schmidt RJ, Cruz C, Faber M, Zasuwa G. Single center success with a high risk peritoneal dialysis population. Adv Perit Dial 1992;82105—7. Dumler F, Stalla K, Mohini R, Zasuwa G, Levin NW. Clinical experience with short-time hemodialysis. Am J Kidney Dis 1992 Jan;19(1):49—56. Ehrich JH, Loirat C, Brunner FP, Geerlings W, Landais P, Mallick NP, Margreiter R, Raine AE, Selwood NH, Tufveson G, et a1. Report on management of renal failure in children in Europe, XXII, 1991. Nephrol Dial Transplant 1992; 7 Suppl 2:36-48. Ehrich J H, Rizzoni G, Brunner FP, Fassbinder W, Geerlings W, Mallick NP, Raine AE, Selwood NH, Tufveson G. Renal replacement therapy for end- stage renal failure before 2 years of age. Nephrol Dial Transplant 1992;7(12):1171-7. Erroa M, Goldwasser P, Collier J T, Mittman N, Avram MM. Prealbumin and mortality risk in hemodialysis [abstract]. J Am Soc Nephrol 1992;3(3):364. Fassbinder W, Brunner FP, Brynger H, Ehrich JH, Geerlings W, Raine AE, Rizzoni G, Selwood NH, Tufveson G, Wing A]. Combined report on regular dialysis and transplantation in Europe, XX, 1989. Nephrol Dial Transplant 1991;6 Suppl 1:5-35. Feldman HI, Klag MJ, Chiapella AP, Whelton PK. End-stage renal disease in US minority groups. Am J Kidney Dis 1992 May;19(5):397-410. Comment in: Am J Kidney Dis 1992 May;19(5):411-3. Fine RN. Choice of treatment modality for the infant, child and adolescent with end-stage renal disease. Contrib Nephrol 1991;89:231-6. Finkelstein F0, Sorkin M, Cramton CW, Nolph K. Initiatives in peritoneal dialysis: where do we go from here? Perit Dial Int 1991;11(3):274-8. Firanek CA, Vonesh EF, Korbet SM. Patient and technique survival among an urban population of peritoneal dialysis patients: an 8-year experience. Am J Kidney Dis 1991 Jul;18(1):91-6. Published erratum appears in Am J Kidney Dis 1992 Jan; 19(1):93. Fox E, Peace K, Neale TJ, Morrison RB, Hatfield PJ, Mellsop G. "Quality of life" for patients with end- stage renal failure. Ren Fail 1991;13(1):31-5. Fox JG, Fowler I, Boulton-Jones JM. Audit of a decade of continuous ambulatory peritoneal dialysis. Nephrol Dial Transplant 1993;8(3):240—3. Garcia C, Goldani J, Garcia V. Paediatric dialysis and renal transplantation in the state of Rio Grande do Sul, Brazil. Pediatr Nephrol 1992 Jan;6(1):74-7. Garcia CD, Goldani JC, Garcia VD. Twenty years of pediatric renal replacement therapy in the state of Rio Grande do Sul, Brazil. Transplant Proc 1992 Oct;24(5):1804-5. Garcia V, Goldani JC, Bittar A, Mattos A. End-stage renal disease in the state of Rio Grande do Sul, Brazil. Transplant Proc 1992 Oct;24(5):1806. Gaylin DS, Held PJ, Port FK, Hunsicker LG, Wolfe RA, Kahan BD, Jones CA, Agodoa LY. The impact of comorbid and sociodemographic factors on access to renal transplantation. 1 AMA 1993 Feb 3;269(5):603-8. Gentil MA, Carriazo A, Pavon MI, Rosado M, Castillo D, Ramos B, Algarra GR, Tejuca F, Banasco VP, Milan J A. Comparison of survival in continuous ambulatory peritoneal dialysis and hospital haemodialysis: a multicentric study. Nephrol Dial Transplant 1991;6(6):444-51 . Geronemus RP, Schneider NS, Epstein M. Survival in patients treated with continuous arteriovenous hemodialysis for acute renal failure and chronic renal failure. Preliminary observations. Contrib Nephrol 1991;93:29-31. Gorban-Brennan N, Kliger AS, Finkelstein F0. CAPD therapy for patients over 80 years of age. Perit Dial Int 1993;13(2):140-1. Grant AC, Rodger RS, Howie CA, Junor BI, Briggs JD, Macdougall AI. Dialysis at home in the west of Scotland: a comparison of hemodialysis and continuous ambulatory peritoneal dialysis in age- and sex-matched controls. Perit Dial Int 1992; 12(4):365-8. Hamburger RJ, Brier ME. Peritoneal dialysis mortality rate network 9 [abstract]. J Am Soc Nephrol 1992; 3(3):411. Held PI, Levin NW, Bovbjerg RR, Pauly MV, Diamond LH. Mortality and duration of hemodialysis treatment. JAMA 1991 Feb 20;265(7): 871-5. Comment in: JAMA 1991 Feb 20;265(7): 909-10; JAMA 1991 Jun 12;265(22):2958-9. Held PI, Port FK, Webb RL, Wolfe RA, Garcia JR, Blagg CR, Agodoa LY. The United States Renal Data System’s 1991 annual data report: an introduction. Am J Kidney Dis 1991 Nov; 18(5 Suppl 2):1-16. Held PJ, Turenne MN, Liska DW, Zobel DL, Webb RL, Alexander SR, Jones C. Treatment modality patterns and transplantation among the United States pediatric end-stage renal disease population: a longitudinal study. Clin Transpl 1991;71-85. Hiatt WR, Koziol BJ, Shapiro II, Brass EP. Carnitine metabolism during exercise in patients on chronic hemodialysis. Kidney Int 1992 Jun;41(6):1613-9. Hirsch] MM, Heinz G, Sunder-Plassmann G, Derfler K. Renal replacement therapy in type 2 diabetic patients: 10 years’ experience. Am J Kidney Dis 1992 Dec;20(6):564-8. Holley JL, Foulks CJ. The utility of a structured evaluation of elderly patients for continuous peritoneal dialysis. Perit Dial Int 1991;11(2):162-5. Holley JL, Nespor SL. Nephrologist—directed primary health care in chronic dialysis patients. Am J Kidney Dis 1993 Jun;21(6):628-31. Homberger I C, Chemew M, Petersen J, Garber AM. A multivariate analysis of mortality and hospital admissions with high-flux dialysis. I Am Soc Nephrol 1992 Dec;3(6):1227-37. Hughes DA, Beattie TI, Murphy AV. Haemolytic uraemic syndrome: 17 years’ experience in a Scottish paediatric renal unit. Scott Med J 1991; 36(1):9—12. Hull AR. Impact of reimbursement regulations on patient management. Am J Kidney Dis 1992 Jul; 20(1 Suppl 1):8-11. Hylander B, Lundblad H, Kjellstrand CM. Changing patient characteristics in chronic hemodialysis. Scand J Urol Nephrol 1991;25(l):59-63. Ilson BE, Bland PS, Jorkasky DK, Shusterman N, Allison NL, Dubb J W, Parr GV, Goebel TK, State RM. Intraoperative versus routine hemodialysis in end-stage renal disease patients undergoing open- heart surgery. Nephron 1992;61(2):170—5. Iseki K, Kawazoe N, Osawa A, Fukiyama K. Survival analysis of dialysis patients in Okinawa, Japan (1971-1990). Kidney Int 1993 Feb;43(2):404-9. Ishikawa I, Shikura N, Nagahara M, Shinoda A, Saito Y. Comparison of severity of acquired renal cysts between CAPD and hemodialysis. Adv Perit Dial 1991;7z91-5. Ishitani M, Wilkowski M, Stevenson W, Pruett T. Outcome of patients requiring hemodialysis after liver transplantation. Transplant Proc 1993 Apr; 25(2): 1762-3 . 25 Jenkins DA, Temple RM, Winney RJ, Allan PL, Notgi A, Wild SR. Effect of treatment mode on the natural history of acquired cystic disease of the kidney in patients on renal replacement therapy. Nephrol Dial Transplant 1992;7(7):613-7. Joglar F, Saade M. Improved overall survival of elderly patients on peritoneal dialysis. Adv Perit Dial 1991; 7:63-7. Kandoussi A, Cachera C, Pagniez D, Dracon M, Fruchart J C, Tacquet A. Plasma level of lipoprotein Lp(a) is high in predialysis or hemodialysis, but not in CAPD. Kidney Int 1992 Aug;42(2):424-5. Kawaguchi Y. Shaded areas of CAPD. Blood Purif 1992;10(1):30-4. Keller E, Reetze-Bonorden P, Lucking HP, Bohler I, Schollmeyer P. Continuous arteriovenous hemodialysis: experience in twenty-six intensive care patients. Contrib Nephrol 1991;93:47-50. Khan IH, Catto GR, Edward N, Fleming LW, Henderson IS, MacLeod AM. Influence of coexisting disease on survival on renal-replacement therapy. Lancet 1993 Feb 13;341(8842):415-8. Comment in: Lancet 1993 Feb 13;341(8842):412-3; Lancet 1993 Apr 10;341(8850):954; discussion. 955; Lancet 1993 Apr 10;341(8850):954-5. King LK, Kingswood J C, Sharpstone P. Comparison of the efficacy cost and complication rate of APD and CAPD as long-term outpatient treatments for renal failure. Adv Perit Dial 1992;82123-6. Klein JR, Grunewald RW, Steffgen J, Franz HE. Clearance of osteocalcin in adults with end-stage renal disease undergoing CAPD. Adv Perit Dial 1991;7z225—9. Kumar H, Alam F, Naqvi SA. Experience of haemodialysis at the Kidney Centre. JPMA J Pak Med Assoc 1992 Oct;42(10):234-6. Kurtin PS, Davies AR, Meyer KB, DeGiacomo JM, Kantz ME. Patient-based health status measures in outpatient dialysis. Early experiences in developing an outcomes assessment program. Med Care 1992 May;30(5 Suppl):MS136-49. Kyllonen L, Helantera A, Salmela K, Ahonen J. Dialysis method and kidney graft survival. Transplant Proc 1992;24(1):354. Lindblad AS, Nolph KD. Recovery of renal function in continuous ambulatory peritoneal dialysis: a study of National CAPD Registry data. Perit Dial Int 1992;12(1):43-7. Lowrie EG. Renal replacement therapy: practice, case- mix, and outcome. Lancet 1993 Feb 13;341(8842): 412-3. Comment on: Lancet 1993 Feb 13; 341(8842):415-8. 26 Lowrie EG, Lew NL. Commonly measured laboratory variables in hemodialysis patients: relationships among them and to death risk. Semin Nephrol 1992 May;12(3):276-83. Lunde NM, Port FK, Wolfe RA, Guire KE. Comparison of mortality risk by choice of CAPD versus hemodialysis among elderly patients. Adv Perit Dial 1991;7z68-72. Lupo A, Cancan'ni G, Catizone L, Cocchi R, de Vecchi A, Viglino G, Salomone M, ifgoloni G, Giangrande A, Limido A, et Comparison of survival in CAPD and heinodialysis: a multicenter study. Adv Perit Dial 1992; 8: 136-40. Lysaght MJ, Vonesh EF, Gotch F, Ibels L, Keen M, Lindholm B, Nolph KD, Pollock CA, Prowant B, Farrell PC. The influence of dialysis treatment modality on the decline of remaining renal function. ASAIO Trans 1991 Oct-Dec;37(4):598-604. Maheshwari HG, Rifkin I, Butler J, Norman M. Growth hormone binding protein in patients with renal failure. Acta Endocrinol (Copenh) 1992 Dec; 127(6):485-8. Mailloux LU. With the right population, HHD means better dialysis, outcome. Nephrol News Issues 1992 Nov;6(11):38-9. Mailloux LU, Bellucci AG, Wilkes BM, Napolitano B, Mossey RT, Lesser M, Bluestone PA. Mortality in dialysis patients: analysis of the causes of death. Am J Kidney Dis 1991 Sep;18(3):326-35. Maiorca R, Cancarini GC, Brunori G, Camerini C, Manili L. Morbidity and mortality of CAPD and hemodialysis. Kidney Int Suppl 1993 Feb;40:S4-15. Maiorca R, Vonesh EF, Cavalli P, De Vecchi A, Giangrande A, La Greca G, Scarpioni LL, Bragantini L, Cancarini GC, Cantaluppi A, et al. A multicenter, selection-adjusted comparison of patient and technique survivals on CAPD and hemodialysis. Perit Dial Int 1991;11(2):118-27. Comment in: Perit Dial Int l993;13(1):71-2. Mallofre C, Almirall J, Campistol JM, Andreu J, Cardesa A, Revert L. Acquired renal cystic disease in HD: a study of 82 nephrectomies in young patients. Clin Nephrol 1992 Jun;37(6):297-302. Mattoo TK. Acute peritoneal dialysis in newborn babies. Indian Pediatr 1992;29(12):1591-6. McClellan WM, Flanders WD, Gutman RA. Variable mortality rates among dialysis treatment centers. Ann Intern Med 1992 Aug 15;117(4):332—6. Morduchowicz G, Winkler J, Boner G. CAPD versus haemodialysis: a comparison in the same patients. Int Urol Nephrol 1992;24(5):575-9. Morduchowicz G, Winkler J, Derazne E, Van Dyk DJ, Wittenberg C, Zabludowski JR, Shohat J, Rosenfeld JB, Boner G. Causes of death in patients with end- stage renal disease treated by dialysis in a center in Israel. Isr J Med Sci 1992 Nov;28(11):776-9. Moss AH, Holley JL, Upton MB. Outcomes of cardiopulmonary resuscitation in dialysis patients. J Am Soc Nephrol 1992 Dec;3(6):1238-43. Muthny FA, Koch U. Quality of life of patients with end-stage renal failure. A comparison of hemodialysis, CAPD, and transplantation. Contrib Nephrol 1991;89:265-73. Nelson CB, Port FK, Wolfe RA, Guire KE. Comparison of continuous ambulatory peritoneal dialysis and hemodialysis patient survival with evaluation of trends during the 1980s. I Am Soc Nephrol 1992 Nov ,3(:5) 1147-55. Nissenson AR. Chronic peritoneal dialysis in the elderly. Geriatr Nephrol Urol 1991;1(1):3-12. Nolph KD. What’s new in peritoneal dialysis--an overview. Kidney Int Suppl 1992 0ct;38:S148-52. Nube MJ, De Vet J A, Steffens A, Van Geelen J A. Long-term results of continuous ambulatory peritoneal dialysis: the first hundred patients. A single centre study. Neth J Med 1993;42(4):112-21. O’Donoghue D, Manos J, Pearson R, Scott P, Bakran A, Johnson R, Dyer P, Martin S, Gokal R. Continuous ambulatory peritoneal dialysis and renal transplantation: a ten—year experience in a single center. Perit Dial Int 1992;12(2):242, 245-9. Padovese P, Gallieni M, Brancaccio D, Pietra R, Fortaner S, Sabbioni E, Minoia C, Markakis K, Berlin A. Trace elements in dialysis fluids and assessment of the exposure of patients on regular hemodialysis, hemofiltration and continuous ambulatory peritoneal dialysis. Nephron l992;61(4): 442-8. Peterson RA, Kimmel PL, Sacks CR, Mesquita ML, Simmens SJ, Reiss D. Depression, perception of illness and mortality in patients with end-stage renal disease. Int J Psychiatry Med 1991;21(4):343-54. Pollak VE, Thornley-Brown D, Kant KS, Pesce A, Deddens IA. A case study of a recent decline in the dialysis fatality rate. Contrib Nephrol 1993;102: 59-72. Port FK. The end-stage renal disease program: trends over the past 18 years. Am J Kidney Dis 1992 Jul; 20(1 Suppl 1):3-7. Qamar IU, Balfe J W. Experience with chronic peritoneal dialysis in infants. Child Nephrol Urol 1991;11(3):159-64 Qureshi N, Held PJ, Bovbjerg RR, Levin NW, Pauly MV, Diamond LH. Mortality and duration of hemodialysis treatment. JAMA 1991;265(22): 2958-9. Rees L, Rigden SP, Chantler C. The influence of steroid therapy and recombinant human erythropoietin on the growth of children with renal disease. Pediatr Nephrol 1991 Jul;5(4):556-8. Reinberg Y, Matas A, Manivel JC, Gonzalez R, Gillingham KJ, Pryor JL. Outcome of renal transplantation or dialysis in patients with a history of renal cancer. Cancer 1992;70(6):1564—7. Reynolds HN, Borg U, Belzberg H, Wiles CE 3d. Efficacy of continuous arteriovenous hemofiltration with dialysis in patients with renal failure. Crit Care Med 1991 Nov;19(ll):l387-94. Rfidah EI, Gill DG, Ni Dhomhnaill T, Shortt H. Continuous ambulatory peritoneal dialysis in children. Ir Med J 1992 Sep;85(3):107-9. Ritz E, Koch M. Morbidity and mortality due to hypertension in patients with renal failure. Am J Kidney Dis 1993 May;21(5 Suppl 2):113-8. Rizzoni G, Ehrich JH, Broyer M, Brunner FP, Brynger H, Fassbinder W, Geerlings W, Selwood NH, Tufveson G, Wing AJ. Successful pregnancies in women on renal replacement therapy: report from the EDTA Registry. Nephrol Dial Transplant 1992;7(4):279—87. Roger SD, Piper J, Tucker B, Raine AE, Baker LR, Kovacs IB. Comparison of haemostatic activity in haemodialysis and peritoneal dialysis patients with a novel technique, haemostatometry. Nephron 1992; 62(4):422-8. Rotellar C, Black J, Winchester J F, Rakowski TA, Mosher WF, Mazzoni MJ, Amiranzavi M, Garagusi V, Alijani MR, Argy WP. Ten years’ experience with continuous ambulatory peritoneal dialysis. Am J Kidney Dis 1991 Feb;17(2):158-64. Rottembourg J. Residual renal function and recovery of renal function in patients treated by CAPD. Kidney Int Suppl 1993 Feb;40:8106—10. Rottembourg J, Allouache M, Issad B, Diab R, Baumelou A, Jacobs C. Outcome and follow-up on CAPD. Contrib Nephrol 1991;89:16—27. Saxenhofer H, Scheidegger J, Descoeudres C, Jaeger P, Horber FF. Impact of dialysis modality on body composition in patients with end-stage renal disease. Clin Nephrol 1992 0ct;38(4):219—23. Schafer GE, Doring C, Sodemann K, Russ A, Schroder HM. Continuous arteriovenous and venovenous hemodialysis in critically ill patients. Contrib Nephrol 1991;93:23-8. 27 Scharer K, Reiss U, Mehls O, Gretz N, Mohring K, Muller-Wiefel DE, Wingen A. Changing pattern of chronic renal failure and renal replacement therapy in children and adolescents: a 20-year single centre study. Eur J Pediatr 1993 Feb;152(2):166-71. Schwalbe M, Neiberger R, Pena D, Iravani A, Richard G. Mortality in children on dialysis [abstract]. Pediatr Res 1991;29(4 part 2):351a. Singh S, Hatiharan S. Renal replacement therapy in autosomal dominant polycystic kidney disease. Nephron 1991;57(1):40-4. Singh S, Yium J, Macon E, Clark E, Schaffer D, Teschan P. Multicenter study of change in dialysis therapy-maintenance hemodialysis to continuous ambulatory peritoneal dialysis. Am J Kidney Dis 1992 Mar;19(3):246—51. Skroeder NR, Jacobson SH, Holmquist B, Kjellstrand P, Kjellstrand CM. Beta 2-microglobulin generation and removal in long slow and short fast hemodialysis. Am J Kidney Dis 1993 May;21(5): 519—26. Spiegel DM, Anderson M, Campbell U, Hall K, Kelly G, McClure E, Breyer JA. Serum albumin: a marker for morbidity in peritoneal dialysis patients. Am J Kidney Dis 1993 Jan;21(l):26—30. Sreide R, Svarstad E, Iversen BM. CAPD in patients above 70 years of age. Adv Perit Dial 1991;7z73-6. Storch RL, Storch S, London R, Pordy WT. Differences in pattern visual evoked potential (PVEP) between hemodialysis and peritoneal dialysis patients. Clin Electroencephalogr 1992 Oct;23 (4): 169-76. Stratta P, Canavese C, Dogliani M, Thea A, Porcu M, Salomone M, Vercellone A. Long-term outcome in patients with vasculitis on chronic dialytic treatment. Contrib Nephrol 1991;94:151-7. Stratta R], Taylor R], Ozaki CF, Bynon J S, Miller SA, Knight TF, Fischer JL, Neumann TV, Wahl T0, Duckworth WC, et al. A comparative analysis of results and morbidity in type I diabetics undergoing preemptive versus postdialysis combined pancreas- kidney transplantation. Transplantation 1993 May; 55(5):1097-103. Sulkova S, Laurincova Z, Valek A. Haemofiltration or haemodialysis in aluminium elimination? Nephrol Dial Transplant 1991;6 Suppl 3:3-5. Takahashi C, Ujihara N, Babazono T, Yokoyama H, Nakanishi K, Tomonaga O, Sanaka T, Hirata Y. Analysis of the clinical course of 130 Japanese non- insulin-dependent diabetic patients undergoing dialysis. J Diabet Complications 1991 Apr-Sep; 5(2-3):171-2. 28 Tannen R, Jacobson H. Summary of the joint National Institutes of Health/Renal Physician’s Association workshop on dialysis, morbidity and mortality. Am J Kidney Dis 1993 Jan;21(1):114-5. Thompson TJ, Fisher M, Hatfield PJ, Morrison RB, Neale TJ. Diabetic end stage renal failure-the Wellington experience 1975-1988. Aust N Z J Med 1991 Feb;21(1):29-35. Tucker CM, Ziller RC, Smith WR, Mars DR, Coons MP. Quality of life of patients on in-center hemodialysis versus continuous ambulatory peritoneal dialysis. Perit Dial Int 1991;11(4):341-6. Comment in: Perit Dial Int 1992;12(2):264—5. Tzamaloukas AH, Murata GH, Avasthi PS. Outcome of cardiopulmonary resuscitation in patients on chronic dialysis. ASAIO Trans 1991 Jul-Sep;37(3): M369-70. Verbeelen D, De Neve W, Van Der Niepen P, Sennesael I. Dialysis in patients over 65 years of age. Kidney Int Suppl 1993 ;41:SZ7-30. Verrina E, Andreetta B, Bassi S, Bonaudo R, Caringella DA, Castellani A, Cavalli P, Edefonti A, Lavoratti G, Longo L, et a1. Chronic peritoneal dialysis in paediatrics: experience of a national registry. Pediatr Nephrol 1992 Jan;6(1):78-81. Verrina E, Zacchello G, Perfumo F, Edefonti A, Bassi S, Capasso G, Castellani A, Longo L, Penza R, Piaggio G, et al. Five years’ experience of the Italian Registry of Pediatric Chronic Peritoneal Dialysis. Adv Perit Dial 1992;8:416-8. Vonesh EF, Maiorca R. A multicenter, selection- adjusted comparison of patient and technique survival on CAPD and hemodialysis: a clarification. Perit Dial Int 1993;13(1):71-2. Wadhwa NK, Mendelson WB. A comparison of sleep- disordered respiration in ESRD patients receiving hemodialysis and peritoneal dialysis. Adv Perit Dial 1992;8z195-8. Wassermann RI, Saroyan RM, Rice JC, Kerstein MD. Infrainguinal revascularization for limb salvage in patients with end-stage renal disease. South Med J 1991 Feb;84(2):190-2. Winchester JF, Rotellar C, Goggins M, Robino D, Alijani MR, Rakowski TA, Argy WP. Transplantation in peritoneal dialysis and hemodialysis. Kidney Int Suppl 1993 Feb;40: SlOl-S. Wolfe RA, Gaylin DS, Port FK, Held PI, Wood CL. Using USRDS generated mortality tables to compare local ESRD mortality rates to national rates. Kidney Int 1992 Oct;42(4):99l-6. Wright LF. Survival in patients with end-stage renal disease. Am J Kidney Dis 1991 Jan;17(1):25-8. Yamamoto Y, Fujimoto S, Eto T. Long-term outcome of chronic hemodialysis patients [abstract]. Blood Put-if 1991;9(1):22. Ylinen K, Gronhagen—Riska C, Honkanen E, Ekstrand A, Metsarinne K, Kuhlback B. Outcome of patients with secondary amyloidosis in dialysis treatment. Nephrol Dial Transplant 1992;7(9):908-12. Ziegler TR, Lazarus JM, Young LS, Hakim R, Wilmore DW. Effects of recombinant human growth hormone in adults receiving maintenance hemodialysis. J Am Soc Nephrol 1991 Dec;2(6): 1130-5. ADEQUACY OF DIALYSIS: ACCESS AND DOSE -Clinical Trials Barron PI‘, Wellington JL, Lorimer JW, Cole CW, Moher D. A comparison between expanded polytetrafluoroethylene and plasma tetrafluoroethylene grafts for hemodialysis access. Can J Surg 1993 Apr;36(2):184-6. Beathard GA. Gianturco self-expanding stcnt in the treatment of stenosis in dialysis access grafts. Kidney Int 1993 Apr;43(4):872-7. Bellomo R, Tipping P, Boyce N. Continuous veno- venous hemofiltration with dialysis removes cytokines from the circulation of septic patients. Crit Care Med 1993 Apr;21(4):522-6. Cheung AK, Dalpias D, Emmerson R, Leypoldt IK. A prospective study on intradialytic symptoms associated with reuse of hemodialyzers. Am I Nephrol 1991;11(5):397-401. Churchill DN, Bird DR, Taylor DW, Beecroft ML, Gorman J, Wallace JE. Effect of high-flux hemodialysis on quality of life and neuropsychological function in chronic hemodialysis patients. Am J Nephrol 1992;12(6):412-8. Collins D, Lambert M, Tannenbaum J, Oliverio M, Schwab S. Tolerance of hemodialysis a randomized prospective trial of high flux vs. conventional high efficiency hemodialysis [abstract]. J Am Soc Nephrol 1992;3(3):360. Davenport A, Will El, Davidson AM. Improved cardiovascular stability during continuous modes of renal replacement therapy in critically ill patients with acute hepatic and renal failure. Crit Care Med 1993 Mar;21(3):328-38. Gurudev KC, Pathak V, Prabhakar KS, Bhaskar S, Prakash KC, Prabhakaran, Mani MK. Short term study on relative merits of acetate and bicarbonate dialysis. J Assoc Physicians India 1991 Dec;39(12): 921-4. Helling TS, Nelson PW, Shelton L. A prospective evaluation of plasma-TFE and expanded PTFE grafts for routine and early use as vascular access (slur-ing hemodialysis. Ann Surg 1992 Nov;216(5): 96-9. Hibberd AD. Brachiobasilic fistula with autogenous basilic vein: surgical technique and pilot study. Aust N Z J Surg 1991 Aug;6l(8):631-5. Jaffers G, Angstadt JD, Bowman IS 3d. Early cannulation of plasma TFE and Gore-Tex grafts for hemodialysis: a prospective randomized study. Am J Nephrol 1991;11(5):369—73. 29 Kindler J. Torasemide in advanced renal failure. Cardiovasc Drugs Ther 1993 Jan;7 Suppl 1:75-80. Knight F, Gorynski L, Bentson M, Harmon W. Chronic hemodialysis as a treatment for the infant or small child with end stage renal disease. ANNA J 1992 Apr;19(2):156. Kramer BK, Pickert A, Hohmann C, Liebich HM, Muller GA, Hablitzel M, Risler T. In vivo clearance and elimination of nine marker substances during hemofiltration with different membranes. Int J Artif Organs 1992 Jul;15(7):408-12. Nurmoharned MT, ten Cate J, Stevens P, Hoek JA, Lins RL, ten Cate JW. Long-term efficacy and safety of a low molecular weight heparin in chronic hemodialysis patients. A comparison with standard heparin. ASAIO Trans 1991 Jul-Sep;37(3): M459-61. Owen IE, Walker RG, Lemon J, Brett L, Mitrou D, Becker GJ. Randomized study of peritonitis with conventional versus O—set techniques in continuous ambulatory peritoneal dialysis. Perit Dial Int 1992; 12(2):216-20. Ring T, Nielsen C, Andersen SP, Behrens IK, Sodemann B, Komerup HJ. Calcium acetate versus calcium carbonate as phosphorus binders in patients on chronic haemodialysis: a controlled study. Nephrol Dial Transplant 1993;8(4):341-6. Stegmayr BG, Esbensen K, Gutierrez A, Lundberg L, Nielsen B, Stroemsaeter CE, Wehle B. Granulocyte elastase, beta-thromboglobulin, and C3d during acetate or bicarbonate hemodialysis with Hemophan compared to a cellulose acetate membrane. Int J Artif Organs 1992 Jan;15(1):10-8. Zaoui P, Green W, Hakim RM. Hemodialysis with cuprophane membrane modulates interleukin-2 receptor expression. Kidney Int 1991 May;39(5): 1020-6. Zimmerman SW, Ahrens E, Johnson CA, Craig W, Leggett J, O’Brien M, Oxton L, Roecker EB, Engeseth S. Randomized controlled trial of prophylactic rifampin for peritoneal dialysis-related infections. Am J Kidney Dis 1991 Aug;18(2): 225-31. -Other Acchiardo SR, Hatten KW, Ruvinsky MI, Dyson B, Fuller J, Moore LW. Inadequate dialysis increases gross mortality rate. ASAIO I 1992 Jul-Sep;38(3): M282-5. Acchiardo SR, Kraus AP Jr, Kaufman PA, LaI-latte G, Adkins D, Moore LW. Evaluation of CAPD prescription. Adv Perit Dial 1991;7z47-50. 30 Acchiardo SR, Kraus AP Jr, LaHatte G, Kaufman PA, Adkins D, Moore LW. Urea kinetics evaluation of hemodialysis and CAPD patients. Adv Perit Dial 1992;8:55-8. al-Momen AK, Huraib SO. Low-dose danazol for vascular access and dialyzer thrombosis in hemodialysis patients. Haemostasis 1992;22(1): 12-6. Alarabi A, Eklund T, Claesson K, Wikstrom B, Danielson BG. Experience with vascular access for acute renal failure: using Buselmeier shunt and femoral vessel catheter. Nephron 1991;58(2):192-5. Alarabi AA, Hansell P, Wikstrom B, Danielson BG. Plasma atrial natriuretic factor (alpha ANF) during hemodialysis (HD) and hemofiltration (HF). Scand J Urol Nephrol 1991;25(1):65-9. Albouze G, Yanai M, Calamai M, Testou D, Jungers P, Man NK. Urea rebound and residual renal function in the calculation of Kt/V and protein catabolic rate. Kidney Int Suppl 1993;41:S278-81. Ansari MM, Viridi J S, Beg MH, Reyazuddin, HS. Smooth venous loop arterio venous fistula for hemodialysis. Vasc Surg 199l;25(7):565—8. Antonucci F, Salomonowitz E, Stuckmann G, Stiefel M, Hugentobler M, Zollikofer CL. Hemodialysis related venous stenoses: treatment with self- expanding endovascular prostheses. Eur J Radiol 1992 May-Jun;14(3):195—200. Antonucci F, Salomonowitz E, Stuckmann G, Stiefel M, Largiader J, Zollikofer CL. Placement of venous stents: clinical experience with a self- expanding prosthesis. Radiology 1992 May;l83(2): 493-7. Ashton DN, Mehta RL, Ward DM, McDonald BR, Aguilar MM. Recent advances in continuous renal replacement therapy: citrate anticoagulated continuous arteriovenous hemodialysis. ANNA J 1991 Jun;18(3):263-7, 329. Avendano C, Alvarez J S, Sacristan JA, Adin J, Alsar MJ. Interference of digoxin-like immunoreactive substances with TDx digoxin II assay in different patients. Ther Drug Monit 1991 Nov;l3(6):523-7. Bajo MA, Selgas R, Fdez-Reyes MJ, Bosque E, Lopez- Revuelta K, Campos C, Jimenez C, Borrego F, Rinon C, et a1. Adequacy of dialysis in patients longer than 4 years on CAPD. Significance of the urea kinetic model and its relationship with clinical parameters [abstract]. Nephrol Dial Transplant 1992;7(7):742. Ballard J L, Bunt TJ, Malone J M. Major complications of angioaccess surgery. Am J Surg 1992 Sep; 164(3):229-32. Balteau PR, Peluso FP, Coles GA, Michel C, Mignon FM, Tranaeus AP, Verger C, Zaruba K. Design and testing of the Baxter Integrated Disconnect Systems (IDS). Perit Dial Int 1991;11(2):131—6. Bandiani G, Camaiora E, Farina D, Nicolini MA, Perotta U, Tagliazucchi A. Long-term influence of dialysis treatment of beta 2-microglobulin, interleukin-2 R and tumour necrosis factor. Nephrol Dial Transplant 1991;6 Suppl 2:61-3. Baraldi A, Bonucchi D, Di Felice A, Lusvarghi E, Artini P, Manenti A, Gresele P, Quero E, Nenci GC. Liquid nitrogen snap frozen saphenous vein for vascular access in dialysis. ASAIO Trans 1991 Jul-Sep;37(3):M225-7. Barrett NK, Brown E, McIvor J, Picus D, Surratt S, Hicks M, Darcy M. Subclavian vein and dialysis access planning. Am J Roentgenol 1991;157(5): 1125-6. Barth RH. Urea modeling and Kt/V: a critical appraisal. Kidney Int Suppl 1993;41:S252—60. Baurmeister U, Vienken J, Grassmann A. Biocompatibility and membrane development. Nephrol Dial Transplant 1991;6 Suppl 3:17-21. Beathard GA. Percutaneous transvenous angioplasty in the treatment of vascular access stenosis. Kidney Int 1992 Dec;42(6): 1390-7. Bellomo R, Boyce N. Acute continuous hemodiafiltration: a prospective study of 110 patients and a review of the literature. Am J Kidney Dis 1993 May;21(5):508-18. Bellomo R, Parkin G, Love J, Boyce N. A prospective comparative study of continuous arteriovenous hemodiafiltration and continuous venovenous hemodiafiltration in critically ill patients. Am J Kidney Dis 1993 Apr;21(4):400-4. Berman J, Celoria G, Garb J. Upper arm arteriovenous bridge grafts for hemodialysis. Vasc Surg 1992; 26(2):85—92. Berry C, Cestero RV. Indications of hemodialysis access demise related to clotting and possible associated vessel stenosis: what to look for. ANNA J 1992 Apr;19(2):162. Besarab A, Dorrell S, Moritz M, Michael H, Sullivan K. Determinants of measured dialysis venous pressure and its relationship to true intra-access venous pressure. ASAIO Trans 1991 Jul-Sep;37(3): M270-1. Besarab A, Moritz M, Sullivan K, Dorrell S, Price JJ. Venous access pressures and the detection of intra- access stenosis. ASAIO J 1992 Jul-Sep;38(3): M519-23. Besley M, Thomas A, Salter S, Sang YY, Vas M, Uldall PR. Control of oral anticoagulation in patients using long-term internal jugular catheters for haemodialysis access. Int J Artif Organs 1992 May;15(5):277-80. Beyerlein-Buchner C, Albert FW. Endoscopic peritoneal dialysis catheter placement. Contrib Nephrol 1991;89:28-30. Blagg CR. Hemodialysis 1991. Blood Purif 1992;10(1): 22-9. Blagg CR. The US Renal Data System and the Case- Mix Severity Study. Am J Kidney Dis 1993 I an; 21(1):106-8. Blagg CR, Liedtke RJ, Batjer I D, Racoosin B, Sawyer TK, Wick MJ, Lawson L, Wilkens K. Serum albumin concentration-related Health Care Financing Administration quality assurance criterion is method-dependent: revision is necessary. Am J Kidney Dis 1993 Feb;21(2):138-44. Blake PG, Balaskas EV, Izatt S, Oreopoulos DG. Is total creatinine clearance a good predictor of clinical outcomes in continuous ambulatory peritoneal dialysis? Perit Dial Int 1992;12(4):353-8. Comment in: Perit Dial Int 1992;12(4):343-5. Blake PG, Balaskas E, Blake R, Oreopoulos DG. Urea kinetics has limited relevance in assessing adequacy of dialysis in CAPD. Adv Perit Dial 1992;8265-70. Blake PG, Flowerdew G, Blake RM, Oreopoulos DG. Serum albumin in patients on continuous ambulatory peritoneal dialysis--predictors and correlations with outcomes. J Am Soc Nephrol 1993 Feb;3(8):1501—7. Blake PG, Sombolos K, Abraham G, Weissgarten J, Pemberton R, Chu GL, Oreopoulos DG. Lack of correlation between urea kinetic indices and clinical outcomes in CAPD patients. Kidney Int 1991 Apr;39(4):700—6. Published erratum appears in Kidney Int 1991 Aug;40(2):388. Bonomini V. Introducing the biology of bioincompati— bility in dialysis. Nephrol Dial Transplant 1991; 6 Suppl 2:1-3. Bourquia A, Ramdani B, Essamadi JE, Zaid D. Venous thrombosis after subclavian vein catheterization for haemodialysis. Rev Med Inteme 1993;14(2):79-83. Bowen J, Gough DCS. Venous loop fistula for vascular access in childhood haemodialysis. Pediatr Surg Int 1993;8(2):182-3. Brandes JC, Piering WF, Beres JA, Blumenthal SS, Fritsche C. Clinical outcome of continuous ambulatory peritoneal dialysis predicted by urea and creatinine kinetics. J Am Soc Nephrol 1992 Mar; 2(9):1430-5. 31 Briceno JC, Runge TM. Tubing spallation in extracorporeal circuits. An in vitro study using an electronic particle counter. Int J Artif Organs 1992 Apr;15(4):222—8. Brock JS, Sussman M, Wamsley M, Mintzer R, Baumann FG, Riles TS. The influence of human immunodeficiency virus infection and intravenous drug abuse on complications of hemodialysis access surgery. J Vasc Surg 1992 Dec;16(6):904-10; discussion 911-2. Brock AP, Teunis HA, Bargcman D, Sprengers ED, Smolders CA. Characterization of hollow fiber hemodialysis membranes: pore size distribution and performance. J Membr Sci 1992;73(2-3):143-52. Brunner MC, Matalon TA, Patel SK, McDonald V, Jensik SC. Ultrarapid urokinase in hemodialysis access occlusion. J Vasc Interv Radiol 1991 Nov; 2(4):503-6. Buckley MM, Sorkin EM. Enoxaparin. A review of its pharmacology and clinical applications in the prevention and treatment of thromboembolic disorders. Drugs 1992;44(3):465-97. Burger H, Kootstra G, de Charro F, Leffers P. A survey of vascular access for haemodialysis in the Netherlands. Nephrol Dial Transplant 1991;6(1): 5-10. Burhop KE, Johnson RJ, Simpson 1, Chenoweth DE, Borgia J. Biocompatibility of hemodialysis membranes: evaluation in an ovine model. J Lab Clin Med 1993 Feb;121(2):276-93. Comment in: J Lab Clin Med 1993 Feb;121(2):203-4. Burkart JM. Adequacy of peritoneal dialysis. Dial Transplant 1993;22(5):234-43. Burkart JM, Jordan JR, Dumell TA, Case LD. Comparison of exit-site infections in disconnect versus nondisconnect systems for peritoneal dialysis. Perit Dial Int 1992;12(3):317-20. Comment in: Perit Dial Int 1993;13(1):67-8. Campbell D, Fritsche C, Brandes J. A review of urea and creatinine kinetics in predicting CAPD outcome. Adv Perit Dial 1992;8279-83. Campos A, Taylor JH, Garin EM. Long term experience with hickman catheters in pediatric hemodialysis patients [abstract]. Pediatr Res 1991:29(4 Pt 2):340a. Canada-USA (CANU SA) multicentre study of peritoneal dialysis adequacy: description of the study population and preliminary results. CANU SA Peritoneal Dialysis Study Group. Adv Perit Dial 1992;8288-92. Canaud B, Cristol I P, Mion C. Silastic twin catheters the answer to temporary vascular access for hemodialysis [abstract]. Blood Purif 1991;9(1):43. 32 Capdevila JA, Segarra A, Planes AM, Ramirez- Arellano M, Pahissa A, Piera L, Martinez-Vazquez J M. Successful treatment of haemodialysis catheter- related sepsis without catheter removal. Nephrol Dial Transplant 1993;8(3):231-4. Capelli JP, Kushner H, Camiscioli T, Chen SM, Stuccio-White NM. Factors affecting survival of hemodialysis patients utilizing urea kinetic modeling. A critical appraisal of shortening dialysis times. Am J Nephrol 1992;12(4):212—23. Carlisle EJ, Blake P, McCarthy F, Vas S, Uldall R. Septicemia in long-term jugular hemodialysis catheters; eradicating infection by changing the catheter over a guidewire. Int J Artif Organs 1991 Mar;14(3):150—3. Caruana R], Smith MC, Clyne D, Crow JW, Zinn JM, Diehl J H. Controlled study of heparin versus epoprostenol sodium (prostacyclin) as the sole anticoagulant for chronic hemodialysis. Blood Purif 199l;9(5-6):296-304. Cases A, Reverter JC, Escolar G, Sanz C, Lopez- Pedret J, Revert L, Ordinas A. Platelet activation on hemodialysis: influence of dialysis membranes. Kidney Int Suppl 1993;41:8217—20. Cassioumis D, Fatouros MS, Siamopoulos KC, Giannoukas AD. Short- and long-term evaluation of arteriovenous fistulas for chronic hemodialysis. Microsurgery 1992;13(5):236-7. Castiglione A, Pagliaro P, Romagnoni M, Beccari M, Cavaliere G, Veneroni G, Sorgato G. Flow cytometric analysis of leukocytes eluted from haemodialysers. Nephrol Dial Transplant 1991; 6 Suppl 2:31-5. Catizone L, Cantaluppi A, Peluso F, Zucchelli P. A new catheter to prevent exit-site infection in peritoneal dialysis. Adv Perit Dial 1992;8z283-7. Chan PC, Wu PG, Tam SC, Ip MS, Fang GX, Cheng IK. Factors affecting lymphatic absorption in Chinese patients on continuous ambulatory peritoneal dialysis (CAPD). Perit Dial Int 1991; 11(2): 147-51 . Chandramouly B, Cao H, Cochavi S. Gallium scintigraphy in hemodialysis access graft infection. Clin Nucl Med 1993;18(2):155-6. Chandran P, Lane TM, McCleary RA, Burkey S. Residual peritoneal volumes by CT scanning in CAPD patients. Perit Dial Int 1992;12(2):260-2. Charra B, Calemard E, Chazot C, Terrat JC, Vanel T, Ruffet M, Laurent G. Dose of dialysis: what index? Blood Purif 1992;10(1):l3-21. Charra B, Calemard E, Ruffet M, Chazot C, Terrat IC, Vane] T, Laurent G. Survival as an index of adequacy of dialysis. Kidney Int 1992 May;41(5): 1286-91. Chauveau P, Poignet JL, Kuno T, Bonete R, Kerembrun A, Naret C, Delons S, Man NK, Rist E. Phosphate removal rate: a comparative study of five high-flux dialysers. Nephrol Dial Transplant 1991;6 Suppl 2:114—5. Cheng BC, Cheng KK, Lai ST, Yu TI, Kuo SM, Weng ZC, Chang Y, Lee PC. Long term result of PTFE grafl for hemodialytic vascular access. J Surg Assoc Repub China 1992;25(2):1070-6. Cheung AK. Clinical phenomena induced by complement and leukocyte interactions with artificial surfaces. J Clin Apheresis 1992;7(3): 147-8. Cheung AK, Hohnholt M, Gilson J. Adherence of neutrophils to hemodialysis membranes: role of complement receptors. Kidney Int 1991 Dec;40(6): 1123-33. Cheung AK, Parker CJ, Janatova J, Brynda E. Modulation of complement activation on hemodialysis membranes by immobilized heparin. J Am Soc Nephrol 1992 Feb;2(8):1328-37. Chong TK, Piraino B, Bemardini J. Vestibqu toxicity due to gentamicin in peritoneal dialysis patients. Perit Dial Int 1991;11(2):152-5. Christensson A, Ljunggren L, Nilsson—Thorell C, Arge B, Diehl U, Hagstam KB, Lundberg M. In vivo comparative evaluation of hemodialysis tubing plasticized with DEHP and TEHTM. Int J Artif Organs 1991 Jul;14(7):4U7-10. Civati G, Guastoni C, Ballerini L, Perego A, Teatini U, Perrino ML, Benazzi E, Minetti L. Survival and morbidity in 20 chronic patients treated by high flux hemodialysis [abstract]. J Am Soc Nephrol 1992; 3(3):359. Civati G, Guastoni C, Teatini U, Perego A, Perrino ML, Benazzi E, Minetti L. High-flux acetate haemodialysis: a single-centre experience. Nephrol Dial Transplant 1991;6 Suppl 2:75-81. Clark KR, Forsythe IL, Rigg KM, Sharp J, Rangecrofi L, Wagget J, Parrott NR, Lennard TW, Coulthard MG. Surgical aspects of chronic peritoneal dialysis in the neonate and infant under 1 year of age. J Pediatr Surg 1992 Jun;27(6):780-3. Collins DM, Lambert MB, Middleton JP, Proctor RK, Davidson CJ, Newman GE, Schwab SJ. Fistula dysfunction: effect on rapid hemodialysis. Kidney Int 1992 May;41(5):1292-6. Colombi A, Ayer G, Burri G. The straight Tenckhoff catheter. Contrib Nephrol 1991;89:31-4. Coronel F, Martin-Rabadan P, Romero J. Chemical peritonitis after intraperitoneal administration of amphotericin B in a fungal infection of the catheter subcutaneous tunnel. Peritoneal Dial Int 1993;13(2): 161-2. Cruz C, Dumler F, Schmidt R, Gotch F. Enhanced peritoneal dialysis delivery with PD-PLUS. Adv Perit Dial 1992;82288-90. Cruz C, Faber MD. Peritoneoscopic implantation of catheters for peritoneal dialysis: effect on functional survival and incidence of tunnel infection. Contrib Nephrol 1991;89:35—9. Culpepper RM, Hirsch JI, Fratkin MJ. Clearance of 1311 by hemodialysis. Clin Nephrol 1992 Aug; 38(2):110—4. Curry SH, Lorenz A, Henderson GN, Mars DR, Stacpoole PW. Haemodialysis studies with dichloroacetate. Eur J Clin Pharmacol 1991;40(6): 613—7. Daniels ID, Berlyne GM, Barth RH. Blood flow rate and access recirculation in hemodialysis. Int J Artif Organs 1992 Aug;15(8):470-4. Darbord JC, DeCool A, Goury V, Vincent F. Biofilm model for evaluating hemodialyzer reuse processing. Dial Transplant 1992;21(10):644-5, 649-50. D’Arcy PF. Anaphylactic reactions with high-flux polyacrylonitrile membranes and ACE inhibitors. Int Pharm J 1992;6(3):109. Dasgupta MK, Kowalewska-Grochowska K, Bettcher KB, Tyrrell DL. Stable biofilms causing recurrent peritonitis and catheter loss in continuous ambulatory peritoneal dialysis CAPD [abstract]. Clin Invest Med 1991;14(4 Suppl):A136. Davidson CJ, Newman GE, Sheikh KH, Kisslo K, Stack RS, Schwab SJ. Mechanisms of angioplasty in hemodialysis fistula stenoses evaluated by intrgvascular ultrasound. Kidney Int 1991 Ju1;40(1): 91- . Davies SJ , Brown B, Bryan J, Russell GI. Clinical evaluation of the peritoneal equilibration test: a population-based study. Nephrol Dial Transplant l993;8(1):64-70. De Alvaro F, Bajo MA, Alvarez-Ude F, Vigil A, Molina A, Coronel F, Selgas R. Adequacy of peritoneal dialysis: does KT/V have the same predictive value as in HD? A multicenter study. Adv Perit Dial 1992;8z93-7. de Chatel R, Mako J, Toth M, Barna I, Lang RE. Atrial natriuretic peptide (ANP) in patients with chronic renal failure on maintenance haemodialysis. Int Urol Nephrol 1991;23(2):177-83. 33 de Vries JP, Olthof CG, Visser V, Kouw PM, van Es A, Donker JM, de Vries PM. Continuous measurement of blood volume during hemodialysis by an optical method. ASAIO J 1992 Jul-Sep;38(3): M181—5. Deguchi N, Ohigashi T, Tazaki H, Handa M, lkeda Y. Haemodialysis and platelet activation. Nephrol Dial Transplant 1991;6 Suppl 2:40-2. Dell’Aquila R, Feriani M, Mascalzoni E, Bragantini L, Ronco C, La Greca G. Oxalate removal by differing dialysis techniques. ASAIO J 1992 Oct-Dec;38(4):797—800. Deppisch R, Betz M, Hansch GM, Rauterberg EW, Ritz E. Biocompatibility of the polyamide membranes. Contrib Nephrol 1992;96:26-46. DeSoi CA, Sahm DF, Umans JG. Vancomycin elimination during high-flux hemodialysis: kinetic model and comparison of four membranes. Am J Kidney Dis 1992 Oct;20(4):354-60. Dewanjee MK, Kapadvanjwala M, Sanchez A, Elson R, Serafini AN, Zilleruelo GE, Sfakianakis GN. Quantitation of comparative thrombogenicity of dog, pig, and human platelets in a hemodialyzer. ASAIO J 1992 Apr-Jun;38(2):88—90. Diaz-Buxo JA. Advances in peritoneal dialysis prescription. Transplant Proc 1991 Apr;23(2): 1845-6. Diaz-Buxo JA. Mechanical complications of chronic peritoneal dialysis catheters. Semin Dial 1991 Apr-Jun;4(2):106-11 . Didlake R, Curry E, Rigdon EE, Raju S, Bower J. Outpatient vascular access surgery: impact of a dialysis unit-based surgical facility. Am J Kidney Dis 1992;19(1):39—44. Docci D, Bilancioni R, Pistocchi E, Baldrati L, Capponcini C, Delvecchio C, Feletti C. Evolution of serum prealbumin following hemodialysis: effect of different dialysis membranes. Nephron 1992; 62(2): 145-9. Dodson TF, Stewart MT, Martin LG. Polytetrafluoro- ethylene aorta-vena cava grafi for hemodialysis: report of a case. J Vasc Surg 1993 Apr;17(4): 759-61. Domoto DT, Bauman J E, Joist J H. Combined aspirin and sulfinpyrazone in the prevention of recurrent hemodialysis vascular access thrombosis. Thromb Res 1991 Jun 15;62(6):737-43. Donnelly PK, Morton D, Woffindin C, Hoenich NA. Characterisation and evaluation of a new double lumen central venous catheter. Int J Artif Organs 1992 Jun;15(6):331-8. 34 Donovan KL, Pacholok S, Phillips A, Humes JL, Coles GA, Williams JD. Effect of dialyser composition and reuse on neutrophil count and elastase alpha-1 proteinase inhibitor complex formation. Int J Artif Organs 1992 Mar;15(3):139—43. Dousset V, Grenier N, Douws C, Senuita P, Sassouste G, Ada L, Potaux L. Hemodialysis grafts: color Doppler flow imaging correlated with digital subtraction angiography and functional status. Radiology 1991;181(1):89-94. Dryden MS, Ludlam HA, Wing AJ, Phillips I. Active intervention dramatically reduces CAPD-associated infection. Adv Perit Dial 1991;7z125-8. Dryden MS, Mch M, Wing A], Phillips 1. Controlled trial of a Y-set dialysis delivery system to prevent peritonitis in patients receiving continuous ambulatory peritoneal dialysis. J Hosp Infect 1992 Mar;20(3):185—92. Dryden MS, Samson A, Ludlam HA, Wing AJ, Phillips 1. Infective complications associated with the use of the Quinton "Permeath" for long-term central vascular access in haemodialysis. J Hosp Infect 1991 Dec;19(4):257—62. Dryden MS, Talsania HG, Martin S, Cunningham M, Richardson JF, Cookson B, Marples R, Phillips I. Evaluation of methods for typing coagulase-negative staphylococci. J Med Microbiol 1992 Aug;37(2): 109- 17. Dumler F, Brickman C, Michaels RS, Sally V, Laude B, Perry M. Differences in biocompatibility induced by modification of polysulfone membrane permeability characteristics [abstract]. J Am Soc Nephrol 1991;2(3):322. Dumler F, Stalla K, Mohini R, Zasuwa G, Levin NW. Clinical experience with short-time hemodialysis. Am J Kidney Dis 1992 Jan;19(l):49—56. Duncan J M, Baldwin RT, Caralis JP, Cooley DA. Subclavian vein-to-right atrial bypass for symptomatic venous hypertension. Ann Thorac Surg 1991 Dec;52(6):1342-3. Dunea G, Domenico L, Gunnerson P, Winston-Willis F. A survey of permanent double lumen catheters in hemodialysis patients. ASAIO Trans 1991 Jul-Sep; 37(3):M276-7. Durand PY, Chanliau J, Gamberoni J, Hestin D, Kessler M. Routine measurement of hydrostatic intraperitoneal pressure. Adv Perit Dial 1992;8: 108- 12. Dy GR, Bloom EJ, Ijelu GK, Merritts GW, Kramer MS, Raja RM. Effect of recombinant human erythropoietin on vascular access. ASAIO Trans 1991 Jul-Sep;37(3):M274-5. Dzurik R, Lajdova I, Spustova V, Opatrny K Jr. Pseudouridine excretion in healthy subjects and its accumulation in renal failure. Nephron 1992;61(1): 64-7. Edefonti A, Picca M, Ghio L, Bassi S, Cattarelli D, Leccese V. Adequacy of solute and water removal in children treated with nightly intermittent peritoneal dialysis. Adv Perit Dial 1992;8:402-5. Ehrman KO, Gaylord GM. Thrombolytic therapy for occluded dialysis access grafts. Semin Intervent Radiol 1992;9(3):190—4. Eisele G, Bailie GR, Lomaestro B. Relationship between peritonitis and exit site infections in CAPD. Adv Perit Dial 1992;8z227-9. El-Kashef E, El-Lakany SA, Aggan HAE, Saaran AE, Halim AH. Plasma antithrombin III concentration and platelet count in hemodialysis patients. J Med Res Inst 1991;12(4):227—39. Ellis EN, Watts K, Wells TG, Arnold WC. Use of the peritoneal equilibration test in pediatric dialysis patients. Adv Perit Dial 1991;7:259-6l. Emmett M, Sirmon MD, Kirkpatrick WG, Nolan CR, Schmitt GW, Cleveland MB. Calcium acetate control of serum phosphorus in hemodialysis patients. Am J Kidney Dis 1991 May;17(5):544-50. England RE, Jackson A. Imaging of dialysis access: a review of 67 failing fistulas investigated by intravenous digital subtraction angiography. Br J Radiol 1993 Jan;66(781):32-6. Espana F, Gilabert J, Vicente V, Estelles A, Vazquez L, Hendl S, Aznar J. Activated protein C: alpha 1- antitrypsin (APC: alpha 1 AT) complex as a marker for in vitro diagnosis of prethrombotic states. Thromb Res 1992 Jun 1;66(5):499-508. Evans J H, Smye SW, Brocklebank J T. Mathematical modelling of haemodialysis in children. Pediatr Nephrol 1992 Ju1;6(4):349-53. Fahal IH, Yaqoob M. How to insert a temporary peritoneal dialysis cannula. Saudi Med J 1991; 12(6):526-7. Falkenhagen D, Brown GS. Clinical evaluation of three haemodialysers containing PMMA membranes of different surface area, with special attention to thrombogenicity. Nephrol Dial Transplant 1991; 6 Suppl 2:43-8. Fang JT, Huang CC. Percutaneous internal jugular vein catheterization with double lumen for temporary hemodialysis: experience of 100 cases. Chang Keng I Hsueh 1992 Sep;15(3):114-20. Feldman HI, Held PJ, Hutchinson JT, Stoiber E, Hartigan MF, Berlin JA. Hemodialysis vascqu access morbidity in the United States. Kidney Int 1993 ;43(5): 1091-6. Fessia SL, Grabowy RS, Bouaquet GG. Effectiveness of microwave moist-heat intraluminal disinfection of CAPD connectology. Adv Perit Dial 1991;7:204-7. Fischth M. Assessment of the adequacy of hemodialysis (HD) in children [abstract]. Pediatr Nephrol 1992;6(5):C40. Fischbach M, Hamel G, Simeoni U, Geisert J. Phosphate dialytic removal: enhancement of phosphate cellular clearance by biofiltration (with acetate-free buffer dialysate). Nephron 1992;62(2): 155-60. Flanigan MJ, Doyle C, Lim VS, Ullrich G. Tidal peritoneal dialysis: preliminary experience. Perit Dial Int l992;12(3):304—8. Flanigan MJ, Ullrich G, Lim VS. Tidal peritoneal dialysis. Urea and total nitrogen losses. ASAIO Trans 1991 Jul-Sep;37(3):M398-400. Fleming SJ, Foreman K, Shanley K, Mihrshahi R, Siskind V. Dialyser reprocessing with Renalin. Am J Nephrol 1991;11(1):27—31. Flores L, Haser PB, Bradbury K, Carryl S, Shaftan G. Improved venous outflow by double vein anastomosis in graft angioaccess. Surg Gynecol Obstet 1992 Apr;174(4):332-4. Follis F, Miller KB, Paone RF, Wernly JA. Iatrogenic pseudoaneurysm of the innominate artery. Tex Heart Inst J 1992;19(4):294—6. Fong IW, Capellan JM, Simbul M, Angel J. Infection of arterio—venous fistulas created for chronic haemodialysis. Scand J Infect Dis 1993;25(2): 215-20. Fox K, Adcock A, Raymond K, Walker P. Analysis of clinical experience with a new twist lock connectology. Adv Perit Dial 1992;8z291-3. Francis DM, Goodman DJ, Millar RJ, Walker RG, Becker GJ. Right atrial catheters: reliable, immediate and durable vascular access for heamodialysis and plasma exchange. Aust N Z J Surg 1993;63(4):284—8. Francoise Gachon AM, Mallet J, Tridon A, Deteix P. Analysis of proteins eluted from hemodialysis membranes. J Biomater Sci Polym Ed 1991;2(4): 263-76. Freedman BI, Anderson RL, Tuttle AB, Canzanello VJ. The Thomas shunt revisited. Am J Kidney Dis 1992 Jan;19(1):45-8. Gagnon RF, Richards GK, Subang R. Experimental Staphylococcus epidermidis implant infection in the 35 mouse. Kinetics of rifampin and vancomycin action. ASAIO J 1992 Jul-Sep;38(3):M596-9. Gallimore B, Gagnon RF, Subang R, Richards GK. Natural history of chronic Staphylococcus epidermidis fore'gn body infection in a mouse model. J Infect Dis 1991 Dec;164(6):1220-3. Gani J S, Fowler PR, Steinberg AW, Wlodarczyk JH, Nanra RS, Hibberd AD. Use of the fistula assessment monitor to detect stenoses in access fistulae. Am J Kidney Dis 1991 Mar;l7(3):303-6. Gao W, Sun EW, Lin MZ. Titanium nails used in A-V fistulation for hemodialysis in 428 patients. Chin Med J (Engl Ed) 1992;105(12):980—6. Garel L. Pediatric gastrostomy and gastrojejunostomy. Semin Interv Radiol 1991;8(3):210—3. Gault MH, Vasdev SC, Longerich I, Purchase L, Sampon C, Johnson E. Heparin, fatty acids and sodium, potassium-ATPase inhibition by plasma factors during hemodialysis. Nephron 1992;60(3): 292-301. Gawaz MP, Ward RA. Effects of hemodialysis on platelet-derived thrombospondin. Kidney Int 1991 Aug;40(2):257-65. Gearing AJ, Hemingway I, Pigott R, Hughes J, Rees AJ, Cashman SJ. Soluble forms of vascular adhesion molecules, E—selectin, ICAM-1, and VCAM-l: pathological significance. Ann N Y Acad Sci 1992;667:324-31. Geary DF, Gajaria M, Fryer-Keene S, Willumsen J. Low-dose and heparin-free hemodialysis in children. Pediatr Nephrol 1991 Mar;5(2):220—4. Geary DF, Harvey EA, MacMillan JH, Goodman Y, Scott M, Balfe J W. The peritoneal equilibration test in children. Kidney Int 1992 Jul;42(1):102—5. Gellert R, Billip-Tomecka Z, Hijaz H, Bogdanska— Straszynska B, Malecka B Sicinski A. Intradialytic erythrocyte volume changes. Nephrol Dial Transplant 1991;6 Suppl 3:10-3. Germain M, Harlow P, Mulhem J, Lipkowitz G, Braden G. Low protein catabolic rate and serum albumin correlate with increased mortality and abdominal complications in peritoneal dialysis patients. Adv Perit Dial 1992;82113-5. Ghezzi PM, Gervasio R, Botella J. Continuous pH and HC03 monitoring during hemodiafiltration without blood sampling. ASAIO Trans 1991 Oct-Dec;37(4): 605-7. Gianese F, Nurmohamed MT, Imbimbo BP, Bullet HR, Berckmans RJ, ten Cate JW. The pharmacokinetics and pharmacodynamics of dermatan sulphate MF701 during haemodialysis for chronic renal 36 failure. Br J Clin Pharmacol 1993 Mar;35(3):335-9. Gibson SP, Mosquera D. Five years experience with the Quinton Permcath for vascular access. Nephrol Dial Transplant 1991;6(4):269-74. Girolami JP, Bascands JL, Vega Vidalle C, Pecher C, Moatti JP, Adam A, Suc JM. Increase in urinary kallikrein excretion following hemodialysis. Nephron 1991;59(1):51-6. Godai K, Uemasu J, Kawasaki H. Clinical significance of serum and urinary neopterins in patients with chronic renal disease. Clin Nephrol 1991 Sep;36(3): 141-6. Gohl H, Buck R, Strathmann H. Basic features of the polyamide membranes. Contrib Nephrol 1992;96: 1-25. Gokal R. Recent perspectives on peritoneal dialysis. Contrib Nephrol 1993;102:98-109. Gokal R, Ash SR, Helfrich GB, Holmes CJ, Joffe P, Nichols WK, Oreopoulos DG, Riella MC, Slingeneyer A, Twardowski ZJ, et a1. Peritoneal catheters and exit-site practices: toward optimum peritoneal access. Perit Dial Int 1993;13(1):29—39. Gonella M, Calabrese G, Pratesi G, Baldin C, Mazzotta A, Vagelli G. New reinfusate composition in high UF haemodiafiltration: electrolyte solution combined with bicarbonate. Nephrol Dial Transplant 1993;8(1):54-9. Gonella M, Calabrese G, Pratesi G, Mazzotta A, Vagelli G, Baldin C. The polyamide membrane in hemodiafiltration. Contrib Nephrol 1992;96:99-105. Gonthier D, Bemardini J , Holley IL, Piraino B. Erythema: does it indicate infection in a peritoneal catheter exit site? Adv Perit Dial 1992;8z230-3. Gora ML, Seth S, Visconti JA, Shields B, Bay W. Stability of dobutamine hydrochloride in peritoneal dialysis solutions. Am J Hosp Pharm 1991;48(6): 1234-7. Gordge MP, Neild GH. Platelets from patients on haemodialysis show impaired responses to nitric oxide. Clin Sci 1992 Sep;83(3):313-8. Gordge MP, Neild GH. Reduced sensitivity to nitric oxide in uraemic platelets [abstract]. J Am Soc Nephrol 1991;2(3):505. Gorman SP, Mawhinney WM, Adair CG. The influence of catheter surface microrugosity on the development and persistence of recurrent peritonitis in CAPD [abstract]. Pharmacotherapy 1991;11(3): 267. Gotch FA. Adequacy of peritoneal dialysis. Am J Kidney Dis 1993 Jan;21(1):96-8. Gotch FA. Interpreting and applying kinetics for peritoneal and hemodialysis. ANNA J 1991 Jun;18(3):272-9. Gouge SF, Moore J Jr, Atkins F, Hirszel P. Radiocontrast removal by dialysis membranes. Blood Purif 1991;9(4):182-7. Graff J, Joffe P, Ladefoged SD. An assessment of the flow rate within peritoneal dialysis catheters, using a standardized in vitro technique. Adv Perit Dial 1992;8:294-7. Grant ME, Lovell HB, Wiegmann TB. Current use of anticoagulation in hemodialysis. Semin Dial 1991 Jul-Sep;4(3):168-73 . Gray RJ, Dolmatch BL, Buick MK. Directional atherectomy treatment for hemodialysis access: early results. J Vasc Interv Radiol 1992 Aug;3(3): 497-503. Gray RR. Radiologic placement of indwelling central venous lines for dialysis TPN and chemotherapy. J Intervent Radiol 1991;6(4):133-44. Grosse-Siestrup C, Kahl K, Becker H, Gahl GM. A silver device to prevent catheter-exit-infections [abstract]. Int J Artif Organs 1992;15(9):514. Grote J, Hausmann D, Daniel WG, Muegge A, Nikutta P, Bahlmann J, Lichtlen PR. Transesophageal echocardiographic assessment of superior vena cava thrombosis in patients with long-term central venous dialysis catheters [abstract]. Eur Heart J 1992; 13(Abstr Suppl):284. Grote J, Hausmann D, Muegge A, Nikutta P, Balilmann J, Daniel WG. Transesophageal echocardiographic assessment of superior vena cava thrombosis in patients with long-term central venous hemodialysis catheters [abstract]. Circulation 1992;86(4 Suppl 1): 1124. Grzegonewska AE, Moore HL, Chen TW, Nolph KD. Peritoneal transfer during maximal hyperosmotic ultrafiltration in the rat. ASAIO I 1993;39(1): 66-70. Gurland HJ. Biocompatibility of haemodialysis systems: present and future: closing remarks. Nephrol Dial Transplant 1991;6 Suppl 2:126. Gurudev KC, Ramkumar TS, Pathak V, Prabhakar KS, Bhaskar S, Prakash KC, Mani MK. Subclavian vein catheters for haemodialysis with and without a subcutaneous tunnel. J Assoc Physicians India 1992 Iun;40(6):370—3. Gutierrez A, Alvestrand A, Bergstrom J. Membrane selection and muscle protein catabolism. Kidney Int Suppl 1992;38:586-90. Hafner G, Swars H, Ehrenthal W, Schinzel H, Weilemann LS, Prellwitz W. The control of anti- coagulation in acute dialyses with sensitive laboratory parameters. Scand J Clin Lab Invest 1992 Jun;52(4):289—96. Hakim RM, Depner TA, Parker TF 3d. Adequacy of hemodialysis. Am J Kidney Dis 1992 Aug;20(2): 107-23. Hakim RM, Lawrence P, Schulman G, Breyer J, Ismail N. Increasing dose of dialysis improved mortality and nutritional parameters in hemodialysis (HD) patients [abstract]. J Am Soc Nephrol 1992;3(3): 367. Han DC, Cha HK, Chung SH, Park MS, Lee SK, Hwang SD, Moon C, Lee I-IB. Effects of subcutaneously implanted catheters on the incidence of peritonitis during CAPD [abstract]. J Am Soc Nephrol 1991;2(3):361. Han DC, Cha HK, So IN, Chung SH, Park MS, Lee SK, Woo JH, Hwang SD, Moon C, Lee I-IB. Subcutaneously implanted catheters reduce the incidence of peritonitis during CAPD by eliminating infection by periluminal route. Adv Perit Dial 1992; 8:298-301. Hannah A, Buttimore AL. Thrombolysis of blocked hemodialysis catheter using recombinant tissue-type plasminogen activator. Nephron 1991;59(3):517—8. Harmon WE. Are there advantages to bicarbonate dialysis as a standard procedure for chronic hemodialysis in children? Pediatr Nephrol 1991 Ju1;5(4):392. Hasbargen IA, Hasbargen BI, Fortenbery El. Effect of intraperitoneal neostigrnine on peritoneal transport characteristics in CAPD. Kidney Int 1992 Dec; 42(6): 1398-400. Hatjibaloglou A, Grekas D, Saratzis N, Megalopoulos A, Moros I, Kiskinis D, Dalainas V. Transposed basilic vein-brachial arteriovenous fistula: an alternative vascular access for hemodialysis. Artif Organs 1992 Dec;16(6):623-5. Heimburger O, Waniewski J, Werynski A, Lindholm B. A quantitative description of solute and fluid transport during peritoneal dialysis. Kidney Int 1992 May;41(5):1320-32. Held PJ, Blagg CR, Liska DW, Port FK, Hakim R, Levin N. The dose of hemodialysis according to dialysis prescription in Europe and the United States. Kidney Int Suppl 1992 Oct;38:816-21. Held PI, Levin NW, Bovbjerg RR, Pauly MV, Diamond LH. Mortality and duration of hemodialysis treatment. JAMA 1991 Feb 20;265(7): 871-5. Comment in: JAMA 1991 Feb 20;265(7): 909-10; JAMA 1991 Jun 12;265(22):2958-9. Hemodialysis machines. Health Devices 1991 Jun; 20(6): 187-232. 37 Hernandez D, Diaz F, Suria S, Machado M, Lorenzo V, Losada M, Gonzalez-Posada JM, De Bonis E, Dominguez ML, Rodriguez AP, et al. Subclavian catheter-related infection is a major risk factor for the late development of subclavian vein stenosis. Nephrol Dial Transplant 1993;8(3):227—30. Hester RL, Ashcraft D, Curry E, Bower J. Non- invasive determination of recirculation in the patient on dialysis. ASAIO J 1992 Jul-Sep;38(3):M190-3. Hester RL, Curry E, Bower J. The determination of hemodialysis blood recirculation using blood urea nitrogen measurements. Am J Kidney Dis 1992 Dec;20(6):598-602. Hill SL, Donate AT. Complications of dialysis access: a six-year study. Am J Surg 1991;162(3):265-7. Himmelfarb J, Gerard NP, Hakim RM. Intradialytic modulation of granulocyte C5a receptors. J Am Soc Nephrol 1991 Oct;2(4):920-6. Hirsch DJ, Jindal KK. Late leaks in peritoneal dialysis patients. Nephrol Dial Transplant 1991;6(9):670-1. Hoenich NA, Smirthwaite PT, Woffindin C, Lancaster P, Frost TH, Vanholder R. A technique for the laboratory determination of recirculation in single needle dialysis. Int J Artif Organs 1993 Feb;16(2): 63-70. Holemans IA, McIvor J, Brown EA. Recurrent subclavian vein stenosis following successful angioplasty. Nephrol Dial Transplant 1993 ;7(3): 270-1. Holley J, Bernardini I, Piraino B. Catheter infections in insulin-dependent diabetics on continuous ambulatory peritoneal dialysis. Perit Dial Int 1991; 11(4):347-50. Horber FF, Thomi F, Casez JP, Fonteille J, Jaeger P. Impact of hydration status on body composition as measured by dual energy X—ray absorptiometry in normal volunteers and patients on haemodialysis. Br J Radiol 1992;65(778):895—900. Horiuchi T, Ohta Y, Tada Y, Dohi T, Azuma N, Matsugane T, Sakurai H, Mizumura H, Suzuki M. Measurement of peritoneal dialysate volume by CT. ASAIO Trans 1991 Jul-Sep;37(3):M156—8. Homberger JC, Chemew M, Petersen J, Garber AM. A multivariate analysis of mortality and hospital admissions with high-flux dialysis. J Am Soc Nephrol 1992 Dec;3(6):1227—37. Horowitz MD, Alkire MJ, Lickstein DA, Bauerlein EJ. Aortic injury as a complication of central venous catheterization. Am Heart J 1991 Aug;122(2): 595-7. 38 Hull AR. Impact of reimbursement regulations on patient management. Am J Kidney Dis 1992 Jul; 20(1 Suppl 1):8-11. Hutchison AJ, Gokal R. Improved solutions for peritoneal dialysis: physiological calcium solutions, osmotic agents and buffers. Kidney Int Suppl 1992; 38:5153-9. Hutchison AJ, Gokal R. Peritoneal dialysis fluids for the future: do we have the solution? Dial Transplant 1992;21(2):57, 59-61, 63, 108. Hutchison AJ, Ofsthun NJ, Howarth D, Gokal R. The effect of hemoglobin concentration on peritoneal mass transfer and drain volumes in continuous ambulatory peritoneal dialysis. Perit Dial Int 1992; 12(2):230—3. Hyver SW, Petersen J, Cajias J. An in vivo analysis of reverse ultrafiltration during high-flux and high- efficiency dialysis. Am J Kidney Dis 1992 May; 19(5):439—43. Ifediora 0C, Teehan BP, Sigler MH. Solute clearance in continuous venovenous hemodialysis. A comparison of cuprophane, polyacrylonitrile, and polysulfone membranes. ASAIO J 1992 Jul-Sep; 38(3):M697-701. Ignotus PI, Gray RR, Macklin N. Review of radiological insertion of indwelling central venous catheters. Minim Invasive Ther 1992;1(6):373-88. Ikomi-Kumm J, Ljunggren L, Lund U, Monti M, Thysell H. Microcalorimetric evaluation of blood compatibility of hemodialysis membranes. Blood Purif 1991;9(4):177-81. Inagaki O, Nishian Y, Iwaki R, Nakagawa K, Takamitsu Y, Fujita Y. Adsorption of nafamostat mesilate by hemodialysis membranes. Artif Organs 1992 Dec;16(6):553-8. Ing TS, Yu AW, Thompson KD, Ansari AU, McShane AP, Gandhi VC, Filkins JP. Peritoneal dialysis using conventional, lactate-containing solution sterilized by ultrafiltration. Int J Artif Organs 1992 Nov;15(11):658-60. Ireland HA, Boisclair MD, Lane DA, Thompson E, Curtis JR. Hemodialysis and heparin. Alternative methods of measuring heparin and of detecting activation of coagulation. Clin Nephrol 1991 Jan; 35(1):26-33. Ishihara K, Takayama R, Nakabayashi N, Fukumoto K, Aoki J. Improvement of blood compatibility on cellulose dialysis membrane. 2. Blood compatibility of phospholipid polymer grafted cellulose membrane. Biomaterials 1992;13(4):235—9. Ittel TH, Schafer C, Schmitt H, Gladziwa U, Sieberth HG. Calcium carbonate as a phosphate binder in dialysis patients: evaluation of an enteric-coated preparation and effect of additional aluminium hydroxide on hyperaluminaemia. Klin Wochenschr 1991 Jan 22;69(2):59-67. Jabar Z, Dawson M. An in vitro investigation of the role of surfactant in continuous ambulatory peritoneal dialysis. Toxicol Vitro 1991;5(5-6): 467-71. Jacobs IG, Gray RR, Elliott DS, Grosman H. Radiologic placement of peritoneal dialysis catheters: preliminary experience. Radiology 1992 Jan;182(1):251-5. Jain KM, Sirnoni EJ. Cross-over bypass to axillary Vein in haemodialysis patients. Eur J Vasc Surg 1992 Jan;6(1):101-3. Janatova J, Cheung AK, Parker CJ. Biomedical polymers differ in their capacity to activate complement. Complement Inflamm 1991;8(2):61-9. Janicki K, Dmoszynska A, Janicka L, Stettner S, Jesipowicz J. Influence of antiplatelet drugs on occlusion of arteriovenous fistula in uraemic patients. Int Urol Nephrol 1992;24(1):83-9. J ayasree G, Sharma CP. Polyether urethane urea membrane for an improved hemodialysis. Biomater Artif Cells Immobilization Biotechnol 1991;19(3): 649-59. Jenkins RD, Harrison HL, Jackson EC, Funk JE. Continuous renal replacement in infants and toddlers. Contrib Nephrol 1991;93:245-9. Jirasiritham S, Panichapan S, Sumethkul V, Jirasiritham S. Staged vascular access for hemodialysis in end- stage renal disease patients. Transplant Proc 1992 Aug;24(4): 1461 . J offe P, Christensen AL, Jensen C. Intra—abdominal location of peritoneal catheters during CAPD. Adv Perit Dial 1991;72214-7. Joffe P, Christensen AL, Jensen C. Peritoneal catheter tip location during non-complicated continuous ambulatory peritoneal dialysis. Perit Dial Int 1991; 1 1(3):261-4. Joffe P, Ladefoged SD, Cintin C, Lehmann H. 1 alpha- hydroxycholecalciferol adsorption to peritoneal dialysis bags: influence of time, glucose concentration, temperature, and albumin. Nephrol Dial Transplant 1992;7(12): 1249-51. Jones CE, Walters GK. Efficacy of the supraclavicular route for tern hemodialysis access. South Med J 1992 Jul;85(7):725—8. Jones JG, Bembridge JL, Sapsford DJ, Tumey JH. Continuous measurements of oxygen saturation during haemodialysis. Nephrol Dial Transplant 1992;7(2):110—6. Jorres A, Jorres D, Gahl GM, Schulz E, Mahiout A. Leukotriene release from neutrophils of patients on hemodialysis with cellulose membranes. Int J Artif Organs 1992 Feb;15(2):84-8. Jorres A, Topley N, Gahl GM. Biocompatibility of peritoneal dialysis fluids. Int J Artif Organs 1992;15(2):79-83. Kalil K, Grosse-Siestrup C, Kahl A, Becker H, Rueden H, Hahn H, Gahl GM. Clinical application of a new silver device to prevent catheter-exit infections in peritoneal dialysis [abstract]. Nephrol Dial Transplant 1992;7(7):744. Kalra OP, Aggarwal HK, Mahajan SK, Seth RK. Effect of vasodilator and surface active drugs on the efficacy of peritoneal dialysis. J Assoc Physicians India 1992 Apr;40(4):233-6. Karatson A, Racz L, Buzogany I. Catheter types and their abdominal implantation in peritoneal dialysis. Int Urol Nephrol 1992;24(3):327-33. Kathrein H, Judmaier G, Braunsteiner H. Assessment of arteriovenous haemodialysis fistulas. Lancet 1992;339(8799):996. Kaufman JL. Hemodialysis access catastrophies. Semin Dial 1991 Jan-Mar;4(1):33-9. Kaupke CI, Ahdout J, Vaziri ND, Deutsch LS. Perforation of the superior vena cava by a subclavian hemodialysis catheter: early detection by angiography. Int J Artif Organs 1992 Nov;15(11): 666-8. Kazmi HR, Raffone FD, Kliger AS, Finkelstein F0. Pseudomonas exit site infections in continuous ambulatory peritoneal dialysis patients. J Am Soc Nephrol 1992 Apr;2(10): 1498-501 . Keferstein RD, Fiedler C, Pelster FW, Reers B. Infection prophylaxis and infection control in vascular access surgery. Vasc Surg 1992;26(4): 300-6. Kelber J, Delmez J, Windus D. The effects of double lumen catheter placement site and blood flow rate on effective clearance in hemodialysis. J Am Soc Nephrol 1992;3(3):373. Keoghane SR, Leow CK, Gray DW. Routine use of arteriovenous fistula construction to dilate the venous outflow prior to insertion of an expanded polytetrafluoroethylene (PTFE) loop graft for dialysis. Nephrol Dial Transplant 1993;8(2):154-6. Kems DB, Frymoyer PA, Kopecky RT, Tice D, Fillinger MF, Bruch D, Schwartz RA. Is heparin- induced platelet activation an unrecognized cause of thrombosis in chronic dialysis patients? Vasc Surg 1992;26(6):487-93. 39 Kerr PG, Argiles A, Canaud B, Flavier JL, Mion C. The effects of reprocessing high-flux polysulfone dialyzers with peroxyacetic acid on beta 2- microglobulin removal in hemodiafiltration. Am J Kidney Dis 1992 May;19(5):433-8. Keshavialr P. Adequacy of CAPD: a quantitative approach. Kidney Int Suppl 1992;38:S160—4. Keshaviah P. Urea kinetic and middle molecule approaches to assessing the adequacy of hemodialysis and CAPD. Kidney Int Suppl 1993 Feb;402528-38. Keshaviah PR, Nolph KD. Protein catabolic rate calculations in CAPD patients. ASAIO Trans 1991 Jul-Sep;37(3):M400—2. Kessler M, Hoen B, Mayeux D, Hestin D, Fontenaille C. Bacteremia in patients on chronic hemodialysis. A multicenter prospective survey. Nephron 1993; 64(1):9_5-100. Keuchel M, Dittmar A, Saure B, Laage C, Ebel H, Lange H. Fluid-shift during computer-modulated profile hemodialysis (CMP-HD). Int J Artif Organs 1991 Oct;14(10):630-3. Khan IH, Catto GRD. Long-term complications of dialysis: infection. Kidney Int Suppl 1993;41: S143-8. Khanna S, Sniderman K, Simons M, Besley M, Uldall R. Superior vena cava stenosis associated with hemodialysis catheters. Am J Kidney Dis 1993 Mar;21(3):278-81. Kimmelstiel FM, Miller RE, Molinelli BM, Lorch JA. Laparoscopic management of peritoneal dialysis catheters. Surg Gynecol Obstet 1993;176(6):565-70. Kirschbaum B. Acid-base regulation in hemodialyzed renal failure patients: effect of serum proteins and bicarbonate buffering. Artif Organs 1991 Dec; 15(6):443-8. Kitaevich Y, Bissler J, Benzing G 3d, Hemasilpin N, Marchevsky G, McEnery P, Hammitt M. Development of a high-precision continuous extracorporeal hemodiafiltration system. Biomed Instrum Technol 1993 Mar-Apr;27(2):150—6. Kitamoto Y, Kano T, Mishima M, Matsushita K, Yasumoto N, Nakano M, Morioka T, Sato T. Dermal patch anesthesia: pain-free puncture of blood access in hemodialysis patients. Am J Kidney Dis 1992 Nov;20(5):489-91. Kjellstrand P, Boberg U. Toxicity testing of polymer materials for use in haemodialysis. Toxicol Vitro 1991;5(5-6):443-8. Kjellstrand P, Okmark P, Odselius R, Thysell H, Riede G, Holmquist B. Adherence of blood cells to dialyzer membranes as a measure of 40 biocompatibility. Int J Artif Organs 1991 Nov; 14(11):698-702. Klaus G, Schafer F, Querfeld U, Soergel M, Wolf S, Mehls 0. Treatment of relapsing peritonitis in pediatric patients on peritoneal dialysis. Adv Perit Dial 1992;8z302-5. Knabe C, Grosse-Siestrup C, Becker H, Pustelnik A, Gahl G. A new method to evaluate the CAPD- catheter-exit and other percutaneous devices. Int J Artif Organs 1991 Feb;14(2):83-6. Kobrin SM, Kimmel PL, Simmens SJ, Reiss D. Behavioral and biochemical indices of compliance in hemodialysis patients. ASAIO Trans 1991 Jul-Sep;37(3):M378-80. Kolb G, Fischer W, Seitz R, Muller T, Egbring R, Lange H, Havemann K. Hemodialysis and blood coagulation: the effect of hemodialysis on coagulation factor XIII and thrombin-antithrombin III complex. Nephron 1991;58(1):106—8. Kolb G, Muller T, Hoffken H, Joseph K, Lange H, Havemann K. Hemophan versus hemophan - a philippic against the suggestion of constant membrane quality. Biomater Artif Cells Immobilization Biotechnol 1992;20(5):1233-48. Kolb G, Nolting C, Eckle I, Muller T, Lange H, Havemarm K. The role of membrane contact in hemodialysis-induced granulocyte activation. Nephron 1991;57(1):64-8. Kooman JP, Gladziwa UL, Booker G, Van Bortel LM, Van Hooff JP, Leunissen KM. Role of the venous system in hemodynamics during ultrafiltration and bicarbonate dialysis. Kidney Int 1992;42(3):718-26. Korbet SM, Vonesh EF, Firanek CA. The effect of hematocrit on peritoneal transport. Am J Kidney Dis 1991 Nov;18(5):573-8. Korzets A, Chagnac A, Ori Y, Katz M, Zevin D. Subclavian vein stenosis, permanent cardiac pacemakers and the haemodialysed patient. Nephron 1991;58(1):103-5. Kouw PM, Olthof CG, ter Wee PM, Oe LP, Donker A], Schneider H, de Vries PM. Assessment of post- dialysis dry weight: an application of the conductivity measurement method. Kidney Int 1992 Feb;41(2):440-4. Kouw PM, Olthof CG, Gruteke P, de Vries PM, Meijer J H, Oe PL, Schneider H, Donkcr AJ. Influence of high and low sodium dialysis on blood volume preservation. Nephrol Dial Transplant 1991;6(11): 876-80. Krack G, Viglino G, Cavalli PL, Gandolfo C, Magliano G, Cantaluppi A, Peluso F. Intraperitoneal administration of phosphatidylcholine improves ultrafiltration in continuous ambulatory peritoneal dialysis patients. Perit Dial Int 1992;12(4):359-64. Comment in: Perit Dial Int 1992;12(4):346-9. Kristensen SR, Pedersen FB. Cytotoxicity testing of two CAPD dialysis fluids in a model system of quiescent fibroblasts. Nephrol Dial Transplant 1993;8(2):163-7. Krzesinski JM, Du F, Pequeux ML, Rorive GL. Plasma Na-K ATPase inhibitor activity and intracellular ions during hemodialysis. Int J Artif Organs 1993 Jan;16(l):23-30. Kubey W, Holmes C]. In vitro studies on the microbicidal effectiveness of a xenon-based ultraviolet light device for continuous ambulatory peritoneal dialysis connections. Blood Purif 1991; 9(2):102-8. Kumano K, Yokota S, Go M, Suyama K, Sakai T, Era S, Sogami M. Quantitative and qualitative changes of serum albumin in CAPD patients. Adv Perit Dial 1992;8z127—30. Kumpe DA, Cohen MA. Angioplasty/thrombolytic treatment of failing and failed hemodialysis access sites: comparison with surgical treatment. Prog Cardiovasc Dis 1992 Jan-Feb;34(4):263-78. Kumpe DA, Cohen MA, Durham JD. Treatment of failing and failed hemodialysis access sites: Comparison of surgical treatment with thrombolysis/angioplasty. Semin Vasc Surg 1992; 5(2):118-27. Kuzniewski M, Suowicz W, Lisiewicz J . Effect of heparin and prostacyclin—heparin infusion on blood coagulation in haemodialysed patients. Int Urol Nephrol 1991;23(1):89—96. Kuzniewski M, Suowicz W. Influence of prostacyclin infusion on haemodialysis efficiency and blood cells. Int Urol Nephrol 1992;24(5):555—63. Kwan JT, Almond MK, Altmann P. Percutaneo‘us insertion of cuffed silicone rubber double-lumen hemodialysis catheters for long-term use. I Am Soc Nephrol 1991;2(3):335. Lafleur D, Cordy P, Gallimore B, Adam J. Peritonitis rates for CAPD patients using the SCD 210 (Inpersol sterile connecting device): a Canadian survey. Adv Perit Dial 1991;7:196-203. Lameire NH, Vanholder R, Veyt D, Lambert MC, Ringoir S. A longitudinal, five year survey of urea kinetic parameters in CAPD patients. Kidney Int 1992 Aug;42(2):426-32. Langley PG, Keays R, Hughes RD, Forbes A, Delvos U, Williams R. Antithrombin III supplementation reduces heparin requirement and platelet loss during hemodialysis of patients with fulminant hepatic failure. Hepatology 1991 Aug;14(2):251-6. Latham D, Geisman J. Case management of the anemic patient. Epoetin alfa: focus on dialysis efficiency. ANNA J 1991 Dec;18(6):588-9. Lauster F, Fulle HJ, Gerzer R, Schiffl H. The postdialytic plasma cyclic guanosine 3’:5’- monophosphate level as a measure of fluid overload in chronic hemodialysis. J Am Soc Nephrol 1992 Mar;2(9):1451-4. Lauster F, Heim JM, Drummer C, Fulle HJ, Gener R, Schiffl H. Plasma cGMP level as a marker of the hydration state in renal replacement therapy. Kidney Int Suppl 1993;41:S57-9. Lauster F, Heim JM, Drummer C, Gerzer R, Schiffl H. Plasma ANP and cGMP levels in CAPD patients. Contrib Nephrol 1993;101:44—50. Lee GS, Woo KT. Infection in continuous ambulatory peritoneal dialysis (CAPD): aetiology, complications and risk factors. Ann Acad Med Singapore 1992 May;21(3):354—60. Lee SJ, Neiberger R. Subclavian vein stenosis: complication of subclavian vein catheterization for hemodialysis. Child Nephrol Urol 1991;11(4): 212—4. LeFebvre JM, Spanner E, Heidenheim AP, Lindsay RM. Kt/V: patients do not get what the physician prescribes. ASAIO Trans 1991 Iul-Sep;37(3): M132—3. Leitienne P, Trzeciak MC, Adeleine P, Ville D, Dechavanne M, Traeger J , Zech P. Comparison of hemostasis with two high-flux hemocompatible dialysis membranes. Int J Artif Organs 1991 Apr; 14(4):227-33. Leonard DK. Vascular access thrombosis in epoetin alfa therapy. ANNA J 1991 Aug;18(4):371-6; discussion 377. Leone M, Bottacchi E, Alloatti S, Nebiolo PE, Aimino M, Baldini S. Follow—up of nerve conduction in chronic uremic patients during hemodialysis. Ital J Neurol Sci 1992 May;13(4):317-21. Lettgen B, Bald M, Vallee H, Bonzel KE, Rascher W. Atrial natriuretic peptide and cyclic 3’5 ’-guanosine monophosphate as indicators of fluid volume overload in children with chronic renal failure. Pediatr Nephrol 1992 Jan;6(1):60-4. Leunissen KM, Kouw P, Kooman JP, Cheriex EC, De Vries PM, Donker A], Van Hooff JP. New techniques to determine fluid status in hemodialyzed patients. Kidney Int Suppl 1993;41:850-6. Levin A, Mason Al, Jindal KK, Fong IW, Goldstein MB. Prevention of hemodialysis subclavian vein catheter infections by topical povidone-iodine. Kidney Int 1991 Nov;40(5):934-8. 41 Lev-Ran A, Hwang DL, Ahmad B, Bixby H. Immunoreactive epidermal growth factor in serum, plasma, platelets, and urine in patients on chronic dialysis. Nephron 1991;57(2):164-6. Levy FL, Grayburn PA, Foulks CJ, Brickner ME, Henrich WL. Improved left ventricular contractility with cool temperature hemodialysis. Kidney Int 1992 Apr;41(4):961-5. Levy SS, Sherman RA, Nosher IL. Value of clinical screening for detection of asymptomatic hemodialysis vascular access stenoses. Angiology 1992 May;43(5):421-4. Lewis MA, Nycyk J A. Practical peritoneal dialysis--the Tenckhoff catheter in acute renal failure. Pediatr Nephrol 1992 Sep;6(5):470-5. Leypoldt IK, Blindauer KM. Convection does not govern plasma to dialysate transport of protein. Kidney Int 1992 Dec;42(6):1412-8. Leypoldt JK, Kablitz C, Gregory MC, Senekjian HO, Cheung AK. Prescribing hemodialysis using a weekly urea mass balance model. Blood Purif 1991; 9(5-6):271-84. Comment in: Blood Purif 1991; 9(5-6):241-5. Leypoldt IK, Schmidt B, Gurland HJ. Measurement of backfiltration rates during hemodialysis with highly permeable membranes. Blood Purif 1991;9(2): 74-84. Liberek T, Topley N, Jorres A, Coles GA, Gahl GM, Williams J D. Peritoneal dialysis fluid inhibition of phagocyte function: effects of osmolality and glucose concentration. I Am Soc Nephrol 1993 Feb;3(8):1508-15. Limido A, Cantu P, Renzetti G, Levati M, Farfaglia P, Colombo A. Ultrasonographic examination of the Tenckhoff catheter course. Nephrol Dial Transplant 1992;7(7):745. Lindsay RM, Heidenheim AP, Spanner E, Baird J, Simpson K, Allison ME. Urea monitoring during dialysis: the wave of the future. A tale of two cities. ASAIO Trans 1991 Apr-lun;37(2):49-53. Lindsay RM, Spanner E, Heidenheim P, Kortas C, Blake PG. PCR, Kt/V and membrane. Kidney Int Suppl 1993;41:8268-73. Lindsay RM, Spanner E, Heidenheim RP, LeFebvre JM, Hodsman A, Baird J, Allison ME. Which comes first, Kt/V or PCR - chicken or egg? Kidney Int Suppl 1992;38:S32-6. Litherland 1, Gibson M, Sambrook P, Lupton E, Beaman M, Ackrill P. Investigation and treatment of poor drains of dialysate fluid associated with anterior abdominal wall leaks in patients on chronic ambulatory peritoneal dialysis. Nephrol Dial Transplant 1992;7(10):1030—4. 42 Ljungberg B, Jacobson SH, Lins LE, Pejler G. Effective anticoagulation by a low molecular weight heparin (Fragmin) in hemodialysis with a highly permeable polysulfone membrane. Clin Nephrol 1992 Aug;38(2):97-100. Lo WK, Chan KT, Leung AC, Pang SW, Tse CY. Sclerosing peritonitis complicating prolonged use of chlorhexidine in alcohol in the connection procedure for continuous ambulatory peritoneal dialysis. Perit Dial Int 1991;11(2):166-72. Comment in: Perit Dial Int 1992;12(3):330. Lo WK, Cheung WC, Chan TM, Lo CY, Lui SL, Cheng 1K. Result of lower paramedian insertion of Tenckhoff catheter. J Hong Kong Med Assoc 1992; 44(3):159-63. Lopot F. Is urea kinetic modelling an appropriate tool for guiding ultrashort high-flux dialysis therapy? Nephrol Dial Transplant 1991;6 Suppl 3:86-7. Lopot F, Blaha J, Valek A. An equation for calculating postdialysis plasma sodium. Int J Artif Organs 1992;15(6):354-7. Ludlam HA. Infectious consequences of continuous ambulatory peritoneal dialysis. J Hosp Infect 1991 Jun;18 Suppl A:341-54. Ludlam HA, Baker LRI. The prevention of infection associated with continuous ambul peritoneal dialysis. Curr Opin Infect Dis l991;4(4):541-8. Ludlow MK, Yap E. Vascular access thrombosis following human recombinant erythropoietin (EPO) therapy. ANNA J 1992 Apr;19(2):154. Luzar MA. Exit-site infection in continuous ambulatory peritoneal dialysis: a review. Perit Dial Int 1991; ll(4):333-40. Lye WC, Lee E], Tan CC. Prophylactic antibiotics in the insertion of Tenckhoff catheters. Scand J Urol Nephrol 1992;26(2):177-80. Lye WC, Leong SO, Lee E]. Methicillin-resistant Staphylococcus aureus nasal carriage and infections in CAPD. Kidney Int 1993;43(6):1357-62. Lysaght MJ, Moran J, Lysaght CB, Schindhelm K, Farrell PC. Plasma water filtration and lymphatic uptake during peritoneal dialysis. ASAIO Trans 1991 Jul-Sep;37(3):M402-4. Mactier RA. Investigation and management of ultrafiltration failure in CAPD. Adv Perit Dial 1991;7:57-62. Mahurkar SD. Memory-induced curved extensions for hemodialysis Mahurkar catheters. Dial Transplant 1992;21(3):128-9. Majdalani G, Chomant J, Kachko A, Yanai M, Man NK. Kinetics of technetium-labeled heparin in hemodialyzed patients. Kidney Int Suppl 1993; 41:8131-4. Malacarne F, De Paoli Vitali E, Prandini N, Feggi L, Perini L, Cervi PM, Reverberi R, Lodi L, Gilli P. Increased uptake of radio labelled white blood cells into abdomen of uremics on peritoneal dialysis. Adv Perit Dial 1992;8239—41. Malsch G, Paul D, Kramer S, Wolf H, Thomaneck U, Brown GS, Falkenhagen D. Chemical modification of cellulose membranes with improved blood compatibility. Clin Mater 199l;8(1-2):65—9. Man NK, Chauveau P, Kuno T, Poignet JL, Yanai M. Phosphate removal during hemodialysis, hemodiafiltration, and hemofiltration. A reappraisal. ASAIO Trans 1991 Jul-Sep;37(3):M463-5. Marangella M, Bagnis C, Bruno M, Petrarulo M, Gabella P, Linari F. Determinants of oxalate balance in patients on chronic peritoneal dialysis. Am J Kidney Dis 1993 Apr;21(4):419—26. Marangella M, Petrarulo M, Cosseddu D, Vitale C, Linari F. Plasma profiles and removal rates of inorganic sulphate, and their influence on serum ionized calcium, in patients on maintenance haemodialysis. Clin Sci 1991 May;80(5):489-95. Marangella M, Petrarulo M, Mandolfo S, Vitale C, Cosseddu D, Linari F. Plasma profiles and dialysis kinetics of oxalate in patients receiving hemodialysis. Nephron 1992;60(l):74-80. Marangoni R, Savino R, Colombo R, Cimino R, Civardi F. Short time treatment with high-efficiency paired filtration dialysis for chronic renal failure. Artif Organs 1992 Dec;16(6):547—52. Markell MS, Cohen L, Lundin AP, Hong I, Friedman EA. Hospitalization for complications of hemodialysis; vascular access variables affecting length of stay (LOS) [abstract]. J Am Soc Nephrol l991;2(3):337. Markert M, Wauters JP. New aspects on oxidative metabolism of neutrophils during hemodialysis on different dialyzer membranes. Adv Exp Med Biol 1991;297:207—13. Markwardt F, Nowak G, Bucha E. Hirudin as anticoagulant in experimental hemodialysis. Haemostasis 1991;21 Suppl 12149-55. Martin U, Winney R, Prescott LF. Frusemide disposition in patients on continuous ambulatory peritoneal dialysis (CAPD). Br J Clin Pharmacol 1991;31(2):227-8. Martinez V, Garcia Caballero J, Munoz I, Celadilla O, Miranda B, Selgas R. Heat sterilization of safe.lock connectors using Thermoclav in experimental conditions. Contrib Nephrol 1991;89:59—61. Martin-Malo A, Castillo D, Castro M, Perez R, Rios A, Jaraba M, Aljama P. Biocompatibility of dialysis membranes: a comparative study. Nephrol Dial Transplant 1991;6 Suppl 2:55-8. Martin-Malo A, Velasco F, Rojas R, Castillo D, Rodriguez M, Torres A, Aljama P. Fibrinolytic activity during hemodialysis: a biocompatibility- related phenomenon. Kidney Int Suppl 1993;41: S213-6. Martinson E, Wieslander A, Kjellstrand P, Boberg U. Toxicity of heat sterilized peritoneal dialysis fluids is derived from degradation of glucose. ASAIO J 1992 Jul-Sep;38(3):M370—2. Marumo F, Shichiri M, Emori T, Ando K. Circulating and excreted forms of atrial natriuretic peptide in healthy subjects and patients with renal diseases. Clin Nephrol 1992 Oct;38(4):203-8. Masin G, Polenakovic M, Ivanovski N, Atanasov N, Olivera S, Cakalaroski K. Hypersensitivity reactions to ethylene oxide: clinical experience. Nephrol Dial Transplant 1991;6 Suppl 3:50-2. Matthews R, Clugston R, Eisenhauer A, Dake M, Schatz R, Feinstein E. Balloon expandable stents to treat central venous stenoses in hemodialysis patients. Am J Nephrol 1992;12(6):451-6. Maurin N. Antithrombotic management with a stable prostacyclin analogue during extracorporeal circulation. Contrib Nephrol 1991;93:205-9. Mawhinney WM, Adair CG, Gorman SP. Incidence of microbial biofilm on peritoneal catheters removed from peritonitis-free CAPD patients following renal transplant [abstract]. Pharmacotherapy 1991;11(3): 277. Mayers J, Cohen L, Markell M, Friedman E. Factors affecting length of stay (LOS) in hospitalization for vascular access surgery. ANNA J 1992 Apr;19(2): 152. Mayers JD, Markell MS, Cohen LS, Hong J, Lundin P, Friedman EA. Vascular access surgery for maintenance hemodialysis. Variables in hospital stay. ASAIO J 1992 Apr-Jun;38(2):113-5. McMullen K, Hayes D, Hussey JL, Boudreaux JP. Salvage of hemodialysis access in infected arteriovenous fistulas. Arch Surg 1991 Oct;126(10): 1303-5. Mege JL, Olmer M, Purgus R, Bertocchio P, Famarier C, Kaplanski S, Capo C, Bongrand P. Haemodialysis membranes modulate chronically the production of TNF alpha, ILl beta and IL6. Nephrol Dial Transplant 1991;6(11):868-75. Mege JL, Sanguedolce MV, Purgus R, Moulin B, Bongrand P, Capo C, Olmer M. Chronic and intradialytic effects of high-flux hemodialysis on 43 tumor necrosis factor-alpha production: relationship to endotoxins. Am J Kidney Dis 1992 Nov;20(5): 482-8. Memoli B, Libetta C, Rampino T, De Simone W, Meccariello S, Stangerlin P, Dal Canton A, Andreucci VE. Interleukin-6 production of uraemic haemodialysed patients: effects of different membranes. Nephrol Dial Transplant 1991; 6 Suppl 2:96-8. Menth M, Rockel A, Abdelhamid S, Fiegel P, Walb D. Low-molecular-weight protein-permeable cuprammonium rayon haemofilter. Nephrol Dial Transplant 1992;7(8):844-7. Merchant MR, Hutchinson AJ, Butler SJ, Boulton H, Hintchliffe R, Gokal R. Calcium, magnesium mass transfer and lactate balance study in CAPD patients with reduced calcium/magnesium and high lactate dialysis fluid. Adv Perit Dial 1992;8z365-8. Mineshima M, Watanuki M, Yamagata K, Era K, Nakazato S, Suga H, Agishi T, Ota K, Sakai K, Fukui K. Development of continuous recirculating peritoneal dialysis using a double lumen catheter. ASAIO J 1992 Jul-Sep;38(3):M377-81. Miranda B, Selgas R, Celadilla 0, Munoz J, Sanchez Sicilia L. Peritoneal resting and heparinization as an effective treatment for ultrafiltration failure in patients on CAPD. Contrib Nephrol 1991;89: 199-204. Mitwalli AH. Does omentectomy affect ultrafiltration in peritoneal dialysis. Saudi Med J 1991;12(3):232—5. Miura Y, Ishiyama T, Inomata A, Takeda T, Senma S, Okuyama K, Suzuki Y. Radiolucent bone cysts and the type of dialysis membrane used in patients undergoing long—term hemodialysis. Nephron 1992; 60(3):268-73. Moncrief J W, Popovich RP, Broadrick LJ, He ZZ, Simmons EE, Tate RA. The Moncrief-Popovich catheter. A new peritoneal access technique for patients on peritoneal dialysis. ASAIO J 1993 Jan-Mar;39(1):62-5. Montagnac R, Schillinger F. Rifampicin—protamine protocol applied for prevention of central catheter sepsis in haemodialysis (2). Nephrol Dial Transplant 1993;8(3):289-99. Montenegro J, Echevarria J, Gonzalez R, Martinez I, Saracho R, Cruz C. Testing the safety of non- disconnect disposable Y sets for peritoneal dialysis. Adv Perit Dial 1991;7z183-5. Montenegro J, Martinez 1, Saracho R, Gonzalez R. Beta 2 microglobulin in CAPD. Adv Perit Dial 1992;8z369-72. Morgan JD, Tilsed J V, Bell PR, Veitch PS, Donnelly PK. Continuous ambulatory peritoneal dialysis in patients with aortic grafts. Br J Surg 1992 Aug; 79(8):755—6. Mosquera DA, Gibson SP, Goldman MD. Vascular access surgery: a 2—year study and comparison with the Permcath. Nephrol Dial Transplant 1992;7(11): 1111-5. Mrowka CH, Schiffl H. Comparative evaluation of beta 2-microglobulin removal by different hemodialysis membranes: a six-year follow-up. Nephron 1993; 63(3):368-9. Muirhead N, Mitton R. Use of bone char as an adsorbent in preparation of water for dialysis. ASAIO J 1992 Jul-Sep;38(3):M334-7. Mujais SK, Ivanovich P. Adequacy of dialytic therapy: hydra complex and statistical concealment. Artif Organs 1993 Apr;17(4):254-9. Mulloy LL, Caruana RJ, Steele JC Jr, Wynn JJ. Polymicrobial bacteremia during long-term hemodialysis. South Med J 1991 May;84(5):594-6. Mulvihill J, Cazenave JP, Mazzucotelli JP, Crost T, Collier C, Renaux JL, Pusineri C. Minimodule dialyser for quantitative ex vivo evaluation of membrane haemocompatibility in humans: comparison of acrylonitrile copolymer, cuprophan and polysulphone hollow fibres. Biomaterials 1992; 13(8):527-36. Mwaniki DL, Courtney JM, Forbes CD, Paul JP. Assessment of blood compatibility of haemodialysis membranes using a miniature flat sheet dialyser. East Afr Med J 1992 Mar;69(3):149-52. Nahman NS Jr, Middendorf DF, Bay WH, McElligott R, Powell S, Anderson J. Modification of the percutaneous approach to peritoneal dialysis catheter placement under peritoneoscopic visualization: clinical results in 78 patients. J Am Soc Nephrol 1992 Jul;3(1):103-7. Nakamura Y, Ikeda T, Takata S, Yokoi H, Hirono M, Abe T, Takazakura E, Kobayashi K. The role of peripheral capacitance and resistance vessels in hypotension following hemodialysis. Am Heart J 1991 Apr;121(4 Pt 1):1170—7. Nakane K, Shinzato T, Maeda K. Continuous measurement of pressure in internal arteriovenous fistulae and prevention of symptomatic hypotension during hemodialysis. ASAIO Trans 1991 Jul-Sop; 37(3):M232—4. Nankivell BJ, Lake N, Gillies A. Intracatheter streptokinase for recurrent peritonitis in CAPD. Clin Nephrol 1991 Jan;35(1):20—3. Comment in: Clin Nephrol 1991 0ct;36(4):214. Nannery WM, Stoldt HS, Fares LG 2d. Hemodialysis access operations performed upon patients with human immunodeficiency virus. Surg Gynecol Obstet 1991 Nov;l73(5):387-90. Navarro J, Serrano C, Donna E, Perez GO. Disordered breathing patterns during bicarbonate hemodialysis in COPD. Effect of cuprophane versus polysulfone membranes. ASAIO J 1992 0ct-Dec;38(4):811—4. Nebel M, Marczewski K, Finke K. Three years of experience with the swan-neck Tenckhoff catheter. Adv Perit Dial 1991;7:208-13. Newman GE, Saeed M, Himmelstein S, Cohan RH, Schwab SJ. Total central vein obstruction: resolution with angioplasty and fibrinolysis. Kidney Int 1991 Apr;39(4):761-4. Ney AL, Odland MD, Andersen RC. Causes and evaluation of incipient vascular access failure in chronic hemodialysis. Semin Dial 1991 Jul-Sep; 4(3):174-8. Nicholson ML, Burton PR, Donnelly PK, Veitch PS, Walls J. The role of omentectomy in continuous ambulatory peritoneal dialysis. Perit Dial Int 1991;11(4):330—2. Nielsen G, Bredahl C, Nielsen C. Continuous blood gas monitoring in haemodialysis using an electrode inserted in the extracorporeal dialysis circulation. Scand J Clin Lab Invest 1993 Apr;53(2):19’7-200. Nolph KD. Access problems plague both peritoneal dialysis and hemodialysis. Kidney Int Suppl 1993 Feb;40:S81_—4. Nolph KD. What’s new in peritoneal dialysis--an overview. Kidney Int Suppl 1992 Oct;38:Sl48-52. Nolph KD, Moore HL, Twardowski ZJ, Khanna R, Prowant B, Meyer M, Ponferrada L. Cross- sectional assessment of weekly urea and creatinine clearances in patients on continuous ambulatory peritoneal dialysis. ASAIO J 1992 Jul-Sep;38(3): M139-42. Nolph KD, Twardowski ZJ, Keshaviah PR. Weekly clearances of urea and creatinine on CAPD and NIPD. Perit Dial Int 1992;12(3):298-303. Nonnast—Daniel B, Martin RP, Lindert O, Mugge A, Schaeffer J, v.d. Lieth H, Sochtig E, Galanski M, Koch KM, Daniel WG. Colour Doppler ultrasound assessment of arteriovenous haemodialysis fistulas. Lancet 1992 Jan 18;339(8786):143-5. Comment in: Lancet 1992 Apr 18;339(8799):996. Novak Z, Buzas E, Salgo L, Gal G. Effects of haemodialysis with acetate or bicarbonate-containing solutions on deformability of red blood cells. Rev Port Hemorreologia 1991;5(2):239-47. Nube MJ, De Vet JA, Steffens A, Van Geelen JA. Long-term results of continuous ambulatory peritoneal dialysis: the first hundred patients. A single centre study. Neth J Med 1993;42(4):112—21. Odar-Cederlof I, Eriksson CG, Theodorsson E, Kjellltrand C. Antidiuretic hormone regulation in hemodialysis. ASAIO Trans 1991 Jul-Sep;37(3): M227-9. Odar-Cederlof I, Theodorsson E, Ericsson F, Kjellstrand CM. Plasma concentrations of calcitonin gene-related peptide in fluid overload. Lancet 1991; 338(8764):411-2. Odland MD, Kelly PH, Ney AL, Andersen RC, Bubrick MP. Management of dialysis-associated steal syndrome complicating upper extremity arteriovenous fistulas: use of intraoperative digital photoplethysmography. Surgery 1991 Oct;110(4): 664-9; discussion 669-70. Ofsthun NJ, Jensen J C, Kray M. Effect of high hematocrit and high blood flow rates on transmembrane pressure and ultrafiltration rate in hemodialysis. Blood Purif 1991;9(3):169—76. Okadome K, Komori K, Fukumitsu T, Sugimachi K. The potential risk for subclavian vein occlusion in patients on haemodialysis. Eur J Vasc Surg 1992 Nov;6(6):6(YZ-6. Olivas E, Jimenez C, Lopez A, Andres E, Sanchez Tarraga L. Reduction of the incidence of peritonitis in CAPD: effectiveness of heat sterilization of Safe.Lock connectors. Contrib Nephrol 1991;89: 62-7. Olthof CG, de Vries PM, Kouw PM, Oe PL, Gerlag PG, Schneider H, Donker AJ. The recovery of the fluid balance afier hemodialysis and hemofiltration. Clin Nephrol 1992 Mar;37(3):135-9. Os 1, Nordby G, Lyngdal PT, Eide I. Plasma vasopressin, catecholamines and atrial natriuretic factor during hemodialysis and sequential ultrafiltration. Scand J Urol Nephrol 1993 ;27(l): 93-9. Ota K. Biocompatibility and capability of haemopurification systems: review and future development. Nephrol Dial Transplant 1991; 6 Suppl 2:86-90. Ota K, Nakagawa Y, Kitano Y, Oshima T, Teraoka S. Clinical application of modified polyurethane graft to blood access. Artif Organs 1991 Dec;15(6): 449-53. Pacitti A, Tetta C, Mangiarotti G, Canavese C, Segoloni GP. Beta-Z-microglobulin serum profiles in different settings of mass transport and fluid pyrogen content. Kidney Int Suppl 1993 ;4l:S96-9. Paczek L, Schaefer RM, Heidland A. Dialysis membranes decrease immunoglobulin and interleukin-6 production by peripheral blood 45 mononuclear cells in vitro. Nephrol Dial Transplant 1991;6 Suppl 3:41-4. Padberg FT Jr, Lee BC, Curl GR. Hemoaccess site infection. Surg Gynecol Obstet 1992;174(2):103-8. Parker TF. Trends and concepts in the prescription and delivery of dialysis in the United States. Semin Nephrol 1992 May;12(3):267-75. Pastan S, Gassensmith C, Manatunga AK, Copley JB, Smith EJ, Hamburger RJ. Prospective comparison of peritoneoscopic and surgical implantation of CAPD catheters. ASAIO Trans 1991 Jul-Sep; 37(3):M154-6. Patel KR, Chan FA, Batista RJ, Clauss RH. True venous aneurysms and arterial "steal" secondary to arteriovenous fistulae for dialysis. J Cardiovasc Surg 1992;33(2):185—8. Pegues DA, Beck-Sague CM, Woollen SW, Greenspan B, Burns SM, Bland LA, Arduino MJ, Favero MS, Mackow RC, Jarvis WR. Anaphylactoid reactions associated with reuse of hollow-fiber hemodialyzers and ACE inhibitors. Kidney Int 1992;42(5):1232-7. Pengloan J, Petit A, Thibaut G, Blanchier D, Bardos P. Biocompatibility of dialyser membranes: roles of membranes and of patients. Nephrol Dial Transplant 1991;6 Suppl 2:59-60. Pereira BJ, Poutsiaka DD, Strom JA, Narayan G, Levey AS, King AJ, Dinarello CA. Effect of first use and reuse of cuprophane membrane on interleukin-l-beta il-l-beta production by peripheral blood mononuclear cells (PBMC). J Am Soc Nephrol 1991;2(3):344. Pertosa G, Marfella C, Tarantino EA, Di Cillo M, Manno C, Russo R, Schena FP. Involvement of peripheral blood monocytes in haemodialysis: in vivo induction of tumour necrosis factor alpha, interleukin 6 and beta Z-microglobulin. Nephrol Dial Transplant 1991;6 Suppl 2:18-23. Pertosa G, Tarantino EA, Gesualdo L, Montinaro V, Schena FP. C5b-9 generation and cytokine production in hemodialyzed patients. Kidney Int Suppl 1993;41:8221-5. Petar B, Tomislav I, Miodrag I, Snezana A. Strecker stent in stenotic hemodialysis Brescia-Cimino arteriovenous fistulas. Cardiovasc Intervent Radiol 1992 Jul-Aug;15(4):217-20. Petersen J, Moore RM Jr, Kaczmarek RG, Singh B, Yeh I, Hamburger S, Kankam M. The effects of reprocessing cuprophane and polysulfone dialyzers on beta 2-microglobulin removal from hemodialysis patients. Am J Kidney Dis 1991 Feb;17(2):l74—8. Published erratum appears in Am J Kidney Dis 1991 Jul;18(1):144. 46 Piraino B, Bemardini J, Centa PK, Johnston JR, Sorkin MI. The effect of body weight on CAPD related infections and catheter loss. Perit Dial Int 1991; 11(1):64-8. Piraino B, Holley JL, Bemardini J, Burkart JM. Are exit-site infection rates lower with disconnect systems? Perit Dial Int 1993;13(1):67-8. Plum J, Grabensee B. Atrial natriuretic peptide in dialysis patients under various conditions of volume homeostasis. J Intern Med 1991 Mar;229(3): 209-16. Plum J, Sudkamp S, Grabensee B. Is ultrasound a suitable tool to detect and to control tunnel infections in patients undergoing capd? J Am Soc Nephrol 1992;3(3):416. Poisetti P, Bergonzi G, Ballocchi S, Fontana F, Scarpioni L. Aging of silastic peritoneal catheters. Int J Artif Organs 1991 Dec;14(12):765—70. Ponikvar R, Kovac D, Malovrh M, Premru V. Silicone jugular vein catheters as permanent vascular access for hemodialysis [abstract]. Int J Artif Organs 1992; 15(9):565. Pontari MA, McMillen MA. The straight radial- antecubital PTFE angio-access graft in an era of high-flux dialysis. Am J Surg 1991 Apr;161(4): 450-3. Port FK, Held PI, Nolph KD, Turenne MN, Wolfe RA. Risk of peritonitis and technique failure by CAPD connection technique: a national study. Kidney Int 1992 Oct;42(4):967-74. Postiglione A, Faccenda F, Gallotta G, Rubba P, Federico S. Changes in middle cerebral artery blood velocity in uremic patients after hemodialysis. Stroke 1991;22(12):1508-11. Potcmpa LA, Motie M, Anderson B, Klein E, Baurmeister U. Conjugation of a modified form of human C-reactive protein to affinity membranes for extracorporeal adsorption. Clin Mater 1992;11(1-4): 105-17. - Poulain F, Raynaud A, Bourquelot P, Knight C, Rovani X, Gaux JC. Local thrombolysis and thromboaspiration in the treatment of acutely thrombosed arteriovenous hemodialysis fistulas. Cardiovasc Intervent Radiol 1991 Mar-Apr;14(2): 98- 101. Premru V, Ponikvar R, Malovrh M, Benedik M. Subclavian vein catheters as long-term vascular access for hemodialysis [abstract]. Int J Artif Organs 1992;15(9):565. Pronai W, Silberbauer K. 66 months of hemodialysis without a shunt; longtime experience with a central vein catheter [abstract]. Int J Artif Organs 1991; 14(9):582. Prowant BF, Warady BA, Nolph KD. Peritoneal dialysis catheter exit-site care: results of an international survey. Perit Dial Int 1993;13(2): 149-54. Pudelski B, Bednarz D. Nursing intervention to improve dialysis adequacy of intensive care patients in acute renal failure. ANNA J 1992 Apr; 19(2):163. Purchase L, Gault MH. Hemodialysis with a permeath kept open with streptokinase and later citrate in a heparin-sensitive patient. Nephron 1991;58(1): 1 19-20. Quinn SF, Schuman ES, Hall L, Gross GF, Uchida BT, Standage BA, Rosch J, Ivancev K. Venous stenoses in patients who undergo hemodialysis: treatment with self-expandable endovascular stents. Radiology 1992 May;183(2):499-504. Raja RM, Ijelu G, Goldstein M. Influence of Kt/V and protein catabolic rate on hemodialysis morbidity. A long-term study. ASAIO J 1992 Jul-Sep;38(3): M179-80. Rallison LR, Kushner RF, Penn D, Schoeller DA. Errors in estimating peritoneal fluid by bioelectrical impedance analysis and total body electrical conductivity. J Am Coll Nutr 1993 Feb;12(1): 66-72. Rault R. Optimal dialysate bicarbonate during hemodialysis. ASAIO Trans 1991 Jul-Sep;37(3): M372—3. Reber G, Stoermann C, de Moerloose P, Ruedin P, Leski M. Hemostatic disturbances induced by two hollow-fiber hemodialysis membranes. Int J Artif Organs 1992 May;15(5):269—76. Redaelli B, Limido D, Sforzini S, Beretta P, Bonoldi G, Dadone C, Di Filippo G, Mariani P, Mascia F, Pincella G, et al. Forecasting correct sodium balance in hemodiafiltration procedures involving infusions. Blood Purif 1991;9(3):123—8. A Reed J, Fellner S. Tolerance of high flux hemodialysis hd by elderly patients [abstract]. J Am Soc Nephrol 1991;2(3):346. Remuzzi A, Boccardo P, Benigni A. In vitro platelet adhesion to dialysis membranes. Nephrol Dial Transplant 1991;6 Suppl 2236-9. Richards NT, Clarke A, Condon S, Elliot T, Adu D, Michael J. Elimination of CAPD catheter exit site infection due to staphylococcus-aureus with peri- operative antiseptics [abstract]. Nephrol Dial Transplant 1992;7(7):745. Rivers SP, Scher LA, Veith Fl. Correction of steal syndrome secondary to hemodialysis access fistulas: a simplified quantitative technique. Surgery 1992 Sep;112(3):593-7. Roberts M. Wearable artificial kidneys for continuous dialysis. A personal view. ASAIO J 1993 Jan-Mar; 39(1):19-23. Roberts M, Montez AJ, Lee DB. Component selection to optimize blood flow for continuous arteriovenous hemofiltration and dialysis. ASAIO Trans 1991 Jul-Sep;37(3):M382—3. Roberts M, Winney RJ. Errors in fluid balance with pump control of continuous hemodialysis. Int J Artif Organs 1992 Feb;15(2):99-102. Robles NR, Murga L, Galvan S, Esparrago JF, Sanchez-Casado E. Hemodialysis with cuprophane or polysulfone: effects on uremic polyneuropathy. Am J Kidney Dis 1993 Mar;21(3):282—7. Ronco C, Brendolan A, Bragantini L, Crepaldi C, Dell’Aquila R, Milan M, Feriani M, Chiaramonte S, Conz P, La Greca G. High-performance continuous arteriovenous hemofiltration in infants with the new Minifilter plus. Contrib Nephrol 1991; 93:254-6. Rovner MS, Brouhard BH, Cunningham RJ, Firor H. Comparison of cuffed vs. uncuffed catheters for extracorporeal therapy in pediatric patients. Dial Transplant 1992;21(8):513-15, 518, 520, 522. Rueckmann 1, Berry C, Ouriel K, Hoffart N. The synthetic axillofemoral graft for hemodialysis access. ANNA J 1991 Dec;18(6):567—71. Ruedin P, Laverriere C, Bertschi AP, Etienne T, Stoermann C, Leski M. Successful use of percutaneously inserted double-lumen catheters for permanent haemodialysis access: a prospective study [abstract]. Nephrol Dial Transplant 1992; 7(7):737. Ruedin P, Laverriere C, Etienne T, Leski M. Three years experience with a percutaneously inserted double lumen catheter for permanent hemodialysis access a prospective study [abstract]. J Am Soc Nephrol 1992;3(3):389. Saad F, Paquin J M, Perreault JP, Faucher R, Mauffette F, Valiquette L. Simple technique for making subcutaneous tunnel in creation of A-V fistula using prosthesis. Urology 1991 May;37(5):468-9. Saha LK, Van Stone JC. Differences between KT/V measured during dialysis and KT/V predicted from manufacturer clearance data. Int J Artif Organs 1992 Aug;15(8):465—9. Salem ME, Naga SS. Loop versus straight PFTE gore- tex grafts for arterio-venous shunts in hemodialysis patients. J Med Res Inst 1992;13(1):95-105. Sands J, Young S, Miranda C. The effect of Doppler flow screening studies and elective revisions on dialysis access failure. ASAIO J 1992 Jul-Sep; 38(3):M524—7. 47 Saniabadi AR, Fisher TC, Lau CS, Bridges A, Taylor J, Belch J, Forbes CD. Dipyridamole increases human red blood cell deformability. Eur J Clin Pharmacol 1992;42(6):651-4. _ Santoro A, Spongano M, Ferrari G, Bolzani R, Augella F, Borghi M, Briganti M, Cagnoli L, Docci D, Feletti C, Fusaroli M, Gattiani A, Sanna G, Stallone C, Zucchelli P. Analysis of the factors influencing bicarbonate balance during acetate-free biofiltration. Kidney Int Suppl 1993;41:8184-7. Scabardi M, Ronco C, Chiaramonte S, Feriani M, Agostini F, La Greca G. Dynamic catheterography in the early diagnosis of peritoneal catheter malfunction. Int J Artif Organs 1992 Jun;15(6): 358-64. Scalamogna A, Castelnovo C, De Vecchi A, Ponticelli C. Exit-site and tunnel infections in continuous ambulatory peritoneal dialysis patients. Am J Kidney Dis 1991 Dec;18(6):674-7. Schaefer RM, Paczek L, Heidland A. Suppression of beta 2-microglobulin release from lymphocytes by dialysis membranes. Nephrol Dial Transplant 1991;6 Suppl 3:53-6. Schambye HT, Flesner P, Pedersen RB, Hardt-Madsen M, Chemnitz J, Christensen HK, Detmer A, Pedersen FB. Bicarbonate- versus lactate-based CAPD fluids: a biocompatibility study in rabbits. Perit Dial Int 1992;12(3):281-6. Comment in: Perit Dial Int 1992;12(3):276-7. Schambye HT, Pedersen FB, Wang P. Bicarbonate is not the ultimate answer to the biocompatibility problems of CAPD solutions: a cytotoxicity test of CAPD solutions and effluents. Adv Perit Dial 1992; 8242-6. Schanzer H, Skladany M, Haimov M. Treatment of angioaccess—induced ischemia by revascularization. J Vasc Surg 1992 Dec;16(6):861-4; discussion 864-6. Schauer S, Stein G, Suss J, Falkenhagen D, Linss W. Phagocytosis activity of polymorphonuclear cells of normal persons and dialysis patients is influenced by different dialysis membranes. Nephrol Dial Transplant 1991;6 Suppl 3:35-40. Schiffl H, D’Agostini B, Held E. Removal of beta 2- microglobulin by hemodialysis and hemofiltration: a four year follow up. Biomater Artif Cells Immobilization Biotechnol 1992;20(5):1223-32. Schillinger F, Schillinger D, Montagnac R, Milcent T. Post catheterisation vein stenosis in haemodialysis: comparative angiographic study of 50 subclavian and 50 internal jugular accesses. Nephrol Dial Transplant 1991;6(10):722-4. Schleifer CR, Snyder S, Jones K. The influence of urea kinetic modeling UKM on gross mortality in 48 hemodialysis [abstract]. I Am Soc Nephrol 1991; 2(3):349. Schmidt DF, Schniepp BI, Kurtz SB, McCarthy IT. Inaccurate blood flow rate during rapid hemodialysis. Am I Kidney Dis 1991 Ian;17(1): 34—7. Schmidt R, Zasuwa G, Schell D, Dumler F. Proper dialyzer reprocessing does not impair urea mass transfer [abstract]. I Am Soc Nephrol 1991;2(3): 349. Schmitz—Rode T, Bohndorf K, Gunther RW. New "mesh basket" for percutaneous removal of wall— adherent thrombi in dialysis shunts. Cardiovasc Intervent Radiol 1993 Ian-Feb;16(1):7-10. Schmitz-Rode T, Pfeffer I G, Bohndorf K, Gunther RW. Percutaneous thrombectomy of the acutely thrombosed dialysis graft: in vitro evaluation of four devices. Cardiovasc Intervent Radiol 1993 Mar-Apr;16(2):72-5. Schneditz D, Kaufman AM, Polaschegg HD, Levin NW, Daugirdas IT. Cardiopulmonary recirculation during hemodialysis. Kidney Int 1992 Dec;42(6): 1450-6. Schneditz D, Polaschegg HD, Levin NW, Cu GA, Morris AT, Kramer M, Daugirdas IT, Kaufman AM. Cardiopulmonary recirculation in dialysis. An underrecognized phenomenon. ASAIO I 1992 Iul-Sep;38(3):Ml94-6. Schoenfeld PS, I ones DM, Lawson IM. Conducted current on guidewires in single lumen papillotomes. Gastrointest Endosc 1991 May-Iun;37(3):344w6. Schohn DC, Iahn HA, Pelletier BC. Dose-related cardiovascular effects of spironolactone. Am I Cardiol l993;71(3):40a-45a. Schroder CH, van Dreumel MI, Reddingius R, Theeuwes AG, Willems HL, de long MC, Monnens LA. Peritoneal transport kinetics of glucose, urea, and creatinine during infancy and childhood. Perit Dial Int 1991;11(4):322-5. Schulak IA, Lukens ML, Mayes IT. Salvage of thrombosed forearm polytetrafluoroethylene vascular access grafis by reversal of flow direction and venous bypass grafting. Am I Surg 1991 Apr; 161(4):485-7. Schulman G. A review of the concept of biocompatibility. Kidney Int Suppl 1993;41: 8209-12. Schulman G, Hakim RM. Recent advances in the biocompatibility of haemodialysis membranes. Nephrol Dial Transplant 1991;6 Suppl 2:10-3. Segarra A, Capdevila I, Planes AM, Fort I , Roca R, Bartolome I, Olmos I, Piera LL. Treatment of jugular catheter sepsis by administering antibiotics locally and systemically without removing the catheter [abstract]. Nephrol Dial Transplant 1992; 7(7):739. Selby JB Ir, Pruett TL, Westervelt FB Ir, Tegtmeyer CI, Poole CL. Treatment of hemodialysis fistula pseudoaneurysms with detachable balloons: technique and preliminary results. I Vasc Interv Radiol 1992 Aug;3(3):505-10. Selgas R, Cuesta MV, Rinon C, Romero IR, de Alvaro F, Bajo MA, Sanchez-Sicilia L. Tissue plasminogen activator (t-PA) and plasminogen activator inhibitor- 1 (PAI-I) levels in plasma and peritoneal effluent in patients on CAPD. Adv Perit Dial 1992;8:160-5. Seres DS, Strain GW, Hashim SA, Goldberg II, Levin NW. Improvement of plasma lipoprotein profiles during high-flux dialysis. I Am Soc Nephrol 1993 Ian;3(7):1409-15. Seyfert UT, Hauck W, Kirsch I , Kiesewetter H, Albert FW, Wenzel E. Contributions to biorheology during hemodialysis. Biorheology 1991;28(5):473-81. Shaffer D, Madras PN, Williams ME, D’Elia IA, Kaldany A, Monaco AP. Use of Dacron cuffed silicone catheters as long—term hemodialysis access. ASAIO I 1992 Ian-Mar;38(l):55-8. Shaldon S. Dialyzer reuse: the time has come to stop this practice. Dial Transplant l993;22(3):122, 125-6. Shaldon S. Unanswered questions pertaining to dialysis adequacy in 1992. Kidney Int Suppl 1993;41: 8274—7. Shand BI, Buttimore AL, Hurrell MA, Wells IE, Inkster IA, Bailey RR, Robson RA, Lynn KL. Hemorheology and fistula function in home hemodialysis patients following erythropoietin treatment: a prospective placebo-controlled study. Nephron 1993;64(1):53-7. Shelton DM. A comparison of the effects of two antiseptic agents on Staphylococcus epidermidis colony forming units at the peritoneal dialysis catheter exit site. Adv Perit Dial 1991;7:120—4. Sherman RA, Levy SS. Assessment of a two-needle technique for the measurement of recirculation during hemodialysis. Am I Kidney ‘Dis 1991 Jul; 18(1):80—3. Shimomura A, Tahara D, Azekura H, Matsuo H, Kamo M. Key factors to improve survival of elderly patients on CAPD. Adv Perit Dial 1992;8z166-72. Shirai D, Kajimoto Y, Ochi S, Tanaka Y, Wada A, Yano F, Izumi M, Fujita Y, Nakahama H. Evaluation of hemodialysis efficiency by an edema fluid model. Ren Fail 1992;14(l):63-8. Silberman H, Berne TV, Escandon R. Prospective evaluation of a double-lumen subclavian dialysis catheter for acute vascular access. Am Surg 1992 Aug;58(8):443-5. Silver SM, DeSimone JA Jr, Smith DA, Sterns RH. Dialysis disequilibrium syndrome (DDS) in the rat: role of the "reverse urea effect". Kidney Int 1992 Ju1;42(1):161-6. Simon P, Ang KS, Cam G, Benziane A, Bonn F. Indices of adequate dialysis in patients hemodialyzed with AN 69 membrane. Kidney Int Suppl 1993;41:8291-5. Skroeder R, Jacobsson S, Kjellstrand P, Boberg U, Kjellstrand CM. K & T covariate with V in hemodialysis. As K increases and T decreases, V also decreases. ASAIO Trans 1991 Jul-Sep;37(3): M129—32. Smit JC, Jones JG. Oxygen saturation during hemodialysis. Ren Fail 1993;15(2):239-45. Smye SW, Evans JH, Will E, Brocklebank JT. Paediatric haemodialysis: estimation of treatment efficiency in the presence of urea rebound. Clin Phys Physiol Meas 1992 Feb;13(1):51-62. Sodemann K, Niedenthal A, Russ A, Weber C, Schafer GE. Automated fluid balance in continuous hemodialysis with blood safety module BSM 22/VPM. Contrib Nephrol 1991;93:184-92. Solski I, Ksiazek A, Szymonik—Lesiuk S, Marzec Z. Membrane ATPase, erythrocyte sodium and sium in haemodialysis patients. Int Urol Nephrol 1991;23(3):275—80. Soundararajan R, Soundararajan P. A simple and practical method for assessing the adequacy of hemodialysis. ASAIO Trans 1991 Jul-Sep;37(3): M3934. Spustova V, Gajdos M, Opatrny K Jr, Stefikova K, Dzurik R. Serum hippurate and its excretion in conservatively treated and dialysed patients with chronic renal failure. Physiol Res 1991;40(6): 599-606. Stegmayr BG, Granbom L, Tranaeus A, Wikdahl AM. Reduced risk for peritonitis in CAPD with the use of a UV connector box. Perit Dial Int 1991;11(2): 128-30. Steinhauer I-IB, Lubrich-Birkner I, Kluthe R, Baumann G, Schollmeyer P. Effect of amino acid based dialysis solution on peritoneal permeability and prostanoid generation in patients undergoing continuous ambul peritoneal dialysis. Am J Nephrol 1992;12(1-2):61-7. Steuer RR, Harris DH, Conis JM. A new optical technique for monitoring hematocrit and circulating 49 blood volume: its application in renal dialysis. Dial Transplant 1993;22(5):260-5. Stiller S, Mann H. Microfilter for drawing plasma samples from the extracorporeal circulation. Contrib Nephrol 1991;93:193-5. Stiller S, Wirtz D, Waterbar F, Gladziwa U, Dakshinamurty KV, Mann H. Less symptomatic hypotension using blood volume controlled ultrafiltration. ASAIO Trans 1991 Jul-Sep;37(3): M139—41. Strauch BS, O’Connell RS, Geoly KL, Grundlehner M, Yakub YN, Tietjen DP. Forecasting thrombosis of vascular access with Doppler color flow imaging. Am J Kidney Dis 1992 Jun;19(6):554-7. Strauss FG, Holmes DL, Dennis RL, Nortman DF. Pre-spiking dialysate bags: improved peritonitis prevention in patients on CAPD. Adv Perit Dial 1991;7:193-5. Sullivan KL, Besarab A, Bonn J, Shapiro MJ, Gardiner GA Jr, Moritz MJ. Hemodynamics of failing dialysis grafts. Radiology 1993 Mar;186(3):867-72. Sullivan KL, Besarab A, Dorrell S, Moritz MI. The relationship between dialysis grafi pressure and stenosis. Invest Radiol 1992;27(5):352-5. Sumirnoto K, Tanaka I, Oshiro H, Ito H, Fukuda Y, Dohi K, Tsuchiya T, Ikada Y. Clinical use of synthetic absorbable cuff material for peripheral vascular anastomosis. Surg Gynecol Obstet 1992; 175(5):421-7. Summers S, Drazan K, Gomes A, Freischlag J. Urokinase therapy for thrombosed hemodialysis access grafts. Surg Gynecol Obstet 1993;176(6): 534-8. Sundaram S, Irvine L, Courtney JM, Lowe GD. Modification of the influence of biomaterials on contact activation. Int J Artif Organs 1991 Nov; 14(11):729—31. Surratt RS, Picus D, Hicks ME, Darcy MD, Kleinhoffer M, Jendrisak M. The importance of preoperative evaluation of the subclavian vein in dialysis access planning. AJR Am J Roentgenol 1991 Mar;156(3):623-5. Comment in: AJR Am J Roentgenol 1991 Nov;157(5):1125-6. Suzuki M, Ohno M, Miyagi M, Ukai T. Cellulose triacetate hemodialysis membrane design for beta-2 microglobulin removal. Blood Purif 1991;9(1):51. Svehag SE. Adverse effects of clinical intervention on the complement system. Complement Inflamm l991;8(5-6):359-69. Swan SK, Bennett WM. Drug dosing guidelines in patients with renal failure. West J Med 1992 Jun; 156(6):633—8. 50 Swartz R, Messana J, Holmes C, Williams J. Biofilm formation on peritoneal catheters does not require the presence of infection. ASAIO Trans 1991 Oct-Dec;37(4):626-34. Swartz R, Messana J, Reynolds J, Ranjit U. Simultaneous catheter replacement and removal in refractory peritoneal dialysis infections. Kidney Int 1991 Dec;40(6):1160-5. Swartz R, Messana J, Starmann B, Weber M, Reynolds J. Preventing Staphylococcus aureus infection during chronic peritoneal dialysis. J Am Soc Nephrol 1991 Dec;2(6):1085—91. Synhavsky A. Central venous hemodialysis catheters. Am J Kidney Dis 1993;21(4):454. Szromba C, Bowman-Riney S. Successful intervention in the reduction of methicillin resistant staphylococcus aureus (MRSA) catheter related bacteremia. ANNA J 1992 Apr;19(2):153. Taber TE, Hegeman TF, York SM, Kinney RA, Webb DH. Treatment of Pseudomonas infections in peritoneal dialysis patients. Perit Dial Int 1991; 11(3):213-6. Tagawa H, Nagano M, Saito H, Umezu M, Yamakado M. Echocardiographic findings in hemodialysis patients treated with recombinant human erythropoietin: proposal for a hematocrit most beneficial to hemodynamics. Clin Nephrol 1991 Jan;35(l):35-8. Takai I, Shinzato T, Morita H, Fujita Y, Inoue I, Kobayakawa H, Maeda K. A new treatment strategy using both intermittent short dialysis and continuous ambul hemofiltration. ASAIO Trans 1991 Jul-Sep;37(3):M325-7. Tang IY, Vrahnos D, Valaitis D, Lau AH. Vascular access thrombosis during recombinant human erythropoietin therapy. ASAIO J 1992 Jul-Sep; 38(3):M528-31. Taraba I, Polner K, Mako J. Biocompatibility study on cuprophane and polysulphone dialysers. Nephrol Dial Transplant 1991;6 Suppl 3222—5. Tattersall JE, Cramp M, Shannon M, Farrington K, Greenwood RN. Rapid high-flux dialysis can cure uraemic peripheral neuropathy. Nephrol Dial Transplant 1992;7(6):539-40. Tattersall JE, Farrington K, Raniga PD, Thompson H, Tomlinson C, Aldridge C, Greenwood RN. Haemodialysis recirculation detected by the three- sample method is an artefact. Nephrol Dial Transplant 1993;8(1):60-3. Taylor B, Sigley RD, May KJ. Fate of infected and eroded hemodialysis grafts and autogenous fistulas. Am J Surg 1993 May;165(5):632-6. Taylor J E, MacTier RA, Henderson IS, Belch J], Stewart WK. Dialysis efficiency in continuous ambulatory peritoneal dialysis patients treated with erythropoietin. Perit Dial Int 1992;12(2):221-6. Taylor JE, McLaren M, Mactier RA, Henderson IS, Stewart WK, Belch II. Effect of dialyzer geometry during hemodialysis with cuprophane membranes. Kidney Int 1992 Aug;42(2):442-7. Teixido J, Borras M, Bonet J, Galimany R, Biosca C, Caralps A. Peritoneal function tests: usefulness of simplified methods. Adv Perit Dial l992;8:177-80. Tetta C, Fidelio T, Licata C, Iacono L, Sancipriano G, Biancone L, Ragni R, Segoloni G, Camussi G. Production of tumor necrosis factor-alpha in patients on hemodiafiltration. Nephron 1992;6l(2): 135-8. Tetta C, Segoloni G, Mariano F, Montrucchio G, Turello E, Camussi G. Leukocyte-derived mediators and biocompatibility. Nephrol Dial Transplant 1991;6 Suppl 2:24-30. Thomas M, Argiles A, Kerr PG, Canaud B, Flavier JL, Mion CM. Measurement of vascular access recirculation without contralateral venous puncture. Nephron 1992;62(2):224-5. Thylen P, Ericsson F, Odar-Cederlof I, Kjellstrand CM. Hypertension profiling by total body water (TBW) determinations in patients on chronic hemodialysis. Int J Artif Organs 1991 Jan;14(1): 18-22. Thylen P, Lundahl J, Fernvik E, Hed J, Svenson SB, Jacobson SH. Mobilization of an intracellular glycoprotein (Mac-1) on monocytes and granulocytes during hemodialysis. Am J Nephrol 1992;12(6):393-400. Tobe S, Chu MG, Bargman J M. Characterization of peritoneal transport in patients with failed renal allografts receiving CAPD. Adv Perit Dial 1991;7: 39-43. Tokars JI, Alter MJ, Favero MS, Moyer LA, Bland LA. National surveillance of hemodialysis associated diseases in the United States, 1990. ASAIO J 1993 Jan-Mar;39(1):71-80. Tordoir JH, Leunisse KM, Kitslaar PJ, Kootatra G. Arteriovenous fistulas for hemodialysis and diagnostic methods in the evaluation of fistula complications. J Nephrol 1991;4(2):97- 104. Tunnel-Rodrigues L, Pengloan J, Blanchier D, Abaza M, Birmele B, Haillot 0, Blanchard D. Insufficient dialysis shunts: improved long-term patency rates with close hemodynamic monitoring, repeated percutaneous balloon angioplasty, and stent placement. Radiology 1993 Apr;187(1):273-8. Turner K, Edgar D, Hair M, Uttley L, Stemland R, Hunt L, Gokal R. Does catheter immobilization reduce exit-site infections in CAPD patients? Adv Perit Dial 1992;8:265-8. Twardowski ZJ, Dobbie JW, Moore HL, Nichols WK, DeSpain JD, Anderson PC, Khanna R, Nolph KD, Loy TS. Morphology of peritoneal dialysis catheter tunnel: macroscopy and light microscopy. Perit Dial Int 1991;11(3):237-51. Twardowski ZJ, Nichols WK, Nolph KD, Khanna R. Swan neck prestemal ("bath tub") catheter for peritoneal dialysis. Adv Perit Dial 1992;8z316-24. Twardowski ZJ, Prowant BF, Nichols WK, Nolph KD, Khanna R. Six-year experience with swan neck catheters. Perit Dial Int 1992;12(4):384-9. Twardowski ZJ, Van Stone JC, Jones ME, Klusmeyer MS. Blood recirculation (REC) in intravenous catheters (IVC) for hemodialysis (HD). J Am Soc Nephrol 1992;3(3):399. Uldall R, Besley ME, Thomas A, Salter S, Nuezca LA, Vas M. Maintaining the patency of double-lumen silastic jugular catheters for haemodialysis. Int J Artif Organs 1993 Jan;16(1):37-40. Uldall R, DeBruyne M, Besley M, McMillan J, Simons M, Francoeur R. A new vascqu access catheter for hemodialysis. Am J Kidney Dis 1993 Mar;21(3): 270-7. Update: acute allergic reactions associated with reprocessed hemodialyzers--United States, 1989-1990. MMWR Morb Mortal Wkly Rep 1991 Mar 8;40(9):147, 153-4. Urena P, Herbelin A, Zingraff J, Lair M, Man NK, Descamps-Latscha B, Drueke T. Permeability of cellulosic and non-cellulosic membranes to endotoxin subunits and cytokine production during in-vitro haemodialysis. Nephrol Dial Transplant 1992;7(1):16—28. Valeri A, Radhakrishnan J, Vemocchi L, Carmichael LD, Stern L. The epidemiology of peritonitis in acute peritoneal dialysis: a comparison between open- and closed-drainage systems. Am J Kidney Dis 1993 Mar;21(3):300—9. Valji K, Bookstein J], Roberts AC, Davis GB. Phannacomechanical thrombolysis and angioplasty in the management of clotted hemodialysis grafts: early and late clinical results. Radiology 1991 Jan; l78(1):243-7. van Asseldonk JP, Schroder CH, Severijnen RS, de Jong MC, Monnens LA. Infectious and surgical complications of childhood continuous ambulatory peritoneal dialysis. Eur J Pediatr 1992 May;151(5): 377-80. 51 van der Meulen J, Janssen MJ, Langendijk PN, Bouman AA, 0e PL. Citrate anticoagulation and dialysate with reduced buffer content in chronic hemodialysis. Clin Nephrol 1992 Jan;37(l):36-41. van Olden RW, van Meyel JJ, Gerlag PG. Acute and long-term effects of therapy with high-dose furosemide in chronic hemodialysis patients. Am J Nephrol 1992;12(5):351-6. Vanherweghem JL. Infections in chronic hemodialysis patients. Semin Dial 1991 Oct-Dec;4(4):240-4. Vanholder R, De Smet R, Gervasio R, Ringoir S. In vivo solute elimination of paired filtration dialysis. Int J Artif Organs 1991 Jan;14(l):23-7. Vanholder R, Van Haecke E, Veys N, Ringoir S. Endotoxin transfer through dialysis membranes: small- versus largepore membranes. Nephrol Dial Transplant 1992;7(4):333—9. Vanholder R, Vanhaecke E, Ringoir S. Pseudomonas septicemia due to deficient disinfectant mixing during reuse. Int J Artif Organs 1992 Jan;15(1): 19-24. Vasilakakis DM, D’Haese PC, Lamberts LV, Lemoniatou E, Digenis PN, De Broe ME. Removal of aluminoxamine and ferrioxamine by charcoal hemoperfusion and hemodialysis. Kidney Int 1992 May;41 (5): 1400—7. Vasson MP, Paul JL, Couderc R, Albuisson E, Bargnoux PJ, Baguet JC, Raichvarg D. Serum alpha-1 acid glycoprotein in chronic renal failure and hemodialysis. Int J Artif Organs 1991 Feb; 14(2):92-6. Vega N, Fernandez A, Hortal L, Macias M, Rodriguez JC, Plaza C, Perdomo M, Vega R, Palop L. Peritoneal dialysis efficiency in CAPD patients in treatment with rHuEPO. Adv Perit Dial 1992;8: 467-70. Verbeelen D, Jochmans K, Herman AG, Van der Niepen P, Sennesael J, De Waele M. Evaluation of platelets and hemostasis during hemodialysis with gix different membranes. Nephron 1991;59(4): 67-72. Verreet PR, Passlick—Deetjen J, Grabensee B. The Oreopoulos-Zellermann catheter. Contrib Nephrol 1991;89:47—52. Vincent I-IH, Akcahuseyin E, Vos MC, van Duyl WA, Schalekamp MA. Continuous arteriovenous hemodiafiltration: filter design and blood flow rate. Contrib Nephrol 1991;93:196-8. Vincent C, Chanard J, Caudwell V, Lavaud S, Wong T, Revillard JP. Kinetics of lZSI-beta 2- microglobulin turnover in dialyzed patients. Kidney Int 1992 Dec;42(6):1434-43. 52 Vitali ED, Malacarne F, Perini L, Soffritti S, Storari A, Gilli P. Haemodialysis venous catheters jugular and femoral routes. Nephrol Dial Transplant 1992; 7(7):723-4. Vlaanderen K, Bos HJ, de Fijter CW, Oe LP, van der Meulen J, Verbrugh HA, Beelen RH. Short dwell times reduce the local defence mechanism of chronic peritoneal dialysis patients. Nephron 1991; 57(1):29-35. von Sengbusch G, Bowry S, Vienken J. Focusing on membranes. Artif Organs 1993 Apr;17(4):244-53. Vorstrup S, Lass P, Waldemar G, Brandi L, Schmidt JF, J ohnsen A, Paulson 0B. Increased cerebral blood flow in anemic patients on long-term hemodialytic treatment. J Cereb Blood Flow Metab 1992 Sep;12(5):745—9. Wadhwa NK, Cabralda T, Suh H, Kvilekval K, Mason R. Exit-site/tunnel infection and catheter outcome in peritoneal dialysis patients. Adv Perit Dial 1992;8: 325-7. Wadhwa NK, Cabralda T, Suh H, Stratos J, Cascio C, Young N. Multiple use of cycler set in cycler peritoneal dialysis. Adv Perit Dial 1992;8z192-4. Waniewski J, Werynski A, Heimburger 0, Lindholm B. A comparative analysis of mass transport models in peritoneal dialysis. ASAIO Trans 1991 Apr-Jun; 37(2):65-75. Y'aniewski J, Werynski A, Heimburger O, Lindholm B. Simple membrane models for peritoneal dialysis. Evaluation of diffusive and convective solute transport. ASAIO J 1992 Oct-Dec;38(4):788-96. Ward RA, Schaefer RM, Falkenhagen D, Joshua MS, Heidland A, Klinkmann H, Gurland HJ. Biocompatibility of a new high-permeability modified cellulose membrane for haemodialysis. Nephrol Dial Transplant 1993;8(1):47-53. Watson AR, Coleman J E, Taylor EA. Gastrostomy buttons for feeding children on continuous cycling peritoneal dialysis. Adv Perit Dial 1992;82391-5. West JC, Bertsch DJ, Peterson SL, Gannon MP, Norkus G, Latsha RP, Kelley SE. Arterial insufficiency in hemodialysis access procedures: correction by "banding" technique. Transplant Proc 1991 Apr;23(2):1838-40. West ML, J indal KK. Peritonitis presenting as acute catheter obstruction in noncontinuous forms of peritoneal dialysis (PD) [abstract]. Clin Invest Med 1992;15(4 Suppl):A97. Wieslander AP, Nordin MK, Kjellstrand PT, Boberg UC. Toxicity of peritoneal dialysis fluids on cultured fibroblasts, L-929. Kidney Int 1991 Jul; 40(1):77-9. Wikdahl AM, Granbom L, Stegmayr BG. CAPD bag changing with integrated disconnect system gives lower incidence of peritonitis than with UV-box system. Adv Perit Dial 1992;8z276—80. Wilcox CM, Woods BL, Mixon HT. Prospective evaluation of a peritoneal dialysis catheter system for large volume paracentesis. Am J Gastroenterol 1992 0ct;87(10):1443-6. Wilske J , Bjorck S, Delin K. Serum concentrations of calcitriol and PI‘H in hemo-dialysis patients on treatment with calcium carbonate. Scand J Urol Nephrol 1992;26(1):51-4. Winchester JF, Rottellar C, Goggins M, Robino D, Rakowski TA, Argy WP. Calcium and phosphate balance in dialysis patients. Kidney Int Suppl 1993; 41:Sl74-8. Windus DW. Permanent vascular access: a nephrologist’s view. Am J Kidney Dis 1993 May; 21(5):457-71. Windus DW, Jendrisak MD, Delmez JA. Prosthetic fistula survival and complications in hemodialysis patients: effects of diabetes and age. Am J Kidney Dis 1992 May;19(5):448-52. Winters CJ, Vesely DL. Change in plasma immunoreactive N—terminus, C-terminus, and 4,000—dalton midportion of atrial natriuretic factor prohormone with hemodialysis. Nephron 1991; 58(1):17-22. Wizemann V, Soetanto R, Thormann J, Dubbecke F, Kramer W. Effects of acetate on left ventricular function in hemodialysis patients. Nephron 1993; 64(1):101-5. Wood B, Abbott WC, Erickson DG, Tzamaloukas AH. Delayed infectious complications of peritoneal dialysis catheters. Am J Nephrol 1992;12(3): 199-200. Yamamoto T, Sakakura T, Yamakawa M, Horiuchi N, Hirata S, Iritani Y, Nishitani H, Kim M, Kishimoto T, Chiku T, et al. Clinical effects of long-term use of neutralized dialysate for continuous ambulatory peritoneal dialysis. Nephron 1992;60(3):324-9. Yamazaki M, Asakura H, Sato T, Tsugawa Y, Matsumura M, Kawamura Y, Ohka T, Matsuda T. Changes in plasma levels of thrombomodulin during haemodialysis. Blood Coagul Fibrinolysis 1992 Feb;3(1):113-7. Yan F, Dejardin P, Mulvihill JN, Cazenave JP, Crost T, Thomas M, Pusineri C. Influence of a preadsorbed terpolymer on human platelet accumulation, fibrinogen adsorption, and ex vivo blood activation in hemodialysis hollow fibers. J Biomater Sci Polym Ed 1992;3(5):389-402. Yasuda T, Ozawa S, Shiba C, Maeba T, Kanazawa T, Sugiyama M, Owada S, Ishida M. D-lactate metabolism in patients with chronic renal failure undergoing CAPD. Nephron 1993;63(4):416-22. Yasumoto N, Kitamoto Y, Yoshimura N, Nakayama M, Sato T. Effect of blood access on the platelets of azotemic patients initiating dialysis therapy. Artif Organs 1993;17(3):185—8. Yatzidis H. Hemodialysis with a new single stable bicarbonate dialysate. Nephron 1993;64(l):27-31. Yeh TJ, Wei CF, Chin TW. Catheter-related complications of continuous ambulatory peritoneal dialysis. Eur J Surg 1992 May;158(5):277-9. Yohay DA, Butterly DW, Schwab SJ, Quarles LD. Continuous arteriovenous hemodialysis: effect of dialyzer geometry. Kidney Int 1992 Aug;42(2): 448-51. Yokobori AT Jr, Yokobori T. The mechanical test method of cardiovascular and related biomaterials. Biomed Mater Eng 1991;1(1):25-43. Yu AW, Manahan FJ, Filkins JP, Mohammed MS, Soundararajan R, McShane AP, Gandhi VC, Ing TS. Peritoneal dialysis using bicarbonate-containing solution sterilized by ultrafiltration. Int J Artif Organs 1991 Aug;14(8):463-5. Yu AW, Zhou XJ, Zhou FQ, Nawab ZM, Gandhi VC, Ing TS, Vaziri ND. Neutrophilic intracellular acidosis induced by conventional, lactate-containing peritoneal dialysis solutions. Int J Artif Organs 1992 Nov;15(11):661-5. Zappacosta AR, Perras S, Closkey G. 2.3 mm peritoneal catheter tunnel-exit site [abstract]. J Am Soc Nephrol 1992;3(3):422. Zappacosta AR, Perras ST, Closkey GM. Seldinger technique for Tenckhoff catheter placement. ASAIO Trans 1991 Jan-Mar;37(1):13-5. Zazgomik J, Kuska J, Kokot F, Koch S, Van Peer A, Huang ML, Heykants J. Pharmacokinetics of ritanserin in patients undergoing hemodialysis. J Clin Pharmacol 1991 Jul;3l(7):657-61. Zeplin HE, Schneckenberger K, Fassbinder W, Stegmann T. Percutaneous vena cava catheters as vascular access for chronic hemodialysis [abstract]. Int J Artif Organs 1992;15(9):517. Ziegler TR, Lazarus JM, Young LS, Hakim R, Wilmore DW. Effects of recombinant human growth hormone in adults receiving maintenance hemodialysis. J Am Soc Nephrol 1991 Dec;2(6): 1130-5. Zoccali C, Mallamaci F, Ciccarelli M, Parlongo S, Salnitro F, Curatola A. The reflex control of 53 vasopressin in haemodialysis patients. Nephrol Dial Transplant l991;6(9):631-6. Zucchelli P, Santoro A. Correction of acid-base balance by dialysis. Kidney Int Suppl 1993;41:8179-83. Zwaan M, Weiss I-ID, Gothlin JH, Kummer D, Scheu M, Kagel H, Gmelin E, Rinast E. Initial clinical experience with a new pulsed dye laser device in angioplasty of limb ischemia and shunt fistula obstructions. Eur J Radiol 1992 Jan-Feb;14(l):72-6. 54 CO—MORBIDITY -Clinical Trials Churchill DN, Bird DR, Taylor DW, Beecroft ML, German 1, Wallace I E. Effect of high—flux hemodialysis on quality of life and neuropsychological function in chronic hemodialysis patients. Am I Nephrol 1992;12(6):412-8. Laupacis A, Muirhead N, Keown P, Wong C. A disease-specific questionnaire for assessing quality of life in patients on hemodialysis. Nephron 1992; 60(3):302—6. Published erratum appears in Nephron 1992;61(2):248. Laupacis A, Wong C, Churchill D. The use of generic and specific quality-of-life measures in hemodialysis patients treated with erythropoietin. The Canadian Erythropoietin Study Group. Controlled Clin Trials 1991 Aug;12(4 Suppl):168S-l79S. Morniere P, Maurouard C, Boudailliez B, Westeel PF, Achard J M, Boitte F, e1 Esper N, Compagnon M, Maurel G, Bouillon R, et 31. Prevention of hyperparathyroidism in patients on maintenance dialysis by intravenous l-alpha-hydroxyvitamin D3 in association with Mg(OH)2 as sole phosphate binder. A randomized comparative study with the association CaCO3 +/- Mg(OH)2. Nephron 1992; 60(2): 154-63 . Turk S, Yeksan M, Tamer N, Gurbilek M, Erdogan Y, Erkul I. Effect of 1,25 (OH)2D3 treatment on glucose intolerance in uraemia. Nephrol Dial Transplant 1992;7(12):12U7-12. -0ther Aghanashinikar PN, Al-Dhahry SH, Al-Marhuby HA, Buhl MR, Daar AS, Al-Hasani MK. Prevalence of hepatitis B, hepatitis delta, and human immunodeficiency virus infections in Omani patients with renal diseases. Transplant Proc 1992 Oct; 24(5):1913-4. ' al-Dhahry SH, Aghanashinikar PN, al-Hasani MK, Buhl MR, Daar AS. Antibodies to hepatitis C virus in Omani patients with renal disease. Transplant Proc 1992 Oct;24(5):1938-9. al-Ghamdi MS, al-Mohanna FA, al-Mustafa ZH, al- Saeed IS. The effect of haemodialysis on the pharmacokinetics of tenoxicam in patients with end- stage renal disease. Eur J Clin Pharmacol 1992; 43(2):197-9. al-Mugeiren M, al-Faleh FZ, Ramia S, al-Rasheed S, Mahmoud MA, al-Nasser M. Seropositivity to hepatitis C virus (HCV) in Saudi children with chronic renal failure maintained on haemodialysis. Ann Trop Paediatr 1992;12(2):217-9. al Nasser MN, al Mugeiren MA, Assuhaimi SA, Obineche E, Onwabalili J, Ramia S. Seropositivity to hepatitis C virus in Saudi haemodialysis patients. Vox Sang 1992;62(2):94-7. Alfurayh O, Sobh M, Buali A, Ali MA, Barri Y, Qunibi W, Taher S. Hepatitis C virus infection in chronic haemodialysis patients, a clinicopathologic study. Nephrol Dial Transplant 1992;7(4):327-32. Comment in: Nephrol Dial Transplant 1992;7(12): 1259-60. Alivanis P, Derveniotis V, Dioudis C, Grekas D, Mandraveli P, Vasiliou S, Tourkantonis A. Hepatitis C virus antibodies in hemodialysed and in renal transplant patients: correlation with chronic liver disease. Transplant Proc l991;23(5):2662-3. Allegra V, Vasile A, Maschio M, Mengozzi G. Immune response after vaccination with recombinant hepatitis surface antigen in maintenance hemodialysis patients and healthy controls. Nephron 1992;61(3):339-40. Almroth G, Ekermo B, Franzen L, Hed J. Antibody responses to hepatitis C virus and its modes of transmission in dialysis patients. Nephron 1991; 59(2):232-5. Amarapurkar DN, Kumar A, Parikh SS, Chopra KB, Murti P, Kalro RH, Desai HG. Hepatitis C virus infection in chronic liver disease in Bombay. Indian J Gastroenterol 1992 Oct;11(4):162-3. Ansari A, Kaupke CJ, Vaziri ND, Miller R, Barbari A. Cardiac pathology in patients with end—stage renal disease maintained on hemodialysis. Int J Artif Organs 1993 Ian;16(1):31-6. Artis AK, Alpert MA, Van Stone J, Kelly DL, Mukerji V, Graham BM, Nolph KD. Effect of hemodialysis on left ventricular systolic function in the presence and absence of beta-blockade: influence of left ventricular mass. Am J Nephrol 199l;11(4):289-94. Asai K, Miura S, Kawahara H, Toriyama T, Kuzuya F. A comparative study of atherosclerosis and osteopenia in elderly and young hemodialysis patients. Aging (Milano) 1991 Mar;3(1):79—87. Avella F, Irlando A, Scancariello G, Iovino R. On the positivity of the test for anti-HCV considerations in dialized patients. Nephron 1992;61(3):341. Avendano C, Alvarez J S, Sacristan JA, Adin J, Alsar MI. Interference of digoxin—like immunoreactive substances with TDx digoxin II assay in different patients. Ther Drug Monit 1991 Nov;13(6):523-7. Ayoola EA, Huraib S, Arif M, al-Faleh FZ, al-Rashed R, Ramia S, al-Mofleh IA, Abu-Aisha H. Prevalence and significance of antibodies to hepatitis C virus among Saudi haemodialysis patients. J Med Virol 1991 Nov;35(3):155—9. Bahakim H, Bakir TM, Arif M, Ramia S. Hepatitis C virus antibodies in high-risk Saudi groups. Vox Sang 1991;60(3):162—4. Batiuk TD, Kurtz SB, Oh JK, Orszulak TA. Coronary artery bypass operation in dialysis patients. Mayo Clin Proc 1991 Jan;66(1):45—53. Bechstein W0, Blumhardt G, Rossaint R, Gahl G, Steffen R, Neuhaus P. Improved outcome of dialysis afier liver transplantation. Transplant Proc 1991 Jun;23(3):1982—3. Benazzi F. Mania during hemodialysis: causal or casual association? Am J Psychiatry 1992 Mar;149(3):414. Bender FH, Piraino B. Polycythemia in diabetic patients on CAPD. Adv Perit Dial 1991;7z77—80. Benhamou PY, Marwah T, Balducci F, Zmirou D, Borgel F, Cordonnier D, Halimi S, Papoz L. Classification of diabetes in patients with end-stage renal disease. Validation of clinical criteria according to fasting plasma C-peptide. Clin Nephrol 1992 Nov;38(5):239-44. Berman DH, Friedman EA, Lundin AP. Aggressive ophthalmological management in diabetic end-stage renal disease: a study of 31 consecutively referred patients. Am J Nephrol 1992;12(5):344—50. Besso L, Rovere A, Peano G, Menardi G, Fenoglio LM, Fenoglio S, Ghezzi PM. Prevalence of HCV antibodies in a uraemic population undergoing maintenance dialysis therapy and in the staff members of the dialysis unit. Nephron 1992;61(3): 304—6. Blagg CR. Hemodialysis 1991. Blood Purif l992;10(1): 22-9. Blythe WB, Maddux FW. Hypertension as a causative diagnosis of patients entering end-stage renal disease programs in the United States from 1980 to 1986. Am J Kidney Dis 1991 Jul;18(1):33-7. Borgel F, Benhamou PY, Zmirou D, Balducci F, Halimi S, Cordonnier D. Assessment of handicap in chronic dialysis diabetic patients (uremidiab section study). Scand J Rehabil Med 1992;24(4):203-8. Boros L, Cacek T, Pine RB, Battaglia AC. Distribution characteristics of mitoxantrone in a patient undergoing hemodialysis. Cancer Chemother Pharmacol 1992;31(1):57-60. Bracchi o, Orazi E, Lupi GP, Bronzieri C, Comalba L, Grassi C. Hepatitis C: reality of a renal unit. Nephron 1992;61(3):369-70. Brennan DT. Diabetes and end-stage renal disease: issues in diabetic nephropathy. ANNA Update 1991 Nov-Dec;21(6):1-8 . 55 Breyer IA, Harbison MA. Isolation of human immunodeficiency virus from peritoneal dialysate. Am J Kidney Dis 1993 Jan;21(1):23-5. Brock JS, Sussman M, Wamsley M, Mintzer R, Baumann FG, Riles TS. The influence of human immunodeficiency virus infection and intravenous drug abuse on complications of hemodialysis access surgery. J Vasc Surg 1992 Dec;16(6):904-10; discussion 911-2. Brown I H, Short CD, Mallick NP. Ischaemic heart disease, lipids and the kidney. Contrib Nephrol 1993;102:198-219. Brugnano R, Francisci D, Quintaliani G, Gaburri M, Nori G, Verdura C, Giombini L, Buoncristiani U. Antibodies against hepatitis C virus in hemodialysis patients in the central Italian region of Umbria: evaluation of some risk factors. Nephron 1992; 61(3):263-5. Bunchman TE, Meldrum IVIK, Meliones JE, Sedman AB, Walters MB, Kershaw DB. Pulmonary function variation in ventilator dependent critically ill infants on peritoneal dialysis. Adv Perit Dial 1992;8:75-8. Buur T, Larsson R, Regardh CG, Aberg I. Pharmacokinetics of felodipine in chronic hemodialysis patients. J Clin Pharmacol 1991 Aug;31(8):709—13. Byrick RJ, Goldstein MB, Wong PY. Increased plasma tumor necrosis factor concentration in severe rhabdomyolysis is not reduced by continuous arteriovenous hemodialysis. Crit Care Med 1992; 20(10): 1483-6. Cappa M, del Balzo P, Rizzoni G, Benedetti S, Borrelli P. Somatostatinergic tone in children on chronic haemodialysis and after renal transplantation. Pediatr Nephrol 1991 Jul;5(4):548-51. Carletti P, Bibiano L, Boggi R, Bordoni E, Ricciatti AM, Della Bella S, Pauri P, Salvoni G, Mioli VA. I-IBV infection in hemodialysis patients: monitoring and prevention. Nephron 1992;61(3):269-70. Carson RW, Dunnigan EJ, DuBose TD Jr, Goeger DE, Anderson KE. Removal of plasma porphyrins with high-flux hemodialysis in porphyria cutanea tarda associated with end-stage renal disease. J Am Soc Nephrol 1992 Mar;2(9):1445-50. Cases A, Filella X, Molina R, Ballesta AM, Lopez- Pedret J, Revert L. Tumor markers in chronic renal failure and hemodialysis patients. Nephron 1991; 57(2): 183-6. Cefali EA, Poynor WI, Sica D, Cox S. Pharmacokinetic comparison of flurbiprofen in end- stage renal disease subjects and subjects with normal renal function. J Clin Pharmacol 1991 Sep; 31(9):808-14. 56 Chang DB, Kuo SH, Yang PC, Shen FH, Luh KT. Clearance of theophylline by hemodialysis in one patient with chronic renal failure. Chest 1992 Nov; 102(5): 1621-3. Cheigh J S, Milite C, Sullivan JF, Rubin AL, Stenzel KH. Hypertension is not adequawa controlled in hemodialysis patients. Am J Kidney Dis 1992; 19(5):453-9. Cheigh JS, Stenzel KH. End-stage renal disease in systemic lupus erythematosus. Am J Kidney Dis 1993 Jan;21(1):2-8. Cheung WC, Yuen KY, Chang CM, Cheng KP. Herpes zoster associated encephalitis in dialysis patients. J Infect 1991 Sep;23(2):169-74. Chiegh J, Raghavan V, Sullivan J, Tapia L, Rubin A, Stenzel KH. Is insufficient dialysis a cause for high morbidity in diabetic patients? [abstract]. J Am Soc Nephrol l991;2(3):317. Christensen AJ, Turner CW, Smith TW, Holman J M Jr, Gregory MC. Health locus of control and depression in end-stage renal disease. J Consult Clin Psychol 1991 Jun;59(3):4l9-24. Chu NF, Ferng SH, Shieh SD. Quality of life assessment in end-stage renal disease patients with maintenance hemodialysis therapy. Chung Hua I Hsueh Tsa Chih 1992 Aug;50(2):103-7. Churchill DN, Wallace JE, Ludwin D, Beecrofi ML, Taylor DW. A comparison of evaluative indices of quality of life and cognitive function in hemodialysis patients. Controlled Clin Trials 1991 Aug; 12(4 Suppl):159S-167S. Conte JE Jr. Pharmacoldnetics of intravenous pentamidine in patients with normal renal function or receiving hemodialysis. J Infect Dis 1991 Jan; 163(1):169-75. Coronel F, Tomero F, Macia M, Sanchez A, De Oleo P, Naranjo P, Barrientos A. Peritoneal clearances, protein losses and ultrafiltration in diabetic patients after four years on CAPD. Adv Perit Dial 1991;7: 35-8. Coronel F, Tomero F, Torrente J, Naranjo P, De Oleo P, Macia M, Barrientos A. Treatment of hyperlipemia in diabetic puients on dialysis with a physiological substance. Am J Nephrol 1991;11(1): 32-6. Covarsi A, Rodriguez AM, Mar-igliano N, Novillo R. Metastasizing renal cell carcinoma and acquired renal cystic disease in a hemodialysis patient. Am J Nephrol 1991;11(3):224—8. Cozma G, Cozma MC, Mattes U. Beneficial effect of recombinant human erythropoietin in beta thalassaemia patients on dialysis. Nephrol Dial Transplant 1992;7(1):82-3. Cressman MD, Heyka RJ, Paganini EP, O’Neil J, Skibinski CI, Hoff HF. Lipoprotein(a) is an independent risk factor for cardiovascular disease in hemodialysis patients. Circulation 1992 Aug;86(2): 475-82. Cressman MD, Hoff HF, Nally JV Jr, Schreiber M Jr, Van Lente F. Lipoprotein a and the cardiovascular risk of end stage renal disease [abstract]. J Am Soc Nephrol 1991;2(3):234. Davenport A, Goel S, Mackenzie J C. Neurotoxicity of acyclovir in patients with end—stage renal failure treated with continuous ambulatory peritoneal dialysis. Am J Kidney Dis 1992 Dec;20(6):647-9. De Lima JJ, Abensur H, Bernardes-Silva H, Bellotti G, Pileggi F. Role of arterial hypertension in lefi ventricle hypertrophy in hemodialysis patients: an echocardiographic study. Cardiology 1992;80(3-4): 161-7. Dedman DJ, Treffry A, Candy JM, Taylor GA, Morris CM, Bloxham CA, Perry RH, Edwardson JA, Harrison PM. Iron and aluminium in relation to brain ferritin in normal individuals and Alzheimer’s-disease and chronic renal-dialysis patients. Biochem J 1992 Oct 15;287(Pt 2):509-14. D’Elia JA, Weinrauch LA, Paine DF, Domey PE, Smith-Ossman SL, Williams ME, Kaldany A. Increased infection rate in diabetic dialysis patients exposed to cocaine. Am J Kidney Dis 1991 Sep; 18(3):349-52. Devins GM,~Edworthy SM, Seland TP, Klein GM, Paul LC, Mandin H. Differences in illness intrusiveness across rheumatoid arthritis, end-stage renal disease, and multiple sclerosis. J Nerv Ment Dis 1993 Jun;181(6):377-81. Dominguez JM, Cruz N, Ramos-Barrow A, Ramos Umpierre E. Pregnancy in chronic hemodialysis. Transplant Proc 1991 Apr;23(2):1836-7.- Duntas L, Wolf CF, Keck FS, Rosenthal J. Thyrotropin-releasing hormone: pharmacokinetic and pharmacodynamic properties in chronic renal failure. Clin Nephrol 1992 Oct;38(4):214—8. Edmunds ME, Devoy M, Tomson CR, Krishna U, Clayworth A, Durrant ST, Feehally J, Walls J. Plasma erythropoietin levels and acquired cystic disease of the kidney in patients receiving regular haemodialysis treatment. Br J Haematol 1991 Jun; 78(2):275—7. Comment in: Br J Haematol 1991 Nov;79(3):529—30. Ekstrand A. Kidney transplantation with and without prior dialysis therapy in diabetic patients with end- stage renal failure. Scand J Urol Nephrol 1993; 27(1):83-7. Elisaf M, Tsianos E, Mavridis A, Dardamanis M, Pappas M, Siamopoulos KC. Antibodies against hepatitis C virus (anti-HCV) in haemodialysis patients: association with hepatitis B serological markers. Nephrol Dial Transplant 1991;6(7):476—9. Emoto M, Tabata T, Inoue T, Nishizawa Y, Morii H. Plasma 1,5—anhydroglucitol concentration in patients with end-stage renal disease with and without diabetes mellitus. Nephron 1992;61(2):181-6. Erdberg A, Korzets Z, Neufeld D, Rathaus M, Cordoba M, Bernheim J. Malignant hypertension: a possible precursor to the future development of mesenteric ischaemia in chronically haemodialysed patients. Nephrol Dial Transplant 1992;7(6):541-4. Esteban R. Epidemiology of hepatitis C virus infection. J Hepatol 1993;17 Suppl 3:867-71. Evans RW. Recombinant human erythropoietin and the quality of life of end-stage renal disease patients: a comparative analysis. Am J Kidney Dis 1991 Oct; 18(4 Suppl 1):62-70. Falchetti A, Bale AE, Amorosi A, Bordi C, Cicchi P, Bandini S, Marx SJ, Brandi ML. Progression of uremic hyperparathyroidism involves allelic loss on chromosome 11. J Clin Endocrinol Metab 1993 Jan; 76(1):139-44. Faranna P, Cozzi G, Belloni M, Pedrini L. Immunization and vaccination protocol in hemodialysis patients with naturally acquired hepatitis B antibody. Nephron 1992;61(3):311-2. Favazza A, Motanaro D, Messa P, Antonucci F, Gropuzzo M, Mioni G. Peritoneal clearances in hypertensive CAPD patients afier oral administration of clonidine, enalapril, and nifedipine. Perit Dial Int 1992;12(3):287-91. Fernandez A, Hortal L, Rodriguez JC, Vega N, Plaza C, Palop L. Anemia in dialysis: its relation to acquired cystic kidney disease and serum levels of erythropoietin. Am J Nephrol 1991;11(1):12-5. Ferrans CE, Powers MJ. Psychometric assessment of the Quality of Life Index. Res Nurs Health 1992 Feb;15(1):29-38. Franco E, Olivadese A, Valeri M, Albertoni F, Petrosillo N. Control of hepatitis B virus infection in dialysis units in Latium, Italy. Nephron 1992; 61(3):329-30. Friedman EA. Diabetic nephropathy in the inner city. N Y State J Med 1991 May;91(5):203-7. Fujiyama S, Kawano S, Sato S, Sato T, Shimada H, Matsushita K, Hara M, Ito J. The prevalence of anti-HCV antibodies in hemodialysis patients. Gastroenterol Jpn 1991 Jul;26 Suppl 3:206-8. Fujiyama S, Kawano S, Sato S, Tanaka M, Goto M, Taura Y, Sato T, Kawahara T, Mizuno K. Prevalence of hepatitis C virus antibodies in 57 hemodialysis patients and dialysis staff. Hepatogastroenterology 1992 Apr;39(2):161-5. Fukunishi I, Norris P, Fahrion S, Baer C, Porter R. A comparison of alexithymia in American and Japanese dialysis patients. Psychother Psychosom 1992;57(1-2):75—80. Fukunishi I, Saito S, Ozaki S. The influence of defense mechanisms on secondary alexithymia in hemodialysis patients. Psychother Psychosom 1992; 57(1-2):50-6. Gagne ER, Urena P, Leite-Silva S, Zingraff J, Chevalier A, Sarfati E, Dubost C, Drueke TB. Short- and long-term efficacy of total parathyroidectomy with immediate autografting compared with subtotal parathyroidectomy in hemodialysis patients. J Am Soc Nephrol 1992 Oct;3(4):1008-17. Gallar P, Vigil A, Oliet A, Ortega O, Guijo G. Intraperitoneal erythromycin for diabetic gastroparesis in CAPD. Perit Dial Int 1992;12(2): 265-6. Gallicano KD, Tobe S, Sahai J, McGilveray IJ, Cameron DW, Kriger F, Garber G. Pharmacokinetics of single and chronic dose zidovudine in two HIV positive patients undergoing continuous ambulatory peritoneal dialysis (CAPD). J Acquir Immune Defic Syndr 1992;5(3):242—50. Galpin C. Body image in end-stage renal failure. Br J Nurs 1992 Apr 23-May 13;1(1):21-3. Garcia-Maldonado M, Patterson D, Smith ZM. PTH levels correlate with mental performance in CAPD. Adv Perit Dial 1991;72234—6. Garcia-Martin F, De Arriba G, Carrascosa T, Moldenhauer F, Martin-Escobar E, Val J, Saiz F. Anticardiolipin antibodies and lupus anticoagulant in end-stage renal disease. Nephrol Dial Transplant 1991;6(8):543-7. Garred LI, Pretlac R. Mathematical modeling of erythropoietin therapy. ASAIO Trans 1991 Jul-Sep; 37(3):M457-9. Garzia F, Todor R, Scalea T. Continuous arteriovenous hemofiltration countercurrent dialysis (CAVH-D) in acute respiratory failure (ARDS). J Trauma 1991 Sep;31(9):1277-84; discussion 1284-5. Gault MH, Longerich L, Prabhakaran V, Purchase L. Ischemic heart disease, serum cholesterol, and apolipoproteins in CAPD. ASAIO Trans 1991 Jul-Sep;37(3):M513-4. Gaylin DS, Held PJ, Port FK, Hunsicker LG, Wolfe RA, Kahan BD, Jones CA, Agodoa LY. The impact of comorbid and sociodemographic factors on access to renal transplantation. JAMA 1993 Feb 3;269(5):603-8. 58 Gertz MA, Kyle RA, O’Fallon WM. Dialysis support of patients with primary systemic arnyloidosis. A study of 211 patients. Arch Intern Med 1992 Nov; 152(11): 2245-50. Giammaria U, De Meo F, Acitelli S, Tancredi M, Daniele M, Barnabei R, Maschio C. HCV infection in hemodialyzed patients: incidence and correlation with dialytic age. Nephron l992;61(3):335-6. Gilli P, Cavazzini L, Stabellini N, Malacame F, Soffritti S, Storari A. Histological features of non- A, non-B hepatitis in hemodialysis patients. Nephron 1992;61(3):296-7. Gladziwa U, Wagner S, Dakshinamurty KV, Bechtel B, Mann H, Sieberth HG. Intragastric long-term pH- metry in hemodialysis patients. A study with famotidine. Clin Nephrol 1991 Aug;36(2):97-102. Glass GE, Watson A], LeDuc JW, Kelen GD, Quinn TC, Childs JE. Infection with a ratbome hantavirus in US residents is consistently associated with hypertensive renal disease. J Infect Dis 1993 Mar; 167(3):614-20. Gokal R. Quality of life in patients undergoing renal replacement therapy. Kidney Int Suppl 1993 Feb; 40:S23-7. Gokal R, Rottembourg J, Friedman EA, Tzamaloukas AH, Becker GJ. Peritoneal dialysis in diabetic ESRD patients. Dial Transplant 1991;20(2):59—63, 66, 88. Gubertini G, Scorza D, Beccari M, Buccianti G, Costantino A, Spotti D, Graziani G. Prevalence of hepatitis C virus antibodies in hemodialysis patients in the area of Milan. Nephron l992;61(3):271-2. Gupta A, Yuan ZY, Balaslras EV, Khanna R, Oreopoulos DG. CAPD and pancreatitis: no connection. Perit Dial Int 1992;12(3):309-16. Hampl H, Steinmuller T, Stabell U, Klingenberg HI, Schnoy N, Neuhaus P. Recurrent hyperparathyroidism afier total parathyroidectomy and autotransplantation in patients with long-term hemodialysis. Miner Electrolyte Metab 1991;17(4): 256-60. Hampton JK. Long-term effects of hemodialysis in diabetic patients with end stage renal disease. ANNA J 1992 Oct;19(5):455-6. Hardy NM, Sandroni S, Danielson S, Wilson WJ. Antibody to hepatitis C virus increases with time on hemodialysis. Clin Nephrol 1992 Jul;38(l):44-8. Hiatt WR, Koziol BJ, Shapiro JI, Brass EP. Camitine metabolism during exercise in patients on chronic hemodialysis. Kidney Int 1992 Jun;41(6):1613-9. Hirschl MM, Heinz G, Sunder-Plassmann G, Derfler K. Renal replacement therapy in type 2 diabetic patients: 10 years’ experience. Am J Kidney Dis 1992 Dec;20(6):564-8. Hogg RJ. Acquired renal cystic disease in children prior to the start of dialysis. Pediatr Nephrol 1992 Mar;6(2):l76-8. Hokl J, Sobotova D, Filkuka J. The occurrence of anti- CMV and anti-HIV antibodies and HBsAG in kidney allografi recipient and haemodialysis patients. Scr Med (Brno) 1991;64(3):143-6. Holley J, Bernardini J, Piraino B. Catheter infections in insulin~dependent diabetics on continuous ambulatory peritoneal dialysis. Perit Dial Int 1991; 1 1(4) : 347-50. Hong SY, Yang DH, Lee BH, Ki EK, Chung KH. The urine urokinase concentration in end stage renal disease with acquired renal cyst. Korean J Intern Med 1991 Jul;6(2):64-8. Hoyer J, Schulte KL, Lenz T. Clinical pharmacokinetics of angiotensin converting enzyme (ACE) inhibitors in renal failure. Clin Pharmacokinet 1993 Mar;24(3):230-54. Hsieh TT, Chen KC, Cheng BJ, Chiu TH. Pregnancy outcome in patients undergoing long-term hemodialysis. Acta Obstet Gynecol Scand 1991; 70(4-5):299-302. Huting J. Predictive value of mitral and aortic valve sclerosis for survival in end-stage renal disease on continuous ambulatory peritoneal dialysis. Nephron 1993;64(1):63-8. Huting J. Progression of valvular sclerosis in end-stage renal disease treated by long-term peritoneal dialysis. Clin Cardiol 1992 Oct;15(10):745-50. Dson BE, Bland PS, Jorkasky DK, Shusterman N, Allison NL, Dubb JW, Parr GV, Goebel TK, Stote RM. Intraoperative versus routine hemodialysis in end-stage renal disease patients undergoing open- heart surgery. Nephron 1992;61(2):170-5. Inagaki Y, Amano I. Clinical effect of continuous gastric cooling for massive GI bleeding in uremia. Int J Artif Organs 1991 Mar;14(3):141-6. Inamoto H, Ozaki R, Matsuzalri T, Wakui M, Saruta T, Osawa A. Incidence and mortality patterns of malignancy and factors affecting the risk of malignancy in dialysis patients. Nephron 1991; 59(4):6ll-7. Innocenti M, Mazzoni A, Moretti A, Palla P. Comparison of anti-hepatitis C virus detection with ELISA assay and RIBA 4 in dialysis patients: our experience. Nephron l992;61(3):315. Ippolito E, Aterini S, Salvadori M, D’Elia G, Amato M. HCV incidence in a dialysis center: preliminary reports. Nephron l992;61(3):375-6. Ishikawa I. Acquired cystic disease: mechanisms and manifestations. Semin Nephrol 1991;ll(6):67l-84. Ishikawa I. Acquired renal cystic disease and its complications in continuous ambulatory peritoneal dialysis patients. Perit Dial Int 1992;12(3):292-7. Ishikawa I. Renal cell carcinoma in chronic hemodialysis patients — a 1990 questionnaire study in Japan. Kidney Int Suppl 1993;41:8167-9. Ishikawa I, Kovacs G. High incidence of papillary renal cell tumours in patients on chronic haemodialysis. I-Iistopathology 1993 Feb;22(2):l35—9. Ishikawa I, Shikura N, Nagahara M, Shinoda A, Saito Y. Comparison of severity of acquired renal cysts between CAPD and hemodialysis. Adv Perit Dial 1991;7:91-5. Ishitani M, Wilkowski M, Stevenson W, Pruett T. Outcome of patients requiring hemodialysis after liver transplantation. Transplant Proc 1993 Apr; 25(2): 1762-3 . Kemperman FA, van Leusen R, van Liebergen FJ, Oosting J, Boeschoten EW, Struijk DG, Krediet RT, Arisz L. Continuous ambulatory peritoneal dialysis (CAPD) in patients with diabetic nephropathy. Neth J Med 1991 Jun;38(5-6):236—45. Khan IH, Catto GR, Edward N, Fleming LW, Henderson IS, MacLeod AM. Influence of coexisting disease on survival on renal-replacement therapy. Lancet 1993 Feb 13;341(8842):415-8. Comment in: Lancet 1993 Feb 13;341(8842):412-3; Lancet 1993 Apr 10;341(8850):954; discussion. 955; Lancet 1993 Apr 10;341(8850):954-5. Khanna R. Dialysis considerations for diabetic patients. Kidney Int Suppl 1993;40:858-64. Ko W, Kreiger KH, Isom OW. Cardiopulmonary bypass procedures in dialysis patients. Ann Thorac Surg 1993 Mar;55(3):677-84. Koksal I, Biberoglu K, Biberoglu S, Koc F, Ayma Y, Aker F, Koksal H. Hepatitis C virus antibodies among risk groups in Turkey. Infection 1991 Jul-Aug;19(4):228-9. Kooman JP, Wijnen JA, Draaijer P, van Bortel LM, Gladziwa U, Peltenburg HG, Struyker-Boudier HA, van Hooff JP, Leunissen KM. Compliance and reactivity of the peripheral venous system in chronic intermittent hemodialysis. Kidney Int 1992 Apr; 41(4):1041-8. Kopple JD, Brunori G, Leiserowitz M, Mattirnore C, Hirschberg R. Growth hormone treatment for patients with renal failure. Nippon J inzo Gakkai Shi 1991 May;33(5):468-74. Korzets A, Chagnac A, Ori Y, Katz M, Zevin D. Subclavian vein stenosis, permanent cardiac 59 pacemakers and the haemodialysed patient. Nephron 1991;58(1):103-5. Korzets Z, Golan E, Nafiali T, Bernheim J. Peritoneal dialysis in the presence of a stoma. Perit Dial Int 1992;12(2):258-60. Kremer D, Munar MY, Kohlhepp SJ, Swan SK, Stinnett FA, Gilbert DN, Young EW, Bennett WM. Zidovudine pharmacokinetics in five HIV seronegative patients undergoing continuous ambulatory peritoneal dialysis. Pharmacotherapy 1992;12(1):56-60. Krzesinski JM, Du F, Rorive G. Intracellular cation concentrations in essential hypertension and chronic renal failure. Clin Exp Hypertens 1993;15(3): 461-78. Kusakari J, Hara A, Takeyama M, Suzuki S, Igari T. The hearing of the patients treated with hemodialysis: a long term follow-up study. Auris Nasus 'Larynx 1992;19(2):105—13. Kutner NG, Brogan DJ. Assisted survival, aging, and rehabilitation needs: comparison of older dialysis patients and age-matched peers. Arch Phys Med Rehabil 1992 Apr;73(4):309-15. Kutner NG, Brogan D, Fielding B, Hall WD. Older renal dialysis patients and quality of life. Dial Transplant 1991;20(4):171-5. Kutner NG, Cardenas DD, Bower JD. Rehabilitation, aging and chronic renal disease. Am J Phys Med Rehabil 1992 Apr;71(2):97-101. Kwan JT, Hart PD, Raftery MJ, Cunningham J, Marsh FP. Mycobacterial infection is an important infective complication in British Asian dialysis patients. J Hosp Infect 1991 Dec;19(4):249—55. La Russa A, Bufano G, Cauzzi L, Pecchini P. Non-A, non-B hepatitis: clinical laboratory course in patients on hemodialysis and its correlation with the presence of anti-hepatitis C virus antibodies. Nephron 1992;61(3):273-5. La Russa A, Bufano G, Cauzzi L, Pecchini P. Non-A, non-B hepatitis in patients on dialysis: retrospective evaluation of measures taken to limit the diffusion of the virus. Nephron 1992;61(3):333—4. Lai KN, Li PK, Woo KS, Lui SF, Leung JC, Law E, Nicholls MG. Vasoactive hormones in uremic patients on continuous ambulatory peritoneal dialysis. Clin Nephrol 1991 May;35(5):218-23. Lai KN, Wong KC, Li PK, Lui SF. Use of recombinant erythropoietin in thalassemic patients on dialysis. Am J Kidney Dis 1992 Mar;19(3): 239-45. Langley PG, Keays R, Hughes RD, Forbes A, Delvos U, Williams R. Antithrombin HI supplementation 60 reduces heparin requirement and platelet loss during hemodialysis of patients with fulminant hepatic failure. Hepatology 1991 Aug;14(2):251-6. Laupacis A, Muirhead N, Keown P, Wong C. A disease-specific questionnaire for assessing quality of life in patients on hemodialysis. Nephron 1992; 60(3):302-6. Published erratum appears in Nephron 1992;61(2):248. Lee BW, Yap HK, Tan M, Guan R, Quak SH, Choong L, Murugasu B, Woo KT, Jordan SC. Cell- mediated immunity in patients on hemodialysis: relationship with hepatitis B carrier status. Am J Nephrol 1991;11(2):98-101. Levine E, Slusher SL, Grantham JJ, Wetzel LH. Natural history of acquired renal cystic disease in dialysis patients: a prospective longitudinal CT study. AJR Am J Roentgenol 1991 Mar;156(3): 501-6. Lin DY, Lin HH, Huang CC, Liaw YF. High incidence of hepatitis C virus infection in hemodialysis patients in Taiwan. Am J Kidney Dis 1993 Mar; 21(3):288-91. Lin J L. Varicella pneumonitis in children with hemodialysis. Nephron 1992;61(4):481-2. Lind L, Wengle B, Lithell H, Ljunghall S. Reduction in serum alkaline phosphatase levels by treatment with active vitamin D (alphacalcidol) in primary and secondary hyperparathyroidism and in euparathyroid individuals. Scand J Urol Nephrol 1991;25(3): 233-6. Lombardi M, Pizzarelli F, Righi M, Cerrai T, Dattolo P, Nigrelli S, Michelassi S, Sisca S, Alecci A, Di Geronimo P, Maggiore Q. Hepatitis B vaccination in dialysis patients and nutritional status. Nephron 1992;61(3):266-8. Losito A. Essential hypertension and renal failure. Compr Ther 1991 Feb;17(2):20—5. Lowenthal DT, Saris SD, Paran E, Cristal N. The use of transdermal clonidine in the hypertensive patient with chronic renal failure. Clin Nephrol 1993 Jan; 39(1):37-43. Luke DR, Awni WM, Halstenson CE, Opsahl JA, Matzke GR. Bioavailability of labetalol in patients with end—stage renal disease. Ther Drug Monit 1992;14(3):203-8. Lundin AP. Measuring quality care in hemodialysis. Nephrol News Issues 1991 Feb;5(2):22, 30. MacGregor RR, Graziani AL, Weiss R, Grunwald JE, Gambertoglio JG. Successful foscamet therapy for cytomegalovirus retinitis in an AIDS patient undergoing hemodialysis: rationale for empiric dosing and plasma level monitoring. J Infect Dis 1991 Oct;164(4):785—7. Maheshwari HG, Rifkin I, Butler J, Norman M. Growth hormone binding protein in patients with renal failure. Acta Endocrinol (Copenh) 1992 Dec; 127(6):485-8. Mak RH. Amelioration of hypertension and insulin resistance by 1,25-dihydroxycholecalciferol in hemodialysis patients. Pediatr Nephrol 1992 Jul; 6(4):345-8. Mak RH. Intravenous 1,25 dihydroxycholecalciferol corrects glucose intolerance in hemodialysis patients. Kidney Int 1992 Apr;41(4):1049-54. Makita Z, Radoff S, Rayfield EJ, Yang Z, Skolnik E, Delaney V, Friedman EA, Cerami A, Vlassara H. Advanced glycosylation end products in patients with diabetic nephropathy. New Engl J Med 1991; 325(12):836-42. Mako J, Potyondi M. Use of Tensiomin in hypertensive patients with impaired renal function. Ther Hung 1992;40(1):20—4. Malaguti M, Capece R, Marciano M, Arena G, Luciani MP, Striano M, Biagini M. Antibodies to hepatitis C virus (anti-HCV): prevalence in the same geographical area in dialysis patients, staff members, and blood donors. Nephron 1992;61(3): 346. Malberti F, Surian M, Cosci P. Effect of chronic intravenous calcitn'ol on parathyroid function and set point of calcium in dialysis patients with refractory secondary hyperparathyroidism. Nephrol Dial Transplant 1992;7(8):822—8. Malberti F, Surian M, Cosci P. Improvement of secondary hyperparathyroidism and reduction of the set point of calcium after intravenous calcitriol. Kidney Int Suppl 1993 ;41:S125-30. Marangella M, Vitale C, Petrarulo M, Cosseddu D, Gallo L, Linari F. Pathogenesis of severe hyperoxalaemia in Crohn’s disease-related renal failure on maintenance haemodialysis: successful management with pyridoxine. Nephrol Dial Transplant 1992;7(9):960—4. Marchais SJ, Boussac I, Guerin AP, Delavaux G, Metivier F, London GM. Arteriosclerosis and antihypertensive response to calcium antagonists in end-stage renal failure. J Cardiovasc Pharmacol 1991;18 Suppl 52814-8. Marcus EL, Rudensky B, Sonnenblick M. Occult elevation of CK as a manifestation of rhabdomyolysis in the elderly. J Am Geriatr Soc 1992;40(5):454-6. Marcus R, Favero MS, Banerjee S, Solomon SL, Bell DM, Jarvis WR, Martone WJ. Prevalence and incidence of human immunodeficiency virus among patients undergoing long-term hemodialysis. Am J Med 1991;90(5):614-27. Marcus RG, Messana J, Swartz R. Peritoneal dialysis in end-stage renal disease patients with preexisting chronic liver disease and ascites. Am J Med 1992 Ju1;93(1):35-40. Markell MS, Friedman EA. Diabetic nephropathy. Management of the end-stage patient. Diabetes Care 1992 Sep;15(9):1226-38. Martin KJ, Ballal HS, Domoto DT, Blalock S, Weindel M. Pulse oral calcitriol for the treatment of hyperparathyroidism in patients on continuous ambulatory peritoneal dialysis: preliminary observations. Am J Kidney Dis 1992 Jun;19(6): 540-5. Martinez M, Ausejo M, Miguel JL, Gonzalez ML, Balaguer G, Catalan P, Selgas R. Comparative study between intact PTH and fragments of PTH in patients on hemodialysis and CAPD. Perit Dial Int 1991;11(2):137—40. Masumura H, Miki S, Kaifu Y, Kitajima W, Abe Y. Pharmacokinetics and efficacy of carvedilol in hypertensive patients with chronic renal failure and hemodialysis patients. J Cardiovasc Pharmacol 1992;19 Suppl 1:8102-7. Mayer DR, Kosmus W, Pogglitsch H, Mayer D, Beyer W. Essential trace elements in humans. Serum arsenic concentrations in hemodialysis patients in comparison to healthy controls. Biol Trace Elem Res 1993 Apr;37(1):27-38. Mazzoni A, Innocenti M, Consaga M. Retrospective study on the prevalence of B and non-A, non-B hepatitis in a dialysis unit: 17-year follow-up. Nephron 1992;61(3):316-7. Mazzotta L, Landucci G, Pfanner L, Carlini A, Angelini D, Giusti R, Antonelli A. Comparison between first and second generation tests to determine the frequency of anti-HCV antibodies in uremic patients in replacement dialytic therapy. Nephron 1992;61(3):354—5. McClellan WM, Anson C, Birkeli K, Tuttle E. Functional status and quality of life: predictors of early mortality among patients entering treatment for end stage renal disease. J Clin Epidemiol 1991; 44(1):83-9. Medici G, Depetri GC, Mileti M. Anti-hepatitis C virus positivity and clinical correlations in hemodialyzed patients. Nephron 1992;61(3):363-4. Meyer KB, Kurtin PS, Deoreo PB, Kaufman AM, Levin NW, Davies AR. Health-related quality of life (HBRQL) and clinical variables in hemodialysis patients [abstract]. J Am Soc Nephrol 1992;3(3): 379. Miki S, Masumura H, Kaifu Y, Yuasa S. Pharmacokinetics and efficacy of carvedilol in 61 chronic hemodialysis patients with hypertension. J Cardiovasc Pharmacol 1991;18 Suppl 4:862-8. Mioli VA, Balestra E, Bibiano L, Carletti P, Della Bella S, Fanciulli E, Gaffi G, Marinelli R, Perilli R, Ricciatti AM, et al. Epidemiology of viral hepatitis in dialysis centers: a national survey. Nephron 1992;61(3):278-83. Mitwalli A. Tuberculosis in patients on maintenance dialysis. Am J Kidney Dis 1991 Nov;18(5):579—82. Mitwalli A, al-Mohaya S, a1 Wakeel J, el Gamal H, Rotimi V, al-Zeben A, al-Aska A. Hepatitis C in chronic renal failure patients. Am I Nephrol 1992; 12(5):288-91. Mondelli MU, Cristina G, Piazza V, Cerino A, Villa G, Salvadeo A. High prevalence of antibodies to hepatitis C virus in hemodialysis units using a second generation assay. Nephron 1992;61(3): 350-1. Morachiello P, Landini S, Fracasso A, Righetto F, Scanferla F, Toffoletto P, Genchi R, Bazzato G. Combined hemodialysis-hemoperfusion in the treatment of secondary hyperparathyroidism of uremic patients. Blood Purif 1991;9(3):148-52. Morales Otero LA, Molina M, Gonzalez ZA. Incidence and fate of HIV-positive dialysis and transplant patients. Transplant Proc 1991;23(2):1841-2. Moriniere P, El Esper N, Viron B, Judith D, Bourgeon B, Farquet C, Gheerbrant J, Chapuy MC, Van Orshoven A, Pamphile R, Fournier A. Improvement of severe secondary hyperparathyroidism in dialysis patients by intravenous lalpha(OH) vitamin D3, oral CaCO3 and low dialysate calcium. Kidney Int Suppl 1993; 41:8121-4. Mosconi G, Campieri C, Miniero R, Coli L, Orsi C, La Manna G, De Sanctis LB, Stefoni S, Sprovieri G, Bonomini V. Epidemiology of hepatitis C in a population of hemodialysis patients. Nephron 1992; 61(3):298-9. Muirhead N, Churchill DN, Goldstein M, Nadler SP, Posen G, Wong C, Slaughter D, Laplante P. Comparison of subcutaneous and intravenous recombinant human erythropoietin for anemia in hemodialysis patients with significant comorbid disease. Am J Nephrol 1992;12(5):303-10. Muthny FA, Koch U. Quality of life of patients with end-stage renal failure. A comparison of hemodialysis, CAPD, and transplantation. Contrib Nephrol 1991;89:265-73. Nannery WM, Stoldt HS, Fares LG 2d. Hemodialysis access operations performed upon patients with human immunodeficiency virus. Surg Gynecol Obstet 1991 Nov;173(5):387-90. 62 Navarro I, Serrano C, Donna E, Perez GO. Disordered breathing patterns during bicarbonate hemodialysis in COPD. Effect of cuprophane versus polysulfone membranes. ASAIO I 1992 Oct-Dec;38(4):811-4. Nelson CB, Port FK, Wolfe RA, Guire KE. Comparison of continuous ambulatory peritoneal dialysis and hemodialysis patient survival with evaluation of trends during the 1980s. I Am Soc Nephrol 1992 Nov;3(5):ll47-55. Ng YY, Lee SD, Wu SC, Liu WT, Chia WL, Huang TP. The need for second-generation antihepatitis C virus testing in uremic patients on continuous ambulatory peritoneal dialysis. Perit Dial Int 1993; 13(2):132-5. Ng YY, Lee SD, Wu SC, Yang WC, Chiang SS, Huang TP. Antibodies to hepatitis C virus in uremic patients on continuous ambulatory peritoneal dialysis. J Med Virol 1991 Dec;35(4):263-6. Nicolucci A, Cubasso D, Labbrozzi D, Mari E, Impicciatore P, Procaccini DA, Forcella M, Stella I, Querques M, Pappani A, et al. Effect of coexistent diseases on survival of patients undergging dialysis. ASAIO J 1992 Iul-Sep;38(3): M291- . Nissenson AR. Chronic peritoneal dialysis in the elderly. Geriatr Nephrol Urol 1991;1(1):3-12. Nissenson AR. Dialysis therapy in the elderly patient. Kidney Int Suppl 1993 Feb;40:SSl-7. Niu MT, Alter MJ, Kristensen C, Margolis HS. Outbreak of hemodialysis-associated non-A, non-B hepatitis and correlation with antibody to hepatitis C virus. Am J Kidney Dis 1992;19(4):345-52. Niutta A, Scorcia G, Princi P, Palombi E, Perilli R, Mannino G, Balacco Gabrieli C. Visual disturbances associated with primary empty sella syndrome in patients with chronic renal failure. Ann Ophthalmol 1992 Feb;24(2):56-63. Oddone EZ, Cowper PA, Hamilton JD, Feussner IR. A cost-effectiveness analysis of hepatitis B vaccine in predialysis patients. Health Serv Res 1993 Apr; 28(1):97—121. O’Doherty MJ, Breen D, Page C, Barton I, Nunan TO. Lung 99mTc DTPA transfer in renal disease and pulmonary infection. Nephrol Dial Transplant 1991; 6(8):582-7. Oguchi H, Miyasaka M, Tokunaga S, Hora K, Ichikawa S, Ochi T, Yamada K, Nagasawa M, Kanno Y, Aizawa T, et al. Hepatitis virus infection (HBV and HCV) in eleven Japanese hemodialysis units. Clin Nephrol 1992 Ju1;38(l):36-43. Oliva JA, Maymo RM, Car'rio J, Delgado O, Mallafre J M. Late seroconversion of C virus markers in hemodialysis patients. Kidney Int Suppl 1993;41: 5153-6. Pachon J, Cisneros J M, Castillo JR, Garcia-Pesquera F, Canas E, Viciana P. Pharmacokinetics of zidovudine in end-stage renal disease: influence of haemodialysis. AIDS 1992 Aug;6(8):827-30. Comment in: AIDS 1993 Jan;7(1):141-2. Pannekeet MM, Krediet RT, Boeschoten EW, Arisz L. Acute pancreatitis in patients on CAPD treatment. Kidney Int 1992;42(5):1287. Parfrey PS, Harnett ID, Barre PB. The natural history of myocardial disease in dialysis patients. J Am Soc Nephrol 1991 Jul;2(1):2—12. Park H, Bang WR, Kim SJ, Kim ST, LeeJS, Kim S, Han JS. Quality of life of ESRD patients: development of a tool and comparison between transplant and dialysis patients. Transplant Proc 1992 Aug;24(4):1435-7. Park YM, Kim IS, Lee CD, Kim BS. Seroprevalence of antibody against hepatitis C virus (anti-HCV) in various groups of individuals in Korea. Gastroenterol Jpn 1991;26 Suppl 3:159-63. Parsons V, Baldwin D, Moniz C, Marsden J, Ball E, Rifkin I. Successful control of hyperparathyroidism in patients on continuous ambulatory peritoneal dialysis using magnesium carbonate and calcium carbonate as phosphate binders. Nephron 1993; 63(4):379-83. Pasqualini T, Zantleifer D, Balzaretti M, Granillo E, Fainstein—Day P, Ramirez J, Ruiz S, Gutman R, Fen-aria J. Evidence of hypothalamic-pituitary thyroid abnormalities in children with end-stage renal disease. J Pediatr 1991 Jun;118(6):873-8. Comment in: J Pediatr 1991 Jun;118(6):896—8. Pauri P, Salvoni G, Vitolo W, Carletti P, Fanciulli E, Ricciatti AM, Della Bella S, Mioli VA. Risk factors and clinical expression of HCV infection in hemodialysis patients. Nephron 1992;6l(3):313—4. Peterson RA, Kimmel PL, Sacks CR, Mesquita ML, Simmens SJ, Reiss D. Depression, perception of illness and mortality in patients with end-stage renal disease. Int J Psychiatry Med 1991;21(4):343-54. Petrarulo F, Maggi P, Sacchetti A, Pallotta G, Dagostino F, Basile C. HCV infection occupational hazard at dialysis units and virus spread, among relatives of dialyzed patients. Nephron 1992;61(3): 302-3. Piccoli G, Bonello F, Massara C, Salomone M, Maffei S, Iadarola GM, Stramignoni E, Rosati C, Borca M, Belardi P, Quarello F, Piccoli G, Vercellone A. Death in conditions of cachexia: the price for the dialysis treatment of the elderly? Kidney Int Suppl 1993;41:8282—6. Pizzarelli F, Fabrizi F, Postorino M, Curatola G, Zoccali C, Maggiore Q. Parathyroidectomy and blood pressure in hemodialysis patients. Nephron 1993;63(4):384—9. Pluvio M, Saggese A, Cirillo D, Castellino P, Pempinello R, Iannece MD, Guarnaccia D, Tassinaro P, Pluvio C, Cicchella T, et al. Hepatitis C virus-related acute and chronic hepatitis in hemodialysis patients. Nephron 1992;61(3):322—3. Poch E, Almirall J, Alsina M, del Rio R, Cases A, Revert L. Calciphylaxis in a hemodialysis patient: appearance afler parathyroidectomy during a psoriatic flare. Am J Kidney Dis 1992 Mar;l9(3): 285-8. Ponz E, Campistol JM, Barrera JM, Gil C, Pinto J, Andreu J, Bruguera M. Hepatitis C virus antibodies in patients on hemodialysis and after kidney transplantation. Transplant Proc 1991 Feb; 23(1 Pt 2):1371-2. Portigliatti Barbos M, Cadario A, Canavese C, Pavan I. Clinical, histological, and chemical characterization of ectopic calcification in dialde and non-dialyzed patients. Ital J Orthop Traumatol 1991 Dec;17(4): 523-32. Raccosta G, Merletti MG, Lisi E, Ciccarelli P, Trivelli G, Capponi E. Prevalence of hepatitides in our hemodialyzed population. Nephron 1992;61(3): 300-1. Rahman MM, Caglayan F, Rahman B. Periodontal health parameters in patients with chronic renal failure and renal transplants receiving immunosuppressive therapy. J Nihon Univ Sch Dent 1992 Dec;34(4):265-72. Reinberg Y, Matas A, Manivel JC, Gonzalez R, Gillingham KJ, Pryor IL. Outcome of renal transplantation or dialysis in patients with a history of renal cancer. Cancer 1992;70(6):1564-7. Reusscr LM, White HJ, Sexson R, Osborn LA, Crawford MH. Increased morbidity following coronary angioplasty in chronic hemodialysis patients. Clin Res 1993;41(1):12a. Reyes A, Turchetto E, Bernis C, Cereijo E. Acid-base derangements during sorbent regenerative hemodialysis in mechanically ventilated patients. Crit Care Med 1991 Apr;19(4):554-9. Rizzoni G, Ehrich J H, Broyer M, Brunner FP, Brynger H, Fassbinder W, Geerlings W, Selwood NH, Tufveson G, Wing AJ. Rehabilitation of young adults during renal replacement therapy in Europe. 1. The presence of disabilities. Nephrol Dial Transplant 1992;7(7):573-8. Rizzoni G, Ehrich JH, Broyer M, Brunner FP, Brynger H, Fassbinder W, Geerlings W, Selwood NH, Tufveson G, Wing A]. Successful pregnancies in 63 women on renal replacement therapy: report from the EDTA Registry. Nephrol Dial Transplant 1992; 7(4):279—87. Rosansky SJ, Jackson K. Rate of change of end-stage renal disease treatment incidence 197 8-1987--has there been selection? I Am Soc Nephrol 1992 Apr; 2(10):lSUZ—6. Roy LF, Dufresne LR, Legault L, Long H, Morin C. Acetazolamide in hemodialysis patients: a rational use after ocular surgery. Am J Kidney Dis 1992 Dec;20(6):650-2. Rubin I, Hsu H. Continuous ambulatory peritoneal dialysis: ten years at one facility. Am J Kidney Dis 1991 Feb;17(2):165—9. Ruedin P, Pechere Bertschi A, Chapuis B, Benedet P, Leski M. Safety and efficacy of recombinant human erythropoietin treatment of anaemia associated with multiple myeloma in haemodialysed patients. Nephrol Dial Transplant 1993;8(4):315-8. Sakamoto N, Enomoto N, Marumo F, Sato C. Prevalence of hepatitis C virus infection among long-term hemodialysis patients: detection of hepatitis C virus RNA in plasma. J Med Virol 1993 Jan;39(1):11-5. Salunkhe PN, Naik SR, Semwal SN, Naik S, Kher V. Prevalence of antibodies to hepatitis C virus in HBsAg negative hemodialysis patients. Indian J Gastroenterol 1992 Oct;11(4):164-5. Sasagawa I, Terasawa Y, Imai K, Sekino H, Takahashi H. Acquired cystic disease of the kidney and renal carcinoma in haemodialysis patients: ultrasonographic evaluation. Br J Urol 1992 Sep; 70(3):236—9. Sasagawa I, Terasawa Y, Ishizaki M, Takahashi H, Suzuki K, Imai K, Nakada T. Comparison of ultrasonography, computerized tomography and angiography in dialysis patients with renal cell carcinoma. Urol Int 1992;49(4):206-10. Schloth T, Genabe I, Pilgrim W, Jorden A, Fein PA, Avram MM. Peritonitis and the patient with human immunodeficiency virus (HIV). Adv Perit Dial 1992;8z250-2. Schmid C, Ziemer G, Laas J, Borst HG. Open-heart surgery in patients requiring chronic hemodialysis. Scand J Thorac Cardiovasc Surg 1992;26(2): 97-100. Schmidt RI, Cruz C, Dumler F. Effective continuous ambulatory peritoneal dialysis following abdominal aortic aneurysm repair. Perit Dial Int 1993;13(1): 40-4. Schneider MS, Friend R, Whitaker P, Wadhwa NK. Fluid noncompliance and symptomatology in end- stage renal disease: cognitive and emotional variables. Health Psychol 1991;10(3):209—15. Schulman SL, Defuest A, Kaiser BA, Polinsky MS, Baluarte HJ. Response to measles-mumps—rubella vaccine in children on dialysis. Pediatr Nephrol 1992 Mar;6(2):187—9. Scipioni F, Di Filippo L, Maccarone M, Viola D, Ruzzi L, Terlizzi R. HCV in a group of chronic hemodialysis patients. Nephron 1992;61(3):362. Scopelite JA. Dietary modifications: impact on diabetic nephropathy. ANNA J 1992 Oct;l9(5):447-52 Scotto G, Savastano AM, Forcella M, Tantimonaco G, Amato G, Salatino G, Pappani A, Stella I. HCV infections in dialysis pflients. Nephron 1992;61(3): 320-1. Sennesael I, Verbeelen D, Vanhaelst L, Pirola R, Bareggi SR. Pharmacokinetics of intravenous and oral chlordesmethyldiazepam in patients on regular haemodialysis [published erratum appears in Eur J Clin Pharmacol 1991;41(4):386]. Eur J Clin Pharmacol 1991;41(1):65-8. Sheikh F, Khubchandani IT, Rosen L, Sheets JA, Stasik I]. Is anorectal surgery on chronic dialysis patients risky? Dis Colon Rectum 1992;35(1):56-8. Singlas E, Taburet AM, Lebas FB, De Curzon 0P, Sobel A, Chauveau P, Viron B, Khayat RA, Poignet JL, Mignon F, Humbert G, Fillastre JP. Didanosine pharmacokinetics in patients with normal and impaired renal function: influence of hemodialysis. Antimicrob Agents Chemother 1992; 36(7):1519—24. Sitter T, Spannagl M, Schiffl H. Anticardiolipin antibodies and lupus anticoagulant in patients treated with different methods of renal replacement therapy in comparison to patients with systemic lupus erythematosus. Ann Hematol 1992 Aug;65(2): 79-82. Smetana Z, Leventon—Kriss S, Broide A, Iedwab M, Smetana SS. Varicella—zoster virus immune status in CAPD and chronic hemodialysis patients. Am I Nephrol 1991 ; 1 1(3) 2229-36. Solhaug MJ, Adelman RD, Chan J C. Hypertension in the child with chronic renal insufficiency or undergoing dialysis. Child Nephrol Urol 1992; 12(2-3):133-8 . Spiegel DM, Anderson M, Campbell U, Hall K, Kelly G, McClure E, Breyer JA. Serum albumin: a marker for morbidity in peritoneal dialysis patients. Am J Kidney Dis 1993 Jan;21(1):26—30. Spisni C, Stingone A, Di Vito R, Rondinella I, D’Amario C, Tucci E, Caravelli L, D’Angelo B, Cerasoli P. Serum epidemiological trial on the prevalence of the anti-cytomegalovirus antibodies in patients under substitutive treatment with hemodialysis and CAPD. Nephron 1992;61(3): 373-4. Stratta RJ, Taylor R], Ozaki CF, Bynon J S, Miller SA, Knight TF, Fischer JL, Neumann TV, Wahl TO, Duckworth WC, et al. A comparative analysis of results and morbidity in type I diabetics undergoing preemptive versus postdialysis combined pancreas- kidney transplantation. Transplantation 1993 May; 55(5):1097-103. Takahashi C, Ujihara N, Babazono T, Yokoyama H, Nakanishi K, Tomonaga O, Sanaka T, Hirata Y. Analysis of the clinical course of 130 Japanese non- insulin—dependent diabetic patients undergoing dialysis. J Diabet Complications 1991 Apr-Sep; 5(2-3):171-2. Thompson TI, Fisher M, Hatfield PI, Morrison RB, Neale TI. Diabetic end stage renal failure--the Wellington experience 1975-1988. Aust N Z J Med 1991 Feb;21(l):29—35. Tomson CR. Renal replacement therapy for patients with diabetes. Pract Diabetes 1992;9(6):224-9. Tsobanelis T, Kurz P, Hoppe D, Schoeppe W, Vlachojannis J. Hemodialysis and CAPD in diabetic patients. Contrib Nephrol 1991;89:248-53. Tucker CM, Ziller RC, Smith WR, Mars DR, Coons MP. Quality of life of patients on in-center hemodialysis versus continuous ambula peritoneal dialysis. Perit Dial Int 1991;11(4):341-6. Comment in: Perit Dial Int 1992;12(2):264~5. Tzamaloukas AH, Avasthi PS. Hypoglycemia during hemodialysis in diabetics treated with insulin. Nephron 1992;61(4):470-1. Tzamaloukas AH, Murata GH, Eisenberg B, Murphy G, Avasthi PS. Hypoglycemia in diabetics on dialysis with poor glycemic control: hemodialysis versus continuous ambulatory peritoneal dialysis. Int J Artif Organs 1992 Jul;15(7):390—2. Tzamaloukas AH, Murata GH, Harford AM, Sena P, Zager PG, Eisenberg B, Wood B, Simon D, Goldman RS, Kanig SP, et a1. Hand gangrene in diabetic patients on chronic dialysis. ASAIO Trans 1991 Oct-Dec;37(4):638-43. Tzamaloukas AH, Oreopoulos DG. Subcutaneous versus intraperitoneal insulin in the management of diabetics on CAPD: a review. Adv Perit Dial 1991; 7:81-5. Tzamaloukas AH, Yuan ZY, Balaskas E, Oreopoulos DG. CAPD in end stage patients with renal disease due to diabetes mellitus--an update. Adv Perit Dial 1992;8zl85-91. Vandelli L, Medici G, Savazzi AM, De Palma M, Vecchi C, Zanchetta G, Lusvarghi E. Behavior of antibody profile against hepatitis C virus in patients on maintenance hemodialysis. Nephron 1992;61(3): 260-2. Weinrauch LA, D'Elia IA, Gleason RE, Hampton LA, Smith-Ossman S, DeSilva RA, Nesto RW. Usefulness of left ventricular size and function in predicting survival in chronic dialysis patients with diabetes mellitus. Am J Cardiol 1992 Aug 1;70(3): 300-3. Willems M, de Jong G, Moshage H, Verresen L, Goubau P, Desmyter J, Yap SH. Surrogate markers are not useful for identification of HCV carriers in chronic hemodialysis patients. J Med Virol 1991 Dec;35(4):303-6. Windus DW, Jendrisak MD, Delmez IA. Prosthetic fistula survival and complications in hemodialysis patients: effects of diabetes and age. Am J Kidney Dis 1992 May;19(5):448-52. Wizemann V, Kaufmann J, Kramer W. Effect of erythropoietin on ischemia tolerance in anemic hemodialysis patients with confirmed artery disease. Nephron 1992;62(2):161-5. Yaqoob M, Ahmad R, McClelland P, Terry E. Continuous ambulatory peritoneal dialysis in blind diabetic patients. Dial Transplant 1992;21(2):65, 68-9, 108. Yaqoob M, McClelland P, Bell GM, Ahmad R, Bakran A. Bladder tumours in paraplegic patients on renal replacement therapy. Lancet l992;338(8782-8783): 1554-5. Yoshida CF, Takahashi C, Gaspar AM, Schatzmayr HG, Ruzany F. Hepatitis C virus in chronic hemodialysis patients with non-A, non-B hepatitis. Nephron 1992;60(2):150-3. Zeferos N, Digenis GE, Christophoraki M, Alexopoulos I, Kostakis A, Gyflaki H, Moulopoulos S. Tumor markers in patients undergoing hemodialysis or kidney transplantation. Nephron 1991;59(4):618-20. Zoccali C, Mallamaci F, Ciccarelli M, Parlongo S, Salnitro F. The influence of autonomic failure on plasma ANF concentration in uremic pmients on chronic hemodialysis. Clin Nephrol 1992 Apr; 37(4): 198-203 . 65 COMPLICATIONS 0F DIALYSIS Anemia and Erythropoietin ~Clinical Trials Abraham PA, Macres MG. Blood pressure in hemodialysis patients during amelioration of anemia with erythropoietin. J Am Soc Nephrol 1991 Oct; 2(4):927-36. Barany P, Freyschuss U, Pettersson E, Bergstrom J. Treatment of anaemia in haemodialysis patients with erythropoietin: long-term effects on exercise capacity. Clin Sci (Colch) 1993 Apr;84(4):441-7. De Marchi S, Cecchin E. Hepatic computed tomography for monitoring the iron status of haemodialysis patients with haemosiderosis treated with recombinant human erythropoietin. Clin Sci 1991 Jul;81(1):113-21. Effect of recombinant human erythropoietin therapy on blood pressure in hemodialysis patients. Canadian Erythropoietin Study Group. Am J Nephrol 1991; 11(1):23-6. Granolleras C, Leskopf W, Shaldon S, Fourcade J. Experience of pain after subcutaneous administration of different preparations of recombinant human erythropoietin: a randomized, double-blind crossover study. Clin Nephrol 1991 Dec;36(6):294—8. Laupacis A. A randomized double-blind study of recombinant human erythropoietin in anaemic hemodialysis patients. Canadian Erythropoietin Study Group. Transplant Proc 1991 Apr;23(2): 1825-6. Laupacis A, Wong C, Churchill D. The use of generic and specific quality-of—life measures in hemodialysis patients treated with erythropoietin. The Canadian Erythropoietin Study Group. Controlled Clin Trials 1991 Aug;12(4 Suppl):168S-l79S. Muirhead N, Laupacis A, Wong C. Erythropoietin for anaemia in haemodialysis patients: results of a maintenance study (the Canadian Erythropoietin Study Group). Nephrol Dial Transplant 1992;7(8): 811-6. Nissenson AR. National cooperative rHu erythropoietin study in patients with chronic renal failure: a phase IV multicenber study. Report of National Cooperative rHu Erythropoietin Study Group. Am J Kidney Dis 1991 Oct;l8(4 Suppl l):24-33. Sheingold S, Churchill D, Muirhead N, Laupacis A, Labelle R, Goeree R. The impact of recombinant human erythropoietin on medical care costs for hemodialysis patients in Canada. Soc Sci Med 1992 May;34(9):983-91. 66 Slingeneyer A, Faller B, Laroche B, Ehmer B, Mion C. Self-administered daily subcutaneous recombinant human erythropoietin: an open randomised dose- finding study in ESRD patients receiving peritoneal dialysis. Contrib Nephrol 1991;88:159-68. -0ther Acchiardo SR, Moore LW, Sargent IA, Burk LB. Is hematologic response to iron and erythropoietin in hemodialysis patients affected by other factors? ASAIO Trans 1991 Jul-Sep;37(3):M183-5. Acchiardo SR, Quinn BP, Moore LW, Burk LB, Miles DE. Evaluation of hemodialysis patients treated with erythropoietin. Am J Kidney Dis 1991 Mar; 17(3):290-4. Adair C, Lappin TR, Cotes PM. Changes in concentrations of ATP and other nucleotides in erythrocytes during erythropoietin treatment in haemodialysis patients. Biochem Soc Trans 1992; 20(2):93s. Adamson J W. Erythropoietin: its role in the regulation of erythropoiesis and as a therapeutic in humans. Biotechnology 1991;19:351-615. Allegra V, Mengozzi G, Vasile A. Iron deficiency in maintenance hemodialysis patients: assessment of diagnosis criteria and of three different iron treatments. Nephron 1991;57(2):175—82. Anderson S. Effects of erythropoietin in predialysis patients. Am J Kidney Dis 1991 May; 17(5 Suppl 1):103-6. Andre M, Ferster A, Toppet M, Fondu P, Dratwa M, Bergmann P. Performance of an immunoradiometric assay of erythropoietin and results for specimens from anemic and polycythemic patients. Clin Chem 1992 May;38(5):758-63. Auer J, Simon G, Stevens J, Griffiths P, Howarth D, Anastassiades E, Gokal R, Oliver D. Quality of life improvements in CAPD patients treated with subcutaneously administered erythropoietin for anemia. Perit Dial Int 1992;12(1):40-2. Aunsholt NA, Ahlbom G, Steffensen G, Glud T. Fibrinolytic capacity in hemodialysis patients treated with recombinant human erythropoietin. Nephron 1992;62(3):284-8. Azzadin A, Bialkowska A, Buczko W, Malyszko J, Kalinowski M, Mysliwiec M. Serotonergic mechanism of erythropoietin-induced hypertension. Nephrol Dial Transplant 1992;7(8):882-3. Bahlmann J, Schoter KH, Scigalla P, Gurland HJ, Hilfenhaus M, Koch KM, Muthny FA, Neumayer HH, Pommer W, Quelhorst E, et al. Morbidity and mortality in hemodialysis patients with and without erythropoietin treatment: a controlled study. Contrib Nephrol 1991;88:90—106. Bailie GR, Plitnick R, Eisele G, Clement C, Rasmussen R. Experience with subcutaneous erythropoietin in CAPD patients. Adv Perit Dial l991;7:292—5. Baj Z, Pokoca L, Majewska E, Luciak M, Tchorzewski H. T lymphocyte subsets and NK cell cytotoxicity in chronic hemodialysis patients. The effect of recombinant human erythropoietin (rHu—EPO) treatment. Arch Immunol Ther Exp (Warsz) 1992; 40(3-4):201-6. Bajo MA, Selgas R, Miranda B, Fernandez-Zamorano A, Borrego F, Romero JR, Caparros G, Rinon C, Sanchez Sicilia L. Medium term response to H—R erythropoietin in CAPD patients: the influence of erythropoietin plasmatic levels and the effects on peritoneal transport capacity. Adv Perit Dial 1991; 7:296-300. Ballal SH, Domoto DT, Polack DC, Marciulonis P, Martin KJ. Androgens potentiate the effects of erythropoietin in the treatment of anemia of end- stage renal disease. Am J Kidney Dis 1991 Jan;17(1):29-33. Comment in: Am J Kidney Dis 1991 Jul;18(1):143; Am J Kidney Dis 1992 Jan; 19(1):94. Barany P, Fehrman I, Godoy C. Long-term effects on lymphocytotoxic antibodies and immune reactivity in hemodialysis patients treated with recombinant human erythropoietin. Clin Nephrol 1992 Feb; 37(2):90-6. Barany P, Pettersson E, Ahlberg M, Hultman E, Bergstrom J. Nutritional assessment in anemic hemodialysis patients treated with recombinant human erythropoietin. Clin Nephrol 1991 Jun; 35(6):270-9. Bergstrom J. New aspects of erythropoietin treatment. Aten Primaria 1993 Apr 30;11(7):445-62. Bergstrom J. New aspects of erythropoietin treatment. J Intern Med 1993 Jun;233(6):445—62. Berns J S, Rudnick MR, Cohen RM. A controlled trial of recombinant human erythropoietin and nandrolone decanoate in the treatment of anemia in patients on chronic hemodialysis. Clin Nephrol 1992 May;37($:264—7. Besarab A, Besarab FM, Miller D. Effects of dialysis factors and route of administration on response of hemodialysis patients to recombinant human erythropoietin. ASAIO Trans 1991 Jul-Sep;37(3): M181-2. Besarab A, Flaharty KK, Erslev A], McCrea JB, Vlasses PH, Medina F, Caro J, Morris E. Clinical pharmacology and economics of recombinant human erythropoietin in end-stage renal disease: the case for subcutaneous administration. I Am Soc Nephrol 1992 Mar;2(9):1405—16. Besarab A, Golper TA. Response of continuous peritoneal dialysis patients to subcutaneous recombinant human erythropoietin differs from that of hemodialysis patients. ASAIO Trans 1991 Jul-Sep;37(3):M395—6. Besarab A, McCrea J B. Evolution of recombinant human erythropoietin usage in clinical practice in the United States. Is there an optimal way to use rHuEPO? ASAIO J 1993 Jan-Mar;39(1):11-8. Bianchetti MG, Hammerli I, Roduit C, Neuhaus TJ, Leumann EP, Oetliker OH. Epoetin alfa in anaemic children or adolescents on regular dialysis. Eur J Pediatr 1991 May;150(7):509—12. Binkley LS. Management of the chronic renal failure patient receiving epoetin alfa for the treatment of anemia. Transplant Proc 1991 Apr;23(2):1831-2. Binkley LS. Vascular access thrombosis in epoetin alfa therapy. ANNA J 1991 Dec;18(6):540. Bommer J. Response to EPO therapy. Przegl Lek 1992; 49(1-2):36-7 . Bozfakioglu S, Alptekin N, Seckin S, Ark E, Kocak— Toker N. Red cell lipid peroxidation and antioxidant system in chronic renal failure patients treated with recombinant human erythropoietin. Nephron 1992;61(2):228-9. Braun A, Ding R, Seidel C, Fies T, Kurtz A, Scharer K. Pharmacokinetics of recombinant human erythropoietin applied subcutaneously to children with chronic renal failure. Pediatr Nephrol 1993; 7(1):61-4. Brown J M. Nursing care of predialysis patients receiving epoetin alfa. ANNA J 1991 Jun;18(3): 306-14. Brown WS, Marsh JT, Wolcott D, Takushi R, Carr CR, Higa J, Nissenson AR. Cognitive function, mood and P3 latency: effects of the amelioration of anemia in dialysis patients. Neuropsychologia 1991; 29(1):35-45. Brunati C, Cappellini MD, De Feo T, Stefanoni I, Civati G, Ballerini L, Fiorelli G, Minetti L. Circulating burst-forming—unit erythroid and the responsiveness to recombinant human erythropoietin in patients on regular hemodialytic treatment. Nephron 1992;62(2)2150-4. Brunier G, Graydon J. The relationship of anemia, nonspecific uremic symptoms, and physical activity to fatigue in patients with end stage renal disease on hemodialysis. ANNA J 1992 Apr;19(2):157. Buemi M, Allegra A, Aloisi C, Frisina N. Influence of therapy with recombinant erythropoietin on serum 67 levels of neopterin in hemodialyzed subjects. Am J Nephrol 1991;11(4):281-3. Campos A, Garin EH. Therapy of renal anemia in children and adolescents with recombinant human erythropoietin (rHuEPO). Clin Pediatr (Phila) 1992 Feb;31(2):94-9. Carmella G, La Carma G, Sandrini M, Gaggiotti M, Nordio G, Movilli E, Mombelloni S, Visioli 0, Maiorca R. Reversal of left ventricular hypertrophy following recombinant human erythropoietin treatment of anaemic dialysed uraemic patients. Nephrol Dial Transplant 1991;6(1):3l-7. Carletti P, Bibiano L, Boggi R, Taruscia D, Mioli V. Does anemia correction by rHuEPO improve uremic cardiopathy? Kidney Int Suppl 1993,41: S70-1. Carlini R, Obialo CI, Rothstein M. Intravenous erythropoietin (rHuEPO) administration increases plasma endothelin and blood pressure in hemodialysis patients. Am J Hypertens 1993 Feb; 6(2):103-7. Carlini RG, Dusso AS, Obialo CI, Alvarez UM, Rothstein M. Recombinant human erythropoietin (rHuEPO) increases endothelin-l release by endothelial cells. Kidney Int 1993;43(5):10104. Chan PC, Liu P, Cronin C, Heathcote J, Uldall R. The use of nuclear magnetic resonance imaging in monitoring total body iron in hemodialysis patients with hemosiderosis treated with erythropoietin and phlebotomy. Am J Kidney Dis 1992 May;19(5): 484-9. Cheng IK, Cy C, Chan MK, Yu L, Fang GX, Wei D. Correction of anemia in patients on continuous ambulatory peritoneal dialysis with subcutaneous recombinant erythropoietin twice a week: a long- term study. Clin Nephrol 1991 May;35(5):207-12. Cheung AK, Hohnholt M, Leypoldt JK, DeSpain M. Hemodialysis membrane biocompatibility: the case of erythropoietin. Blood Purif 1991;9(3):153-63. . Conlon PJ, Walshe JJ, O’Donnell R, O’Donohoe A, Spencer R, Donohoe J, Carmody M. The use of recombinant human erythropoietin in end stage renal disease. Ir J Med Sci 1993 Jan;162(1):17-9. Costagliola C, Romano L, Scibelli G, de Vincentiis A, Sorice P, Di Benedetto A. Anemia and chronic renal failure: a therapeutical approach by reduced glutathione parenteral administration. Nephron 1992;61(4):404-8. Cremagnani L, Cantalamessa L, Orsatti A, Vigna L, Vallino F, Buccianti G. Recombinant human erythropoietin (rhEPO) treatment potentiates growth hormone (GH) response to growth hormone releasing hormone (GI-IRH) stimulation in 68 hemodialysis patients. Clin Nephrol 1993;39(5): 282-6. Davenport A, King RF, Ironside JW, Will EJ, Davison AM. The effect of treatment with recombinant human erythropoietin on the histological appearance and glycogen content of skeletal muscle in patients with chronic renal failure treated by regular hospital haemodialysis. Nephron 1993;64(1):89—94. Davenport A, Will EJ, Khanna SK, Davison AM. Blood lactate is reduced following successful treatment of anaemia in haemodialysis patients with recombinant human erythropoietin both at rest and afier maximal exertion. Am J Nephrol 1992;12(5): 357-62. De Santo NG, Manzo M, Raiola P, Lanzetti N, Capasso G, Ficociello R, Anastasia P, Esposito R. Failure of blood pressure to increase following erythropoietin therapy in the renoprival status. Int J Artif Organs 1992 Mar;15(3):144-6. Di Paolo B, Di Liberate L, Summa R, Catucci G, Del Rosso G, Muscianese P, Albertazzi A. Clinical effects of recombinant human erythropoietin in hemodialysis patients. Results of the "Abruzzo" Multicenter Trial. ASAIO Trans 1991 Jul-Sep; 37(3):M380—1. Diez JJ, Sastre J, Iglesias P, Selgas R, Romero JR, Mendez J, Gomez-Pan A. Growth hormone responses to pituitary and hypothalamic stimuli in CAPD patients treated with recombinant human erythropoietin. Adv Perit Dial 1992;8z340—5. Donnelly SM, Posen GA, Ali MA. Oral iron absorption in hemodialysis patients treated with erythropoietin. Clin Invest Med 1991 Aug; 14(4):271-6. Drinovec J, Varl J. Subcutaneous erythropoietin in the treatment of renal anaemia. Przegl Lek 1992; 49(1-2):38-40. Duff DR, Golper TA, Sloan RS, Brier ME, Aronoff GR. Low-dose recombinant human erythropoietin therapy in chronic hemodialysis patients. Am J Kidney Dis 1991 Jul;18(1):60-4. Dukanovic L, Clemons GK, Ikonomovski J, Biljanovic- Paunovic L, Pavlovic-Kentera V. Erythropoietin and improvement of anemia in long-term hemodialysis patients. Acta Med Iugosl 1991;45(2): 151-60. Dy GR, Bloom EJ, Ijelu GK, Merritts GW, Kramer MS, Raja RM. Effect of recombinant human hropoietin on vascqu access. ASAIO Trans 1991 Jul-Sep;37(3):M274-5. Edmunds ME, Walls J. Pathogenesis of seizures during recombinant human erythropoietin therapy. Semin Dial 1991 Jul-Sep;4(3):163-7. Effectiveness and safety of recombinant human erythropoietin in predialysis patients. Austrian Multicenter Study Group of r-HuEPO in Predialysis Patients. Nephron 1992;61(4):399-403. Eisele G, Bailie GR, Clement C, Wong E. Erythropoietin in continuous ambulatory peritoneal dialysis: experience with subcutaneous administration. Perit Dial Int 1992;12(1):34-6. Eschbach JW. Erythropoietin 1991--an overview. Am J Kidney Dis 1991 Oct;18(4 Suppl 1):3-9. Eschbach JW, Aquiling T, Haley NR, Fan MH, Blagg CR. The long-term effects of recombinant human erythropoietin on the cardiovascular system. Clin Nephrol 1992;38 Suppl 1:S98-103. Eschbach J W, Egrie JC, Downing MR, Browne IK, Adamson JW. The safety of epoetin-alpha: results of clinical trials in the United States. Contrib Nephrol 1991;88:72-80. Eschbach JW, Haley NR, Egrie JC, Adamson J W. A comparison of the responses to recombinant human erythropoietin in normal and uremic subjects. Kidney Int 1992 Aug;42(2):407—16. Evans RW. Recombinant human erythropoietin and the quality of life of end-stage renal disease patients: a comparative analysis. Am J Kidney Dis 1991 Oct; 18(4 Suppl 1):62-70. Fabris F, Cordiano I, Randi ML, Casonato A, Montini G, Zacchello G, Girolami A. Effect of human recombinant erythropoietin on bleeding time, platelet number and function in children with end— stage renal disease maintained by haemodialysis. Pediatr Nephrol 1991 Mar;5(2):225-8. Fernandez A, Hortal L, Rodriguez "JC, Vega N, Plaza C, Palop L. Anemia in dialysis: its relation to acquired cystic kidney disease and serum levels of erythropoietin. Am J Nephrol l991;11(1):12—5. Fernandez A, Vega N, Hortal L, Jimenez F, Laraudogoitia E, Macia M, Plaza C, Perdomo M, Palop L. Could CAPD modulate the hemodynamic changes induced by rHuEPO treatment? Adv Perit Dial 1992;8z435-9. Fernandez A, Vega N, Jimenez F, Macia M, Laraudiogoitia E, Hortal L, Perdomo M, Plaza C, Rodriguez J C, Palop L. Effect of recombinant human erythropoietin treatment on hemodynamic parameters in continuous ambulatory peritoneal dialysis and hemodialysis patients. Am J Nephrol 1992;12(4):207-11. Fine RN. Subcutaneous recombinant human erythropoietin treatment of children undergoing peritoneal dialysis. Contrib Nephrol 1991;89:186-9. Fleming LW, Stewart WK, Parratt D. Dextran antibodies, complement conversion and circulating immune complexes after intravenous iron dextran therapy in dialysed patients. Nephrol Dial Transplant l992;7(1):35—9. Frenken LA, Struijk DG, Coppens PJ, Tiggeler RG, Krediet RT, Koene RA. Intraperitoneal administration of recombinant human erythropoietin. Perit Dial Int 1992;12(4):378—83. Comment in: Perit Dial Int 1992;12(4):350—2. Fruits RG, Kinney R, Hegeman T. Maintaining iron balance by decreasing blood loss. ANNA J 1992 Apr;19(2):156 Gallar P, Vigil A, Oliet A, Ortega O, Guijo G. Intraperitoneal erythromycin for diabetic gastroparesis in CAPD. Perit Dial Int 1992;12(2): 265-6. Girelli D, Lupo A, Trevisan MT, Olivieri O, Bernich P, Zorzan P, Bassi A, Stanzial AM, Ferrari S, Corrocher R. Red blood cell susceptibility to lipid peroxidation, membrane lipid composition, and antioxidant enzymes in continuous ambulatory peritoneal dialysis patients. Perit Dial Int 1992; 12(2):205-10. Glassman E. Oral iron therapy with ferrous fumarate and polysaccharide iron complex. ANNA J 1992 Jun;19(3):277-8, 323. Goldberg N, Lundin AP, Delano B, Friedman EA, Stein RA. Changes in left ventricular size, wall thickness, and function in anemic patients treated with recombinant human erythropoietin. Am Heart J 1992 Aug;124(2):424-7. Goldraich I, Goldraich N. Once weekly subcutaneous administration of recombinant erythropoietin in children treated with CAPD. Adv Perit Dial 1992; 8:440-3. Golper TA. The effect of recombinant erythropoietin on the early hematocrit rise after CAPD initiation. Perit Dial Int 1992;12(1):37-9. Granolleras C, Branger B, Shaldon S, Nonnast-Daniel B, Koch KM, Pollok M, Baldamus CA. Subcutaneous erythropoietin: a comparison of daily and thrice weekly administration. Contrib Nephrol 1991;88:144-8; discussion 149-51. Grutzmacher P, Tsobanelis T, Roth P, Werner E, Vlachojannis J, Kaltwasser J, Kurz P, Scheuermann EH, Schoeppe W. Effect of recombinant human erythropoietin on iron balance in maintenance hemodialysis: theoretical considerations, clinical experience and consequences. Clin Nephrol 1992; 38 Suppl l:S92-7. Guthrie M, Cardenas D, Eschbach JW, Haley NR, Robertson HT, Evans RW. Effects of erythropoietin on strength and functional status of patients on 69 hemodialysis. Clin Nephrol 1993 Feb;39(2):97-102. Haedersdal C, Mehlsen J, Stenver D, Jeppesen L, Nielsen B, Winther K. Haemodynamic effects of recombinant erythropoietin in patients on maintenance haemodialysis. Clin Physiol 1992; 12(3):359—60. Hamzeh Y, Said R. Benefits of recombinant human erythropoietin on the anemia of chronic renal failure in patients maintained on hemodialysis. Jordan Med J 1991;25(1):25—30, 135. Harris DC, Chapman JR, Stewart JH, Lawrence S, Roger SD. Low dose erythropoietin in maintenance haemodialysis: improvement in quality of life and reduction in true cost of haemodialysis. Aust N Z J Med 1991 Oct;21(5):693-700. Hase H, Imamura Y, Nakamura R, Inishi Y, Machii K, Yamaguchi T. Effects of rHuEPO therapy on exercise capacity in hemodialysis patients with coronary artery disease. Jpn Circ J 1993 Feb;57(2): 131-7. Hegbrant J, Thysell H, Ekman R. Effects of recombinant human erythropoietin on the plasma levels of vasoactive regulatory peptides in patients on maintenance hemodialysis. Int J Artif Organs 1991 Jul;14(7):411-6. Hegbrant J, Thysell H, Ekman R. Erythropoietin treatment and plasma levels of corticotropin- releasing hormone, delta sleep-inducing peptide and opioid peptides in hemodialysis patients. Scand J Urol Nephrol 1992;26(4):393-6. Hendriks MW, Peters FP, Hooymans PM, Van de Wiel TW, Janknegt D, Janknegt R, Lehman I]. Is recormon less painful than Eprex after subcutaneous administration? Pharm Weekbl Sci 1992;14(2):55—8. Hirakata H, Yao H, Osato S, Ibayashi S, Onoyama K, Otsuka M, Ichiya Y, Kuwabara Y, Masuda Y, Fujishima M. CBF and oxygen metabolism in hemodialysis patients: effects of anemia correction with recombinant human EPO. Am J Physiol 1992 May;262(5 Pt 2):F737-43. Hisano S, Kaku Y, Ueda K, Onoyama K. Efficacy of once weekly erythropoietin therapy in children on continuous ambulatory peritoneal dialysis. Acta Paediatr Jpn 1991 Aug;33(4):450—4. Hisano S, Kaku Y, Ueda K, Onoyama K. Human erythropoietin in children undergoing continuous ambulatory peritoneal dialysis. Acta Paediatr Jpn 1992 Feb;34(l):36-41. Hood VL, Ingraham A. Erythropoietin for chronic ambulatory peritoneal dialysis patients: once a week can be enough. J Am Soc Nephrol 1992 Apr;2(10): 1545-6. 70 Horina JH, Schmid CR, Roob JM, Winkler HM, Samitz MA, Hammer HF, Pogglitsch H, Krejs 6]. Bone marrow changes following treatment of renal anemia with erythropoietin. Kidney Int 1991 Nov; 40(5):917-22. Horl WI-I. Optimal route of administration of erythropoietin in chronic renal failure patients: intravenous versus subcutaneous. Acta Haematol 1992;87 Suppl 1:16-9. Hotta T, Ogawa H, Saito A, Ito A. Iron balance following recombinant human erythropoietin therapy for anemia associated with chronic renal failure. Int J Hematol 1991 Jun;54(3):195—200. Hou S, Orlowski J, Pahl M, Ambrose S, Hussey M, Wong D. Pregnancy in women with end-stage renal disease: treatment of anemia and premature labor. Am J Kidney Dis 1993 Jan;21(1):l6—22. Howarth IE, Waters HM, Shanks D, Hyde K, Yin JA, Geary CG, Anastassiades E, Howarth D, Gokal R. Effects of azathioprine on response of renal anaemia to subcutaneous recombinant human erythropoietin. J Clin Pathol 1993 Jan;46(1):41-4. Hughes RT, Smith T, Hesp R, Hulme B, Dukes DC, Bending MB, Pearson J, Raja KB, Cotes PM, Pippard MI. Regulation of iron absorption in iron loaded subjects with end stage renal disease: effects of treatment with recombinant human erythropoietin and reduction of iron stores. Br J Haematol 1992 Oct;82(2):445—54. Humphries JE. Anemia of renal failure: use of erythropoietin. Med Clin North Am 1992;76(3): 711-25. Huraib S, al-Momen AK, Gader AM, Mitwalli A, Sulimani F, Abu-Aisha H. Effect of recombinant human erythropoietin (rHuEpo) on the hemostatic system in chronic hemodialysis patients. Clin Nephrol 1991 Nov;36(5):252-7. Icardi A, Paoletti E, Traverso GB, Sarchi C, Cappelli G, Molinelli G. Red cell membrane during erythropoietin therapy in hemodialysis and in hemodiafiltration. Int J Artif Organs 1991 Mar; 14(3): 147-9. Ishimitsu T, Tsukada H, Ogawa Y, Numabe A, Yagi S. Genetic predisposition to hypertension facilitates blood pressure elevation in hemodialysis patients treated with erythropoietin. Am J Med 1993 Apr; 94(4):401-6. Johnson CA, Rosowski E, Zimmerman SW. A prospective open-label study evaluating the efficacy and adverse reactions of the use of Niferex-ISO in ESRD patients receiving EPOGEN. Adv Perit Dial 1992;8z444—7. Jones—Lecointe A, Green F], Lee HA. Sub-optimal doses of human recombinant erythropoietin markedly lower serum ferritin. Clin Lab Haematol l991;13(3):251-3. Kamata K, Marumo F, Onoyama K. Hemodynamic mechanism of the elevation in blood pressure following the improvement of anemia with recombinant human erythropoietin. Jpn Circ J 1991 Jul;55(7):649-56. Kampf D, Eckardt KU, Fischer HC, Schmalisch C, Ehmer B, Schostak M. Pharmacokinetics of recombinant human erythropoietin in dialysis patients after single and multiple subcutaneous administrations. Nephron 1992;61(4):393-8. Kirlin L. Epoetin alfa: focus on hematocrit... case management of the anemic patient. ANNA J 1992 Feb;19(1):66-7. Klinkmann H, Schmidt R, Wieczorek L, Scigalla P. Adverse events of subcutaneous recombinant human erythropoietin therapy. Contrib Nephrol 1992;100: 127-38. Klinkmann H, Wieczorek L, Scigalla P. Adverse events of subcutaneous recombinant human erythropoietin therapy: results of a controlled multicenter European study. Artif Organs 1993 Apr; 17(4): 219-25. Kokot F, Wiecek A, Schmidt-Gayk H, Marcinkowski W, Nieszporek T, Rudka R, Trembecki 1. Influence of long-term erythropoietin therapy on endocrine abnormalities in haemodialyzed patients. Pizegl Lek 1992;49(1-2):43—9. Komatsu Y, Ito K. Erythropoietin associated hypertension among pediatric dialysis patients. Adv Perit Dial 1992;8z448-52. Korbet SM. Anemia and erythropoietin in hemodialysis and continuous ambulatory peritoneal dialysis. Kidney Int Suppl 1993 Feb;40:Slll-9. Lai KN, Lui SF, Leung JC, Law E, Nicholls MG. Effect of subcutaneous and intraperitoneal administration of recombinant human erythropoietin on blood pressure and vasoactive hormones in patients on continuous ambulatory peritoneal dialysis. Nephron 1991;57(4):394-400. Lai KN, Wong KC, Li PK, Lui SF. Use of recombinant erythropoietin in thalassemic patients on dialysis. Am J Kidney Dis 1992 Mar;19(3): 239—45. Latham D, Geisman 1. Case management of the anemic patient. Epoetin alfa: focus on dialysis efficiency. ANNA J 1991 Dec;18(6):588-9. Laupacis A, Bargman J M. Erythropoietin: a hormone finds a purpose. J Rheumatol 1992;19(6):1007. Ledermann SE, Randall M, Knight L, Barratt TM, Dillon MJ, Trompeter RS. Evaluation of recombinant human erythropoietin (RHEPO) in children under 8 years with end stage renal failure (ESRF) [abstract]. Pediatr Nephrol 1992;6(5):C171. Leonard DK. Vascular access thrombosis in epoetin alfa therapy. ANNA J 1991 Aug;18(4):37l-6; discussion 377. Levin NW. Quality of life and hematocrit level. Am J Kidney Dis 1992 Jul;20(l Supplement 1):16-20. Low-Friedrich I, Grutzmacher P, Marz W, Bergmann M, Schoeppe W. Therapy with recombinant human erythropoietin reduces cardiac size and improves heart function in chronic hemodialysis patients. Am J Nephrol 1991;11(l):54—60. Ludlow MK, Yap E. Vascular access thrombosis following human recombinant erythropoietin (EPO) therapy. ANNA J 1992 Apr;19(2):154. Lui SF, Law CB, Ting SM, Li P, Lai KN. Once weekly versus twice weekly subcutaneous administration of recombinant human erythropoietin in patients on continuous ambulatory peritoneal dialysis. Clin Nephrol 1991 Nov;36(5):246—51. Lui SF, Wong KC, Li PK, Lai KN. Once weekly versus twice weekly subcutaneous administration of recombinant human erythropoietin in haemodialysis patients. Am J Nephrol 1992;12(1-2):55—60. Lundin AP. Recombinant erythropoietin and chronic renal failure. Hosp Pract (Off Ed) 1991 Apr 15; 26(4):61-9. Lundin AP, Akerman MJ, Chesler RM, Delano BG, Goldberg N, Stein RA, Friedman EA. Exercise in hemodialysis patients after treatment with recombinant human erythropoietin. Nephron 1991; 58(3):315-9. Lye WC, Lee EJ. Subcutaneous recombinant human erythropoietin in patients on CAPD. Adv Perit Dial 1991;7z285-7. MacDougall IC, Davies ME, Hallett I, Cochlin DL, Hutton RD, Coles GA, Williams JD. Coagulation studies and fistula blood flow during erythropoietin therapy in haemodialysis patients. Nephrol Dial Transplant 1991;6(11):862—7. MacDougall IC, Hutton RD, Coles GA, Williams JD. The use of erythropoietin in renal failure. Postgrad Med J 1991 Jan;67(783):9—15. Marsden JT, Sherwood RA, Hillis A, PeterI TJ. Monitoring erythropoietin therapy for anaemia of chronic renal failure by serum erythropoietin assays. Ann Clin Biochem 1993 Mar;30(Pt 2): 205-6. Marsh JT, Brown WS, Wolcott D, Carr CR, Harper R, Schweitzer SV, Nissenson AR. rHuEPO treatment improves brain and cognitive function of anemic 71 dialysis patients. Kidney Int 1991 Jan;39(1):155—63. Martinez-Vea A, Bardaji A, Garcia C, Ridao C, Richart C, Oliver JA. Long-term myocardial effects of correction of anemia with recombinant human erythropoietin in aged patients on hemodialysis. Am J Kidney Dis 1992 Apr;19(4):353-7. Mayer G, Cada EM, Watzinger U, Barnas U, Graf H. Hemodynamic effects of partial correction of chronic anemia by recombinant human erythropoietin in patients on dialysis. Am J Kidney Dis 1991 Mar;17(3):286—9. McMahon LP, Dawbom JK. Subjective quality of life assessment in hemodialysis patients at different levels of hemoglobin following use of recombinant human erythropoietin. Am J Nephrol 1992;12(3): 162-9. Metra M, Carmella G, La Canna G, Guaini T, Sandrini M, Gaggiotti M, Movilli E, Dei Cas L. Improvement in exercise capacity after correction of anemia in patients with end-stage renal failure. Am J Cardiol 1991 Oct 15;68(10):1060—6. Moinard J, Guenard H. Membrane diffusion of the lungs in patients with chronic renal failure. Eur Respir J 1993 Feb;6(2):225—30. Montini G, Zacchello G, Perfumo F, Edefonti A, Bassi S, Cantaluppi A, Sarchi C, Cazzin M, Ferrari V, Boccazzi A, et al. Pharmacokinetics and hematologic response to subcutaneous administration of recombinant human erythropoietin in children undergoing long-term peritoneal dialysis: a multicenter study. J Pediatr 1993 Feb; 122(2):297—302. Moore GE, Bertocci LA, Painter PL. 31P—magnetic resonance spectroscopy assessment of Iubnormal oxidative metabolism in skeletal much of renal failure patients. J Clin Invest 1993 Feb;91(2):420—4. Moreno F, Aracil J, Perez-Garcia R, Valderrabano F. Improvement of the quality of life (QL) of elderly patients on haemodialysis (HD) treated with erythropoietin (EPO). Nephrol Dial Transplant l992;7(7):770—1. Muirhead N, Churchill DN, Goldstein M, Nadler SP, Posen G, Wong C, Slaughter D, Laplante P. Comparison of subcutaneous and intravenous recombinant human erythropoietin for anemia in hemodialysis patients with significant comorbid disease. Am J Nephrol 1992;12(5):303-10. Nasu T, Mitui H, Shinohara Y, Hayashida S, Ohtuka H. Effect of erythropoietin in continuous ambulatory peritoneal dialysis patients: comparison between intravenous and intraperitoneal administration. Perit Dial Int 1992;12(4):373-7. Comment in: Perit Dial Int 1992;12(4):350—2. 72 Navarro M, Alonso A, Avilla JM, Espinosa L. Anemia of chronic renal failure: treatment with erythropoietin. Child Nephrol Urol 1991;11(3): 146-51. Ng YY, Chow MP, Lyou JY, Hu HY, Yung CH, Fan CD, Huang TP. Resistance to erythropoietin: immunohemolytic anemia induced by residual formaldehyde in dialyzers. Am J Kidney Dis 1993 Feb;21(2):213-6. Nissenson AR. Epoetin and cognitive function. Am J Kidney Dis 1992 Jul;20(1 Suppl 1):21-4. Nissenson AR, Nimer SD, Wolcott DL. Recombinant human erythropoietin and renal anemia: molecular biology, clinical efficacy, and nervous system effects. Ann Intern Med 1991 Mar 1;114(5):4UZ-16. Comment in: Ann Intern Med 1991 Jun 15;114(12): 1063. Norton J, Spiezio R, LaManna L, DeLorme B. Varying heparin requirements in hemodialysis patients receiving erythropoietin. ANNA J 1992 Aug;l9(4): 367-72, 408; discussion 409. Nuwayri—Salti N, Jabre F, Daouk M, Sa’ab G, Salem Z. Hematologic parameters and iron stores in patients on hemodialysis for chronic renal failure. Clin Nephrol 1992 Aug;38(2):101-4. Okada K, Takahashi S. Effect of low doses of recombinant human erythropoietin on the anemia in hemodialyzed patients. Nephron 1991;59(4):689—90. Ongkingco J R, Ruley E], Turner ME. Use of low-dose subcutaneous recombinant human erythropoietin in end-stage renal disease: experience with children receiving continuous cycling peritoneal dialysis. Am J Kidney Dis 1991 Oct;18(4):446-50. Ono K, Hisasue Y. Is folate supplementation necessary in hemodialysis patients on erythropoietin therapy. Clin Nephrol 1992 Nov;38(5):290-2. Ono K, Hisasue Y. The rate of increase in hematocrit, humoral vasoactive substances and blood pressure changes in hemodialysis patients treated with recombinant human erythropoietin or blood transfusion. Clin Nephrol 1992 Jan;37(l):23-7. Onoyama K, Hori K, Osato S, Fujishima M. Haemodynamic effect of recombinant human erythropoietin on hypotensive haemodialysis patients. Nephrol Dial Transplant 1991;6(8):562—5. Park JS, Kim SB, Park SK, Lim TH, Lee DK, Hong CD. Effect of recombinant human erythropoietin on muscle energy metabolism in patients with end-stage renal disease: a 31P-nuclear magnetic resonance spectroscopic study. Am J Kidney Dis 1993 Jun; 21(6):612—8. Pascual J, Teruel J L, Marcen R, Liano F, Moya J L, Jimenez M, Ortuno J. Hemodynamic and cardiac effects of erythropoietin in patients on regular dialysis. Int J Artif Organs 1992 Jun;15(6):349-53. Pascual J, Teruel JL, Marcen R, Liano F, Ortuno J. Blood pressure after three different forms of correction of anemia in hemodialysis. Int J Artif Organs 1992;15(7):393-6. Pascual J, Teruel J L, Moya J L, Liano F, J imenez-Mena M, Ortuno J. Regression of left ventricular hypertrophy afier partial correction of anemia with erythropoietin in patients on hemodialysis: a prospective study. Clin Nephrol 1991 Jun;35(6): 280-7. Comment in: Clin Nephrol 1992 Sep;38(3): 174-6. Piazza V, Villa G, Galli F, Segagni S, Bovio G, Poggio F, Picardi L, Salvadeo A. Recombinant human erythropoietin reduces free erythrocyte protoporphyrin levels in patients on chronic dialysis. Nephron 1992;61(1):54-7. Powe NR, Griffiths RI, De Lissovoy G, Anderson GF, Watson A], Greer J W, Herbert RJ, Eggers PW, Milam RA, Whelton PK. Access to recombinant erythropoietin by Medicare-entitled dialysis patients in the first year after FDA approval. J Am Med Assoc 1992;268(11):1434-40. Ramirez B, Flores A, Perez F, Cordoba C, Garcia L, Vazquez G. Human recombinant erythropoietin (rHuEPO) in the treatment of anemia in patients with chronic renal failure (CRF): experience with a group of patients on chronic haemodialysis treatment. Transplant Proc 1991 Apr;23(2):1833-4. Rao DS, Shih MS, Mohini R. Effect of serum parathyroid hormone and bone marrow fibrosis on the response to erythropoietin in uremia. N Engl J Med 1993 Jan 21;328(3):171-5. Comment in: N Engl J Med 1993 Jan 21;328(3):205-6. Reddingius RE, Schroder CH, Monnens LA. Intraperitoneal administration of recombinant human erythropoietin in children on continuous ambulatory peritoneal dialysis. Eur J Pediatr 1992 Jul;151(7): 540-2. Rees L, Rigden SP, Chantler C. The influence of steroid therapy and recombinant human erythropoietin on the grth of children with renal disease. Pediatr Nephrol 1991 Jul;5(4):556-8. Richmond D, Broyan P, Shea S, Reft C, Poseno M, Gimenez LF. How does rHuEPO effect D/P creatinine ratios? Adv Perit Dial 1992;8:457-9. Roger SD, Baker LR, Raine AE. Autonomic dysfunction and the development of hypertension in patients treated with recombinant human erythropoietin (r—HuEPO). Clin Nephrol 1993 Feb; 39(2): 103- 10. Roger SD, Harris DC, Stewart J H. Possible relation betweeen restless legs and anaemia in renal dialysis patients. Lancet l991;337(8756):1551. Romero R, Novoa D, Otero S, Alonso MC, Alonso R, Arcocha V, Arza D, Lens XM, Sanchez-Guisande D. Direct effect of deferoxamine on hemoglobin synthesis in patients on hemodialysis treated with recombinant human erythropoietin. Nephron 1993; 63(2):164-7. Ruedin P, Pechere Beitschi A, Chapuis B, Benedet P, Leski M. Safety and efficacy of recombinant human erythropoietin treatment of anaemia associated with multiple myeloma in haemodialysed patients. Nephrol Dial Transplant 1993;8(4):315—8. Saldanha LF, Weiler EW, Gonick HC. Effect of continuous ambulatory peritoneal dialysis on blood pressure control. Am J Kidney Dis 1993 Feb;21(2): 184-8. Saleh A, Krane NK, Caballero M, Starks E. Once weekly subcutaneous erythropoietin is an effective maintenance therapy in the treatment of anemia of end stage renal disease in patients on CAPD. Adv Perit Dial l991;7:288-91. Sallay P, Reusz G. The use of human recombinant erythropoietin in children on chronic dialysis. Acta Paediatr Hung 1992;32(4):333—45. Salvati F, Strippoli P, Barchetti M, Scatizzi A. Effect on hemoglobin F synthesis by erythropoietin in patients with anemia of end-stage renal disease maintained by chronic hemodialysis. Nephron 1992; 60(3):371. Samtleben W, Ehmer B, Lutz-Knochenhauer I, Hagmann C, Scigalla P, Gurland HJ. Side effects during recombinant human erythropoietin therapy in 2,000 ESRD patients. Contrib Nephrol 1991;88: 107—16; discussion 117. Schaefer RM, Paczek L, Berthold G, Gilge U, Heidland A. Improved immunoglobulin production in dialysis patients treated with recombinant erythropoietin. Int J Artif Organs 1992 Apr;15(4):204-8. Schaefer RM, Schaefer L, Heidland A. Recombinant human erythropoietin for anaemia associated with chronic renal failure in predialysis patients. Pnegl Lek l992;49(1-2):41-2. Schiffl H. Correlation of blood pressure in end-stage renal disease with platelet cytosolic free calcium concentration during treatment of renal anemia with recombinant human erythropoietin. Int J Artif Organs 1992;15(6):343—8. Schober HC, Winkler R, Schmidt R, Abendroth K, Klinkmann H. Bone histomorphometry in recombinant human erythropoietin-treated patients on chronic haemodialysis. Contrib Nephrol 1991; 88:127-35. 73 Schwartz AB, Kahn SB, Kelch B, Kim KE, Pequignot E. RBC improved survival due to recombinant human erythropoietin explains effectiveness of less frequent, low dose subcutaneous therapy. Clin Nephrol 1992 Nov;38(5):283-9. Shand BI, Buttimore AL, Hurrell MA, Wells JE, Inkster IA, Bailey RR, Robson RA, Lynn KL. Hemorheology and fistula function in home hemodialysis patients following erythropoietin treatment: a prospective placebo-controlled study. Nephron 1993;64(1):53-7. Siems W, Grune T, Hampl H, Wendel G, Gerber G, Riedel E. Changed purine nucleotide concentrations and enzyme activities in erythrocytes of haemodialysis patients undergoing erythropoietin therapy. Eur J Clin Chem Clin Biochem 1992 Aug; 30(8):455—60. Siimes MA, Ronnholm KA, Antikainen M, Holmberg C. Factors limiting the erythropoietin response in rapidly growing infants with congenital nephrosis on a peritoneal dialysis regimen afier nephrectomy. J Pediatr 1992;120(1):44-8. Singh AB, Singh M, Palekar S, Levy S, Nunn C, Mann RA. The effects of recombinant human erythropoietin on the cell mediated immune response of renal failure patients. J Med 1992; 23(5):289-302. Sisk IE, Gianfrancesco FD, Coster JM. Recombinant opoietin and Medicare payment. JAMA 1991 Jul 10;266(2):247-52. Comment in: JAMA 1991 Nov 20;266(19):2705—6. Sobh MA, Abd e1 Hamid IA, Atta MG, Refaie AF. Effect of erythropoietin on sexual potency in chronic haemodialysis patients. A preliminary study. Scand J Urol Nephrol 1992;26(2):181-5. Sobh MA, el-Tantawy AE, Said E, Atta MG, Refaie A, Nagati M, Ghoneim M. Effect of treatment of anaemia with erythropoietin on neuromuscular function in patients on long term haemodialysis. Scand J Urol Nephrol 1992;26(1):65—9. Spinowitz BS, Arslanian J, Charytan C, Golden RA, Rascoff J, Galler M. Impact of epoetin beta on dialyzer clearance and heparin requirements. Am J Kidney Dis 1991 Dec;18(6):668-73. Standage BA, Schuman ES, Ackerman D, Gross GF, Ragsdale J W. Does the use of erythropoietin in hemodialysis patients increase dialysis graft thrombosis rates? Am J Surg 1993 May;165(5): 650-4. Stefanidis CJ, Koulieri A, Siapera D, Kapogiannis A, Mitsioni A, Michelis K. Effect of the correction of anemia with recombinant human erythropoietin on growth of children treated with CAPD. Adv Perit Dial 1992;8:460-3. 74 Stefenelli T, Boszotta A, Kaliman JF, Mayer G, Graf H. Digital vascular reactivity in patients on haemodialysis treated with human recombinant erythropoietin. Vasa 199l;20(1):70-3. Steinberg H, Stead RB. Erythropoietin and visual hallucinations. New Engl J Med 1991;325(4):285. Steinhauer HB, Lubrich-Birkner I, Dreyling KW, Schollmeyer P. Effect of human recombinant erythropoietin on anaemia and dialysis efficiency in patients undergoing continuous ambulatory peritoneal dialysis. Eur J Clin Invest 1991 Feb; 21(1):47-52. Stevens JM, Auer I, Strong CA, Hughes RT, Oliver DO, Winearls CG, Cotes PM. Stepwise correction of anaemia by subcutaneous administration of human recombinant erythropoietin in patients with chronic renal failure maintained by continuous ambulatory peritoneal dialysis. Nephrol Dial Transplant 1991;6(7):487-94. Strauss MJ, Port FK, Somen C, Wolfe RA. An estimate of the size of the US predialysil population with renal insufficiency and anemia. Am J Kidney Dis 1993 Mar;21(3):264-9. Sundal E, Businger J, Kappeler A. Treatment of transfusion-dependent anaemia of chronic renal failure with recombinant human erythropoietin. A European multicentre study in 142 patients to define dose regimen and safety profile. Nephrol Dial Transplant 1991;6(12):955—65. Sungur C, Sungur A, Arik N, Akpolat T, Arinsoy T, Yasavul O, Turgan C, Caglar S. Bone marrow involvement in systemic amyloidosis: another mechanism for erythropoitin resistance. Nephron 1993;63(2):232. Suwata J, Maeda H, Ohmori N, Ohwa M, Ohtsuka H, Shimoyama H. Recombinant human erythropoietin therapy and autonomic nervous system. Nephron 1992;61(1):115—6. Suzuki H, Murakami M, Ichihara A, Saruta T. Alterations in sex hormones and sexual function of patients with renal failure treated with recombinant human erythropoietin. Nippon Jinzo Gakkai Shi 1992 Jan;34(1):79-84. Suzuki Y, Ogura Y, Otsubo 0, Mimura N, Takaku F, Maeda T. Changes of enzyme activity levels in red blood cells in hemodialysis patients by recombinant human erythropoietin. Nippon Jinzo Gakkai Shi 1992 Sep;34(9):1019-23. Tagawa H, Nagano M, Saito H, Umezu M, Yamakado M. Echocardiographic findings in hemodialysis patients treated with recombinant human erythropoietin: proposal for a hematocrit most beneficial to hemodynamics. Clin Nephrol 1991 Jan;35(l):35-8. Takahashi K, Totsune K, Imai Y, Sone M, Nozuki M, Murakami 0, Sekino H, Mouri T. Plasma concentrations of immunoreactive—endothelin in patients with chronic renal failure treated with recombinant human erythropoietin. Clin Sci 1993 Jan;84(1):47—50. Takayama K, Nagai T, Kinugasa E, Akizawa T, Koshikawa S. Changes in endothelial vasoactive substances under recombinant human erythropoietin therapy in hemodialysis patients. ASAIO Trans 1991 Jul-Sep;37(3):Ml87—8. Tanaka H, Kan E, Takegaki Y, Inariba H, Yoshimoto M, Ohno Y, Maekawa M, Tatsumi N, Kishimoto T. Multicenter study with recombinant human erythropoietin. Artif Organs 1993 Apr;17(4):213-8. Tang IY, Vrahnos D, Valaitis D, Lau AH. Vascular access thrombosis during recombinant human erythropoietin therapy. ASAIO I 1992 Jul-Sep; 38(3) :M528-3 1 . Taylor J E, Henderson IS, Mactier RA, Stewart WK. Effects of withdrawing erythropoietin. BMJ 1991 Feb 2;302(6771):272-3. Comment in: BMJ 1991 Feb 2;302(6771):248-9. Taylor IE, Henderson IS, Stewart WK, Belch JJ . Erythropoietin and spontaneous platelet aggregation in haemodialysis patients. Lancet 1991 Nov 30; 338(8779):1361-2. Taylor JE, Henderson IS, Stewart WK, Belch JJ . Platelet aggregation in erythropoietin treated dialysis patients. Platelets l992;3(1):47-52. Taylor J E, MacTier RA, Henderson IS, Belch J], Stewart WK. Dialysis efficiency in continuous ambulatory peritoneal dialysis patients treated with erythropoietin. Perit Dial Int 1992;12(2):221-6. Temple RM, Langan SJ, Deary IJ, Winney RJ. Recombinant erythropoietin improves cognitive function in chronic haemodialysis patients. Nephrol Dial Transplant 1992;7(3):240—5. Teruel IL, Pascual J, Jimenez M, Liano F, Rivera M, Martinez J, Moya JL, Ortuno J. Hemodynamic changes in hemodialyzed patients during treatment with recombinant human erythropoietin. Nephron 1991;58(2):135—7. Tomson CR, Feehally J, Walls J. Crossover comparison of intravenous and subcutaneous erythropoietin in haemodialysis patients. Nephrol Dial Transplant 1992;7(2):129-32. Tsai JC, Lai YH, Tsai ZY, Chien LI, Tsai JH. Clinical efficacy of recombinant human erythropoietin in the treatment of anemia in hemodialysis patients: influence of dosing regimen, iron status, and serum aluminum. Kao Hsiung I Hsueh Ko Hsueh Tsa Chih 1991 Mar;7(3):126-35. Tsao CI, Kao RH, Cheng TY, Huang CC, Chang SL, Lee FN. The effect of recombinant human erythropoietin on hemostatic status in chronic uremic patients. Int J Hematol 1992 Apr;55(2): 197-203. Turi S, Nemeth I, Varga I, Bodrogi T, Matkovics B. The effect of erythropoietin on the cellular defence mechanism of red blood cells in children with chronic renal failure. Pediatr Nephrol 1992 Nov; 6(6):536—41. Urena P, Bonnardeaux A, Eckardt KU, Kurtz A, Drueke TB. Insulin-like growth factor I: a modulator of erythropoiesis in uraemic patients? Nephrol Dial Transplant 1992;7(1):40-4. Valderrabano F, Moreno F, Aracil FJ . A controlled study on the effect of erythropoietin (EPO) on the quality of life (QL) of elderly hemodialysis patients [abstract]. J Am Soc Nephrol 1992;3(3):432. van de Borne P, Tielemans C, Vanherweghem JL, Degaute J P. Effect of recombinant human erythropoietin therapy on ambulatory blood pressure and heart rate in chronic haemodialysis patients. Nephrol Dial Transplant 1992;7(1):45-9. Van Wyck DB. Impact of erythropoietin on the dialysis prescription. Am J Kidney Dis 1991 Oct; 18(4 Suppl 1):71-5. Vega N, Fernandez A, Hortal L, Macias M, Rodriguez JC, Plaza C, Perdomo M, Vega R, Palop L. Peritoneal dialysis efficiency in CAPD patients in treatment with rI-IuEPO. Adv Perit Dial 1992;8: 467-70. Veys N, Vanholder R, Lameire N. Pain at the injection site of subcutaneously administered erythropoietin in maintenance hemodialysis patients: a comparison of two brands of erythropoietin. Am J Nephrol 1992;12(1-2):68-72. Veys N, Vanholder R, Ringoir S. Correction of deficient phagocytosis during erythropoietin treatment in maintenance hemodialysis patients. Am J Kidney Dis 1992 Apr;19(4):358-63. Viron B, Jaar B, Verdy E, Mignon F, Fournier A, El Elsper N, Moriniere P. Erythropoietin-induced protein S deficiency and vena cava thrombosis. Nephrol Dial Transplant 1992;7(9):979-80. Warady BA, Sabath R], Smith CA, Alon U, Hellerstein S. Recombinant human erythropoietin therapy in pediatric patients receiving long-term peritoneal dialysis. Pediatr Nephrol 1991 Nov;5(6):718-23. Washio M, Iseki K, Onoyama K, Oh Y, Nakamoto M, Fujimi S, Fujishima M. Elevation of serum erythropoietin after subtotal parathyroidectomy in chronic haemodialysis patients. Nephrol Dial Transplant 1992;7(2):121-4. 75 Watschinger B, Watzinger U, Templ H, Spona J, Graf H, Luger A. Effect of recombinant human erythropoietin on anterior pituitary function in patients on chronic hemodialysis. Horm Res 1991; 36(1-2):22-6. Wirtz I], van Esser JW, Hamulyak K, Leunissen KM, van Hooff JP. The effects of recombinant human erythropoietin on hemostasis and fibrinolysis in hemodialysis patients. Clin Nephrol 1992 Nov; 38(5):277—82. Wizemann V, Kaufrnann J, Kramer W. Effect of erythropoietin on ischemia tolerance in anemic hemodialysis patients with confirmed coronary artery disease. Nephron 1992;62(2):161-5. Wizemann V, Schafer R, Kramer W. Follow-up of cardiac changes induced by anemia compensation in normotensive hemodialysis patients with left- ventricular hypertrophy. Nephron 1993;64(2): 202-6. Yarnakado M, Umezu M, Nagano M, Tagawa H. Mechanisms of hypertension induced by erythropoietin in patients on hemodialysis. Clin Invest Med 1991 Dec;14(6):623-9. Yaqoob M, Ahmad R, McClelland P, Shivakumar KA, Sallomi DF, Fahal II-I, Roberts NB, Helliwell T. Resistance to recombinant human erythropoietin due to aluminium overload and its reversal by low dose desferrioxamine therapy. Postgrad Med J 1993 Feb; 69(808):124-8 . Yaqoob M, Morris K, Bell GM, Ahmad R. Suppression of the renin-angiotensin—aldosterone axis with erythropoietin therapy by a negative feedback loop. Nephrol Dial Transplant 1992;7(2):125—8. Zappacosta AR, Perras ST, Bell A. Weekly subcutaneous recombinant human erythropoietin corrects anemia of progressive renal failure. Am J Med 1991 Sep;91(3):229-32. Zehnder C, Zuber M, Sulzer M, Meyer B, Straumann E, Jenzer HR, .Blumberg A. Influence of long-term amelioration of anemia and blood pressure control on left ventricular hypertrophy in hemodialyzed patients. Nephron 1992;61(1):21-5. Zimmerman SW, Johnson CA. Erythropoietin use in peritoneal dialysis patients. Am J Kidney Dis 1991 0ct;18(4 Suppl 1):38—4l. Zirkman DM, Zeigler ZR, Fraley DS, Bruns FJ, Adler S. Evaluation of platelet hyperfunction in hemodialysis patients receiving recombinant human erythropoietin. Am J Kidney Dis 1993 Jan;21(1): 31-7. 76 Peritonitis -Clinical Trials Cheng 1K, Chan CY, Wong WT. A randomised prospective comparison of oral ofloxacin and intraperitoneal vancomycin plus aztreonam in the treatment of bacterial peritonitis complicating continuous ambulatory peritoneal dialysis (CAPD). Perit Dial Int 1991;11(1):27-30. Ejlersen E, Brandi L, Lukkegaard H, Ladefoged J, Kopp R, Haarh P. Is initial (24 hours) lavage necessary in treatment of CAPD peritonitis? Perit Dial Int 1991;11(1):38-42. Nakamura Y, Hara Y, Ishida H, Moriwaki K, Shigemoto K. A randomized multicenter trial to evaluate the effects of UV-Flash system on peritonitis rates in CAPD. Adv Perit Dial 1992;8z313-5. Owen JE, Walker RG, Lemon J, Brett L, Mitrou D, Becker GJ. Randomized study of peritonitis with conventional versus O-set techniques in continuous ambulatory peritoneal dialysis. Perit Dial Int 1992; 12(2):216-20. Poole-Warren LA, Hallett MD, Hone PW, Burden SH, Farrell PC. Vaccination for prevention of CAPD associated staphylococcal infection: results of a prospective multicentre clinical trial. Clin Nephrol 1991 May;35(5):198-206. Wale MC, Finch RG, Morgan AG, Burden RP, Holliday A. A prospective randomised trial of teicoplanin plus aztreonam versus cefuroxime in CAPD peritonitis. Int J Antimicrob Agents 1992; 1 Suppl 1:87-14. Zimmerman SW, Ahrens E, Johnson CA, Craig W, Leggett J, O’Brien M, Oxton L, Roecker EB, Engeseth S. Randomized controlled trial of prophylactic rifampin for peritoneal dialysisrrelated infections. Am J Kidney Dis 1991 Aug;18(2): 225-31. -Other Abreo K, Flanagan R, White R, Mccoy R. Catheter- related mycobacterium-fortuitum infections in CAPD patients [abstract]. J Am Soc Nephrol 1992;3(3): 405. Adair CG, German SP, Mawhinney WM, Mcclurg B. Long-term stability of teicoplanin in CAPD dialysis fluid implications for the home-treatment of catheter-related peritonitis [abstract]. Pharmacotherapy 1991;11(3):275. Adcock A, Fox K, Jones D, Kenny R, Harbison J, Taber T, Bloomfield R. Clinical experiences with a single use Y bagless CAPD system applying a quick disconnect clamp for external occlusion. Adv Perit Dial 1991;7:190-2. Ahijado F, Luno J, Soto I, Gallego E, Junco E, Polo JR, Galan A, Valderrabano F. Tuberculous peritonitis in patients on CAPD. Contrib Nephrol 1991;89:79—86. Ahlmen J, Schonborg C. Grading of exit sites cannot predict peritonitis in patients on CAPD. Adv Perit Dial 1991;7z117-9. Ahmed S, Rahman M. Complications of intermittent peritoneal dialysis. Bangladesh Renal J l991;10(2): 57-61. Allen SM, Matthews HR. Surgical treatment of massive hydrothorax complicating continuous ambul peritoneal dialysis. Clin Nephrol 1991 Dec;36(6): 299-301. Al-Wali W, Baillod R, Brumfitt W, Hamilton-Miller JM. Differing prognostic significance of reinfection and relapse in CAPD peritonitis. Nephrol Dial Transplant 1992;7(2):133-6. Al-Wali W, Baillod RA, Brumfitt W, Hamilton-Miller JM. Teicoplanin in the treatment of peritonitis in patients receiving continuous ambulatory peritoneal dialysis: a comparative trial against vancomycin. Int J Antimicrob Agents 1992;1 Suppl 1:81-6. Andreoli SP, Langefeld CM, Stadler S, Smith P, Sears A. Risks of peritoneal membrane failure in children undergoing peritoneal dialysis [abstract]. Pediatr Res 1992;31(4 Pt 2):328a. Antonsen S, Pedersen FB, Wang P. Detection of neutrophil granulocytes in peritoneal dialysis effluents by means of the Cytur-test. Danish Study Group on Peritonitis in Dialysis (DASPID). Scand J Clin Lab Invest 1991 Apr;51(2):149—54. Anwar N, Gokal R. Experience with vancomyCin, aminoglycosides and newer B-lactam antibiotics in CAPD peritonitis. Dial Transplant 1993;22(3):134, 136, 138. Ariza M, Lopez M, Quesada T. Complications of CAPD in children: six years experience in Caracas, Venezuela. Adv Perit Dial 1991;7:269-71. Bailie GR, Eisele G. Continuous ambulatory peritoneal dialysis: a review of its mechanics, advantages, complications, and areas of controversy. Ann Pharmacother 1992 Nov;26(11):1409-20. Bailie GR, Eisele G, Venezia RA, Yocum D, Hollister A. Prediction of serum vancomycin concentrations following intraperitoneal loading doses in continuous ambulatory peritoneal dialysis patients with peritonitis. Clin Pharmacokinet 1992;22(4): 298-307. Bailie GR, Rasmussen R, Eisele G, Luscombe DK. Peritonitis rates in CAPD patients using the UVXD and O-set systems. Ren Fail 1993;15(2):225-30. Barnish MJ. Peritonitis in patients undergoing continuous ambulatory peritoneal dialysis. Complications Surg 1992;11(3):42-8. Beelen RH, Bos HJ, Meyer F, Calame W, van der Meulen J, de Fijter CW, 0e PL. A single administration of peritoneal dialysis fluid in the rat induces an acute inflammatory exudate. Adv Perit Dial 1991;7:138-41. Bernardini J, Holley JL, Johnston JR, Perlmutter JA, Piraino B. An analysis of ten-year trends in infections in adults on continuous ambulatory - peritoneal dialysis (CAPD). Clin Nephrol 1991 Jul; 36(1):29-34. Betjes MG, Tuk CW, Struijk DG, Krediet RT, Arisz L, Hoefsmit EC, Beelen RH. Immuno-effector characteristics of peritoneal cells during CAPD treatment: a longitudinal study. Kidney Int 1993 Mar;43(3):641-8. Boeschoten EW, Rietra PJ , Struijk DG, Krediet RT, Arisz L. Changing antimicrobial resistance in CAPD peritonitis? Contrib Nephrol 1991;89:87-95. Boeschoten EW, Struijk DG, Krediet RT, Arisz L. Metabolic disturbances in CAPD patients. Adv Perit Dial 1991;7:243-6. Bonnardeaux A, Ouimet D, Galameau A, Falardeau M, Cardinal J, Nolin L, Houde M. Peritonitis in continuous ambulatory peritoneal dialysis: impact of a compulsory switch from a standard to a Y- connector system in a single North American Center. Am J Kidney Dis 1992 Apr;19(4):364—70. Bowman RA, Medley AS, Karthigasu KT. Limulus amoebocyte lysate assay in the diagnosis of peritonitis in patients receiving continuous ambulatory peritoneal dialysis. J Clin Pathol 1992 Jan;45(1):72—4. Brown AL, Stephenson JR, Baker LR, Tabaqchali S. Epidemiology of CAPD-associated peritonitis caused by coagulase-negative staphylococci: comparison of strains isolated from hands, abdominal Tenckhoff catheter exit site and peritoneal fluid. Nephrol Dial Transplant 1991;6(9): 643-8. Brown AL, Stephenson JR, Baker LR, Tabaqchali S. Recurrent CAPD peritonitis caused by coagulase- negative staphylococci: re-infection or relapse determined by clinical criteria and typing methods. J Hosp Infect 1991 Jun;18(2):109-22. Burkart J, Haigler S, Caruana R, Hylander B. Usefulness of peritoneal fluid amylase levels in the differential diagnosis of peritonitis in peritoneal 77 dialysis patients. J Am Soc Nephrol 1991 Apr; 1(10):1186-90. Burkart JM, Jordan JR, Durnell TA, Case LD. Comparison of exit-site infections in disconnect versus nondisconnect systems for peritoneal dialysis. Perit Dial Int 1992;12(3):317-20. Comment in: Perit Dial Int 1993;13(1):67-8. Campbell MA. Using information systems to track peritonitis rates. Nephrol News Issues 1993 Mar; 7 (3):18-9. Chan TM, Lok AS, Cheng IK. Hepatitis C infection among dialysis patients: a comparison between patients on maintenance haemodialysis and continuous ambulatory peritoneal dialysis. Nephrol Dial Transplant 1991;6(12):944-7. Chen WT, Kobayashi Y, Huang TP, Chiu CC, Lin CY. Decreased size of peritoneal macrophage during peritonitis in continuous ambulatory peritoneal dialysis patients. Am J Nephrol 1991;11(5):374—9. Chong TK, Piraino B, Bemardini J. Vestibular toxicity due to gentamicin in peritoneal dialysis patients. Perit Dial Int 1991;11(2):152-5. Churchill DN. CAPD peritonitis: a critical appraisal of prophylactic strategies. Semin Dial 1991 Apr-Jun; 4(2):94—100. Coronel F, Martin-Rabadan P, Romero J. Chemical peritonitis after intraperitoneal administration of amphotericin B in a fungal infection of the catheter subcutaneous tunnel. Peritoneal Dial Int 1993;13(2): 161-2. Dabbagh S, Fassinger N, Clement K, Fleischmann LE. The effect of aggressive nutrition on infection rates in patients maintained on peritoneal dialysis. Adv Perit Dial 1991;7:161-4. Dadone C, Redaelli B. Branhamella catarrhalis peritonitis in CAPD: an avoidable complication? Perit Dial Int 1991;11(2):185. Dasgupta MK, Anwar H, Costerton J W. Bacterial biofilms and peritonitis in continuous ambulatory peritoneal dialysis. Int Biodeterior Biodegrad 1992; 30(2-3): 167-76 . Dasgupta MK, Fox S, Gagnon D, Bettcher K, Ulan RA. Significant reduction of peritonitis rate by the use of Twin-bag system in a Canadian regional CAPD program. Adv Perit Dial 1992;8:223-6. Dasgupta MK, Kowalewska-Grochowska K, Bettcher KB, Tyrrell DL. Stable biofilms causing recurrent peritonitis and catheter loss in continuous ambulatory peritoneal dialysis (CAPD) [abstract]. Clin Invest Med 1991;14(4 Suppl):A136. Dasgupta MK, Kowlaska-Grochowska K, Costerton JW. Biofilm culture of peritoneal dialysis (PD) 78 effluents as an indicator of treatment failure in peritonitis [abstract]. J Am Soc Nephrol 1992;3(3): 407. Davenport A, Dealler SF. The epidermo—peritoneal potential in patients treated with continuous ambulatory peritoneal dialysis. Int J Artif Organs 1993 Feb;16(2):71-4. de Fijter CW, Verbrugh HA, 0e LP, Peters ED, van der Meulen J, Donker AJ, Verhoef I. Peritoneal defense in continuous ambulatory versus continuous cyclic peritoneal dialysis. Kidney Int 1992;42(4): 947-50. Delapenha RA, Padmore D, Williams W. Peritonitis in acute peritoneal dialysis at the University Hospital of the West Indies (a five-year review). West Indian Med J 1991 Mar;40(1):29-32. Dobbie J W. Pathogenesis of peritoneal fibrosing syndromes (sclerosing peritonitis) in peritoneal dialysis. Perit Dial Int 1992;12(1):14-27. Domoto DT, Weindel ME, Blalock S, Ballal HS. Efficacy of streptokinase in resistant, relapsing or recurrent CAPD peritonitis. Adv Perit Dial 1991;7: 173-5. Dratwa M, Glupczynski Y, Lameire N, Matthys D, Verschraegen G, Vaneechoutte M, Boelaert J, Schurgers M, Van Landuyt H, Verbeelen D, Lauwers S. Treatment of gram-negative peritonitis with aztreonam in patients undergoing continuous ambulatory peritoneal dialysis. Rev Infect Dis 1991; 13 Suppl 7 :S645-7. Dryden MS, Ludlam HA, Wing A], Phillips 1. Active intervention dramatically reduces CAPD-associated infection. Adv Perit Dial l991;7:125-8. Dryden MS, McCann M, Wing A], Phillips I. Controlled trial of a Y-set dialysis delivery system to prevent peritonitis in patients receiving continuous ambulatory peritoneal dialysis. J Hosp Infect 1992 Mar;20(3):185-92. Dryden MS, Talsania H, Rodgers J, Bayston R, Phillips I. Serological response to coagulase-negative staphylococci in patients with peritonitis on continuous ambulatory peritoneal dialysis. Eur J Clin Microbiol Infect Dis l993;12(2):87-92. Dryden MS, Talsania HG, Martin S, Cunningham M, Richardson JF, Cookson B, Marples R, Phillips I. Evaluation of methods for typing coagulase-negative staphylococci. J Med Microbiol 1992 Aug;37(2): 109- 17. Dryden MS, Wing A], Phillips I. Low dose intraperitoneal ciprofloxacin for the treatment of peritonitis in patients receiving continuous ambulatory peritoneal dialysis (CAPD). J Antimicrob Chemother 1991 Jul;28(1):131-9. Edward A, Nolph K. Streptococcus peritonitis with urticaria. Perit Dial Int 1992;12(2):214-5. Eisele G, Bailie GR, Lomaestro B. Relationship between peritonitis and exit site infections in CAPD. Adv Perit Dial 1992;8z227-9. Elsey RM, Carson RW, DuBose TD Jr. Pasteurella multocida peritonitis in an HIV-positive patient on continuous cycling peritoneal dialysis. Am J Nephrol 1991;11(1):61-3. Faber MD, del Busto R, Cruz C, Mezger E. Response of Weeksella virosa peritonitis to imipenem/cilastin. Adv Perit Dial 1991;7:133-4. Fieren MW, van den Bemd GJ, Ben-Efraim S, Bonta IL. Prostaglandin E2 inhibits the release of tumor necrosis factor-alpha, rather than interleukin 1 beta, from human macrophages. Immunol Lett 1992 Jan; 31(1):85-90. Fieren MW, van den Bemd GJ, Bonta IL. Peritoneal macrophages from patients on continuous ambulatory peritoneal dialysis show a differential secretion of prostanoids and interleukin-1 beta. Prostaglandins Leukot Essent Fatty Acids 1992 Sep; 47(1):23-8. Fieren MW, van den Bemd GI, Bonta IL, Ben-Efraim S. Peritoneal macrophages from patients on continuous ambulatory peritoneal dialysis have an increased capability to release tumour necrosis factor during peritonitis. J Clin Lab Immunol 1991 Jan;34(1):1-9. Fox L, Tzamaloukas AH, Murata GH. Metabolic differences between persistent and routine peritonitis in CAPD. Adv Perit Dial 1992;8z346-50. Freiman JP, Graham DJ, Reed TG, McGoodwin EB. Chemical peritonitis following the intraperitoneal administration of vancomycin. Perit Dial Int 1992; 12(1):57-60. Gendeh BS, Said H, Gibb AG, Aziz NS, Zahir ZM. Gentamicin administration via peritoneal dialysis fluid: the risk of ototoxicity. J Laryngol Otol 1991;105(12):999-1001. Glancey GR, Cameron J S, Ogg CS. Peritoneal drainage: an important element in host defence against staphylococcal peritonitis in patients on CAPD. Nephrol Dial Transplant 1992;7(7):627-31. Gokal R. Recent perspectives on peritoneal dialysis. Contrib Nephrol 1993;102:98-109. Gorban—Brennan N, Kliger AS, Finkelstein F0. CAPD therapy for patients over 80 years of age. Perit Dial Int 1993;13(2):140—1. Gorman SP, Mawhinney WM, Adair CG. The influence of catheter surface microrugosity on the development and persistence of recurrent peritonitis in CAPD [abstract]. Pharmacotherapy 1991;11(3): 267. Greaves I, Kane K, Richards NT, Elliott TS, Adu D, Michael I . Pigeons and peritonitis? Nephrol Dial Transplant 1992;7(9):967-9. Gretz N, Lasserre II, Drescher P, Mall K, Strauch M. Experimental CAPD: a rat model. Contrib Nephrol 1991;89:43—6. Gulanikar AC, Iindal KK, Hirsch DI. Is chronic peritoneal dialysis safe in patients with intra- abdominal prosthetic vascular grafts? Nephrol Dial Transplant 1991;6(3):215—7. Han DC, Cha HK, Chung SH, Park MS, Lee SK, Hwang SD, Moon C, Lee I-IB. Effects of subcutaneously implanted catheters on the incidence of peritonitis during CAPD [abstract]. J Am Soc Nephrol 1991;2(3):361. Han DC, Cha HK, So IN, Chung SH, Park MS, Lee SK, Woo IH, Hwang SD, Moon C, Lee HB. Subcutaneously implanted catheters reduce the incidence of peritonitis during CAPD by eliminating infection by periluminal route. Adv Perit Dial 1992; 8:298-301. Hart PH, Iones CA, Finlay-Jones JI. Peritoneal macrophages during peritonitis. Phenotypic studies. Clin Exp Immunol 1992;88(3):484—91. Hodde LA, Sandroni S. Emergency department evaluation and management of dialysis patient complications. I Emerg Med 1992 May-Iun;10(3): 317-34. Holley IL, Bemardini J, Piraino B. A comparison of peritoneal dialysis-related infections in black and white patients. Perit Dial Int 1993;13(1):45-9. Holley IL, Bemardini J, Piraino B. Polymicrobial peritonitis in patients on continuous peritoneal dialysis. Am J Kidney Dis 1992 Feb;19(2):162-6. Holley IL, Bemardini I, Piraino B. Risk factors for tunnel infections in continuous peritoneal dialysis. Am J Kidney Dis 1991 Sep;18(3):344-8. Hollman AS, McMillan MA, Briggs JD, Iunor BI, Morley P. Ultrasound changes in sclerosing peritonitis following continuous ambulatory peritoneal dialysis. Clin Radiol 1991 Mar;43(3): 176—9. Honkanen E, Kala AR, Gronhagen—Riska C. Divergent etiologies of CAPD peritonitis in integrated double bag and traditional systems? Adv Perit Dial 1991;7: 129—32. Hutchison AI, Turner K, Gokal R. Effect of long-term therapy with 1.25 mmol/L calcium peritoneal dialysis fluid on the incidence of peritonitis in CAPD. Perit Dial Int 1992;12(3):321-3. 79 Iethon FU, Weber-Fursicht I, Steudle V, Guleke R, Kirschner U. Peritonitis prevention by eliminating the risk factor disconnection. Contrib Nephrol 1991;89:53-8. Ioffe P, Jensen LT. Type I and III procollagens in CAPD: markers of peritoneal fibrosis. Adv Perit Dial 1991;72158-60. Johnson DW, Fleming SI. The use of vaccines in renal failure. Clin Pharmacokin 1992;22(6):434-46. Kampf D, Bomer K, Hain H, Conrad W. Multiple- dose-kinetics of ofloxacin after intraperitoneal application in CAPD patients. Perit Dial Int 1991; 11(4):317-21. Keane WF, Everett ED, Golper TA, Gokal R, Halstenson C, Kawaguchi Y, Riella M, Vas S, Verbrugh HA. Peritoneal dialysis-related peritonitis treatment recommendations. 1993 update. The Ad Hoc Advisory Committee on Peritonitis Management. International Society for Peritoneal Dialysis. Perit Dial Int 1993;13(1):14—28. Klaus G, Schafer F, Querfeld U, Soergel M, Wolf S, Mehls 0. Treatment of relapsing peritonitis in pediatric patients on peritoneal dialysis. Adv Perit Dial 1992;8z3UZ-5. Korbet SM, Vonesh EF, Firanek CA. A retrospective assessment of risk factors for peritonitis among an urban CAPD population. Perit Dial Int 1993;13(2): 126-31. Korzets Z, Korzets A, Golan E, Zevin D, Bernheim I. CAPD peritonitis--initial presentation as an acute abdomen with a clear peritoneal effluent. Clin Nephrol 1992 Mar;37(3):155-7. Kraus LM, Kraus AP Ir. Tyrosine and N-carbamoyl- tyrosine in end-stage renal disease during continuous ambulatory peritoneal dialysis. I Lab Clin Med 1991 Dec;118(6):555—62. Lafleur D, Cordy P, Gallimore B, Adam I. Peritonitis rates for CAPD patients using the SCD 210 (Inpersol sterile connecting device): a Canadian survey. Adv Perit Dial 1991;7zl96-203. Lam TY, Vas SI, Oreopoulos DG. Long-term, intraperitoneal vancomycin in the prevention of recurrent peritonitis during CAPD: preliminary results. Perit Dial'Int 1991;11(3):281—2. Lee GS, Woo KT. Infection in continuous ambulatory peritoneal dialysis (CAPD): aetiology, complications and risk factors. Ann Acad Med Singapore 1992 May;21(3):354—60. Lewis I, Abbott I , Crompton K, Fowler I, Smith B. CAPD disconnect systems: UK peritonitis experience. Adv Perit Dial 1992;82306-12. 80 Lin CY, Huang TP. Enhancement of ionized calcium and 1,25—dihydroxycholecalciferol loss from peritoneal fluid during peritonitis in patients treated with continuous ambulatory peritoneal dialysis. Nephron 1991;59(1):90—5. Lin CY, Lin CC, Huang TP. Serial changes of interleukin-6 and interleukin-8 levels in drain dialysate of uremic patients with continuous ambulatory peritoneal dialysis during peritonitis. Nephron 1993;63(4):404-8. Lo WK, Chan KT, Leung AC, Pang SW, Tse CY. Sclerosing peritonitis complicating prolonged use of chlorhexidine in alcohol in the connection procedure for continuous ambulatory peritoneal dialysis. Perit Dial Int 1991;11(2):166—72. Comment in: Perit Dial Int 1992;12(3):330. Ludlam H, Johnston L, Hopkins P. Susceptibility testing of bacteria recovered from patients with peritonitis complicating continuous ambulatory peritoneal dialysis. Antimicrob Agents Chemother 1992 May;36(5):1097—101. Ludlam HA. Infectious consequences of continuous ambulatory peritoneal dialysis. J Hosp Infect 1991 Jun;18 Suppl A:341-54. Ludlam HA, Baker LRI. The prevention of infection associated with continuous ambulatory peritoneal dialysis. Curr Opin Infect Dis 1991;4(4):541-8. Luzar MA. Peritonitis prevention in continuous ambulatory peritoneal dialysis. Nephrologie 1992; 13(4):171-7. Lye WC, Lee EJ, Ang KK. Acinetobacter peritonitis in patients on CAPD: characteristics and outcome. Adv Perit Dial 1991;7zl76-9. Lye WC, Leong SO, Lee E]. Methicillin-resistant Staphylococcus aureus nasal carriage and infections in CAPD. Kidney Int 1993 ;43(6):1357-62. MacKenzie RK, Coles GA, Williams ID. The response of human peritoneal macrophages to stimulation with bacteria isolated from episodes of continuous ambulatory peritoneal dialysis-related peritonitis. J Infect Dis 1991;163(4):837-42. Makin AJ, Cartwright KA, Banks RA. Keeping the cat out of the bag: a hazard in continuous ambulatory peritoneal dialysis. Br Med J 1991;303(6817): 1610-1. Malacarne F, De Paoli Vitali E, Prandini N, Feggi L, Perini L, Cervi PM, Reverberi R, Lodi L, Gilli P. Increased uptake of radio labelled white blood cells into abdomen of uremics on peritoneal dialysis. Adv Perit Dial 1992;8:39—41. Mariano F, Tetta C, Montrucchio G, Cavalli PL, Camussi G. Role of alpha l-proteinase inhibitor in restraining peritoneal inflammation in CAPD patients. Kidney Int 1992 Sep;42(3):735—42. Mawhinney WM, Adair CG, Gorman SP, McClurg B. Stability of vancomycin hydrochloride in peritoneal dialysis solution. Am J Hosp Pharm 1992;49(1): 137-9. Melita—Manoli H, Vatopoulos A, Toutouza M, Drivas G, Katirtzoglou A. The significance of slime- producing coagulase—negative staphylococci in CAPD peritonitis. Clin Nephrol 1993;39(2):111. Melocoton T, Kuhn M, Foley J, Holloway M, Ingles S, Salusky IB. Infectious complications in children on CAPD-CCPD: a ten years experience at a single center [abstract]. J Am Soc Nephrol 1991;2(3):365. Merchant MR, Anwar N, Were A, Uttley L, Tooth IA, Gokal R. Imipenem versus netilmicin and vancomycin in the treatment of CAPD peritonitis. Adv Perit Dial 1992;82234—7. Millikin SP, Matzke GR, Keane WF. Antimicrobial treatment of peritonitis associated with continuous ambulatory peritoneal dialysis. Perit Dial Int 1991; 11(3):252—60. Comment in: Perit Dial Int 1991; 11(3):206. Murphy G, Tzamaloukas AH, Eisenberg B, Gibel LJ, Avasthi PS. Intraperitoneal thrombolytic agents in relapsing or persistent peritonitis of patients on continuous ambulatory peritoneal dialysis. Int J Artif Organs 1991 Feb;14(2):87—91. Murugasu B, Conley SB, Lemire JM, Portman RJ. Fungal peritonitis in children treated with peritoneal dialysis and gastrostomy feeding. Pediatr Nephrol 1991 Sep;5(5):6ZO-1. Nagappan R, Collins IF, Lee WT. ‘Fungal peritonitis in continuous ambulatory peritoneal dialysis--the Auckland experience. Am J Kidney Dis 1992 Nov; 20(5):492—6. Nankivell BJ, Lake N, Gillies A. Intracatheter streptokinase for recurrent peritonitis in CAPD. Clin Nephrol 1991 Jan;35(1):20-3. Comment in: Clin Nephrol 1991 Oct;36(4):214. Neiberger R, Aboushaar MH, Tawan M, Fennell R, Iravani A, Richard G. Peritonitis in children on chronic peritoneal dialysis: analysis at 10 years. Adv Perit Dial 1991;7:272-4. Nielsen H, Espersen F, Kharazmi A, Antonsen S, Ejlersen E, Joffe P, Pedersen FB. Specific opsonic activity for staphylococci in peritoneal dialysis effluent during continuous ambulatory peritoneal dialysis. Am J Kidney Dis 1992 Oct;20(4):372-5. Nye KJ, Gibson SP, Nwosu AC, Manji MR, Robinson BH, Hawkins JB. Single-dose intraperitoneal vancomycin and oral ciprofloxacin for the treatment of peritonitis in CAPD patients: preliminary report. Perit Dial Int 1993;13(1):59-60. O’Donoghue D, Manos J, Pearson R, Scott P, Bakran A, Johnson R, Dyer P, Martin S, Gokal R. Continuous ambulatory peritoneal dialysis and renal transplantation: a ten-year experience in a single center. Perit Dial Int 1992;12(2):242, 245-9. Olivas E, Jimenez C, Lopez A, Andres E, Sanchez Tarraga L. Reduction of the incidence of peritonitis in CAPD: effectiveness of heat sterilization of Safe.Lock connectors. Contrib Nephrol 1991;89: 62-7. Pasadakis P, Thodis E, Euthimiadou A, Panagoutsos S, Oustoglou E, Kartali S, Vargemezis V. Treatment of CAPD peritonitis with clavulanate potentiated ticarcillin. Adv Perit Dial 1992;8:238-41. Peer G, Serban I, Blum M, Cabili S, Iaina A. Early diagnosis of gram-negative peritonitis in continuous ambulatory peritoneal dialysis patients with the Lymulus amebocyte lysate assay. Am J Nephrol 1992;12(1-2):19-21. Perez-Fontan M, Rodriguez-Carmena A, Fernandez- Rivera C, Moncalian-Leon J. Aspergillus peritonitis complication continuous ambulatory peritoneal dialysis [letter]. Nephron 1991;57(4):493-4. Perez-Fontan M, Rosales M, Fernandez F, Moncalian J, Femandez-Rivera C, Alonso A, Valdes F. Ciprofloxacin in the treatment of gram-positive bacterial peritonitis in patients undergoing CAPD. Perit Dial Int 1991;11(3):233-6. Phua RT, Winney IR, Ghosh HK. The microbiology of peritonitis in continuous ambulatory peritoneal dialysis--experience in a provincial centre 1986-1989. Pathology 1991 Oct;23(4):344—5. Piraino B, Bemardini J, Centa PK, Johnston JR, Sorkin MI. The effect of body weight on CAPD related infections and catheter loss. Perit Dial Int 1991; 11(1):64—8. Piraino B, Bemardini J, Holley JL, Perlmutter JA. Increased risk of Staphylococcus epidermidis peritonitis in patients on dialysate containing 1.25 mmol/L calcium. Am J Kidney Dis 1992 Apr;19(4): 371-4. Port FK, Held PJ, Nolph KD, Turenne lva, Wolfe RA. Risk of peritonitis and technique failure by CAPD connection technique: a national study. Kidney Int 1992 Oct;42(4):967—74. Pylypchuk GB, Conly J, Kappel JE, Stein K, Rennie R. Sensitivity of CAPD/IPD peritonitis organisms to ciprofloxacin. Adv Perit Dial 1991;7z135-7. Reddingius RE, Schroder CH, Monnens LA. Intraperitoneal administration of recombinant human erythropoietin in children on continuous ambulatory 81 peritoneal dialysis. Eur J Pediatr 1992 Jul;151(7): 540-2. Richards NT, Clarke A, Condon S, Elliot T, Adu D, Michael J. Elimination of CAPD catheter exit site infection due to staphylococcus-aureus with peri- operative antiseptics [abstract]. Nephrol Dial Transplant 1992;7(7):745. Rotellar C, Black J, Winchester J F, Rakowski TA, Mosher WF, Mazzoni MJ, Amiranzavi M, Garagusi V, Alijani MR, Argy WP. Ten years’ experience with continuous ambulatory peritoneal dialysis. Am J Kidney Dis 1991 Feb;17(2):158-64. Rubin J, Herrera GA, Collins D. An autopsy study of the peritoneal cavity from patients on continuous ambulatory peritoneal dialysis. Am J Kidney Dis 1991 Ju1;18(1):9’7-102. Sanyal D, Bhandari S. CAPD peritonitis caused by Lactobacillus rhamnosus [letter]. J Hosp Infect 1992;22(4):325-7. Schloth T, Genabe I, Pilgrim W, Jorden A, Fein PA, Avram MM. Peritonitis and the patient with human immunodeficiency virus (HIV). Adv Perit Dial 1992;8z250-2. Schroder CH, de Jong MC, Monnens LA. Group B streptococcus: an unusual cause of severe peritonitis in young children treated with continuous ambulatory peritoneal dialysis. Am J Kidney Dis 1991 Feb;17(2):231—2. Selgas R, Castro MJ, Bajo MA, Femandez—Reyes MJ, Lopez-Revuelta K, Romero JR, de Alvaro F, Borrego F, Rinon C. Staphylococcus aureus nasal carrier status (SANCS) in CAPD patients; is it induced or favored by subcutaneous rHu- erythropoietin? Adv Perit Dial 1992;8:253-7. Shelton DM. A comparison of the effects of two antiseptic agents on Staphylococcus epidermidis colony forming units at the peritoneal dialysis catheter exit site. Adv Perit Dial 1991;72120—4. Shulman LM, Rudich C, Sayar Y, Goldfeld G, Mendelson B, Blau A, Vonsover A. Detection of CMV-DNA in cells from peritoneal fluid of IPD/CAPD patients by polymerase chain reaction. Adv Perit Dial 1992;8:258-64. Shusterman NH, Jacobs J. Management of refractory peritonitis to maintain the peritoneum for subsequent dialysis. Perit Dial Int 1992;12(2): 211-3. Smith JA. Treatment of intra-abdominal infections with quinolones. Eur J Clin Microbiol Infect Dis 1991 Apr;10(4):330-3. Stegmayr BG, Granbom L, Tranaeus A, Wikdahl AM. Reduced risk for peritonitis in CAPD with the use 82 of a UV connector box. Perit Dial Int 1991;11(2): 128-30. Strauss FG, Holmes DL, Dennis RL, Nortman DF. Pre-spiking dialysate bags: improved peritonitis prevention in patients on CAPD. Adv Perit Dial 1991;7zl93-5. Swartz R, Messana J, Reynolds J, Ranjit U. Simultaneous catheter replacement and removal in refractory peritoneal dialysis infections. Kidney Int 1991 Dec;40(6):1160-5. Swartz R, Messana J, Starmann B, Weber M, Reynolds J. Preventing Staphylococcus aureus infection during chronic peritoneal dialysis. J Am Soc Nephrol 1991 Dec;2(6):1085-91. Taber TE, Hegeman TF, York SM, Kinney RA, Webb DH. Treatment of Pseudomonas infections in peritoneal dialysis patients. Perit Dial Int 1991; 11(3):213-6. Tan HW, Kon SP, Chua CT, Ngeow NF. Oral pefloxacin in the treatment of CAPD peritonitis. Med J Malaysia 1992 Jun;47(2):128-33. Thomas CA, Interwies EW, Ziegler BL, Vlaehojanis J, Kurz P, Shah PM. Bactericidal activity of human peritoneal macrophages from patients undergoing peritoneal dialysis. Nat lmmun Cell Growth Regul 1991;10(1):12-s. Valdez JM, Asperilla MO, Smego RA Jr. Acinetobacter peritonitis in patients receiving continuous ambulatory peritoneal dialysis. South Med J 1991 May;84(5):607—10. Valeri A, Radhakrishnan J, Vemocchi L, Carmichael LD, Stern L. The epidemiology of peritonitis in acute peritoneal dialysis: a comparison between open- and closed-drainage systems. Am J Kidney Dis 1993 Mar;21(3):300-9. van Asseldonk JP, Schroder CH, Severijnen RS, de Jong MC, Monnens LA. Infectious and surgical complications of childhood continuous ambulatory peritoneal dialysis. Eur J Pediatr 1992 May;151(5): 377-80. van der Hulst RJ, Boeschoten EW, Nielsen FW, Struijk DG, Dreschler WD, Tange RA. Ototoxicity monitoring with ultra-high frequency audiometry in peritoneal dialysis patients treated with vancomycin or gentamicin. ORL J Otorhinolaryngol Relat Spec 1991;53(1):19—22. Verrina E, Edefonti A, Bassi S, Perfumo F, Zacchello G, Andreetta B, Caringella D, Lavoratti G, Picca M, Rinaldi S, et al. Peritonitis in children undergoing chronic peritoneal dialysis (CPD): data from the Italian Registry of Pediatric CPD. Adv Perit Dial 1992;82419-22. Viglino G, Cancarini G, Catizone L, Cocchi R, de Vecchi A, Lupo A, Salomone M, Segoloni GP, Giangrande A. The impact of peritonitis on CAPD results. Adv Perit Dial 1992;8:269-75. von Graevenitz A, Amsterdam D. Microbiological aspects of peritonitis associated with continuous ambulatory peritoneal dialysis. Clin Microbiol Rev 1992 Jan;5(1):36—48. Wadhwa NK, Cabralda T, Suh H, Kvilekval K, Mason R. Exit-site/tunnel infection and catheter outcome in peritoneal dialysis patients. Adv Perit Dial 1992;8z 325-7. Waite NM, Johnson MD, Webster NR, Fong IW. Poor response to oral ciprofloxacin in the treatment of peritonitis in patients on intermittent peritoneal dialysis. Perit Dial Int 1993;13(1):50-4. Wang T, Ye R, Li H. Treatment of resistant peritonitis by temporary discontinuation of peritoneal dialysis [abstract]. J Am Soc Nephrol 1992;3(3):420. Weber J, Kuhlmann U. Intraperitoneal cefazolin and gentamicin in the management of CAPD-related peritonitis. Contrib Nephrol 1991;89:108-18. Were AJ, Marsden A, Tooth A, Ramsden R, Mistry CD, Gokal R. Netilmycin and vancomycin in the treatment of peritonitis in CAPD patients. Clin Nephrol 1992 Apr;37(4):209-13. Wilcox MH, Finch RG, Burden RP, Morgan AG. Peritonitis complicating continuous ambulatory peritoneal dialysis in Nottingham 1983-1988. J Med Microbiol 199l;34(3):137—41. Wilcox MH, Geary I, Spencer RC. In-vitro activity of irnipenem, in comparison with cefuroxime and ciprofloxacin, against coagulase—negative staphylococci in broth and peritoneal dialysis fluid. J Antimicrob Chemother 1992 Jan;29(1):49-55. Wilcox MH, Williams P, Smith DG, Modun B, Finch RG, Denyer SP. Variation in the expression of cell envelope proteins of coagulase—negative staphylococci cultured under iron-restricted conditions in human peritoneal dialysate. J Gen Microbiol 1991 Nov;137(Pt 11):2561-70. Williams JD, Coles GA. Gram-positive infections related to CAPD. J Antimicrob Chemother 1991 Apr;27 Suppl B:31-5. Williams JD, Dharmasena D, Coles GA, Harding 1. Short course antimicrobial therapy in CAPD-related peritonitis. Int J Antimicrob Agents 1992;1 Suppl 1: 521-4. Winchester JF, Rotellar C, Rakowski TA, Argy WP, Schreiner GE. Assist devices used in the prevention of peritonitis in the USA. Contrib Nephrol 1991;89: 748. Wood C], Fleming V, Turnidge J, Thomson N, Atkins RC. Campylobacter peritonitis in continuous ambulatory peritoneal dialysis: report of eight cases and a review of the literature. Am J Kidney Dis 1992 Mar;19(3):257-63. Yamalik N, Delilbasi L, Gulay H, Caglayan F, Haberal M, Caglayan G. The histological investigation of gingiva from patients with chronic renal failure, renal transplants, and periodontitis: a light and electron microscopic study. J Periodontol 1991 Dec; 62(12):737-44. Yuen KY, Seto WH, Ching TY, Cheung WC, Kwok Y, Chu YB. An outbreak of Candida tropicalis peritonitis in patients on intermittent peritoneal dialysis. J Hosp Infect 1992;22(1):65-72. Zaruba K, Peters I, Jungbluth H. Successful prophylaxis for fungal peritonitis in patients on continuous ambulatory peritoneal dialysis: six years’ experience. Am J Kidney Dis 1991 Jan;17(1):43-6. Published erratum appears in Am J Kidney Dis 1991 Jun;17(6):726. Zimmerman SW, 0xton L, Roecker E, Wakeen M, Johnson CA. Risk factors for peritoneal dialysis (PD) related infections [abstract]. I Am Soc Nephrol 1991;2(3):371. 83 Other Dialysis-Related Problems -Clinical Trials Acute intradialytic well-being: results of a clinical trial comparing polysulfone with cuprophan. Bergamo Collaborative Dialysis Study Group. Kidney Int 1991 Oct;40(4):714-9. Akpolat T, Ozdemir O, Arik N, Demirkan F, Sungur C, Ozcebe O, Dundar S, Yasavul O, Turgan C, Kirazli S, Calgar S. Effect of desmopressin (DDAVP) on protein C and protein C inhibitors in uremia. Nephron 1993;64(2):232-4. Balaskas EV, Uldall RP. Erythropoietin treatment does not improve uremic pruritus. Peritoneal Dial Int 1992;12(3):330—1. Bellomo R, Tipping P, Boyce N. Continuous veno- venous hemofiltration with dialysis removes cytokines from the circulation of septic patients. Crit Care Med 1993 Apr;21(4):522—6. Borin MT, Hughes GS, Kelloway I S, Shapiro BE, Halstenson CE. Disposition of cefpodoxime proxetil in hemodialysis patients. J Clin Pharmacol 1992 Nov;32(11):1038—44. Cheung AK, Dalpias D, Emmerson R, Leypoldt JK. A prospective study on intradialytic symptoms associated with reuse of hemodialyzers. Am J Nephrol 1991;11(5):397-401 . Kindler J. Torasemide in advanced renal failure. Cardiovasc Drugs Ther 1993 Jan;7 Suppl 1:75-80. Morniere P, Maurouard C, Boudailliez B, Westeel PF, Achard JM, Boitte F, e1 Esper N, Compagnon M, Maurel G, Bouillon R, et a1. Prevention of hyperparathyroidism in patients on maintenance dialysis by intravenous l-alpha-hydroxyvitamin D3 in association with Mg(OH)2 as sole phosphate binder. A randomized comparative study with the association CaC03 +/- Mg(OH)2. Nephron 1992; 60(2): 154-63 . Roca A0, Jarjoura D, Blend D, Cugino A, Rutecki GW, Nuchikat PS, Whittier FC. Dialysis leg cramps. Efficacy of quinine versus vitamin E. ASAIO I 1992 Jul-Sep;38(3):M481-5. Ryan KE, Lane DA, Flynn A, Ireland H, Boisclair M, Shepperd J, Curtis J R. Antithrombotic properties of dermatan sulphate (MF 701) in haemodialysis for chronic renal failure. Thromb Haemost 1992 Nov 10;68(5):563-9. Ryan KE, Lane DA, Flynn A, Shepperd J, Ireland HA, Curtis JR. Dose finding study of a low molecular weight heparin, Innohep, in haemodialysis. Thromb Haemost 1991 Sep 2;66(3):277-82. Salusky IB, Foley J, Nelson P, Goodman WG. Aluminum accumulation during trmtment with aluminum hydroxide and dialysis in children and young adults with chronic renal disease. N Engl J Med 1991 Feb 21;324(8):527-31. Comment in: N Engl J Med 1991 Feb 21;324(8):558-9; N Engl J Med 1991 Jul 18;325(3):208-9. Schiffl H, Strasser T. Hemodialysis-related leukotriene B4 generation and neutropenia during calcium channel blockade. Biomater Artif Cells Immobilization Biotechnol 1991 ; l9(1):85-96. Schmith VD, Piraino B, Smith RB, Kroboth PD. Alprazolam in end-stage renal disease: I. Pharmacokinetics. J Clin Pharmacol 1991 Jun; 31(6):571-9. Schmith VD, Piraino B, Smith RB, Kroboth PD. Alprazolam in end-stage renal disease. II. Pharmacodynamics. Clin Pharmacol Ther 1992 May;51(5):533-40. Siami G, Clinton ME, Mrak R, Griffis J, Stone W. Evaluation of the effect of intravenous L—carnitine therapy on function, structure and fatty acid metabolism of skeletal muscle in patients receiving chronic hemodialysis. Nephron 1991;57(3):306-13. -0ther Ackrill P, Day JP. The use of desferrioximine in dialysis-associated aluminium disease. Contrib Nephrol 1993;102:125-34. Adamson AS, Kelleher JP, Snell ME, Hulme B. Endoscopic placement of CAPD catheters: a review of one hundred procedures. Nephrol Dial Transplant 1992;7(8):855-7. Agarwal A, Anand IS, Sakhuja V, Chugh KS. Effect of dialysis and renal transplantation on autonomic dysfunction in chronic renal failure. Kidney Int 1991 Sep;40(3):489—95. Ahmed A, Shapiro WB, Porush JG. The use of tissue plasminogen activator to declot arteriovenous accesses in hemodialysis patients. Am J Kidney Dis 1993 Jan;21(1):38-43. Akizawa T, Kinugasa E, Koshikawa S. Endothelin and platelet activating factor. Possible indices for biocompatibility of hemodialysis. ASAIO Trans 1991 Jul-Sep;37(3):M384—5. Alam SM, Bhatt AK. Abnormal lipoprotein in uraemic patients treated conservatively and by maintenance haemodialysis. J Assoc Physicians India 1991 Feb; 39(2):170—1. Alexiewicz JM, Smogorzewski M, Fadda GZ, Massry SG. Impaired phagocytosis in dialysis patients: studies on mechanisms. Am J Nephrol 1991;11(2): 102—11. Alfrey AC. Aluminum and renal disease. Contrib Nephrol 1993;102:110—24. Ali AA, Varghese Z, Moorhead IF, Baillod RA, Sweny P. Calcium set point progressively worsens in hemodialysis patients despite conventional oral 1- alpha hydroxycholecalciferol supplementation. Clin Nephrol 1993 Apr;39(4):205—9. Allon M, Dansby L, Shanklin N. Glucose modulation of the disposal of an acute potassium load in patients with end-stage renal disease. Am J Med 1993 May;94(5):475-82. Allon M, Shanklin N. Adrenergic modulation of extrarenal potassium disposal in men with end-stage renal disease. Kidney Int 1991 Dec;40(6):1103-9. Allon M, Takeshian A, Shanklin N. Effect of insulin- plus-glucose infusion with or without epinephrine on fasting hyperkalemia. Kidney Int 1993 Jan;43(1): 212-7. Alvarez V, Pulido R, Campanero MR, Paraiso V, de Landazuri MO, Sanchez-Madrid F. Differentially regulated cell surface expression of leukocyte adhesion receptors on neutrophils. Kidney Int 1991 Nov;40(5):899-905. Anderson J, Briefel G, Jones JM, Ryu JH, McGuire M, Yun YP. Effects of acetate dialysate on transforming growth factor beta 1, interleukin, and beta 2-microglobulin plasma levels. Kidney Int 1991 Dec;40(6):lllo-7. Ani M, Moshtaghie AA. The effect of chromium on parameters related to iron metabolism. Biol Trace Elem Res 1992;32:57-64. Annenkov AY, Strokov AG, Baranova FS. Alterations in mononuclear cell tumour necrosis factor-alpha (TNF-alpha) response in patients on long term cuprophane haemodialysis. Clin Exp Immunol 1992 0ct;90(1):49-55. Aoyagi R, Miura Y, Ishiyama T, Maruyama Y, Hasegawa H. Influence of dialysis membranes on the development of dialysis associated osteoarthropathy. Kidney Int Suppl 1993;41:8111-5. Appel G. Lipid abnormalities in renal disease [clinical conference]. Kidney Int 1991 Jan;39(1):169-83. Arakawa M, Gejyo F, Shimotori T, Ei K, Oda M, Obata N, Kobayashi N, Kobayashi K, Nagao M, Kawada K, Yada S, Ota T, Watanabe K, Hirasawa Y, Suzuki M, Ohmori H, Miyamura S, Suzuki K, et al. Long-term multicentre study of beta 2- microglobulin removal by PMMA BK membrane. Nephrol Dial Transplant 1991;6 Suppl 2:69-74. Araki T, Ueda M, Ogawa K, Tsuji T. Histological pancreatitis in end-stage renal disease. Int J Pancreatol 1992 Dec;12(3):263-9. Arduino MJ, Bland LA, Aguero SM, Favero MS. Effects of incubation time and temperature on microbiologic sampling procedures for hemodialysis fluids. J Clin Microbiol 1991 Jul;29(7):1462-5. Argiles A, Derancourt J, Jauregui—Adell J, Mion C, Demaille JG. Biochemical characterization of serum and urinary beta 2 microglobulin in end-stage renal disease patients. Nephrol Dial Transplant 1992; 7(11):1106-10. Argiles A, Kerr PG, Canaud B, Flavier JL, Mion C. Calcium kinetics and the long-term effects of lowering dialysate calcium concentration. Kidney Int 1993 Mar;43(3):630—40. Asai K, Miura S, Kawahara H, Toriyama T, Kuzuya F. A comparative study of atherosclerosis and osteopenia in elderly and young hemodialysis patients. Aging (Milano) 1991 Mar;3(1):79-87. Ashton DN, Mehta RL, Ward DM, McDonald BR, Aguilar MM. Recent advances in continuous renal replacement therapy: citrate anticoagulated continuous arteriovenous hemodialysis. ANNA J 1991 Jun;18(3):263-7, 329. Athanasou NA, Ayers D, Rainey AJ, Oliver DO, Duthie RB. Joint and systemic distribution of dialysis amyloid. Q J Med 1991 Mar;78(287): 205- 14. Attman PO, Alaupovic P. Lipid and apolipoprotein profiles of uremic dyslipoproteinemia--relation to renal function and dialysis. Nephron 1991;57(4): 401- 10. Attman PO, Knight-Gibson C, Tavella M, Samuelsson O, Alaupovic P. Increased concentrations of Apo B- containing triglyceride-rich lipoprotein particles in patients with chronic renal failure. Miner Electrolyte Metab 1992;18(2-5):199-202. Ayers DC, Athanasou NA, Woods CG, Duthie RB. Dialysis arthropathy of the hip. Clin Orthop 1993 May;(290):216-24. Balfe J W. Longterm complications of CAPD and CCPD [abstract]. Pediatr Nephrol 1992;5:C39. Ballard J L, Bunt TJ, Malone J M. Major complications of angioaccess surgery. Am J Surg 1992 Sep; 164(3):229-32. Bambauer R, Mestres P, Pirrung KJ. Frequency, therapy, and prevention of infections associated with large bore catheters. ASAIO J 1992 Apr-Jun; 38(2):96-101. Bambauer R, Schmidt R, Falkenhagen D, Walther J, Jung WK. Sterile and endotoxin-free dialysis fluid for hemodialysis. Biomater Artif Cells Immobilization Biotechnol 1991;19(1):71-83. 85 Bandiani G, Camaiora E, Farina D, Nicolini MA, Perotta U, Tagliazucchi A. Long-term influence of dialysis treatment of beta 2-microglobulin, interleukin-2 R and tumour necrosis factor. Nephrol Dial Transplant 1991;6 Suppl 2:61-3. Bargman J M. Complications of peritoneal dialysis related to increased intraabdominal pressure. Kidney Int Suppl 1993 Feb;40:S75-80. Baris E, McGregor M. The reuse of hemodialyzers: an assessment of safety and potential savings. Can Med Assoc J 1993 Jan 15;148(2):175-83. Published erratum appears in Can Med Assoc J 1993 Apr 15; 148(8):1278. Bartels PC, Helleman PW, Soons JB. Haemodialysis- induced changes in red blood cell size-distribution histograms. Scand J Clin Lab Invest 1991 Feb; 51(1):53-7. Baz M, Durand C, Ragon A, Jaber K, Andrieu D, Merzouk T, Purgus R, Olmer M, Reynier JP, Berland Y. Using ultrapure water in hemodialysis delays carpal tunnel syndrome. Int J Artif Organs 1991 Nov;14(11):681-5. Bazzi C, Pagani C, Sorgato G, Albonico G, Fellin G, D’Amico G. Uremic polyneuropathy: a clinical and electrophysiological study in 135 short- and long- term hemodialyzed patients. Clin Nephrol 1991 Apr;35(4):176-81. Comment in: Clin Nephrol 1991 Nov;36(5):265—6. Beasley D, Brenner BM. Role of nitric oxide in hemodialysis hypotension. Kidney Int Suppl 1992 Oct;38:S96-100. Beckers B, Brodersen HP, Stolpmann RM, Jansen G, Larbig D. Efficacy and pharmacokinetics of teicoplanin in hemodialysis patients. Infection 1993 Jan-Feb;21(1):7l-4. Bellazzi R, Romanini D, Bacchella L, Nai M, Aprile C, Santagostino M, De Vincenzi A. Acute effects of repetitive hemodialysis on circulating immunoreactive parathyroid hormone levels in uremic patients undergoing vitamin D (calcitriol) therapy. Nephron 1991;57(3):273-82. Bellinghieri G, Savica V, De Gregorio C, De Gregorio G, Console F. Evidence for Raynaud’s syndrome among haemodialyzed patients: influence of flunarizine treatment. Arch Ital Urol Nefrol Androl 1991 Mar;63(1):163-5. Ben-Ezer D, Shany S, Conforty A, Rapoport J, Edelstein S, Bdolah-Abram T, Kafka DR, Chaimovitz C. Oral administration of 24,25(OH)2D3 suppresses the serum parathyroid hormone levels of dialysis patients. Nephron 1991;58(3):283-7. Published erratum appears in Nephron 1991;59(3):524. 86 Bender FH, Bernardini J, Piraino B. Calcium mass transfer with dialysate containing 1.25 and 1.75 mmol/L calcium in peritoneal dialysis patients. Am J Kidney Dis 1992 Oct;20(4):367—71. Besbas N, Soylemezoglu 0, Saatci U, Bakkaloglu A, Arslan S, Gogus S, Topaloglu R. Peritoneal hemosiderosis in pediatric patients with nephrogenic ascites. Nephron 1992;62(3):292-5. Besselink RA, Schroder CH, van Oort AM. Influence of dialysate exchange on cardiac left ventricular function in children treated with CAPD. Perit Dial Int 1991;11(2):141-3. Biagini M, Malaguti M, Sicoli R, Capece R, Friggi A, Ciaffi G, Bargagna R. Treatment of uraemic hyperphosphatemia with calcium acetate: a safe alternative to calcium carbonate. Biomater Artif Cells Immobilization Biotechnol 1992;20(5):1193-9. Bicknell JM, Lim AC, Raroque HG Jr, Tzamaloukas AH. Carpal tunnel syndrome, subclinical median mononeuropathy, and peripheral polyneuropathy: common early complications of chronic peritoneal dialysis and hemodialysis. Arch Phys Med Rehabil 1991 May;72(6):378-81. Boelaert JR, De Baere YA, Geernaert MA, Godard CA, Van Landuyt HW. The use of nasal mupirocin ointment to prevent Staphylococcus aureus bacteraemias in haemodialysis patients: an analysis of cost-effectiveness. J Hosp Infect 1991; 19 Suppl Bz4l-6. Boelaert JR, Fenves AZ, Coburn J W. Deferoxamine therapy and mucormycosis in dialysis patients: report of an international registry. Am J Kidney Dis 1991 Dec;18(6):660-7. Bohler J, Donauer I, Schollmeyer P, Horl WH. Blood flow dependent granulocyte activation in membranes with and without complement activation. Adv Exp Med Biol 1991;297:215-24. Boje Rasmussen H, Teisner B, Bangsgaard-Petersen F, Yde—Andersen E, Kassem M. Quantification of fetal antigen 2 (FA2) in supernatants of cultured osteoblasts, normal human serum, and serum from patients with chronic renal failure. Nephrol Dial Transplant 1992;7(9):902-7. Bolla KI, Briefel G, Spector D, Schwartz BS, et a1. Neurocognitive effects of aluminum. Arch Neurol 1992 Oct;49(10):1021-6. Bolla KI, Milstien S, Briefel G, Wieler L, Kaufman S. Dihydropteridine reductase activity: lack of association with serum aluminum levels and cognitive functioning in patients with end-stage renal disease. Neurol l991;41(11):1806-9. Bonomini M, Palmieri PF, Evangelism M, Manfrini V, Albertazzi A. Zinc-mediated lymphocyte energy charge modification in dialysis patients. ASAIO Trans 1991 Jul-Sep;37(3):M387-9. Bosch BA, Schlebusch L. Neuropsychological deficits associated with uraemic encephalopathy. A r of 5 patients. S Afr Med J 1991 May 4;79(9): 560-2. Bosch T, Samtleben W, Thiery J, Gurland HJ, Seidel D. Reverse flux filtration: a new mode of therapy improving the efficacy of heparin-induced extracorporeal LDL precipitation in hyperlipidemic hemodialysis patients. Int J Artif Organs 1993 Feb; 16(2):75-85. Boulieu R, Bastien O, Bleyzac N. Pharmacokinetics of ganciclovir in heart transplant patients undergoing continuous venovenous hemodialysis. Ther Drug Monit 1993 Apr; 15(2): 105-7 . Brancaccio D, Avanzini G, Padovese P, Gallieni M, Franceschetti S, Panzica F, Anelli A, Colantonio G, Martinelli D, Bugiani O. Desferrioxamine infusion can modify EEG tracing in haemodialysed patients. Nephrol Dial Transplant 1991;6(4):264-8. Brancaccio D, Ghiggeri G, Garberi A, Anelli A, Ginevri F, Loggi G, Gusmano R. Purification and partial characterization of a new 85 KDa amyloidosis-related protein in chronic hemodialysis. Biochem Biophys Res Commun 1991 May 15; 176(3): 1037-43 . Brandi L, Daugaard H, Tvedegaard E, Nielsen PK, Egsmose C, Storm T, Olgaard K. Long-term suppression of secondary hyperparathyroidism by intravenous 1 alpha-hydroxyvitamin D3 in patients on chronic hemodialysis. Am I Nephrol 1992;12(5): 311-8. Breneman DL, Cardone I S, Blumsack RF, Lather RM, Searle EA, Pollack VE. Topical capsaicin for treatment of hemodialysis-related pruritus. J Am Acad Dermatol 1992 Jan;26(1):91-4. Brennan DC, Sommerfeld DL, Gordon JA. Treatment of HUS/'ITP [letter]. Am J Kidney Dis 1992;19(4): 391-3. Brown JH, Short CD, Mallick NP. Ischaemic heart disease, lipids and the kidney. Contrib Nephrol 1993;102:198-219. Brown KM. Isolated ascending colon ulceration in a patient with chronic renal insufficiency. JAMA 1992;84(2):185—7. Bruckner H, Hausch M. Gas chromatographic characterization of free D—amino acids in the blood serum of patients with renal disorders and of healthy volunteers. J Chromatogr 1993 Apr 21; 614(1):7-17. Brunet P, Jaber K, Berland Y, Baz M. Anaphylactoid reactions during hemodialysis and hemofiltration: role of associating AN69 membrane and angiotensin I-converting enzyme inhibitors. Am J Kidney Dis 1992 May;19(5):444-7. Bush A, Gabriel R. Pulmonary function in chronic renal failure: effects of dialysis and transplantation. Thorax 1991 Jun;46(6):424—8. Comment in: Thorax 1991 Nov;46(11):861; Thorax 1992 Sep;47(9):763. Buti M, Viladomiu L, Jardi R, Olmos A, Rodriguez JA, Bartolome J, Esteban R, Guardia J. Long-term immunogenicity and efficacy of hepatitis B vaccine in hemodialysis patients. Am J Nephrol 1992;12(3): 144-7. Comment in: Am J Nephrol 1992;12(6):477. Caillat-Zucman S, Gimenez JJ, Albouze G, Lebkiri B, Naret C, Jungers P, Bach JF. BLA genetic heterogeneity of hepatitis B vaccine response in hemodialyzed patients. Kidney Int Suppl 1993;41: 5157-60. Cameron J S. Treatment of end-stage renal failure due to diabetes in the United Kingdom. J Diabetes Complicat 1992;6(1):1-6. Campistol JM, Sole M, Bombi JA, Rodriguez R, Mirapeix E, Munoz-Gomez J, Revert 0W. In vitro spontaneous synthesis of beta 2-microglobulin amyloid fibrils in peripheral blood mononuclear cell culture. Am J Pathol 1992;141(1):241-7. Canaud B, Assounga A, Kerr P, Aznar R, Mion C. Failure of a daily haemofiltration programme using a highly permeable membrane to return beta 2— microglobulin concentrations to normal in haemodialysis patients. Nephrol Dial Transplant 1992;7(9):924—30. Canaud B, Nguyen QV, Garred LI, Nicolle R, Mion C. Reuse of "highly" permeable dialyzers with peroxyacetic acid as sole cleansing and disinfecting agent. ASAIO Trans 1991 Oct-Dec;37(4):653-7. Canavese C, Gurioli L, D’Amicone M, Cardelli R, Caligaris F, Bongiorno P, Amaud A, Mattiello G, Marchiori M. Kinetics of aluminoxamine and feroxamine chelates in dialysis patients. Nephron 1992;60(4):411-7. Cantu P, Mangano S, Masini M, Limido A, Crovetti G, DeFilippo C. Prevalence of antibodies against hepatitis C virus in a dialysis unit. Nephron 1992; 61(3):337-8. Canzanello VJ, Hylander-Rossner B, Sands RE, Morgan TM, Jordan J, Burkart JM. Comparison of 50% dextrose water, 25% mannitol, and 23.5% saline for the treatment of hemodialysis-associated muscle cramps. ASAIO Trans 1991 Oct-Dec;37(4): 649-52. Carozzi S, Nasini MG, Caviglia PM, Schelotto C, Pietrucci A. Peritoneal dialysis solution (PDS) calcium concentration regulates peritoneal fibroblast (PF) proliferation and peritoneal macrophage 87 (PMO) and lymphocyte (FLY) cytokine release [abstract]. J Am Soc Nephrol 1992;3(3):407. Carrera F, Silva JG, Pires C, Oliveira C. Prevalence of non-A non-B hepatitis and anti-HCV antibodies in a Portuguese dialysis population. Nephrol Dial Transplant 1992;7(9):913-6. Cepicky P, Sulkova S, Stroufova A, Roth Z, Burdova I. The correlation of serum prolactin level and psychic stress in women undergoing a chronic hemodialysis programme. Exp Clin Endocrinol 1992;99(2):7l—2. Chan CY, Lai KN, Lam AW, Li PK, Chung WW, French GL. Pharmacokinetics of parenteral imipenem/cilastatin in patients on continuous ambulatory peritoneal dialysis. J Antimicrob Chemother 1991 Feb;27(2):225—32. Chan PC, Ip MS, Pun KK. 1,25- Dihydroxycholecalciferol and peritoneal macrophage chemotaxis in patients on continuous ambulatory peritoneal dialysis. Nephron 1991;59(3): 434-9. Chan TM, Pun KK, Cheng 1K. Total and regional bone densities in dialysis patients. Nephrol Dial Transplant 1992;7(8):835-9. Chanard J, Vincent C, Caudwell V, Lavaud S, Toupance O, Wong T, Revillard JP. Beta 2- microglobulin metabolism in uremic patients who are undergoing dialysis. Kidney Int Suppl 1993;41: 883-7. Chandran PK, Lane T, Flynn CT. Patient and technique survival for blind and sighted diabetics on continuous ambulatory peritoneal dialysis: a ten- year analysis. Int J Artif Organs 1991 May;14(5): 262-8. Chassagne PH, Dhib M, Ait Said L, Joannides R, Geffroy-Josse S, Noel LH, La Loet X, Deshayes P. Spinal cord compression revealing a destructive arthropathy of the atlanto-occipital joint associated with beta-2 microglobulin amyloidosis in a haemodialysed patient [letter]. Br J Rheumatol 1992;31(6):427-8. Chaudhry A, Stone WJ, Breyer J A. Occurrence of pyuria and bacteriuria in asymptomatic hemodialysis patients. Am J Kidney Dis 1993 Feb;21(2):180-3. Chauveau P, Courouce AM, Lemarec N, Naret C, Poignet JL, Girault A, Ramdame M, Delons S. Antibodies to hepatitis C virus by second generation test in hemodialyzed patients. Kidney Int Suppl 1993;41:S149-52. Chazot C, Chazot I, Charra B, Terrat JC, Vanel T, Calemard E, Ruffet M, Laurent G. Functional study of hands among patients dialysed for more than 10 years. Nephrol Dial Transplant 1993;8(4):347-51. 88 Cheng 1K, Chan DT, Lok AS. Hepatitis C infection among renal transplant recipients: a comparative study using first- and second-generation anti-HCV EIA and HCV detection by nested PCR. Transplant Proc 1993;25(1 Suppll): 1460-2. Cheung AK, Hohnholt M, Gilson J. Adherence of neutrophils to hemodialysis membranes: role of complement receptors. Kidney Int 1991 Dec;40(6): 1123-33. Cheung AK, Parker CJ, Hohnholt M. Beta 2 integrins are required for neutrophfl degranulation induced by hemodialysis membranes. Kidney Int 1993 Mar; 43(3):649-60. Cheung AK, Parker CJ, Janatova J, Brynda E. Modulation of complement activation on hemodialysis membranes by immobilized heparin. J Am Soc Nephrol 1992 Feb;2(8):1328-37. Chew SL, Lins RL, Daelemans R, Zachee P, De Clerck LS, Vermylen J. Are antiphospholipid antibodies clinically relevant in dialysis patients? Nephrol Dial Transplant 1992;7(12):1194-8. Chiaramonte S, Tagger A, Ribero ML, Grossi A, Milan M, La Greca G. Prevention of viral hepatitis in dialysis units: isolation and technical management of dialysis. Nephron 1992;61(3):287-9. Chimata M, Nagase M, Suzuki Y, Shimomura M, Kakuta S. Pharmacokinetics of meropenem in patients with various degrees of renal function, including patients with end-stage renal disease. Antimicrob Agents Chemother 1993 Feb;37(2): 229-33. Christenson M, Fivush B, Racusen L. Safety of intraperitoneal calcium therapy in a rodent model. Adv Perit Dial 1992;8:15-7. Civati G, Guastoni C, Ballerini L, Perego A, Teatini U, Perrino ML, Benazzi E, Minetti L. Survival and morbidity in 200 chronic patients treated by high flux hemodialysis [abstract]. J Am Soc Nephrol 1992;3(3):359. Cleminson WG, Manchester KL, Diesel WJ, Margolius LP. Adenine nucleotide concentrations and energy charge in muscle of chronic haemodialysis patients. Nephron 1992;60(2):232-4. Cloarec-Blanchard L, Girard A, Houhou S, Grunfeld JP, Elghcui JL. Spectral analysis of short-term blood pressure and heart rate variability in uremic patients. Kidney Int Suppl 1992;37:814-8. Cobby MJ, Adler RS, Swartz R, Martel W. Dialysis- related amyloid arthropathy: MR findings in four patients. AJR Am J Roentgenol 1991 Nov;157(5): 1023-7. Cobby MJ, Martel W. Some commonly unrecognized manifestations of metabolic arthropathies. Clin Imaging 1992 Jan-Mar;16(1):1-14. Coburn JW. Mineral metabolism and renal bone disease: effects of CAPD versus hemodialysis. Kidney Int Suppl 1993 Feb;40:S92—100. Coen G, Mazzaferro S, Ballanti P, Bonucci E. PT H and bone markers of renal osteodystrophy in predialysis chronic renal failure. J Endocrinol Invest 1992; 15(9 Suppl 6):129-33. Cohen EP, Russell TJ, Garancis JC. Mast cells and calcium in severe uremic itching. Am J Med Sci 1992 Jun;303(6):360—5. Colombo P, Filiberti 0, Porcu M, Costantini L, Mangione A, Monzeglio C, Peona C. Prevalence of hepatitis C infection in a hemodialysis unit. Nephron 1992;61(3):326—7. Converse RL Jr, Jacobsen TN, Jost CM, Toto RD, Grayburn PA, Obregon TM, Fouad-Tarazi F, Victor RG. Paradoxical withdrawal of reflex vasoconstriction as a cause of hemodialysis—induced hypotension. J Clin Invest 1992 Nov;90(5):1657-65. Converse RL Jr, Jacobsen TN, Toto RD, Jost CM, Cosentino F, Fouad-Tarazi F, Victor RG. Sympathetic overactivity in patients with chronic renal failure. N Engl J Med 1992 Dec 31;327(27): 1912-8. Conway M, Catterall AP, Brown EA, Tibbs C, Gower PE, Curtis JR, Coleman J C, Murray—Lyon IM. Prevalence of antibodies to hepatitis C in dialysis patients and transplant recipients with possible routes of transmission. Nephrol Dial Transplant 1992;7( 12): 1226-9. Conz PA, Dante S, Bemardini D, Bertoncello V, La Greca G, Bevilacqua PA. Beta-Z-microglobulin and Helicobacter pylori infection in uraemic dialysed patients. J Gastroenterol Hepatol 1992 Mar-Apr; 7(2):l91-3. Copley JB, Hui SL, Leapman S, Slemenda CW, Johnston CC Jr. Longitudinal study of bone mass in end-stage renal disease patients: effects of parathyroidectomy for renal osteodystrophy. J Bone Miner Res 1993 Apr;8(4):415-22. Costagliola C, Di Benedetto A, Piccione V, Rinaldi E. The influence of hemodialysis of intraocular pressure. II. Evaluation of visual-field modifications over five years. Glaucoma 1991;13(1):6-8. Costagliola C, Mastropasqua L. The influence of hemodialysis on intraocular pressure. 111. Aqueous humor dynamics and tissue hydration. Ann Ophthalmol 1991 Jan;23(l):31-4. Crum R, Fairchild R, Bronsther 0, Dominic W, Ward D, Fernandez R, Brown MR. Neuroendocrinology of chronic renal failure and renal transplantation. Transplantation 1991 Nov;52(5):818-23. Cunningham I, Beer J, Coldwell RD, Noonan K, Sawyer N, Makin I-IL. Dialysate calcium reduction in CAPD patients treated with calcium carbonate and alfacalcidol. Nephrol Dial Transplant 1992; 7(1):63-8. Curry SH, Lorenz A, Henderson GN, Mars DR, Stacpoole PW. Haemodialysis studies with dichloroacetate. Eur J Clin Pharmacol 1991;40(6): 613-7. Da Porto A, Adami A, Susanna F, Calzavara P, Poli P, Castelletto MR, Amici GP, Teodori T, Okolicsanyi L. Hepatitis C virus in dialysis units: a multicenter study. Nephron 1992;61(3):309-10. Da Porto A, Poli P, Calzavara P, Castelletto MR, Adami A, Cascone C, Amici GP, Teodori T, Okolicsanyi L. Comparison between first- and second-generation test for anti-hepatitis C virus antibodies in hemodialysis patients. Nephron 1992; 61(3):367-8. Dahl E, Nordal KP, Halse J, Flatmark A. Pretransplant parathyroidectomy in renal failure: effects on bone histology and aluminum deposits during dialysis and afier kidney transplantation. Scand J Urol Nephrol 1992;26(3):283-8. Dalal S, Gandhi VC, Yu AW, Bhate DV, Said RA, Rahman MA, Ing TS. Penile calcification in maintenance hemodialysis patients. Urology 1992 Nov;40(5):422-4. Darbord JC, DeCool A, Goury V, Vincent F. Biofilm model for evaluating hemodialyzer reuse processing. Dial Transplant 1992;21(10):644-5, 649-50. D’Arcy PF. Anaphylactic reactions with high-flux polyacrylonitrile membranes and ACE inhibitors. Int Pharm J 1992;6(3):109. Darenkov AF, Yermolenko VM, Sinyukhin VN, Stetsyuk EA, Kochlov AP, Yarmolinski J S. Pathophysiological effects of a limulus amocbocyte- lysate-positive substance during haemodialysis. Nephrol Dial Transplant 1991;6 Suppl 3:62-5. Daudon M, Lacour B, Jungers P, Drueke T, Reveillaud RJ, Chevalier A, Bader CA. Urolithiasis in patients with end stage renal failure. J Urol 1992 Apr; 147(4):977-80. Davenport A, Shallcross TM, Crabtree JE, Davison AM, Will EJ, Heatley RV. Prevalence of Helicobacter pylori in patients with end-stage renal failure and renal transplant recipients. Nephron 1991;59(4):597-601. 89 David S, Canino F, Ferrari ME, Cambi V. The role of adsorption in beta 2-microglobulin removal. Nephrol Dial Transplant 1991;6 Suppl 2:64-8. De Broe ME, D’Haese PC, Couttenye MM, Van Landeghem GF, Lamberts LV. New insights and strategies in the diagnosis and treatment of aluminium overload in dialysis patients. Nephrol Dial Transplant 1993;8 Suppl 1:47-50. De Deyn PP, Saxena VK, Abts H, Borggreve F, D’Hooge R, Marescau B, Crols R. Clinical and pathophysiological aspects of neurological complications in renal failure. Acta Neurol Belg 1992;92(4):191-206. de Jonge FA, Pauwels EK, Hamdy NA. Scintigraphy in the clinical evaluation of disorders of mineral and skeletal metabolism in renal failure. Eur J Nucl Med 1991;18(10):839-55. De Meyer M, Wyns W, Dion R, Khoury G, Pirson Y, van Ypersele De Strihou C. Myocardial revascularization in patients on renal replacement therapy. Clin Nephrol 1991 Sep;36(3):l47—51. De Vecchi A, Scalamogna A, Paparella M, Colombini M, Rovellini A, Pini C, Castelnovo C. Effect of sirnvastatin in CAPD patients with hypercholcsterolemia. Adv Perit Dial 1992;8:331-3. de Vries JP, Olthof CG, Visser V, Kouw PM, van Es A, Donker JM, de Vries PM. Continuous measurement of blood volume during hemodialysis by an optical method. ASAIO J 1992 Jul-Sep;38(3): M181-5. Dedman DJ, Treffry A, Candy JM, Taylor GA, Morris CM, Bloxham CA, Perry RH, Edwardson JA, Harrison PM. Iron and aluminium in relation to brain ferritin in normal individuals and Alzheimer’s-disease and chronic renal-dialysis patients. Biochem J 1992 Oct 15;287(Pt 2):509-14. Deleixhe-Mauhin F, Krezinski JM, Rorive G, Pierard GE. Quantification of skin color in patients undergoing maintenance hemodialysis. J Am Acad Dennatol 1992 Dec;27(6 Pt 1):950-3. Deleixhe-Mauhin F, Pierard-Franchimont C, Krezinski JM, Rorive G, Pierard GE. Biometrological evaluation of the stratum corneum texture in patients under maintenance hemodialysis. Nephron l993;64(1):110-3. D’Elia JA, Weinrauch LA, Paine DF, Domey PE, Smith-Ossman SL, Williams ME, Kaldany A. Increased infection rate in diabetic dialysis patients exposed to cocaine. Am J Kidney Dis 1991 Sep; 18(3):349—52. Delmez IA. Calcitriol and secondary hyperparathyroidism in continuous ambulatory peritoneal dialysis patients. Perit Dial Int 1993; 13(2):95-7. 90 Delmez JA. Long-term complications of dialysis: pathogenetic factors with special reference to bone. Kidney Int Suppl 1993;41:5116-20. Delmez JA, Slatopolsky E. Hyperphosphatemia: its consequences and treatment in patients with chronic renal disease. Am J Kidney Dis 1992;19(4): 303- 17. Delorme JM, Guidoin R, Canizales S, Charara J, How T, Marois Y, Batt M, Hallade P, Ricci M, Picetti C, et a1. Vascular access for hemodialysis: pathologic features of surgically excised ePT FE grafts. Ann Vasc Surg 1992 Nov;6(6):517-24. Dentico P, Buongiomo R, Volpe A, Carlone A, Carbone M, Manno C, Proscia F, Pastore G, Schiraldi 0. Prevalence and incidence of hepatitis C virus (HCV) in hemodialysis patients: study of risk factors. Clin Nephrol 1992 Jul;38(1):49-52. Dentico P, Volpe A, Buongiorno R, Carlene A, Carbone M, Manno M. Hepatitis C virus in hemodialysis patients. Nephron 1992;61(3):307-8. Dentico P, Volpe A, Buongiorno R, Fiore G, Carbone M, Manno C, Pastore G, Schiraldi 0. Detection of antibodies to HCV in haemodialysis patients using two second generation ELISA tests. Ital J Gastroenterol 1993 Jan;25(1):19-22. Dentico P, Volpe A, Buongiomo R, Maracchione N, Carbone M, Manno C, Proscia F. Immunogenicity and efficacy of anti-hepatitis B vaccines in hemodialysis patients. Nephron l992;61(3):324-5. Deray G, Carayon A, Maistre G, Benhmida M, Masson F, Barthelemy C, Petitclerc T, Jacobs C. Endothelin in chronic renal failure. Nephrol Dial Transplant 1992;7(4):300-5. Derfler K, Kletter K, Balcke P, Heinz G, Dudczak R. Predictive value of thallium-ZOI-dipyridamole myocardial stress scintigraphy in chronic hemodialysis patients and transplant recipients. Clin Nephrol 1991 0ct;36(4):192—202. Descamps-Latscha B, Herbelin A. Long-term dialysis and cellular immunity: a critical survey. Kidney Int Suppl 1993;41:8135-42. Descamps-Latscha B, Herbelin A, Nguyen AT, de Groote D, Chauveau P, Verger C, Jungers P, Zingraff J. Soluble CD23 as an effector of immune dysregulation in chronic uremia and dialysis. Kidney Int 1993 Apr;43(4):878-84. DeSoi CA, Sahm DF, Umans JG. Vancomycin elimination during high-flux hemodialysis: kinetic model and comparison of four membranes. Am J Kidney Dis 1992 0ct;20(4):354-60. DeVita MV, Rasenas LL, Bansal M, Gleim GW, Zabetakis PM, Gardenswartz MH, Michelis MF. Assessment of renal osteodystrophy in hemodialysis patients. Medicine (Baltimore) 1992 Sep;71(5): 284-90. Dhawan A, Marwaha RK. Acute glomerulonephritis in multi-drug resistant Salmonella typhi infection. Indian Pediatr 1992 Aug;29(8):1039—41. Di Benedetto A, Bilotta E, Minale S, Tritto MC, Russo Spena S, Picardi E, Sorice P. Anti-HCV antibody presence in hemodialyzed patients: assessment after one year regarding some preventive measures chosen. Nephron 1992;61(3):356-7. Di Loreto M, Ferrante M, Panaro A, Sorino P, Collela V, Caringella DA. Hepatitis C virus antibodies in dialysis pediatric patients. Nephron 1992;61(3): 365-6. Di Maggio A, Annicchiarico R, De Siati M, Marangi A, Montemurro NE, Loperfido A, Prusciano F, Scatizzi A. Confirmation of high prevalence of hepatitis C antibodies in hemodialysis patients by second generation immunoblot assay. Nephron 1992;61(3):347-9. Diaz RJ, Washburn S, Cauble L, Siskind MS, Van Wyck D. The effect of dialyzer reprocessing on performance and beta 2-microglobulin removal using polysulfone membranes. Am J Kidney Dis 1993 Apr;21(4):405-10. Diebel L, Kmol R, Wilson RF, Mahajan S, Abu- Hamdan D, Thomas D. Gastric intramucosal acidosis in patients with chronic kidney failure. Surgery 1993;113(5):520—6. Dilena BA, White GH. Assessing acute parathyroid responsiveness in hemodialysis patients by measuring intact parathyrin in pre- and post-dialysis serum. Clin Chem 1991 Jul;37(7):1216-20. Dimkovic N, Djukanovic L, Radmilovic A, Bojic P, Juloski T. Uremic pruritus and skin mast cells. Nephron 1992;61(l):5-9. Dinarello CA. Interleukin-1 and tumor necrosis factor and their naturally occurring antagonists during hemodialysis. Kidney Int Suppl 1992;38:S68-77. Direskeneli H, Ozgun S, Ozener C, Lawrence R, Erman M, Sarsmaz N, Akoglu E. Anti-lymphocyte, anti-monocyte, and anti-endothelial cell antibodies in chronic haemodialysis patients. Nephrol Dial Transplant 1992;7(5):422—6. Docci D, Cipolloni PA, Mengozzi S, Baldrati L, Capponcini C, Feletti C. Immunogenicity of a recombinant hepatitis B vaccine in hemodialysis patients: a two-year follow-up. Nephron 1992; 61(3):352—3. Donati D, Degiannis D, Homer L, Gastaldi L, Raskova J, Raska K Jr. Immune deficiency in uremia: interleukin-2 production and responsiveness and interleukin-2 receptor expression and release. Nephron 1991 ;58(3) :268-75 . Donati D, Degiannis D, Homer L, Raska K Jr, Raskova J. Production and kinetics of interleukin-1 in hemodialysis. In vivo and in vitro study. Am J Nephrol 1991;11(6):451-8. Donnelly SM, Ali MA, Churchill DN. Effect of n-3 fatty acids from fish oil on hemostasis, blood pressure, and lipid profile of dialysis patients. J Am Soc Nephrol 1992 May;2(11):1634—9. Drueke TB. Beta-Z-microglobulin amyloidosis and renal bone disease. Miner Electrolyte Metab 1991;17(4): 261-72. Dryden MS, Samson A, Ludlam HA, Wing AJ, Phillips I. Infective complications associated with the use of the Quinton "Permcath" for long-term central vascular access in haemodialysis. J Hosp Infect 1991 Dec;19(4):257-62. Dueymes JM, Bodenes-Dueymes M, Mahe JL, Herman B. Detection of hepatitis B viral DNA by polymerase chain reaction in dialysis patients. Kidney Int Suppl 1993;41:8161—6. Duncan JM, Baldwin RT, Caralis JP, Cooley DA. Subclavian vein-to-right atrial bypass for symptomatic venous hypertension. Ann Thorac Surg 1991 Dec;52(6):1342-3. Durozard D, Pimmel P, Baretto S, Caillette A, Labeeuw M, Baverel G, Zech P. 31P NMR spectroscopy investigation of muscle metabolism in hemodialysis patients. Kidney Int 1993 Apr;43(4): 885-92. Ehn'ch JH, Rizzoni G, Brunner FP, Brynger H, Geerlings W, Fassbinder W, Raine AE, Selwood NH, Tufveson G. Combined report on regular dialysis and transplantation of children in Europe, 1989. Nephrol Dial Transplant 1991;6 Suppl 1: 37-47. Eisenhauer T, Muller U, Schuff-Werner P, Armstrong VW, Bosch T, Thiery J, Gurland H, Seidel D. Simultaneous heparin extracorporeal LDL precipitation and hemodialysis. First clinical experience. ASAIO Trans 1991 Jul-Sep;37(3): M494-6. Elisaf M, Tsianos E, Mavridis A, Dardamanis M, Pappas M, Siamopoulos KC. Antibodies against hepatitis C virus (anti-HCV) in haemodialysis patients: association with hepatitis B serological markers. Nephrol Dial Transplant 1991;6(7):476-9. Elisaf MS, Dardamanis MA, Papagalanis ND, Siamopoulos KC. Lipid abnormalities in chronic uremic patients. Response to treatment with gemfibrozil. Scand J Urol Nephrol 1993;27(1): 101-8. 91 Erdberg A, Korzets Z, Neufeld D, Rathaus M, Cordoba M, Bernheim J. Malignant hypertension: a possible precursor to the future development of mesenteric ischaemia in chronically haemodialysed patients. Nephrol Dial Transplant 1992;7(6):541-4. Ervo R, Faletti P, Magni S, Cavatorta F. Evaluation of treatments for the vaccination against hepatitis B + thymopentine. Nephron l992;61(3):371—2. Fanelli V, Sanna G, Solinas A. Expectation of impaired response to recombinant hepatitis B vaccination. Nephron 1992;61(3):293-5. Fantuzzi S, Caico S, Amatruda O, Cervini P, Abu- Turky H, Baratelli L, Donati D, Gastaldi L. Hemodialysis-associated cardiac arrhythmias: a lower risk with bicarbonate? Nephron 1991;58(2): 196-200. Faranna P, Cozzi G, Belloni M, Pedrini L. Immunization and vaccination protocol in hemodialysis patients with naturally acquired hepatitis B antibody. Nephron 1992;61(3):311-2. Favazza A, Motanaro D, Messa P, Antonucci'F, Gropuzzo M, Mioni G. Peritoneal clearances in hypertensive CAPD patients alter oral administration of clonidine, enalapril, and nifedipine. Perit Dial Int 1992;12(3):287-91. Felsenfeld AJ, Ross D, Rodriguez M. Hysteresis of the parathyroid hormone response to hypocalcemia in hemodialysis patients with low turnover aluminum bone disease. J Am Soc Nephrol 1991 Dec;2(6): 1136-43. Fleming SJ, Moran DM, Cooksley WG, Faoagali JL. Poor response to a recombinant hepatitis B vaccine in dialysis patients. J Infect 1991 May;22(3):251-7. Floege J. Diagnostic approaches to AB—amyloidosis. Blood Purif 1991;9(2):63-9. Floege J, Bartsch A, Schulze M, Shaldon S, Koch KM, Smeby LC. Clearance and synthesis rates of beta 2- microglobulin in patients undergoing hemodialysis and in normal subjects. J Lab Clin Med 1991 Aug; 118(2):153-65. Floege J, Koch KM, Shaldon S. AB—amyloidosis and monokines. Acta Med Biol 1991;39 Suppl:67-74. Floege J, Schaffer J, Koch KM, Shaldon S. Dialysis related amyloidosis: a disease of chronic retention and inflammation? Kidney Int Suppl 1992 Oct;38: $78-85. Floege J, Smeby L. Dialysis-related amyloidosis and high-flux membranes. Contrib Nephrol 1992;96: 124-37. Follis F, Miller KB, Paone RF, Wemly JA. Iatrogenic pseudoaneurysm of the innominate artery. Tex Heart Inst J 1992;19(4):294-6. 92 Fong IW, Capellan JM, Simbul M, Angel I. Infection of uteriovenous fistulas created for chronic haemodialysis. Scand J Infect Dis 1993 ;25(2): 215-20. . Ford PM. Arthropathies associated with renal disease including dialysis-related amyloid. Curr Opin Rheumatol 1992 Feb;4(1):63-7. Fournier A, Moriniere P, Ben Hamida F, cl Esjer N, Shenovda M, Ghazali A, Bouzernidj M, Achard J M, Westeel PF. Use of alkaline calcium salts as phosphate binder in uremic patients. Kidney Int Suppl 1992 Oct;38:S50-61. Franco E, Olivadese A, Valeri M, Albertoni F, Petrosillo N. Control of hepatitis B virus infection in dialysis units in Latium, Italy. Nephron 1992; 61(3):329-30. Frances GC, Kauh YC, Gittlen SD, Schulman ES, Besarab A, Goyal S, Burke JF Jr. Elevated plasma histamine in chronic uremia: effects of ketotifen on pruritus. Int J Dermatol 1991;30(12):8%9. Freiberg AA, Fish DN, Louis DS. Hand manifestations of oxalosis. J Hand Surg [Am] 1993;18(1):140-2. Frinak S, Polaschegg HD, Levin NW, Pohlod DJ, Dumler F, Saravolatz LD. Filtration of dialysate using an on-line dialysate filter. Int J Artif Organs 1991 Nov;14(11):691-7. Fujiyama S, Kawano S, Sato S, Sato T, Shimada H, Matsushita K, Hara M, Ito J. The prevalence of anti-HCV antibodies in hemodialysis patients. Gastroenterol Jpn 1991 Jul;26 Suppl 3:206—8. Fujiyama S, Kawano S, Sato S, Tanaka M, Goto M, Taura Y, Sato T, Kawahara T, Mizuno K. Prevalence of hepatitis C virus antibodies in hemodialysis patients and dialysis staff. Hepatogastroenterology 1992 Apr;39(2):161-5. Fukagawa M, Kurokawa K. Renal osteodystrophy and vitamin D derivatives: cellular mechanisms of hyperparathyroidism in uremia. J Nutr Sci Vitaminol (Tokyo) 1992;Spec No:96-9. Fukunishi I, Saito S, Ozaki S. The influence of defense mechanisms on secondary alexithymia in hemodialysis patients. Psychother Psychosom 1992; 57(1—2):50—6. Furlong T, Chan YL, Cornish C, McDowall D, Mahony J, Clifton-Bligh P. Immunoreactive serum calcitonin and skeletal histology in chronic renal failure. Nephron 1991;58(2):138-43. Furukawa A, Miyamoto T, Tamura M, Kawanishi Y, Numata A, Yuasa M, Imagawa A, Kagawa S. Study of factors related to hypotension in hemodialysis patients. Nippon Jinzo Gakkai Shi 1992 Apr;34(4):417-22. Gagne ER, Urena P, Leite-Silva S, Zingraff J, Chevalier A, Sarfati E, Dubost C, Drueke TB. Short— and long-term efficacy of total parathyroidectomy with immediate autografiing compared with subtotal parathyroidectomy in hemodialysis patients. J Am Soc Nephrol 1992 Oct;3(4): 1008-17. Gal G, Kiss E, Foldes J, Dombi A. Disinfection of regenerated dialyzers with ozone. Int J Artif Organs 1992 Aug;15(8):461-4. Gallieni M, Brancaccio D, Padovese P, Rolla D, Bedani P, Colantonio G, Bronzieri C, Bagni B, Tarolo G. Low-dose intravenous calcitriol treatment of secondary hyperparathyroidism in hemodialysis patients. Italian Group for the Study of Intravenous Calcitriol. Kidney Int 1992 Nov;42(5):1191-8. Ganss R, Aarseth HP, Nordby G. Prevention of hemodialysis associated hypoxemia by use of low- concentration bicarbonate dialysate. ASAIO J 1992 Oct-Dec;38(4):820—2. Garrett PI, Dewhurst AG, Morgan LS, Mason JC, Dathan J R. Renal disease associated with circulating antineutrophil cytoplasm activity. Q J Med 1992; 84(306):731-49. Gatland D, Tucker B, Chalstrey S, Keene M, Baker L. Hearing loss in chronic renal failure-hearing threshold changes following haemodialysis. J R Soc Med 1991 Oct;84(10):587-9. Gaughan WI, Beserab A, Stein HD, Sirota RA, Yudis M. Serum bactericidal activity for Yersinia enterocolitica in hemodialysis patients: effects of iron overload and deferoxamine. Am J Kidney Dis 1992 Feb;l9(2):144-8. Gault MH, Longerich L, Prabhakaran V, Purchase L. Ischemic heart disease, serum cholesterol, and apolipoproteins in CAPD. ASAIO Trans 1991 Jul-Sep;37(3):M513-4. Gehr TW, Sica DA, Grasela DM, Fakhry I, Davis J, Duchin KL. Fosinopril pharmacoldnetics and pharmacodynamics in chronic ambulatory peritoneal dialysis patients. Eur J Clin Pharmacol 1991; 41(2):165-9. Gejyo F, Homma N, Arakawa M. Long-term complications of dialysis: pathogenic factors with special reference to amyloidosis. Kidney Int Suppl 1993;41:878-82. Gejyo F, Homma N, Hasegawa S, Arakawa M. A new therapeutic approach to dialysis amyloidosis: intensive removal of beta 2-microglobu1in with adsorbent column. Artif Organs 1993 Apr;17(4): 240-3. Germain M, Harlow P, Mulhem J, Lipkowitz G, Braden G. Low protein catabolic rate and serum albumin correlate with increased mortality and abdominal complications in peritoneal dialysis patients. Adv Perit Dial 1992;8:113-5. Gerrits GP, Monnens LA, De Abreu RA, Schroder CH, Trijbels JM, Gabreels FJ. Disturbances of cerebral purine and pyrimidine metabolism in young children with chronic renal failure. Nephron 1991;58(3): 310-4. Giammaria U, De Meo F, Acitelli S, Tancredi M, Daniele M, Barnabei R, Maschio C. HCV infection in hemodialyzed patients: incidence and correlation with dialytic age. Nephron 1992;61(3):335-6. Giangrande A, Costanini S, Ballanti P, Castiglioni A, Caligara F, Pisoni B, Giordano R, Vernillo I, Berni S, Bonucci E. Bone mineral and aluminum concentrations in patients undergoing CAPD. Adv Perit Dial 1992;8:351-5. Gill DS, Fonleca VA, Barradas MA, Balliod R, Moorhead JF, Dandona P. Plasma histamine in patients with chronic renal failure and nephrotic syndrome. J Clin Pathol 1991 Mar;44(3):243-5. Gitelman HJ, Alderman FR, Perry SJ. Silicon accumulation in dialysis patients. Am J Kidney Dis 1992 Feb;19(2):140—3. Gladziwa U, Bares R, Klotz U, Dakshinamurty KV, Ittel TH, Seiler KU, Sieberth HG. Pharmacokinetics and pharmacodynamics of cisapride in patients undergoing hemodialysis. Clin Pharmacol Ther 1991 Dec;50(6):673-81. Gladziwa U, Ittel TH, Dakshinamurty KV, Schacht B, Riehl I, Sieberth HG. Secondary hyperparathyroidism and sonographic evaluation of parathyroid gland hyperplasia in dialysis patients. Clin Nephrol 1992 Sep;38(3):162—6. Gladziwa U, Wagner S, Kock R, Mann H, Sieberth HG. Sonographic evaluation of gallbladder motility in patients with end-stage renal disease on haemodialysis. Nephrol Dial Transplant 1992;7(8): 840-3. Glenn CM, Astley SJ, Watkins SL. Dialysis-associated seizures in children and adolescents. Pediatr Nephrol 1992 Mar;6(2):182-6. Glez-Gutierrez M, de Francisco AL, Sanz de Castro S, Ruiz JC, Prieto M, Garcia Fuentes M, Arias M. Interleukin-2 deficit in hemodialysis patients. Role of prostaglandins. Ren Fail 1992;14(4):563-9. Goldberg A, Korzets Z, Bernheim J, Mekori YA. Cutaneous responses to histamine, compound 48/80, and codeine in patients with chronic renal failure. Ann Allergy 1991 Nov;67(5):525—8. Goldberg IJ. Lipoprotein metabolism in normal and uremic patients. Am J Kidney Dis 1993;21(1): 87-90. 93 Gonzalez EA, Martin K]. Aluminum and renal osteodystrophy: a diminishing clinical problem. Trends Endocrinol Metab 1992;3(10):371-5. Gonzalez-Martin G, Thambo S, Paulos C, Vasquez I, . Paredes I. The pharmacokinetics of nifurtimox in chronic renal failure. Eur J Clin Pharmacol 1992; 42(6):671-3. Goodman WG, O’Connor J. Aluminum alters calcium influx and efflux from bone in-vitro. Kidney Int 1991;39(4):6(T2-7. Goodman WG, Salusky IB. Evolution of secondary hyperparathyroidism during oral calcitriol therapy in pediatric renal osteodystrophy. Contrib Nephrol 1991;90:189-95. Gora ML, Seth S, Visconti JA, Shields B, Bay W. Stability of dobutamine hydrochloride in peritoneal dialysis solutions. Am J Hosp Pharm 1991;48(6): 1234-7. Gordge MP, Neild GH. Platelets from patients on haemodialysis show impaired responses to nitric oxide. Clin Sci 1992 Sep;83(3):313-8. Gordge MP, Neild GH. Reduced sensitivity to nitric oxide in uraemic platelets [abstract]. J Am Soc Nephrol 1991;2(3):505. Goren A, Stankiewicz H, Goldstein R, Drukker A. Fish oil treatment of hyperlipidemia in children and adolescents receiving renal replacement therapy. Pediatrics 1991 Aug;88(2):265-8. Grammer LC, Harris KE, Shaughnessy MA, Dolovich 1, Patterson R, Evans S. Antibodies to toluene diisocyanate in patients with and without dialysis anaphylaxis. Artif Organs 1991 Feb;15(1):2-4. Grammer LC, Roberts M, Wiggins CA, Fitzsirnons RR, Ivanovich PT, Roxe DM, Patterson R. A comparison of cutaneous testing and ELISA testing for assessing reactivity to ethylene oxide-human serum albumin in hemodialysis patients with anaphylactic reactions. J Allergy Clin Immunol 1991 Mar;87(3):674—6. Greenberg A, Bernardini J, Piraino BM, Johnston JR, Perlmutter JA. Hemoperitoneum complicating chronic peritoneal dialysis: singlencenter experience and literature review. Am J Kidney Dis 1992 Mar; 19(3):252-6. Grekas D, Alivanis P, Kotzadamis N, Kiriazopoulou V, Pyrpasopoulos M, Tourkantonis A. Influenza vaccination in chronic hemodialysis patients. The effgct of zinc supplementation. Ren Fail 1992;14(4): 57 -8. Grenfell A, Bewick M, Snowden S, Watkins PI, Parsons V. Renal replacement for diabetic patients: experience at King’s College Hospital 1980-1989. Q J Med 1992 Nov-Dec;85(307-308):861-74. 94 Groome PA, Hutchinson TA, Prichard SS. ESRD treatment modality selection: which factors are important in the decision? Adv Perit Dial l991;7: 54-6. Grote J, Hausmann D, Daniel WG, Muegge A, Nikutta P, Bahlmann J, Lichtlen PR. Transesophageal echocardiographic assessment of superior vena cava thrombosis in patients with long-term central venous dialysis catheters [abstract]. Eur Heart J 1992; 13(Abstr Suppl):284. Gubertini G, Scorza D, Beccari M, Buccianti G, Costantino A, Spotti D, Graziani G. Prevalence of hepatitis C virus antibodies in hemodialyIis patients in the area of Milan. Nephron 1992;61(3):271-2. Gupta A, Yuan ZY, Balaskas EV, Khanna R, Oreopoulos DG. CAPD and pancreatitis: no connection. Perit Dial Int l992;12(3):309—16. Halevy A, Halpern Z, Negri M, Hod G, Weissgarten J, Averbukh Z, Modai D. Pulse oximetry in the evaluation of the painful hand after arteriovenous fistula creation. J Vasc Surg 1991 Oct;14(4):537-9. Halstenson CE, Kelloway J S, Affiime MB, Lin CC, Teal MA, Shapiro BE, Awni WM. Isepamicin disposition in subjects with various degrees of renal function. Antimicrob Agents Chemother 1991 Nov; 35(11):2382—7. Hampl H, Steinmuller T, Stabell U, Klingenberg HJ, Schnoy N, Neuhaus P. Recurrent hyperparathyroidism after total parathyroidectomy and autotransplantation in patients with long-term hgmodialysis. Miner Electrolyte Metab 1991;17(4): 2 6-60. Hardy NM, Sandroni S, Danielson S, Wilson WJ. Antibody to hepatitis C virus increases with time on hemodialyIIi. Clin Nephrol 1992 Jul;38(1):44-8. Heintz B, Mann H, Kierdorf H, Konigs F, Nelson K, Kirsten R, Heicke N, Wieland D, Gladziwa U, Sieberth HG. Immunoreactive parathyroid hormone after volume change in normo- and hypotensive hemodialysis patients. Clin Nephrol 1992 Mar; 37(3):140-4. Heintz B, Reiners K, Gladziwa U, Kirsten R, Nelson K, Wieland D, Riehl J, Mann H, Sieberth HG. Response of vasoactive substances to reduction of blood volume during hemodialysis in hypotensive patients. Clin Nephrol 1993 Apr;39(4):198-204. Hernandez D, Diaz F, Suria S, Machado M, Lorenzo V, Losada M, Gonzalez-Ponds: JM, De Bonis E, Dominguez ML, Rodriguez AP, et a1. Subclavian catheter-related infection is a major risk factor for the late development of subclavian vein stenosis. Nephrol Dial Transplant 1993;8(3):227—30. Hirsch DJ, Jindal KK. Late leaks in peritoneal dialysis patients. Nephrol Dial Transplant 1991;6(9):670-1. Hodde LA, Sandroni S. Emergency department evaluation and management of dialysis patient complications. J Emerg Med 1992 May-Jun;10(3): 317-34. HodIman AB, Steer BM. Serum aluminum levels as a reflection of renal osteodystrophy status and bone surface aluminum staining. J Am Soc Nephrol 1992 Feb ;2(8): 13 18-27 . Hollett MD, Marn CS, Ellis JH, Francis IR, Swartz RD. Complications of continuous ambulatory peritoneal dialysiI: evaluation with CT peritoneography. AI R Am J Roentgenol 1992 Nov; 159(5):983-9. Holley JL, Nespor S, Rault R. Characterizing sleep disorders in chronic hemodialysis patients. ASAIO Trans 1991 Jul-Sep;37(3):M456-7. Holley JL, Nespor S, Rault R. A comparison of reported sleep disorders in patients on chronic hemodialysis and continuous peritoneal dialysis. Am J Kidney Dis 1992 Feb;19(2):156—61. Homma N, Gejyo F, Kobayashi H, Saito H, Sakai S, Suzuki M, Hirasawa Y, Arakawa M. Cystic radiolucencies of carpal bones, distal radius and ulna as a marker for dialysis-associated amyloid osteoarthropathy. Nephron 1992;62(1):6—12. Horowitz MD, Alkire MJ, Lickstein DA, Bauerlein EJ. Aortic injury as a complication of central venous catheter-ization. Am Heart J 1991 Aug;122(2): 595-7. Hosokawa S, Yoshida 0. Removal of silicon, aluminum and beta 2-microglobu1in in chronic haemodialysiI patients. Int Urol Nephrol 1991;23(3):281-4. Hoyer J, Schulte KL, Lenz T. Clinical pharmacokinetics of angiotensin converting enzyme (ACE) inhibitors in renal failure. Clin Phannacokinet 1993 Mar;24(3):230—54. Hsieh TI‘, Chen KC, Cheng BJ, Chiu TH. Pregnancy outcome in patients undergoing long—term hemodialysis. Acta Obstet Gynecol Scand 1991; 70(4-5):299-302. Humpfner A, Hummel S, Schulz W. Diagnostic and therapeutic approaches to aluminium overload in dialysed patientI--representative study by questionnaire in West German dialysis units in 1989-1990. Nephrol Dial Transplant 1993; 8 Suppl 1514. Hutchison AJ, Freemont AJ, Lumb GA, Gokal R. Renal osteodystrophy in CAPD. Adv Perit Dial 1991;7:237-9. Hutchison AJ, Ofsthun NJ, Howarth D, Gokal R. The effect of hemoglobin concentration on peritoneal mass tranIfer and drain volumes in continuous ambulatory peritoneal dialysis. Perit Dial Int 1992; 12(2):230-3. Huting J, Alpert MA. Course of left ventricular diastolic dysfunction in end-stage renal disease on long-term continuous ambulatory peritoneal dialysis. Clin Nephrol 1993 Feb;39(2):81-7. Huting J, Alpert MA. Progression of left ventricular hypertrophy in end-stage renal disease treated by continuous ambulatory peritoneal dialysis depends on hypertension and hypercirculation. Clin Cardiol 1992 Mar;15(3):190-6. Huting J, Kramer W, Reitinger J, Kuhn K, Schutterle G, Wizemann V. Abnormal diastolic lefi ventricular filling by pulsed Doppler echocardiography in patients on continuous ambulatory peritoneal dialysis. Clin Nephrol 1991 Ju1;36(1):21-8. Huting J, Schutterle G. Cardiovascular factors influencing survival in end-stage renal disease treated by continuous ambulatory peritoneal dialysis. Am J Cardiol 1992 Jan 1;69(1):123-7. Ippolito E, Aterini S, Salvadori M, D’Elia G, Amato M. HCV incidence in a dialysis center: preliminary reports. Nephron 1992;61(3):375—6. Ito M, Hayashi K, Ito M. Vertebral density distribution pattern: CT classification of patients undergoing maintenance hemodialysis. Radiology 1991 Jul; 180(1):253-7. Jasper HG, Ferraris JR. Insulin-like growth factor I (IGF-I) and growth in children undergoing hemodialysis or after successful renal transplantation. Medicina (B Aires) 1991;51(2): 127-32. Jenkins DA, Temple RM, Winney RJ, Allan PL, Notgi A, Wild SR. Effect of treatment mode on the natural history of acquired cystic disease of the kidney in patients on renal replacement therapy. Nephrol Dial Transplant 1992;7(7):613-7. Joglar FM, Rivera CG, Burgos R, Huffer WE. Experience with aluminum-associated bone disease in end-stage renal disease patients. Transplant Proc 1991 Apr;23(2):l823-4. Johnson DW, Fleming SJ. The use of vaccines in renal failure. Clin Pharmacokin 1992;22(6):434-46. Joumois D, Chanu D, Drevillon C, Dru M, Ballereau M, Safran D. Pefloxacin and metabolites removal in continuous hemofiltration with dialysis. Contrib Nephrol 1991;93:124-6. Kagan A, Gertler A, Ulman M, Bar-Khayim Y. Serum levels and peritoneal loss of prolactin in CAPD patients. Adv Perit Dial 1991;7z247-52. Kampf D, Bomer K, Pustelnik A. Multiple dose kinetics of ofloxacin and ofloxacin metabolites in 95 haemodialysis patients. Eur J Clin Pharmacol 1992;42(1):95-9. Kant KS, Glueck HI, Coots MC, Tonne VA, Brubaker R, Penn I. Protein S deficiency and skin necrosis associated with continuous ambulatory peritoneal dialysis. Am J Kidney Dis 1992 Mar;19(3):264—71. Kaplan B, Wang T, Rammohan M, del Greco F, Molteni A, Atkinson A] Jr. Response to head-up tilt in cramping and noncramping hemodialysis patients. Int J Clin Pharmacol Ther Toxicol 1992 May;30(5): 173-80. Kario K, Matsuo T, Yamada T, Nakao K, Shimano C, Matsuo M. Factor VII hyperactivity in chronic dialysis patients. Thromb Res 1992 Jul 1;67(1): 105-13. Kassmann K, Rappaport R, Broyer M. The short—term effect of testosterone on growth in boys on hemodialysis. Clin Nephrol 1992 Mar;37(3):148-54. Kaupke CJ, Vaziri ND. Pleural complications in end- stage renal disease. Semin Dial 1991 Jul-Sep;4(3): 189-97. Kay J, Benson CB, Lester S, Corson JM, Pinkus GS, Lazarus JM, Owen WF Jr. Utility of high- resolution ultrasound for the diagnosis of dialysis- related amyloidosis. Arthritis Rheum 1992 Aug; 35(8):926—32. Kaye M, Vasilevsky M, Barber E. Correction of hypophosphatemia in patients on hemodialysis using a calcium-free dialysate with added phosphate. Clin Nephrol 1991 Mar;35(3):130-3. Kayima JK, Otieno LS, Gitau W, Mwai S. Thyroid hormone profiles in patients with chronic renal failure on conservative management and regular haemodialysis. East Afr Med J 1992 Jun;69(6): 333-6. Kazmi HR, Raffone FD, Kliger AS, Finkelltein F0. Pseudomonas exit site infections in continuous ambulatory peritoneal dialysis patients. J Am Soc Nephrol 1992 Apr;2(10):1498-501. Kems DB, Frymoyer PA, Kopecky RT, Tice D, Fillinger MF, Bruch D, Schwartz RA. Is heparin- induced platelet activation an unrecognized cause of thrombosis in chronic dialysis patients? Vasc Surg 1992;26(6):487-93. Kessler M, Hoen B, Mayeux D, Hestin D, Fontenaille C. Bacteremia in patients on chronic hemodialysis. A multicenter prospective survey. Nephron 1993; 64(1):95-100. Kessler M, Netter P, Azoulay E, Mayeux D, Pere P, Gaucher A. Dialysis-associated arthropathy: a multicentre survey of 171 patients receiving haemodialysis for over 10 years. The Co-operative 96 Group on Dialysis-associated Arthropathy. Br J Rheumatol 1992 Mar;31(3):157-62. Khan F. Haemodialysis associated amyloidosis. Bangladesh Renal J 1992;11(2):56-7. Khan IH, Catto GR. Long-term complications of dialysis: infection. Kidney Int Suppl 1993 ;41: S143-8. Khoury AE, Charendoff J, Balfe J W, McLorie GA, Churchill BM. Hernias associated with CAPD in children. Adv Perit Dial 1991;72279-82. Kiersztejn M, Smogorzewski M, Thanakitcharu P, Fadda GZ, Massry SG. Decreased 02 consumption by PMNL from humans and rats with CRF: role of secondary hyperparathyroidism. Kidney Int 1992 Sep;42(3):602-9. Kimura Y, Nakayama M, Kuriyama S, Watanabe S, Kawaguchi Y, Sakai 0. Pharmacokinetics of active vitamins D3, 1 alpha-hydroxyvitamin D3 and 1 alpha, 25-dihydroxyvitamin D3 in patients on chronic hemodialysis. Clin Nephrol 1991 Feb;35(2): 72-7. Koch KM. Dialysis-related amyloidosis [clinical conference]. Kidney Int 1992 May;41(5):1416—29. Konishi K, Suzuki H, Saruta T, Hayashi M, Deguchi N, Tazaki H, Hisaka A. Removal of imipenem and cilastatin by hemodialysis in patients with end-stage renal failure. Antimicrob Agents Chemother 1991 Aug;35(8):1616-20. Kooman JP, Wijnen JA, Draaijer P, van Bortel LM, Gladziwa U, Peltenburg HG, Struyker-Boudier HA, van Hooff JP, Leunissen KM. Compliance and reactivity of the peripheral venous system in chronic intermittent hemodialysis. Kidney Int 1992 Apr; 41(4):1041-8. Kowalsky SF, Echols M, Schwartz MT, Bailie GR, McCormick E. Pharmacokinetics of ciprofloxacin in subjects with varying degrees of renal function and undergoing hemodialysis or CAPD. Clin Nephrol 1993 Jan;39(1):53—8. Krane NK, Stock G Jr, Caballero M, Starks E. Lovastatin in the treatment of hypercholesterolemia in CAPD. Adv Perit Dial 1992;8:362-4. Kremastinos D, Paraskevaidis I, Voudiklari S, Apostolou T, Kyriakides Z, Zirogiannis P, Toutouzas P. Painless myocardial ischemia in chronic hemodialysed patients: a real event? Nephron 1992;60(2):164-70. Kremer D, Munar MY, Kohlhepp SJ, Swan SK, Stinnett EA, Gilbert DN, Young EW, Bennett WM. Zidovudine pharmacokinetics in five HIV seronegative patients undergoing continuous ambulatory peritoneal dialysis. Pharmacotherapy 1992;12(1):56-60. Kroner G, Stabler A, Seiderer M, Moran JE, Gurland HJ. Beta 2 microglobulin-related amyloidosis causing atlantoaxial spondylarthropathy with spinal- cord compression in haemodialysis patients: detection by MRI. Nephrol Dial Transplant 1991; 6 Suppl 2:91-5. Knesinski JM, Du F, Rorive G. Intracellular cation concentrations in essential hypertension and chronic renal failure. Clin Exp Hypertens 1993;15(3): 461-78. Kurer MH, Baillod RA, Madgwick J C. Amyloidosis and other musculoskeletal complications of long- term regular haemodialysis. Br J Hosp Med 1991 May;45(5):266, 268-9, 271-3. Kurer MH, Baillod RA, Madgwick J C. Musculoskeletal manifestations of amyloidosis. A review of 83 patients on haemodialysis for at least 10 years. J Bone Joint Surg [Br] 1991 Mar;73(2):271-6. Kusakari J, Hara A, Takeyama M, Suzuki S, Igari T. The hearing of the patients treated with hemodialysis: a long term follow-up study. Auris Nasus Larynx 1992;19(2):105-13. Kustel M, Buki B, Gyimesi J, Mako J, Komora V, Ribari O. Auditory brainstem potentials in uraemia. ORL 1993;55(2):89-92. Kwan JT, Hart PD, Raftery MJ, Cunningham J, Marsh FP. Mycobacterial infection is an important infective complication in British Asian dialysis patients. J Hosp Infect 1991 Dec;19(4):249—55. La Russa A, Bufano G, Cauzzi L, Pecchini P. Non-A, non-B hepatitis: clinical laboratory course in patients on hemodialysis and its correlation with the presence of anti-hepatitis C virus antibodies. Nephron 1992;61(3):273-5. La Russa A, Bufano G, Cauzzi L, Pecchini P. Non-A, non-B hepatitis in patients on dialysis: retrospective evaluation of measures taken to limit the diffusion of the virus. Nephron 1992;61(3):333-4. Leonard DK. Vascular access thrombosis in epoetin alfa therapy. ANNA J 1991 Aug;18(4):371-6; discussion 377. Leone M, Bottacchi E, Alloatti S, Nebiolo PE, Aimino M, Baldini S. Follow-up of nerve conduction in chronic uremic patients during hemodialysis. Ital J Neurol Sci 1992 May;13(4):317-21. Levin N, Gotch F, Bednar B, Gallagher N, Peterson G, Bednar B. Kinetics and quality assurance: prescription therapy through kinetic modeling. ANNA J 1991 Jun;18(3):269-90. Libbey NP, Chazan JA, London MR, Pono L, Abuelo JG. The relevance of mineralization lag time in the evaluation of histologic changes in renal osteodystrophy. Clin Nephrol 1993 Apr;39(4): 214-23. Lim W, Chau SP, Chan PC, Cheng 1K. Histoplasma capsulatum infection associated with continuous ambulatory peritoneal dialysis. J Infect 1991 Mar; 22(2): 179-82. Lin DY, Lin HH, Huang CC, Liaw YF. High incidence of hepatitis C virus infection in hemodialysis patients in Taiwan. Am J Kidney Dis 1993 Mar; 21(3):288-91. Lin HH, Huang CC, Sheen IS, Lin DY, Liaw YF. Prevalence of antibodies to hepatitis C virus in the hemodialysis unit. Am J Nephrol 1991;11(3):192-4. Lindgren SC, Laurell CB, Sterner GN. Plasma protein homeostasis in chronic hemodialysis patients. Scand I Urol Nephrol 1992;26(3):279—82. Lindner A, Gagne ER, Zingraff I, Jungers P, Drueke TB, Hannaert P, Garay R. A circulating inhibitor of the RBC membrane calcium pump in chronic renal failure. Kidney Int 1992 Dec;42(6):1328-35. Linke RP, Kerling A, Rail A. Hemodialysis: demonstration of truncated beta 2-microglobulin in AB-amyloid in situ. Kidney Int Suppl 1993;41: 8100-5. Ljutic D, Rumboldt Z. Should glucose be administered before, with, or after insulin, in the management of hyperkalemia? Ren Fail 1993;15(1):73-6. Llach F. Renal bone disease. Transplant Proc 1991 Apr; 23(2): 1818-22. Lohr JW, Schwab SJ. Minimizing hemorrhagic complications in dialysis patients. I Am Soc Nephrol 1991 Nov;2(5):961-75. London GM, Marchais SJ, Guerin AP, Fabiani F, Metivier F. Cardiovascular function in hemodialysis patients. Adv Nephrol Necker Hosp 1991;20: 249-73. Longfield RN, Wortham WG, Fletcher LL, Nauscheutz WF. Clustered bacteremias in a hemodialysis unit: cross-contamination of blood tubing from ultrafiltrate waste. Infect Control Hosp Epidemiol 1992 Mar;13(3):160-4. Lonnemann G, Floege J, Shaldon S, Koch KM. Blood- dialyzer interactions: their role in long-term complications of hemodialysis. Contrib Nephrol 1992;100:155-71. Lowrie EG, Lew NL, Huang WH. Race and diabetes as death risk predictors in hemodialysis patients. Kidney Int Suppl 1992 Oct;38:822-31. Luke DR, Awni WM, Halstenson CE, Opsahl IA, Matzke GR. Bioavailability of labetalol in patients with end-stage renal disease. Ther Drug Monit 1992;14(3):203-8. Luzar MA. Exit-site infection in continuous ambulatory peritoneal dialysis: a review. Perit Dial Int 1991; 11(4):333—40. Lye WC, Lee El. Renal bone disease in patients on haemodialysis: biochemical and radiological assessment. Ann Acad Med Singapore 1992 Nov; 21(6):760-4. Lynn WA. Unusual infections in the immunocompromised host. Curr Opin Infect Dis 1992;5(3):443-6. Ma KW, Greene EL, Raij L. Cardiovascular risk factors in chronic renal failure and hemodialysis populations. Am J Kidney Dis 1992 Jun;19(6): 505—13. Maeda K, Shinzato T, Nakai S, Takai I, Kobayakawa H. Mechanism of dialysis-induced hypotension. Nagoya J Med Sci 1992 Mar;54(1-4):1-10. Mako J, Potyondi M. Use of Tensiomin in hypertensive patients with impaired renal function. Ther Hung 1992;40(1):20-4. Makoff R. The importance and use of iron supplementation in uremia. Nephrol News Issues 1992 Jun;6(6):14-6, l9. Malberti F, Surian M, Cosci P. Effect of chronic intravenous calcitriol on parathyroid function and set point of calcium in dialysis patients with refractory secondary hyperparathyroidism. Nephrol Dial Transplant 1992;7(8):822—8. Malberti F, Surian M, Cosci P. Improvement of secondary hyperparathyroidism and reduction of the set point of calcium after intravenous calcitriol. Kidney Int Suppl 1993;41:8125-30. Malberti F, Surian M, Farina M, Vitelli E, Mandolfo S, Guri L, De Petri GC, Castellani A. Effect of hemodialysis and hemodiafiltration on uremic neuropathy. Blood Purif 1991;9(5-6):285—95. Mallamaci F, Parlongo S, Zoccali C. Influence of cardiovascular damage and residual renal function on plasma endothelin in chronic renal failure. Nephron 1993;63(3):291-5. Mallofre C, Almirall J, Campistol JM, Andreu J, Cardesa A, Revert L. Acquired renal cystic disease in HD: a study of 82 nephrectomies in young patients. Clin Nephrol 1992 Jun;37(6):297-302. Malluche I-IH, Monier—Faugere MC. Risk of adynamic bone disease in dialyzed patients. Kidney Int Suppl 1992 Oct;38:862-7. Manescalchi F, De Mayo E, Bertoni E, Martinelli F, Parri F, Ciccarelli C, Baccaro C, Lo Nostro A, 98 Comodo N. Anti-hepatitis C virus epidemiological study in two dialysis centers in Florence. Nephron 1992;61(3):342-3. Marangella M, Vitale C, Petrarulo M, Cosseddu D, Gallo L, Linari F. Pathogenesis of severe hyperoxalaemia in Crohn’s disease-related renal failure on maintenance haemodialysis: successful management with pyridoxine. Nephrol Dial Transplant 1992;7(9):960-4. Marchais SJ, Boussac I, Guerin AP, Delavaux G, Metivier F, London GM. Arteriosclerosis and antihypertensive response to calcium antagonists in end-stage renal failure. J Cardiovasc Pharmacol 1991;18 Suppl 5:S14-8. Marcus EL, Rudensky B, Sonnenblick M. Occult elevation of CK as a manifestation of rhabdomyolysis in the elderly. J Am Geriatr Soc 1992;40(5):454-6. Marczewski K, Janicka L, Cudny J. The effect of pilocarpine on electrodermal resistance in chronic hemodialyzed patients. Clin Nephrol 1993 Feb; 39(2):88-91. Marini M, Vidiri A, Guerrisi R, Campodonico F, Ponzio R. Progress of brown tumors in patients with chronic renal insufficiency undergoing dialysis. Eur J Radiol 1992 Jan-Feb;14(1):67-71. Markell MS, Friedman EA. Diabetic nephropathy. Management of the end-stage patient. Diabetes Care 1992 Sep;15(9):1226-38. Martin KJ, Ballal HS, Domoto DT, Blalock S, Weindel M. Pulse oral calcitriol for the treatment of hyperparathyroidism in patients on continuous ambulatory peritoneal dialysis: preliminary observations. Am J Kidney Dis 1992 Jun;19(6): 540-5. Martin JE, Mather K, Swash M, Dodd SM, Dale GE, Garofalo O, Leigh PN. Stress protein inclusions in cerebral vessels in dialysis encephalopathy. Neuropathol Appl Neurobiol 1991 Apr;17(2): 105-11. Martinez M, Ausejo M, Miguel JL, Gonzalez ML, Balaguer G, Catalan P, Selgas R. Comparative study between intact PTH and fragments of PTH in patients on hemodialysis and CAPD. Perit Dial Int 1991;11(2):137-40. Martinez-Vea A, Garcia C, Gaya J, Rivera F, Oliver JA. Abnormalities of thirst regulation in patients with chronic renal failure on hemodialysis. Am J Nephrol 1992;12(1-2):73-9. Maruyama H, Gejyo F, Arakawa M. Clinical studies of destructive spondyloarthropathy in long-term hemodialysis patients. Nephron 1992;61(1):37-44. Maruyama H, Gejyo F, Arakawa M. A magnetic resonance imaging study of destructive spondyloarthropathy in long-term hemodialysis patients. Nephron 1991;59(1):71-4. Masi CM, Cohen EP. Dialysis efficacy and itching in renal failure. Nephron 1992;62(3):257-61. Masin G, Polenakovic M, Ivanovski N, Atanasov N, Olivera S, Cakalaroski K. Hypersensitivity reactions to ethylene oxide: clinical experience. Nephrol Dial Transplant 1991;6 Suppl 3:50-2. Masumura H, Miki S, Kaifu Y, Kitajima W, Abe Y. Pharmacokinetics and efficacy of carvedilol in hypertensive patients with chronic renal failure and hemodialysis patients. J Cardiovasc Pharmacol 1992;19 Suppl 128102-7. Matthys E, Schurgers M, Lamberigts G, Lameire N, Vandecasteele N, Labeur C, Beisiegel U, Rosseneu M. Effect of simvastatin treatment on the dyslipoproteinemia in CAPD patients. Atherosclerosis 1991 Feb;86(2-3):183-92. Mazzaferro S, Coen G, Ballanti P, Costantini S, Bondatti F, Giordano R, Manni M, Pasquali M, Perruzza I, Sardella D, et a1. Deferoxamine test and PTH serum levels are useful not to recognize but to exclude aluminum-related bone disease. Nephron 1992;61(2):151-7. Mazzaferro S, Coen G, Bandini S, Borgatti PP, Ciaccheri M, Diacinti D, Ferranti E, Lusenti T, Mancini G, Monducci I, Pasquali M, Pellegrini F, Perruzza I, Taggi F, Cinotti GA. Role of ageing, chronic renal failure and dialysis in the calcification of mitral annulus. Nephrol Dial Transplant 1993; 8(4):335—40. Mazzoni A, Innocenti M, Consaga M. Retrospective study on the prevalence of B and non-A, non—B hepatitis in a dialysis unit: 17-year follow-up. Nephron 1992;61(3):316-7. Mazzotta L, Landucci G, Pfanner L, Carlini A, Angelini D, Giusti R, Antonelli A. Comparison between first and second generation tests to determine the frequency of anti-HCV antibodies in uremic patients in replacement dialytic therapy. Nephron 1992;61(3):354-5. McCance DR, Maxwell AP, Hill CM, Doherty CC. Glomerulonephritis associated with antibodies to neutrophil cytoplasm and glomerular basement membrane. Postgrad Med J 1992 Mar;68(797): 186-8. McCarthy JT, Hodgson SF, Fairbanks VF, Moyer TP. Clinical and histologic features of iron-related bone disease in dialysis patients. Am J Kidney Dis 1991 May;17(5):551-61. McConnell KN, Rolton HA, Modi KS, Macdougall AI. Plasma oxalate in patients with chronic renal failure receiving continuous ambulatory peritoneal dialysis or hemodialysis. Am J Kidney Dis 1991 Oct;18(4): 441-5. McLigeyo SO, Otieno LS, Kinuthia DM, Mwongera FK, Ongeri SK. Ascites in patients undergoing intermittent haemodialysis at Kenyatta National Hospital. East Afr Med J 1991 Oct;68(10):789-94. McMahon LP, Radford J, Dawborn JK. Shoulder ultrasound in dialysis related amyloidosis. Clin Nephrol 1991 May;35(5):227-32. Medici G, Depetri GC, Mileti M. Anti—hepatitis C virus positivity and clinical correlations in hemodialyzed patients. Nephron 1992;61(3):363-4. Mehta RL, McDonald BR, Ward DM. Regional citrate anticoagulation for continuous arteriovenous hemodialysis. An update after 12 months. Contrib Nephrol 1991;93:210—4. Melappioni M, Baldaasari M, Saldini S, Radicioni R, Panichi N. Use of immunomodulators (Thymopentine) in hepatitis B vaccine in elderly patients undergoing chronic hemodialysis. Nephron 1992;61(3):358-9. Michel C, Bindi P, Dosquet P, Mignon F. CAPD and systemic diseases. Contrib Nephrol 1991;89:237-42. Miki S, Masumura H, Kaifu Y, Yuasa S. Pharmacokinetics and efficacy of carvedilol in chronic hemodialysis patients with hypertension. J Cardiovasc Pharmacol 1991;18 Suppl 4:562-8. Mioli VA, Balestra E, Bibiano L, Carletti P, Della Bella S, Fanciulli E, Gaffi G, Marinelli R, Perilli R, Ricciatti AM, et al. Epidemiology of viral hepatitis in dialysis centers: a national survey. Nephron 1992;61(3):278-83. Miranda B, Selgas R, Celadilla O, Munoz J, Sanchez Sicilia L. Peritoneal resting and heparinization as an effective treatment for ultrafiltration failure in patients on CAPD. Contrib Nephrol 1991;89: 199-204. Mitwalli A, al-Mohaya S, al Wakeel J, e1 Gamal H, Rotimi V, al-Zeben A, al-Aska A. Hepatitis C in chronic renal failure patients. Am J Nephrol 1992; 12(5):288-91. Miura Y, Ishiyama T, Inomata A, Takeda T, Senma S, Okuyama K, Suzuki Y. Radiolucent bone cysts and the type of dialysis membrane used in patients undergoing long-term hemodialysis. Nephron 1992; 60(3):268-73. Miyasaka N, Sato K, Kitano Y, Higaki M, Nishioka K, Ohta K. Aberrant cytokine production from tenosynovium in dialysis associated amyloidosis. Ann Rheum Dis 1992 Jun;51(6):797-8(TZ. 99 Mocan MZ, Mocan H, Fell GS, Junor BJ, Boyce BF. Autonomous hyperparathyroidism not associated with increased aluminum absorption. Isr J Med Sci 1992 Jan;28(1):24~6. Mondelli MU, Cristina G, Piazza V, Cerino A, Villa G, Salvadeo A. High prevalence of antibodies to hepatitis C virus in hemodialysis units using a second generation assay. Nephron 1992;61(3): 350-1. MondeHi MU, Smedile V, Piazza V, Villa G, Barbieri C, Gattarello G, Mancini F, Raimondo G. Abnormal alanine aminotransferase activity reflects exposure to hepatitis C virus in haemodialysis patients. Nephrol Dial Transplant 1991;6(7):480-3. Montagnac R, Schillinger F. Rifampicin-protamine protocol applied for prevention of central catheter sepsis in haemodialysis. Nephrol Dial Transplant 1993;8(3):289-99. Montalto G, Carroccio A, Sparacino V, Lorello D, Di Martino D, Soresi M, Galione A, Notarbartolo A. Pancreatic enzymes in chronic renal failure and transplant patients. Int J Pancreatol 1992 Dec;12(3): 211-7. Morachiello P, Landini S, Fracasso A, Righetto F, Scanferla F, Toffoletto P, Genchi R, Bazzato G. Combined hemodialysis-hemoperfusion in the treatment of secondary hyperparathyroidism of uremic patients. Blood Purif 1991;9(3):148-52. Moriniere P, E] Esper N, Viron B, Judith D, Bourgeon B, Farquet C, Gheerbrant J, Chapuy MC, Van Orshoven A, Pamphile R, Foumier A. Improvement of severe secondary hyperparathyroidism in dialysis patients by intravenous 1 alpha(OH) vitamin D3, oral CaCO3 and low dialysate calcium. Kidney Int Suppl 1993; 41:8121-4. Moroni G, Banfi G, Montoli A, Bucci A, Bertani T, Ravelli M, Pozzi C, Leonelli M, Lupo A, Volpi A, et al. Chronic dialysis in patients with systemic amyloidosis: the experience in northern Italy. Clin Nephrol 1992 Aug;38(2):81-5. Morton LP, Reynolds L, Zent R, Rayner BL. Hearing thresholds in CAPD patients. Adv Perit Dial 1992; 8:150—2. Mosconi G, Campieri C, Miniero R, Coli L, Orsi C, La Manna G, De Sanctis LB, Stefoni S, Sprovieri G, Bonomini V. Epidemiology of hepatitis C in a population of hemodialysis patients. Nephron 1992; 61(3):298-9. Moshtaghie AA, Skillen AW. Desferrioxamine treatment in aluminum overload patients an aluminum binding study. Indian J Pharmacol 1991; 23(2):75-80. 100 Moss AH, Holley JL, Upton MB. Outcomes of cardiopulmonary resuscitation in dialysis patients. J Am Soc Nephrol 1992 Dec;3(6):1238-43. Muhammedi MA, Piraino B, Rault R, Johnston JR, Puschett J B. Iatrogenic hypercalcemia in hemodialysis patients. Clin Nephrol 1991 Nov; 36(5):258-61. Muller GY, Zabaleta ME, Arminio A, Colmenares CJ, Capriles FI, Bianco NE, Machado IV. Risk factors for dialysis-associated hepatitis C in Venezuela. Kidney Int 1992 Apr;41(4):1055-8. Mulloy LL, Caruana RJ, Steele JC Jr, Wynn JJ. Polymicrobial bacteremia during long-term hemodialysis. South Med J 1991 May;84(5):594-6. Murray JC, Tanner CM, Sprague SM. Aluminum neurotoxicity: a reevaluation. Clin Neuropharmacol 1991 Apr;14(2):179-85. Nahata MC. Stability of ceftriaxone sodium in peritoneal dialysis solutions. DICP Ann Pharmacother 1991;25(7-8):741-2. Naito M, Ogata K, Nakamoto M, Goya T, Sugioka Y. Destructive spondylo-arthropathy during long-term haemodialysis. J Bone Joint Surg [Br] 1992 Sep; 74(5):686-90. Nakahama H, Izumi M, Tanaka Y, Wada A, Fujita Y, Orita Y, Shirai D, Karnada T. Pharmacokinetics of denopamine in hemodialysis patients. Ren Fail 1991;l3(1):37-41. Nakamura Y, Ikeda T, Takata S, Yokoi H, Hirono M, Abe T, Takazakura E, Kobayashi K. The role of peripheral capacitance and resistance vessels in hypotension following hemodialysis. Am Heart J 1991 Apr;121(4 Pt 1):1170-7. Nakane K, Shinzato T, Maeda K. Continuous measurement of pressure in internal arteriovenous fistulae and prevention of symptomatic hypotension during hemodialysis. ASAIO Trans 1991 Jul-Sep; 37(3):M232-4. Nelson SR, Hawkins PN, Richardson S, Lavender JP, Sethi D, Gower PE, Pugh CW, Winearls CG, Oliver DO, Pepys MB. Imaging of haemodialysis- associated amyloidosis with 123I-serum amyloid P component. Lancet 1991 Aug 10;338(8763):335—9. Comment in: Lancet 1991 Oct 26;338(8774):1089. Nelson SR, Sharpstone P, Kingswood JC. Does dialysis-associated amyloidosis resolve after transplantation? Nephrol Dial Transplant 1993;8(4): 369-70. Ng YY, Lee SD, Wu SC, Liu WT, Chia WL, Huang TP. The need for second-generation antihepatitis C virus testing in uremic patients on continuous ambulatory peritoneal dialysis. Perit Dial Int 1993; 13(2):132-5. Ng YY, Lee SD, Wu SC, Yang WC, Chiang SS, Huang TP. Antibodies to hepatitis C virus in uremic patients on continuous ambulatory peritoneal dialysis. J Med Virol 1991 Dec;35(4):263-6. Nishimura M, Nakanishi T, Yasui A, Tsuji Y, Kunishige H, Hirabayashi M, Takahashi H, Yoshimura M. Serum calcium increases the incidence of arrhythmias during acetate hemodialysis. Am J Kidney Dis 1992 Feb;19(2): 149-55. Nishitani H, Yamakawa M, Nishizawa Y, Morii H. Bone mineral loss in patients on maintenance hemodialysis with hyperphosphatemia treated with 1 alpha-hydroxycholecalciferol and calcium carbonate. J Nutr Sci Vitaminol (Tokyo) 1991 Dec;37 Suppl: S 1 13-8 . Niu MT, Alter MJ, Kristensen C, Margolis HS. Outbreak of hemodialysis-associated non-A, non-B hepatitis and correlation with antibody to hepatitis C virus. Am J Kidney Dis 1992;19(4):345-52. Nogues MA, Starkstein S, Davalos M, Berthier M, Leiguarda R, Garcia H. Cardiovascular reflexes and pudendal evoked responses in chronic haemodialysis patients. Funct Neurol 1991 Oct-Dec;6(4):359-65. Obialo CI, Rothstein M. Recurrent ischemic hepatitis in chronic hemodialysis patients. Dial Transplant 1992;21(6):342—3, 346-8, 351. Odell RA, Slowiaczek P, Moran JE, Schindhelm K. Beta 2-microglobulin kinetics in end-stage renal failure. Kidney Int 1991 May;39(5):909—19. Odland MD, Kelly PH, Ney AL, Andersen RC, Bubrick MP. Management of dialysis-associated steal syndrome complicating upper extremity arteriovenous fistulas: use of intraoperative digital photoplethysmography. Surgery 1991 Oct;110(4): 664$; discussion 669-70. Oettinger CW, Oliver J C, Macon E]. The effects of calcium carbonate as the sole phosphate binder in combination with low calcium dialysate and calcitriol therapy in chronic hemodialysis patients. J Am Soc Nephrol 1992 Oct;3(4):995-1001. Oguchi H, Miyasaka M, Tokunaga S, Hora K, Ichikawa S, Ochi T, Yamada K, Nagasawa M, Kanno Y, Aizawa T, et al. Hepatitis virus infection (HBV and HCV) in eleven Japanese hemodialysis units. Clin Nephrol 1992 Jul;38(l):36—43. Ohashi K, Hara M, Kawai R, Ogura Y, Honda K, Nihei H, Mirnura N. Cervical discs are most susceptible to beta 2-microglobulin amyloid deposition in the vertebral column. Kidney Int 1992 Jun;4l(6):1646-52. Okadome K, Komori K, Fukumitsu T, Sugirnachi K. The potential risk for subclavian vein occlusion in patients on haemodialysis. Eur J Vasc Surg 1992 Nov;6(6):602-6. Okutsu I, Ninomiya S, Takatori Y, Hamanaka I, Takemura T, Otsubo K, Otsubo O. Endoscopic management of shoulder pain in long-term haemodialysis patients. Nephrol Dial Transplant 1991;6(2):117-9. Oliva JA, Maymo RM, Carrio J, Delgado O, Mallafre JM. Late seroconversion of C virus markers in hemodialysis patients. Kidney Int Suppl 1993;41: 8153-6. Onishi S, Andress DL, Maloney NA, Coburn JW, Sherrard DJ. Beta 2-microglobulin deposition in bone in chronic renal failure. Kidney Int 1991 May; 39(5):990-5. Ozasa H, Chichibu K, Tanaka Y, Kondo T, Kitajima K, Ota K. Relationship between plasma levels of hyaluronic acid and amyloid-associated osteoarthropathy in chronic hemodialysis patients. Nephron 1992;61(2):187-91. Ozdemir O, Arik N, Ozcebe O, Arinsoy T, Sungur C, Dundar S, Turgan C, Yasavul U, Caglar S, Kirazli S. Evidence for the role of dialysis hypoxemia in the pathogenesis of hemodialysis-induced rise in tissue-type plasminogen activator. Thromb Res 1992 Sep 15 ;67(6):697-704. Ozen S, Saatci U, Beksac M, Bakkaloglu A. Dialysis hypotension as a cause of tumour necrosis factor induction: significance of in-vitro detection. Nephrol Dial Transplant 1993;8(4):381. Padberg FT Jr, Lee BC, Curl GR. Hemoaccess site infection. Surg Gynecol Obstet 1992;174(2):103-8. Pagliari B, Baretta A, De Cristofaro V, Sama F, Cantaluppi A, Martis L, Imbasciati E. Short-term effects of low-calcium dialysis solutions on calcium mass transfer, ionized calcium, and parathyroid hormone in CAPD patients. Perit Dial Int 1991; 11(4):326—9. Pannekeet MM, Krediet RT, Boeschoten EW, Arisz L. Acute pancreatitis in patients on CAPD treatment. Kidney Int 1992;42(5):1287. Parfrey PS. Cardiac and cerebrovascular disease in chronic uremia. Am J Kidney Dis 1993 Jan;21(l): 77-80. Parfrey PS, Harriett JD, Barre PE. The natural history of myocardial disease in dialysis patients. J Am Soc Nephrol 1991 Jul;2(1):2—12. Park YM, Kim IS, Lee CD, Kim BS. Seroprevalence of antibody against hepatitis C virus (anti-HCV) in various groups of individuals in Korea. Gastroenterol Jpn 1991;26 Suppl 3:159—63. 101 Pames EL, Shapiro WB. Anaphylactoid reactions in hemodialysis patients treated with the AN69 dialyzer. Kidney Int 1991 Dec;40(6):1148-52. Pames EL, Shapiro WB. Anaphylactoid reactions in hemodialysis patients treated with the AN69 dialyzer [abstract]. J Am Soc Nephrol 1991;2(3): 344. Parsons V, Baldwin D, Moniz C, Marsden J, Ball E, Rifkin 1. Successful control of hyperparathyroidism in patients on continuous ambulatory peritoneal dialysis using magnesium carbonate and calcium carbonate as phosphate binders. Nephron 1993; 63(4):379-83. Pasqualini T, Zantleifer D, Balzaretti M, Granillo E, Fainstein-Day P, Ramirez J, Ruiz S, Gutman R, Ferraris J. Evidence of hypothalamic-pituitary thyroid abnormalities in children with end-stage renal disease. J Pediatr 1991 Jun;118(6):873-8. Comment in: J Pediatr 1991 Jun;118(6):896-8. Patel KR, Chan FA, Batista RJ, Clauss RH. True venous aneurysms and arterial "steal" secondary to arteriovenous fistulae for dialysis. J Cardiovasc Surg 1992;33(2):185—8. Paul JL, Sall ND, Soni T, Poignet JL, Lindenbaum A, Man NK, Moatti N, Raichvarg D. Lipid peroxidation abnormalities in hemodialyzed patients. Nephron 1993;64(1):106~9. Paul K, Mavridis G, Bonzel KE, Scharer K. Pulmonary function in children with chronic renal failure. Eur J Pediatr 1991 Sep;150(11):808-12. Pegues DA, Beck-Sague CM, Woollen SW, Greenspan B, Burns SM, Bland LA, Arduino MJ, Favero MS, Mackow RC, Jarvis WR. Anaphylactoid reactions associated with reuse of hollow-fiber hemodialyzers and ACE inhibitors. Kidney Int 1992;42(5):1232-7. Pegues DA, Oettinger CW, Bland LA, Oliver JC, Arduino MJ, Aguero SM, McAllister SK, Gordon SM, Favero MS, Jarvis WR. A prospective study of pyrogenic reactions in hemodialysis patients using bicarbonate dialysis fluids filtered to remove bacteria and endotoxin. J Am Soc Nephrol 1992 Oct;3(4):1002—7. Pei Y, Hercz G, Greenwood C, Sherrard D, Segre G, Manuel A, Saiphoo C, Fenton S. Non-invasive prediction of aluminum bone disease in hemo— and peritoneal dialysis patients. Kidney Int 1992 May; 41(5):1374-82. Perez-Fontan M, Rosales M, Rodriguez-Carmona A, Moncalian J, Femandez-Rivera C, Cao M, Valdes F. Treatment of Staphylococcus aureus nasal carriers in CAPD with mupirocin. Adv Perit Dial 1992;8z242-5. 102 Perry G, Mant TG, Morrison PJ, Sacks S, Woodcock J, Wise R, Imbimbo BP. Pharmacokinetics of rufloxacin in patients with impaired renal function. Antimicrob Agents Chemother 1993 Apr;37(4): 637-41. Petrarulo F, Maggi P, Sacchetti A, Pallotta G, Dagostino F, Basile C. HCV infection occupational hazard at dialysis units and virus spread, among relatives of dialyzed patients. Nephron 1992;61(3): 302-3. Petrarulo M, Marangella M, Linari F. High- performance liquid chromatographic determination of plasma glycolic acid in healthy subjects and in cases of hyperoxaluria syndromes. Clin Chim Acta 1991 Jan 31;196(l):l7-26. Phocas I, Sarandakou A, Kassanos D, Rizos D, Tserkezis G, Koutsikos D. Hormonal and ultrasound characteristics of menstrual function during chronic hemodialysis and after successful renal transplantation. Int J Gynaecol Obstet 1992 Jan;37(1):19-28. Piccoli G, Bonello F, Massara C, Salomone M, Maffei S, Iadarola GM, Stramignoni E, Rosati C, Borca M, Belardi P, Quarello F, Piccoli G, Vercellone A. Death in conditions of cachexia: the price for the dialysis treatment of the elderly? Kidney Int Suppl 1993;41:5282-6. Pico MR, Lugo-Somolinos A, Sanchez JL, Burgos— Calderon R. Cutaneous alterations in patients with chronic renal failure. Int J Dermatol 1992 Dec; 31(12):860-3. Pietraszek M, Malyszko J, Azzadin A, Malyszko J, Buczko W, Mysliwiec M. Serotonin and hypertension in uraemia: a possible link? Nephrol Dial Transplant 1992;7(9):980-1. Piraino B, Holley JL, Bernardini J, Burkart JM. Are exit-site infection rates lower with disconnect systems? Perit Dial Int 1993;13(1):67-8. Piraino B, Perlmutter JA, Holley JL, Johnston JR, Bemardini J. The use of dialysate containing 2.5 mEq/l calcium in peritoneal dialysis patients. Perit Dial Int 1992;12(1):75-6. Pizzarelli F, Fabrizi F, Postorino M, Curatola G, Zoccali C, Maggiore Q. Parathyroidectomy and blood pressure in hemodialysis patients. Nephron 1993;63(4):384-9. Pluvio M, Saggese A, Cirillo D, Castellino P, Pempinello R, Iannece MD, Guamaccia D, Tassinaro P, Pluvio C, Cicchella T, et a1. Hepatitis C virus-related acute and chronic hepatitis in hemodialysis patients. Nephron 1992;6l(3):322-3. Poch E, Almirall J, Alsina M, del Rio R, Cases A, Revert L. Calciphylaxis in a hemodialysis patient: appearance after parathyroidectomy during a psoriatic flare. Am J Kidney Dis 1992 Mar;19(3): 285-8. Polo A, Lazzarino L, Pitzomo F, Beltram E, Zanette G, de Grandis D. Retinal oscillatory potential abnormalities in patients with chronic renal failure, before and after dialytic treatment. Doc Ophthalmol 1992;82(3):257-65. Ponz E, Campistol JM, Barrera JM, Gil C, Pinto J, Andreu J, Bruguera M. Hepatitis C virus antibodies in patients on hemodialysis and after kidney transplantation. Transplant Proc 1991 Feb; 23(1 Pt 2):1371-2. Popovtzer MM, Levi J, Bar-Khayim Y, Shasha SM, Boner G, Bemheim J, Chaimovitz C, Rubinger D, Gafter U, Gazit D, et 31. Assessment of combined 24,25(0H)2D3 and 1 alpha (OH)D3 therapy for bone disease in dialysis patients. Bone 1992;13(5): 369-77. Portigliatti Barbos M, Cadario A, Canavese C, Pavan I. Clinical, histological, and chemical characterization of ectopic calcification in dialyzed and non-dialyzed patients. Ital J Orthop Traumatol 1991 Dec;17(4): 523-32. Pottman RJ, Scott RC 3d, Rogers DD, Loose-Mitchell DS, Lemire J M, Weinberg RB. Decreased low- density lipoprotein receptor function and mRNA levels in lymphocytes from uremic patients. Kidney Int 1992;42(5):1238-46. Poulos AM, Howard L, Eisele G, Rodgers J B. Peritoneal dialysis therapy for patients with liver and renal failure with ascites. Am J Gastroenterol 1993 Jan;88(1):109-12. Quarles LD, Murphy G, Econs MJ, Martinez 8, Lobaugh B, Lyles KW. Uremic tumoral calcinosis: preliminary observations suggesting an association with aberrant vitamin D homeostasis. Am J Kidney Dis 1991 Dec;18(6):706—10. Querfeld U, Schneble F, Wradzidlo W, Waldherr R, Troger J, Scharer K. Acquired cystic kidney disease before and after renal transplantation. J Pediatr 1992 Jul;121(1):61-4. Querfeld U, Wendtland J, von Hodenberg E, Mehls O. Lipid levels in monocytes of patients with moderate hyperlipoproteinemia. Atherosclerosis 1992 Jun; 94(2-3):129-34. Raccosta G, Merletti MG, Lisi E, Ciccarelli P, Trivelli G, Capponi E. Prevalence of hepatitides in our hemodialyzed population. Nephron 1992;61(3): 300-1. Ramirez JA, Goodman WG, Gombein J, Menezes C, Moulton L, Segre GV, Salusky IB. Direct in vivo comparison of calcium-regulated parathyroid hormone secretion in normal volunteers and patients with secondary hyperparathyroidism. J Clin Endocrinol Metab 1993 Jun;76(6):1489—94. Ramirez JA, Goodman WG, Menezes C, Segre GV, Salusky IB. Disodium ethylenediaminetetraacetate: adverse effects in dialyzed children. Pediatr Nephrol 1993 Apr;7(2):182—4. Rapicetta M. Hepatitis B vaccination in dialysis centres: advantages and limits. Nephron 1992;61(3):284-6. Rayner BL, Pascoe MD, Thebus G. Pcntoxifylline does not prevent haemodialysis induced neutropaenia or hypoxaemia. Nephron 1992;60(3):363-5. Resnik CS, Reiner BI, Young JW. Unusual articular manifestations in chronic renal disease. Md Med J 1992 Jun;41(6):519—22. Reusser LM, White HJ, Sexson R, Osborn LA, Crawford MI-I. Increased morbidity following coronary angioplasty in chronic hemodialysis patients. Clin Res 1993;41(1):12a. Reyes A, Turchetto E, Bemis C, Cereijo E. Acid-base derangements during sorbent regenerative hemodialysis in mechanically ventilated patients. Crit Care Med 1991 Apr;19(4):554—9. Rhodes J, Smolens IA, Tejani A, Schiller MS. Effect of hemodialysis on left ventricular contractility in pediatric patients with end-stage renal disease. South Med J 1993 May;86(5):545-50. Richard MJ, Amaud J, Jurkovitz C, Hachache T, Mefiahi H, Laporte F, Foret M, Favier A, Cordonnier D. Trace elements and lipid peroxidation abnormalities in patients with chronic renal failure. Nephron 1991;57(1):10—5. Rillo 0L, Babini SM, Basnak A, Wainer E, Balbachan E, Cocco JA. Tendinous and ligamentous hyperlaxity in patients receiving longterm hemodialysis. J Rheumatol 1991 Aug;18(8): 1227-31. Ritz E, Koch M. Morbidity and mortality due to hypertension in patients with renal failure. Am J Kidney Dis 1993 May;21(5 Suppl 2):113-8. Robles NR, Murga L, Galvan S, Esparrago JF, Sanchez-Casado E. Hemodialysis with cuprophane or polysulfone: effects on uremic polyneuropathy. Am J Kidney Dis 1993 Mar;21(3):282-7. Rockel A, Abdelhamid S, Fiegel P, Menth M, Walb D, Schneditz D. Characterization of "refilling types" by continuous blood volume monitoring during hemodialysis. Kidney Int Suppl 1993;41:567-9. Rodby RA, Trenholme GM. Vaccination of the dialysis patient. Semin Dial 1991 Apr-Jun;4(2):1UZ—5. Rodriguez M, Felsenfeld A], Williams C, Pederson JA, Llach F. The effect of long-term intravenous 103 calcitriol administration on parathyroid function in hemodialysis patients. J Am Soc Nephrol 1991 Nov;2(5):1014-20. Rodriguez-Perez JC, Plaza C, Torres A, Vega N, Anabitarte A, Fernandez A, Lorenzo V, Hortal L, Palop L. Low turnover bone disease is the more common form of bone disease in CAPD patients. Adv Perit Dial 1992;8z376-80. Rodriguez-Perez J C, Vega N, Torres A, Plaza C, Lorenzo V, Fernandez A, Hortal L, Palop L. Arterial calcification in diabetic patients undergoing CAPD. Contrib Nephrol 1991;89:205-123. Roger SD, Crewe E, Cunningham A, Harris DC. Hepatitis C virus infection in haemodialysis patients. Aust N Z J Med 1991 Feb;21(1):22-4. Roger SD, Piper J, Tucker B, Raine AE, Baker LR, Kovacs IB. Comparison of haemostatic activity in haemodialysis and peritoneal dialysis patients with a novel technique, haemostatometry. Nephron 1992; 62(4):422-8. Roithinger FX, Punzengruber C, Rossoll M, Pachinger O, Kramar R, Prischl FC. Ventricular late potentials in haemodialysis patients and the risk of sudden death. Nephrol Dial Transplant 1992;7(10): 1013-8. Rollino C, Goitre M, Piccoli G, Puiatti P, Martina G, Formica M, Quarello F, Bemengo MG. What is the role of sensitization in uremic pruritus? An allergologic study. Nephron 1991;57(3):319—22. Comment in: Nephron 1992;60(2):241. Romanski SA, McCarthy JT, Kluge K, Fitzpatrick LA. Detection of subtle aluminum-related renal osteodystrophy. Mayo Clin Proc 1993 May;68(5): 419-26. Rombola G, Colussi G, De Ferrari ME, Frontini A, Minetti L. Cardiac arrhythmias and electrolyte changes during haemodialysis. Nephrol Dial Transplant 1992;7(4):318-22. Ropper AH. Accelerated neuropathy of renal failure. Arch Neurol 1993;50(5):536—9. Rosansky SJ. Nocturnal hypertension in patients receiving chronic hemodialysis. Ann Intern Med 1991;114(1):96. Rosansky SJ, Jackson K. Rate of change of end-stage renal disease treatment incidence 1978-1987--has there been selection? J Am Soc Nephrol 1992 Apr; 2(10):1502-6. Rosansky SJ, Johnson KL, McConnell J. Use of transdermal clonidine in chronic hemodialysis patients. Clin Nephrol 1993 Jan;39(1):32-6. Rotellar C, Black J, Winchester J F, Rakowski TA, Mosher WF, Mazzoni MJ, Amiranzavi M, Garagusi 104 V, Alijani MR, Argy‘WP. Ten years’ experience with continuous ambulatory peritoneal dialysis. Am J Kidney Dis 1991 Feb;17(2):158-64. Rotellar C, Sivarajan S, Mazzoni MJ, Aminrazavi M, Mosher WF, Rakowski TA, Argy WP, Winchester J F. Bowel perforation in CAPD patients. Perit Dial Int 1992;12(4):396—8. Roy LF, Dufresne LR, Legault L, Long H, Morin C. Acetazolamide in hemodialysis patients: a rational use after ocular surgery. Am J Kidney Dis 1992 Dec;20(6):650—2. Rozeman CA, Jonkman EJ, Poortvliet DC, Emmen HH, de Weerd AW, van der Maas AP, Tjandra YI, Beermann EM. Encephalopathy in patients on continuous ambulatory peritoneal dialysis and patients on chronic haemodialysis. Nephrol Dial Transplant 1992;7(12):1213-8. Rozich JD, Smith B, Thomas JD, Zile MR, Kaiser J, Mann DL. Dialysis-induced alterations in left ventricular filling: mechanisms and clinical significance. Am J Kidney Dis 1991 Mar;17(3): 277-85. Rroh DD. Is atherogenesis accelerated in hemodialysis patients. Int J Artif Organs 1992;5(6):323-6. Rubin J, Hsu H. Continuous ambulatory peritoneal dialysis: ten years at one facility. Am J Kidney Dis 1991 Feb;17(2):165-9. Ruffatti A, Bortolotti F, Bianco A, Pizzulli N, Cavalletto D, Alberti A, Romagnoli GF. Hepatitis C virus infection in hemodialyzed patients detected by first and second generation assays. Nephron 1992;61(3):344-5. Sabater J, Quereda C, Herrera I, Pascual J, Villafruela JJ, Ortuno J. Nonenzymatic glycosylation of hemoglobin and total plasmatic proteins in end-stage renal disease. Am J Nephrol 1991;11(1):37-43. Sacchetti A, Harris R, Patel K, Attewell R. Emergency department presentation of renal dialysis patients: indications for EMS transport directly to dialysis centers. J Emerg Med 1991 May-Jun;9(3):141-4. Sadler DB, Brown J, Nurse H, Robert: J. Impact of hemodialysis on left and right ventricular Doppler diastolic filling indices. Am J Med Sci 1992 Aug; 304(2):83-90. Sagripanti A, Cupisti A, Baicchi U, Ferdeghini M, Morelli E, Barsotti G. Plasma parameters of the prothrombotic state in chronic uremia. Nephron 1993;63(3):273-8. Saha H, Pietila K, Mustonen I, Pasternack A, Morsky P. Acute effect of dialysate calcium concentration and intravenous vitamin D3 on the secretion of parathyroid hormone in hemodialysis patients. Clin Nephrol 1992 Sep;38(3):145-8. Sakamoto N, Enomoto N, Marumo F, Sato C. Prevalence of hepatitis C virus infection among long-term hemodialysis patients: detection of hepatitis C virus RNA in plasma. J Med Virol 1993 Jan;39(1):11-5. Sakhaee K. Management of renal osteodystrophy. Semin Nephrol 1992 Mar;12(2):101-8. Salunkhe PN, Naik SR, Semwal SN, Naik S, Kher V. Prevalence of antibodies to hepatitis C virus in I-IBsAg negative hemodialysis patients. Indian J Gastroenterol 1992 Oct;11(4):164-5. Salusky IB, Goodman WG. Renal bone disease in pediatric patients receiving treatment with maintenance peritoneal dialysis. Child Nephrol Urol 1991;11(3):165—8. Salusky IB, Goodman WG. Renal osteodystrophy in dialyzed children. Miner Electrolyte Metab 1991; 17(4):273-80. Sapio C, Bonifati A, Confessore A, Gatti M, Maimone I, Minella MP, Scarpino L, D’Alessandro C. Primary prevention: HBV vaccination in hemodialysis unit. Nephron 1992;61(3):360-1. Saragoca MA, Canziani ME, Cassiolato JL, Gil MA, Andrade JL, Draibe SA, Martinez EE. Left ventricular hypertrophy as a risk factor for arrhythmias in hemodialysis patients. J Cardiovasc Pharmacol 1991;17 Suppl 2:8136-8. Saragoca MA, Canziani ME, Gil MA, Castiglioni ML, Cassiolato JL, Barbieri A, Lima VC, Draibe SA, Martinez EE. Dipyridamole—thallium tests are predictive of severe cardiac arrhythmias in patients with left ventricular hypertrophy. J Cardiovasc Phannacol 1991;17 Suppl 2:8139-40. Sasagawa I, Nakada T, Hashimoto T, Ishigooka M, Kubota Y, Hirano K, Hirano J, Suzuki Y. Serum prostatic acid phosphatase, gamma-seminoprotein and prostatic specific antigen in hemodialysis patients. Urol Int 1992;48(2):181-3. Sasagawa I, Terasawa Y, Imai K, Sekino H, Takahashi H. Acquired cystic disease of the kidney and renal carcinoma in haemodialysis patients: ultrasonographic evaluation. Br J Urol 1992 Sep; 70(3):236-9. Sato Y, Takagi T, Seto H, Shibayama S, Narumiya K, Osaku A, Koyama S, Uchiyama T, Kajiwara N. Diastolic properties of the left ventricle in uremic patients undergoing long-term hemodialysis. Nihon Univ J Med 1991;33(4):279-90. Savica V, Bellinghieri G, Barbera CM, Egitto M, Console F. The coagulative system in haemodialyzed patients: the relationship between the elderly and hypertrygliceridaemia. Arch Ital Urol Nefrol Androl 1992 Jun;64(2):155-63. Scalamogna A, Castelnovo C, De Vecchi A, Ponticelli C. Exit-site and tunnel infections in continuous ambulatory peritoneal dialysis patients. Am J Kidney Dis 1991 Dec;18(6):674-7. Scanziani R, Dozio B, Caimi F, De Rossi N, Magri F, Surian M. Peritoneography and peritoneal computerized tomography: a new approach to non- infectious complications of CAPD. Nephrol Dial Transplant 1992;7(10):1035—8. Schaefer F, Hamill G, Stanhope R, Preece MA, Scharer K. Pulsatile growth hormone secretion in peripubertal patients with chronic renal failure. Cooperative Study Group on Pubertal Development in Chronic Renal Failure. J Pediatr 1991 Oct; 119(4):568-77. Schaefer F, Seidel C, Mitchell R, Scharer K, Robertson WR. Pulsatile immunoreactive and bioactive luteinizing hormone secretion in adolescents with chronic renal failure. The Cooperative Study Group on Pubertal Development in Chronic Renal Failure (CSPCRF). Pediatr Nephrol 1991 Ju1;5(4):566—71. Schanzer H, Skladany M, Haimov M. Treatment of angioaccess-induced ischemia by revascularization. J Vasc Surg 1992 Dec;16(6):861-4; discussion 864-6. Schenkier SL, Gertner E. Massive soft tissue calcification causing complete loss of extensor tendon function in renal failure. J Rheumatol 1992 Oct;19(10):1640—2. Scheumann GF, Holch M, Nerlich ML, Brandis A, Ostertag H, Tscheme H. Pathological fractures and lytic bone lesion of the femoral neck associated with beta 2-microglobulin amyloid deposition in long- term dialysis patients. Arch Orthop Trauma Surg 1991;110(2):93-7. Schlatter C. Biomedical aspects of aluminium. Med Lav 1992 Sep-Oct;83(5):470-4. Schmid C, Ziemer G, Laas J, Borst HG. Open-heart surgery in patients requiring chronic hemodialysis. Scand J Thorac Cardiovasc Surg 1992;26(2): 97-100. Schmitz—Rode T, Bohndorf K, Gunther RW. New "mesh basket" for percutaneous removal of wall- adherent thrombi in dialysis shunts. Cardiovasc Intervent Radiol 1993 Jan-Feb;16(1):7—10. Schmitz—Rode T, Pfeffer JG, Bohndorf K, Gunther RW. Percutaneous thrombectomy of the acutely thrombosed dialysis graft: in vitro evaluation of four devices. Cardiovasc Intervent Radiol 1993 Mar-Apr;16(2):72-5. Schneble F, Bonzel KE, Waldherr R, Bachmann S, Roth H, Scharer K. Peritoneal morphology in children treated by continuous ambulatory 105 peritoneal dialysis. Pediatr Nephrol 1992 Nov;6(6): 542-6. Schneider MS, Friend R, Whitaker P, Wadhwa NK. Fluid noncompliance and symptomatology in end- stage renal disease: cognitive and emotional variables. Health Psychol 1991;10(3):209-15. Scipioni F, Di Filippo L, Maccarone M, Viola D, Ruzzi L, Terlizzi R. HCV in a group of chronic hemodialysis patients. Nephron 1992;61(3):362. Scolnik D, Balfe JW. Initial hypoalbuminemia and hyperlipidemia persist during chronic peritoneal dialysis in children. Perit Dial Int 1993;13(2): 136-9. Scotto G, Savastano AM, Forcella M, Tantimonaco G, Amato G, Salatino G, Pappani A, Stella I. HCV infections in dialysis patients. Nephron 1992;61(3): 320-1. Sedman A. Aluminum toxicity in childhood. Pediatr Nephrol 1992 Ju1;6(4):383-93. Segarra A, Capdevila J, Planes AM, Fort J, Roca R, Bartolome J, Olmos J, Piera LL. Treatment of jugular catheter sepsis by administering antibiotics locally and systemically without removing the catheter [abstract]. Nephrol Dial Transplant 1992; 7(7):739. Selgas R, Cuesta MV, Rinon C, Romero JR, de Alvaro F, Bajo MA, Sanchez—Sicilia L. Tissue plasminogen activator (t-PA) and plasminogen activator inhibitor- 1 (PAI-I) levels in plasma and peritoneal effluent in patients on CAPD. Adv Perit Dial 1992;8:160—5. Selgas R, Martinez ME, Miranda B, Bajo MA, Romero I R, Ausejo M, Sanchez-Cabezudo MJ, Lopez- Revuelta K, Sanchez-Sicilia L. The pharmacokinetics of a single dose of calcitriol administered subcutaneously in continuous ambulatory peritoneal dialysis patients. Perit Dial Int 1993;13(2):122-5. Sennesael J, Verbeelen D, Vanhaelst L, Pirola R, Bareggi SR. Pharmacokinetics of intravenous and oral chlordesmethyldiazepam in patients on regular haemodialysis. Eur J Clin Pharmacol 1991;41(1): 65-8. Published erratum appears in Eur J Clin Pharmacol 1991;41(4):386. Serebruany VL, Christenson MJ, Pescetti J, McLean RH. Hypoproteinemia in the hemolytic-uremic syndrome of childhood. Pediatr Nephrol 1993;7(1): 72-3. Sethi D. Dialysis arthropathy and beta 2-microglobulin amyloidosis: a major cause of morbidity in haemodialysis patients. Eur J Intern Med 1992; 2(5—6): 195-203 . Sethi D. Dialysis-associated amyloidosis. Renal Fail 1993;15(3):349-51. 106 Seyfert UT, Hauck W, Kirsch J, Kiesewetter H, Albert FW, Wenzel E. Contributions to biorheology during hemodialysis. Biorheology 199l;28(5):473-81. Sforzini S, Latini R, Mingardi G, Vincenti A, Redaelli B. Ventricular arrhythmias and four-year mortality in haemodialysis patients. Gruppo Emodialisi e Patologie Cardiovascolari. Lancet 1992 J an 25; 339(8787):212-3. Comment in: Lancet 1992 Sep 12;340(8820):670. Shah GM, Ross EA, Sabo A, Pichon M, Reynolds RD, Bhagavan H. Effects of ascorbic acid and pyridoxine supplementation on oxalate metabolism in peritoneal dialysis patients. Am J Kidney Dis 1992 Jul;20(1):42-9. Shapira OM, Bar-Khayim Y. ECG changes and cardiac arrhythmias in chronic renal failure patients on hemodialysis. J Electrocardiol 1992 Oct;25(4): 273-9. Sherrard DJ, Hercz G, Pei Y, Maloney NA, Greenwood C, Manuel A, Saiphoo C, Fenton SS, Segre GV. The spectrum of bone disease in end- stage renal failure--an evolving disorder. Kidney Int 1993 Feb;43(2):436-42. Sheu JC, Lee SH, Wang JT, Shih LN, Wang TH, Chen DS. Prevalence of anti-HCV and HCV viremia in hemodialysis patients in Taiwan. J Med Virol 1992 Jun;37(2): 108- 12. Shieh SD, Lu KC, Chu P, Gou MC, Lin YF, Chen YC, Shyh TP. Effect of erythropoietin on neutrophfl chemiluminescence in hemodialyzed patients. ASAIO Trans 1991 Jul-Sep;37(3): M189-91. Shinzato T, Nakai S, Odani H, Nakane K, Takai I, Maeda K. Relationship between dialysis induced hypotension and adenosine released by ischemic tissue. ASAIO J 1992 Jul-Sep;38(3):M286-90. Shoji T, Nishizawa Y, Nishitani H, Yamakawa M, Morii H. High serum lipoprotein (a) concentrations in uremic patients treated with continuous ambulatory peritoneal dialysis. Clin Nephrol 1992 Nov;38(5):271-6. Shoji T, Nishizawa Y, Nishitani H, Yamakawa M, Morii H. Impaired metabolism of high density lipoprotein in uremic patients. Kidney Int 1992 Jun;41(6):1653-61. Shyu WC, Pittman KA, Wilber RB, Matzke GR, Barbhaiya RH. Pharmacokinetics of cefprozil in healthy subjects and patients with renal impairment. J Clin Pharmacol 1991 Apr;31(4):362-71. Siegler RL, Griffin PM, Barrett TJ, Strockbine NA. Recurrent hemolytic uremic syndrome secondary to Escherichia coli 0157:H7 infection. Pediatrics 1993;91(3):666-8. Sieniawska M, Roszkowska—Blaim M, Weglarska J, Jabczynska A, Welc-Dobies J. Calcium carbonate as a phosphate binder in children on continuous ambulatory peritoneal dialysis and hemodialysis. Mater Med Pol 1991 Jul-Sep;23(3):203—8. Sieniawska M, Roszkowska-Blaim M, Welc-Dobies J. Acquired cystic kidney disease in renal insufficiency. Child Nephrol Urol 1991;11(1):20—4. Sieniawska M, Roszkowska—Blaim M, Wojciechowska B. CAPD as a choice of treatment of renal amyloidosis in children [abstract]. Pediatr Nephrol 1992;6(5):C185. Silver SM, DeSimone JA Jr, Smith DA, Stems RH. Dialysis disequilibrium syndrome (DDS) in the rat: role of the "reverse urea effect." Kidney Int 1992 Jul;42(1):161-6. Singh N, Thompson L, Goldstein MB, Langer A. Detection of ST segment shift in hemodialysis patients: a possible link to high cardiovascular mortality in end-stage renal disease [abstract]. J Am Coll Cardiol 1992;19(3 suppl A):390a. Singlas E, Taburet AM, Lebas FB, De Curzon OP, Sobel A, Chauveau P, Viron B, Khayat RA, Poignet JL, Mignon F, Humbert G, Fillastre JP. Didanosine pharmacokinetics in patients with normal and impaired renal function: influence of hemodialysis. Antimicrob Agents Chemother 1992; 36(7):1519-24. Sissons GR, Jones SM, Evans C, Richards AR. Scintigraphic detection of abdominal hernias associated with continuous ambulatory peritoneal dialysis. Br J Radiol 1991 Dec;64(768):1158-61. Slater ND, Cope GH, Raftery AT. Mesothelial hyperplasia in response to peritoneal dialysis fluid: a morphometric study in the rat. Nephron 1991; 58(4):466-71. Smetana Z, Leventon-Kriss S, Broide A, Jedwab M, Smetana SS. Varicella-zoster virus immune status in CAPD and chronic hemodialysis patients. Am J Nephrol 1991;11(3):229-36. Smolenski O, Tabarowski Z, Miszta H, Dabrowski Z. Effect of haemodialysate and its peptide fractions on lactate dehydrogenase activity in erythrocytes from healthy subjects and patients with end-stage renal disease. Int Urol Nephrol 1992;24(6):673-8. Smollich BP, Falkenhagen D, Schneidewind J, Mitzner S, Klinkmann H. Importance of endotoxins in high— flux dialysis. Nephrol Dial Transplant 1991; 6 Suppl 3:83-5. Comment in: Nephrol Dial Transplant 1992;7(8):884-5. Solal ME, Sebert JL, Boudailliez B, Marie A, Moriniere P, Gueris J, Bouillon R, Foumier A. Comparison of intact, midregion, and carboxy terminal assays of parathyroid hormone for the diagnosis of bone disease in hemodialyzed patients. J Clin Endocrinol Metab 1991 Sep;73(3):516-24. Solhaug MJ, Adelman RD, Chan J C. Hypertension in the child with chronic renal insufficiency or undergoing dialysis. Child Nephrol Urol 1992; 12(2-3):133-8. Soreide E, Skeie B, Kirvela 0, Lynn R, Ginsberg N, Manner T, Katz DP, Askanazi J. Branched-chain amino acid in chronic renal failure patients: respiratory and sleep effects. Kidney Int 1991 Sep; 40(3):539-43. Spiegel DM, Costante N, Janiga AM, Haas M, Soltani K. Deposition and removal of cutaneous beta 2- microglobulin. Am J Nephrol 1992;12(5):330—5. Spiegel DM, Sprague SM. Serum amyloid P component: a predictor of clinical beta 2— microglobulin amyloidosis. Am J Kidney Dis 1992 May;19(5):427-32. Spisni C, Stingone A, Di Vito R, Rondinella I, D’Amario C, Tucci E, Caravelli L, D’Angelo B, Cerasoli P. Serum epidemiological trial on the prevalence of the anti-cytomegalovirus antibodies in patients under substitutive treatment with hemodialysis and CAPD. Nephron 1992;61(3): 373-4. Sprague SM, Moe SM. Safety and efficacy of long-term treatment of secondary hyperparathyroidism by low- dose intravenous calcitriol. Am J Kidney Dis 1992 Jun;19(6):532-9. Stein G, Schneider A, Thoss K, Ritz E, Linke RP, Schaefer K, Sperschneider H, Abendroth K, Funfstuck R. Beta-2-microglobulin—derived amyloidosis: onset, distribution and clinical features in 13 hemodialysed patients. Nephron 1992;60(3): 274-80. Stein G, Schneider A, Thoss K, Ritz E, Schaefer K, Huller M, Sperschneider H, Maron 1. Beta 2- microglobulin serum concentration and associated amyloidosis in dialysis patients. Nephrol Dial Transplant 1991;6 Suppl 3:57-61. Stiller S, Wirtz D, Waterbar F, Gladziwa U, Dakshinamurty KV, Mann H. Less symptomatic hypotension using blood volume controlled ultrafiltration. ASAIO Trans 1991 Jul-Sep;37(3): M139—41. Stockenhuber F, Gottsauner-Wolf M, Marosi L, LiebiSCh B, Kurz RW, Balcke P. Plasma levels of endothelin in chronic renal failure and after renal transplantation: impact on hypertension and cyclosporin A—associated nephrotoxicity. Clin Sci 1992 Mar;82(3):255—8. Stojceva-Taneva O, Masin G, Polenakovic M, Stojcev S, Stojkovski L. Autonomic nervous system dysfunction and volume nonresponsive hypotension 107 in hemodialysis patients. Am J Nephrol 1991;11(2): 123-6. Storch RL, Storch S, London R, Pordy WT. Differences in pattern Visual evoked potential (PVEP) between hemodialysis and peritoneal dialysis patients. Clin Electroencephalogr 1992 Oct; 23 (4): 169-76. Stratta P, Canavese C, Dogliani M, Thea A, Porcu M, Salomone M, Vercellone A. Long-term outcome in patients with vasculitis on chronic dialytic treatment. Contrib Nephrol 1991;94:151-7. Straumann E, Meyer B, Misteli M, Blumberg A, Jenzer HR. Aortic and mitral valve disease in patients with end stage renal failure on long-term haemodialysis. Br Heart J 1992 Mar;67(3):236-9. Stahle—Backdahl M. Pruritus in hemodialysis patients. Skin Pharmacol 1992;5(1):14-20. Sugisaki H, Yamada K, Kataoka H, Kunitomo T. Long- term observation on renal-osteodystrophy-related parameters in dialysis patients. Nephrol Dial Transplant 1991;6 Suppl 2:99- 103. Sub H, Wadhwa NK. Iron dextran treatment in peritoneal dialysis patients on erythropoietin. Adv Perit Dial 1992;8z464-6. Sulowicz W, Hanicki Z, Chichocki T, Zembala M, Ruggiero I, Uracz W. Functional characteristics of peritoneal macrophages of renal failure patients on peritoneal dialysis. Perit Dial Int 1991;11(3):265—9. Sundaram M, Dessner D, Ballal S. Solitary, spontaneous cervical and large bone fractures in aluminum osteodystrophy. Skeletal Radiol 1991; 20(2):91-4. Suowicz W, Hanicki Z, Nowogrodzka—Zagorska M, Kus J, Pawlicki R. Ultrastructural study of human macrophages from peritoneal dialysate. Acta Morphol Hung 1991;39(3):217—28. Sutton RA, Cameron EC. Renal osteodystrophy: pathophysiology. Semin Nephrol 1992;12(2): 91-100. Swartz R, Messana J, Reynolds J, Ranjit U. Simultaneous catheter replacement and removal in refractory peritoneal dialysis infections. Kidney Int 1991 Dec;40(6):1160-5. Swartz RD. Dialysis associated amyloidosis (DAA). Kidney 1991;23(6):1-5. Szromba C, Bowman-Riney S. Successful intervention in the reduction of methicillin resistant staphylococcus aureus (MRSA) catheter related bacteremia. ANNA J 1992 Apr;19(2):153. Tabata T, Shoji S, Morita A, Emoto M, Inoue T, Miki T, Nishizawa Y, Morii H. Effects of dietary 108 phosphorus restriction on secondary hyperparathyroidism in hemodialysis patients during intermittent oral high-dose 1,25(OH)2D3 treatment. J Nutr Sci Vitaminol (Tokyo) 1991 Dec;37 Suppl: 8105-12. Tagger A, Ribero ML, Grossi A, Chiaramonte S, Bortolotti F, Tremolada F. Hepatitis C virus antibody response in acute and chronic non-A, non- B hepatitis. Nephron 1992;61(3):258-9. Takenalca R, Fukatsu A, Matsuo S, Ishikawa K, Toriyama T, Kawahara H. Surgical treatment of hemodialysis-related shoulder arthropathy. Clin Nephrol 1992 Oct;38(4):224-30. Tattersall JE, Cramp M, Shannon M, Farrington K, Greenwood RN. Rapid high-flux dialysis can cure uraemic peripheral neuropathy. Nephrol Dial Transplant 1992;7(6):539—40. Taylor B, Sigley RD, May KJ. Fate of infected and eroded hemodialysis grafts and autogenous fistulas. Am J Surg 1993 May;165(5):632-6. Teraoka S, Naganuma S, Takahashi K, Ota K. Heparin- free hemodialysis with an oral anti-platelet agent. ASAIO J 1992 Iul-Sep;38(3):M560—3. Thomas PP, Samuel BU, Jacob CK, John T], Shastry JC. Low prevalence of hepatitis D (delta) virus infection in a nephrology unit in south India. Trans R Soc Trop Med Hyg 1991 Sep-Oct;85(5):652-3. Thomson BJ, McAreavey D, Neilson JM, Winney RJ, Ewing DJ. Heart rate variability and cardiac arrhythmias in patients with chronic renal failure. Clin Auton Res 1991 Jun;1(2):13l-3. Thylen P, Ericsson F, Odar-Cederlof I, Kjellstrand CM. Hypertension profiling by total body water (TBW) determinations in patients on chronic hemodialysis. Int J Artif Organs 1991 Jan;14(1): 18-22. Tielemans C, Goldman M, Vanherweghem JL. Immediate hypersensitivity reactions and hemodialysis. Adv Nephrol Necker Hosp 1993;22: 401-16. . Tokars JI, Alter MJ, Favero MS, Moyer LA, Bland LA. National surveillance of hemodialysis associated diseases in the United States, 1990. ASAIO J 1993 Jan-Mar;39(1):71-80. Torras J, Cao C, Rivas MC, Cano M, Fernandez E, Montoliu I. Pharmacokinetics of vancomycin in patients undergoing hemodialysis with polyacrylonitrile. Clin Nephrol 1991 Jul;36(1): 35-41. Comment in: Clin Nephrol 1992 May;37(5): 268. Tsunoda K, Abe K, Yoshinaga K. Endothelin in hemodialysis-resistant hypertension. Nephron 1991; 59(4):687—8. Tsuruta K, Kawabata N, Narita M, Maeda K. Cerebrovascular disease in hemodialysis patients. Blood Purif 1991;9(1):20—1. Turner K, Edgar D, Hair M, Uttley L, Stemland R, Hunt L, Gokal R. Does catheter immobilization reduce exit-site infections in CAPD patients? Adv Perit Dial 1992;8z265-8. Tzamaloukas AH, Avasthi PS. Hypoglycemia during hemodialysis in diabetics treated with insulin. Nephron 1992;61(4):470—1. Tzamaloukas AH, Gibel U, Eisenberg B, Simon D, Wood B, Nevarez M, Quintana BI, Avasthi PS, De La Vega OR, Goldman RS, Hartshorne MF, Kanig SP, Spalding CT, Zager PG. Scrotal edema in patients on CAPD: causes, differential diagnosis and management. Dial Transplant 1992;21(9): 581-2, 586, 588-90, 605. Tzamaloukas AH, Murata GH, Eisenberg B, Murphy G, Avasthi PS. Hypoglycemia in diabetics on dialysis with poor glycemic control: hemodialysis versus continuous ambulatory peritoneal dialysis. Int J Artif Organs 1992 Jul;15(7):390-2. Tzamaloukas AH, Murata GH, Harford AM, Sena P, Zager PG, Eisenberg B, Wood B, Simon D, Goldman RS, Kanig SP, et al. Hand gangrene in diabetic patients on chronic dialysis. ASAIO Trans 1991 Oct-Dec;37(4):638-43. Uchida T. Developmental process of acquired renal cysts and neoplasms in patients receiving chronic hemodialysis: ultrasonographic, morphometric and histopathological studies. Nippon Jinzo Gakkai Shi 1991 Sep;33(9):889-97. Ueyoshi A, Ota K. Clinical appraisal of vinpocetine for the removal of intractable tumoral calcinosis in haemodialysis patients with renal failure. J Int Med Res 1992 Sep;20(5):435—43. Update: acute allergic reactions associated with reprocessed hemodialyzers--United States, 1989-1990. MMWR Morb Mortal Wkly Rep 1991 Mar 8;40(9):147, 153-4. van der Voet GB, Marani E, Tio S, de Wolff FA. Aluminium neurotoxicity. Prog Histochem Cytochem l991;23(1-4):235-42. van Es A, Henny FC, Kooistra MP, Lobatto S, Scholte HR. Amelioration of cardiac function by L-carnitine administration in patients on haemodialysis. Contrib Nephrol 1992;98:28-35. Van 6001 S, Van Damme-Lombaerts R, Cobbaert C, Proesmans W, Eggermont E. Lipid and lipoprotein abnormalities in children on hemodialysis and after renal transplantation. Transplant Proc 1991 Feb; 23(1 Pt 2):1375-7. van Ypersele de Strihou C, Jadoul M, Malghem J, Maldague B, Jamart J. Effect of dialysis membrane and patient’s age on signs of dialysis-related amyloidosis. The Working Party on Dialysis Amyloidosis. Kidney Int 1991 May;39(5):1012-9. Vandelli L, Medici G, Savazzi AM, De Palma M, Lusvarghi E. Prevalence of hepatitis C virus (HCV) antibodies in haemodialysis patients. Arch Virol Suppl 1992;4z339-42. Vandelli L, Medici G, Savazzi AM, De Palma M, Vecchi C, Zanchetta G, Lusvarghi E. Behavior of antibody profile against hepatitis C virus in patients on maintenance hemodialysis. Nephron 1992;61(3): 260-2. Vanherweghem JL. Infections in chronic hemodialysis patients. Semin Dial 1991 Oct-Dec;4(4):240—4. Vanholder R, Ringoir S. Cefodizime: enhancement of depressed phagocytosis-associated respiratory burst activity in chronic uremic patients. Infection 1992; 20 Suppl 1:S71-4. Vanholder R, Ringoir S. Polymorphonuclear cell function and infection in dialysis. Kidney Int Suppl 1992 Oct;38:S91-5. Vanholder R, Vanhaecke E, Ringoir S. Pseudomonas septicemia due to deficient disinfectant mixing during reuse. Int J Artif Organs 1992 Jan;15(1): 19-24. Vasile A, Allegra V, Canciani D, Forchi G, Mengozzi G. Prospective and retrospective assessment of clinical and laboratory parameters in maintenance hemodialysis patients with and without HCV antibodies. Nephron 1992;61(3):318-9. Verpooten GA, Genissel PM, Thomas JR, De Broe ME. Single dose pharmacokinetics of perindopril and its metabolites in hypertensive patients with various degrees of renal insufficiency. Br J Clin Pharmacol 1991 Aug;32(2):187—92. Vorstrup S, Lass P, Waldemar G, Brandi L, Schmidt JF, Johnsen A, Paulson OB. Increased cerebral blood flow in anemic patients on long-term hemodialytic treatment. J Cereb Blood Flow Metab 1992 Sep;12(5):745-9. Wadhwa NK, Howell N, Suh H, Cabralda T. Low calcium (2.5 mEq/l) and high calcium (3.5 mEq/l) dialysate in peritoneal dialysis patients. Adv Perit Dial 1992;8z385-8. Wadhwa NK, Mendelson WB. A comparison of sleep- disordered respiration in ESRD patients receiving hemodialysis and peritoneal dialysis. Adv Perit Dial 1992;8:195-8. Wadhwa NK, Seliger M, Greenberg HE, Bergofsky E, Mendelson WB. Sleep related respiratory disorders 109 in end-stage renal disease patients on peritoneal dialysis. Perit Dial Int 1992;12(1):51-6. Walter J, Taraba I. Dialysis hypersensitivity. Nephrol Dial Transplant 1991;6 Suppl 3:47-9. Wanner C, Frommherz K, Horl WH. Hyperlipoproteinemia in chronic renal failure: pathophysiological and therapeutic aspects. Cardiology 1991;78(3):202-17. Warady BA, Hossli S, Fivush B, Kohaut E, Alexander SR. Intraperitoneal albumin infusion and pain. Perit Dial Int 1993;13(2):160—1. Wasan SM, Godley PJ. Phosphate binders in hyperphosphatemia of chronic renal failure. DICP 1991 Sep;25(9):942—5. Wassermann RJ, Saroyan RM, Rice JC, Kerstein MD. Infrainguinal revascularization for limb salvage in patients with end-stage renal disease. South Med J 1991 Feb;84(2):190—2. Wee A, Kang J Y, Wu AY. Absence of amyloid deposition in gastroduodenal mucosa of uraemic patients undergoing dialysis treatment. Aust N Z J Med 1993 Feb;23(1):51-2. Weinreich T, Rambausek M, Ritz B. Is control of secondary hyperparathyroidism optimal with the currently used calcium concentration in the CAPD fluid? Nephrol Dial Transplant 1991;6(11):843-5. Comment in: Nephrol Dial Transplant 1992;7(7): 652-3. Weintraub M, Burstein A, Rassin T, Liron M, Ringel Y, Cabili S, Blum M, Peer G, Iaina A. Severe defect in clearing postprandial chylomicron remnants in dialysis patients. Kidney Int 1992 Nov; 42(5): 1247-52. West ML, J indal KK. Peritonitis presenting as acute catheter obstruction in noncontinuous forms of peritoneal dialysis (PD) [abstract]. Clin Invest Med 1992;15(4 Suppl):A97. Westmark KD, Weissman BN. Radiologic vignette. Amyloid arthropathy accompanying hemodialysis. Arthritis Rheum 1991 Aug;34(8):1061-4. Wilske J , Bjorck S, Delin K. Serum concentrations of calcitriol and PTH in hemo-dialysis patients on treatment with calcium carbonate. Scand J Urol Nephrol 1992;26(1):51-4. Wizemann V, Kramer W. Cardiac status and differential indication for renal replacement methods. Contrib Nephrol 1991;89:254-9. Wizemann V, Soetanto R, Thormann J, Lubbecke F, Kramer W. Effects of acetate on left ventricular function in hemodialysis patients. Nephron 1993; 64(1):101-5. 110 Wizemann V, Timio M, Alpert MA, Kramer W. Options in dialysis therapy: significance of cardiovascular findings. Kidney Int Suppl 1993 Feb;40:S85-91. Wolter K, Fritschka E. Pharmacokinetics and pharmacodynamics of quinaprilat afier low dose quinapril in patients with terminal renal failure. Eur J Clin Pharmacol 1993;44 Suppl 1:S53-6. Wood B, Abbott WC, Erickson DG, Tzamaloukas AH. Delayed infectious complications of peritoneal dialysis catheters. Am J Nephrol 1992;12(3): 199-200. Yamamoto T, Sakakura T, Yamakawa M, Horiuchi N, Hirata S, Iritani Y, Nishitani H, Kim M, Kishimoto T, Chiku T, et al. Clinical effects of long-term use of neutralized dialysate for continuous ambulatory peritoneal dialysis. Nephron 1992;60(3):324-9. Yaqoob M, Ahmad R, Roberts N, Helliwell T. Low- dose desferrioxamine test for the diagnosis of aluminium-related bone disease in patients on regular haemodialysis. Nephrol Dial Transplant 1991;6(7):484-6. Ylinen K, Gronhagen-Riska C, Honkanen E, Ekstrand A, Metsarinne K, Kuhlback B. Outcome of patients with secondary amyloidosis in dialysis treatment. Nephrol Dial Transplant 1992;7(9):908-12. Yoshida CF, Takahashi C, Gaspar AM, Schatzmayr HG, Ruzany F. Hepatitis C virus in chronic hemodialysis patients with non-A, non-B hepatitis. Nephron 1992;60(2):150—3. Yu AW, Zhou XJ, Zhou FQ, Nawab ZM, Gandhi VC, Ing TS, Vaziri ND. Neutrophilic intracellular acidosis induced by conventional, lactate-containing peritoneal dialysis solutions. Int J Artif Organs 1992 Nov;15(11):661-5. Yu BH, Gewurz A. Adverse reactions associated with hemodialysis in a patient with chronic immunologic abnormalities. Immunol Allergy Pract 1991;13(3): 13-6. Yu YL, Cheng IK, Chang CM, Bruce IC, Mok KY, Zhong WY, Chan YW. A multimodal neurophysiological assessment in terminal renal failure. Acta Neurol Scand 1991 Feb;83(2):89-95. Yukawa S, Sonobe M, Tone Y, Yukawa A, Mimura K, Mune M, Maeda T, Nomoto H, Nishide I. Prevention of aortic calcification in patients on hemodialysis by long-term administration of vitamin E. J Nutr Sci Vitaminol (Tokyo) 1992;Spec No: 187-90. Zazgomik J, Kuska I, Kokot F, Koch S, Van Peer A, Huang ML, Heykants J. Pharmacokinetics of ritanserin in patients undergoing hemodialysis. J Clin Pharmacol 1991 Jul;31(7):657-61. Zevin D, Malachi T, Gafter U, Friedman J, Levi I. Impaired DNA repair in patients with end-stage renal disease and its improvement with hemodialysis. Miner Electrolyte Metab 1991;17(5): 303-6. Zingraff J, Drueke T. Can the nephrologist prevent dialysis-related amyloidosis? Am J Kidney Dis 1991 Jul;18(1):1-11. Zins B, Zingraff J, Basile C, Petitclerc T, Urena P, Bardin T, Drueke T. Tumoral calcifications in hemodialysis patients: possible role of aluminum intoxication. Nephron 1992;60(3):260—7. Zoccali C, Mallamaci F, Ciccarelli M, Parlongo S, Salnitro F. The influence of autonomic failure on plasma ANF concentration in uremic patients on chronic hemodialysis. Clin Nephrol 1992 Apr; 37(4): 198-203 . Zoccali C, Mallamaci F, Ciccarelli M, Parlongo S, Salnitro F, Curatola A. The reflex control of vasopressin in haemodialysis patients. Nephrol Dial Transplant 1991;6(9):631-6 . GRATEFUL MEDe Software For Macintosh & IBM Please send me Please send me copies of GRA TEFUL copies of GRATEFUL MED for the MED for IBM and Macintosh. compatibles. Order No. PB92- Order No. PB92- 105451/GBB at $29.95 . V. 10544MGBB at $29.95 each. each. Total Mag versions 4» Total IBM versions 4» Billing Fee‘ = Total $ ‘ Add $7.50 Billing Fee if using a Purchase Order. Please attach this form to any purchase order you use. P.O. #: Enclosed is check /money order payable to NTIS for [Sleéi 132:8 ”men t of Commerce s . ' '. . . . _ National Technical Information Servnce 2th 39. t° (check ”‘9" 5285 Port Royal Rd. encan Express [3 VISA E] MasterCard D Springfield VA 22161 Card Number Exp. Telephone: 1-800-553-6847 For ordering by FAX: (703) 321-8547 (Only for orders using credit card or purchase order) Signature (Required to validate order): te; The information you provide: helow will be used to mail you Last Name: First Initial: Title: Company / Organization: Address: City/ State / Zip: Phone Number: ( ) In addition to your order you will receive information on obtaining a user code required to access the National Library of Medicine's datafiles. July 1992 A: r “:1 E l E National Library of Medicine Reference u r. . ._., .- fimsuunfizvmw—ifcisfi AIDS IIILKXZIAHIY nan-umuw-un-u-um- mun—4|.- CI 4128mm ‘ * $806100 foreign) per year. Amonthly publication. GPO List ID: A1093 Bibliographic listing of re ferences tocurrent journal articles. books. and audiovisuals on Acquired Immmodeficiency Syndrome (AIDS). Each issue consists of about 800- 1000 recent references. Bibliography Series tClURlRlElflt" lBlflBlLHOGLRAlF‘E-filllES HN MEDIIICLWE (Tare and Use i ofLaberatory | l l Animals $24 ($30 foreign) per year. Individual issues: $3.50 ($4.38 foreign) percopy. GPO List ID: CBM93 Approxirn ately seven bibliographies per year are produced on a variety of biomedical topics.excluding AIDS. Topics are chosen for their cunent popular interestindistinctsubject areasofbiomedicine. ‘Subscribcrs receive all issues for a given calendar year without regard to the date of order. Superintendent of Documents Subscriptions Order Form Order ProceSSing Code: 7061 1 YES, please send me the subscription(s) indicated above. The total cost of my order is $ postage and handling and are subject to change. (Company or Personal Name) (Please type or print) (Addilional address/attention litre) (Street address) ((‘ily. Stale. ZII’ (Ride) (Daytime phone including area code) (Purchase Order No.) . YILS N0 May we make your name/address available to other mailers? D [:1 S.‘ Charge your order. i It’s Easy! —VM To fax your orders (202) 512—2233 . lnternational customers please add 25%. Prices include regular domestic Please Choose Method of Payment: D Check Payable to the Superintendent of Documents [3 GPO Deposit Account m ~E] E] VISA or MasterCard Account llllllllfllllllllllll CECE] (Credit card expiration date) TIMNk you/”r your order! (Authorizing Signature) 3/93 Mail To: New Orders. Superintendent ol~ Documents PO. Box 371954. Pittsburgh. PA 6250—7954 a.» PUBUC HiflJTH USKAKY 113189‘ c BERKELEY LIB-RABIES 1 (097255725 xx